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Pseudom onas aeruginosa is a notorious nosocomial opportunist. Planktonic 
forms of this pathogen have been traditionally studied for its pathogenicity. Such 
studies have shown that sub-minimal inhibitory concentrations (sub-MICs) of 
antibiotics are able to negatively modulate pathogenicity. However, more recent 
findings suggest a biofilm basis of infection. In this study, monospecies and binary 
biofilms of P seudom onas aeruginosa ATCC 15692 (PAOl) and E scherich ia coli 
ATCC 10000 were investigated for their pathogenic potential using resistance and 
virulence as key pathogenic determinants, in the presence of sub-MICs of selected 
antibiotics (Ampicillin, Nalidixic acid and Streptomycin).
MICs of biofilms were observed to be at least 7-fold greater than those of the 
corresponding planktonic form of the same species (as judged from results obtained 
from MIC experiments). SDS-PAGE and 2D-PAGE analysis indicate alteration of 
outer membrane proteins (OMPs) within the envelope of the pathogen in sub-MIC 
antibiotic treated samples. The observed rearrangement of lipopolysaccharide (LPS; 
as observed in LPS gel experiments) may also contribute to the pathogens increased 
tolerance to antibiotics within the biofilm state.
While LPS changes may possibly help the biofilm bacteria escape host 
immune system in v ivo , more direct evidence of increases in virulence of the pathogen 
comes from investigation of its secreted proteases and cytotoxins (leucocidin). 
Virulence-specific azocasein and micro-culture tetrazolium (MTT) assays against 
both monospecies and binary biofilms of Pseudom onas aeruginosa  indicate 
significant increases in virulence potential of proteases and cytotoxins, respectively. 
These results were further substantiated in phase contrast microscopy images showing 
advanced stages of oncosis in tissue cultured mouse spleen myeloma (Sp2) cells 
treated with leucocidin isolated from Ps. aeruginosa  treated with sub-MIC of 
ampicillin (8 pg mL'1).
The results reported in this thesis provide evidence of observed increases in 
vimlence and pathogenicity in biofilm cells of P seudom onas aeruginosa  in the 
presence of sub-MICs of selected antibiotics, in vitro . Although these findings are 
those of in vitro  experiments, they may have significant implications regarding the 
usage and therapeutic control of antibiotics in clinical situations.
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Figure 1: Cell associated and extracellular virulence factors of 
P se u d o m o n a s  a eru g in o sa . The cell associated virulence factors are 
flagellum, pilus, non-pilus adhesins, and alginate matrix. The 
extracellular virulence factors include lipopolysaccharide (LPS) 
Proteases, haemolysins, exotoxin A, exoenzyme S and pyocyanin. 
Adapted from Van Delden & Iglewski (1998). ^
Figure 2: Structure of the Gram-negative lipopolysaccharide (LPS). The 
LPS has three basic units; O antigen (exterior to the membrane) 
composed of oligosaccharides (varies according to bacteria), the core 
polysaccharide containing several sugars (heptoses and ketodeoxyoctonic 
acid) and Lipid A (embedded in the outer leaflet of the membrane) made 
of (3-hydroxyfatty acids. Image adapted from: (http:// www.med.sc.edu: 
85/fox/lps.jpg) [Accessed on 02.03.2005]. 8
Figure 3: Quorum sensing circuit in P se u d o m o n a s  a eru g in o sa . The 
circuit is a hierarchical system wherein the las quorum sensing circuit 
controls the rhl circuit. The LasR/3-oxo-C12HSL (homoserine lactones) 
complex activates transcription of rh lR  and 3-oxo-C12HSL blocks 
activation of RhlR by C4HSL (V-butyryl homoserine lactones). 3-oxo- 
C12HSL itself has some immunomodulatory activity and is also required 
for biofilm development. GacA and Vfr positively controls, the Las 
system while RsaL negatively controls it. Both the la s  system and the rh l  
system regulate numerous virulence genes. Adapted from de Kievit and 
Iglewski, (2000). 1 .
Xll
Figure 4: Diagram showing the development of a biofilm as a five-stage 
process. Stage 1: initial attachment of cells to the surface. Stage 2: 
production of EPS resulting in more firmly adhered “irreversible” 
attachment. Stage 3: early development of biofilm architecture. Stage 4: 
maturation of biofilm architecture. Stage 5: dispersion of single cells 
from the biofilm. The b o tto m  p a n e l  (1-5) show each of the five stages of 
development represented by a photomicrograph of Ps. a e ru g in o sa  when 
grown under continuous-flow conditions on a glass substratum. (Adapted 
from Stoodley & Costerton; 2002).
Figure 5: Four possible mechanisms of antimicrobial resistance. The 
yellow region on the top edge of the biofilm indicates the region of slow 
penetration of the antimicrobial. The region coloured red at the lower 
edge within the biofilm is the area where there exists high heterogeneity 
of cells due to altered microenvironments. Cells coloured green are those 
that exhibit a general stress response to the antimicrobials. The violet 
cells represent the persisters. Adapted from image library of Centre for 
Biofilm Engineering http://www.erc.montana.edu/Res-Lib99W/Image 
_Library/Biofilm_Control/ [Accessed on 02.03.2005].
Figure 6: Chromogenic E. c o li /  Coliform plate showing two different 
coloured colonies; the purple ones represent E. c o li ATCC 10000 and the 
straw ones represent Ps. a eru g in o sa  ATCC 15692 (PAOl).
Figure 7: The standard curve for the peristaltic pump calibration. Error 
bars are calculated as the standard deviation of each data point, n = 5 
replicates, (o) Mean of the pumped volume (mL min'1). NB: SD = 0, 
hence error bars are inapparent.
Figure 8: Diagram of the Sorbarod biofilm model showing silicone 
tubing to peristaltic pump and media vessel (A), rubber plunger seal (B), 
2 mL disposable sterile syringe (C), syringe needle (D), PVC tubing (E) 
and Sorbarod (F) (Hodgson^ a l., 1995).
Figure 9: The standard curve for protein estimation. Error bars are 
calculated as the standard deviation of each data point, n = 3 replicates, 
(o) Mean absorbency at 562 nm. Inapparent error bars. NB: SD = 0, 
hence error bars are inapparent. 47
Figure 10: Standard calibration curve for Microculture Tetrazolium 
Assay (MTT). Error bars are calculated as the standard deviation of each 
data point, n = 3 replicates, (o) Mean absorbency at 540 nm. 63
Figure 11: The observation of growth of P se u d o m o n a s  a e ru g in o sa  
PAOl in CDM. Error bars are calculated as the standard deviation of the 
individual data points, n = 3 replicates, (o) logio viable count (CFU mL' 
’); (A) logio OD at 470 nm. 69
Figure 12: Graph of mean biofilm eluate counts (Ps. a e ru g in o sa  PAOl 
perfused with MCDM) over Time. Error bars are calculated as the 
standard deviation of the individual data points, n = 3 replicates, (o) logio 
viable count (CFU mL'1). 70
Figure 13: The observation of growth of E sc h e r ic h ia  c o li ATCC 10000 
in R2A medium. Error bars are calculated as the standard deviation of the 
individual data points, n = 3 replicates, (o) logio OD at 470 nm; (A) logio 
viable count (CFU mL'1). 74
Figure 14: Graph of mean biofilm eluate counts (.E sch erich ia  c o li ATCC 
10000, perfused with modified (MCDM) over Time. Error bars are 
calculated as the standard deviation of the individual data points, n = 3 
replicates, (o) logio viable count (CFU mL'1). 75
Figure 15: Graph of mean binary biofilm eluate counts for P s. 
a e ru g in o sa  ATCC 15692 (PAOl) and E sch erich ia  c o li ATCC 10000 
over Time. Error bars are calculated as the standard deviation of the 
individual data points, n = 3 replicates, (o) logio viable count (CFU mL'1) 
for E. co li; (A) logio viable count (CFU mL'1) for P s. a eru g in o sa . 78
xiv
Figure 16: Summary of MIC results obtained against P s. a e ru g in o sa  
ATCC 15692 (PA01) planktonic, biofilm and eluate cells cultured in 
modified CDM. Error bars are calculated as the standard deviation of the 
individual data points, n = 3 replicates. NB: SD = 0, hence error bars are 
inapparent. 8 8
Figure 17: Summary of MIC results obtained against E. c o li ATCC 
10000 planktonic, biofilm and eluate cells cultured in modified CDM. 
Error bars are calculated as the standard deviation of the individual data 
points, n = 3 replicates. NB: SD = 0, hence error bars are inapparent. 89
Figure 18: Summary of MIC results obtained against binary biofilm and 
eluate cells o f  P s. a eru g in o sa  ATCC 15692 (PAOl) and E. c o li ATCC 
10000 cultured in modified CDM. Error bars are calculated as the 
standard deviation of the individual data points. n= 3 replicates. NB: SD 
= 0, hence error bars are inapparent. 91
Figure 19: The standard calibration curve generated by plotting the 
molecular weight of the low range molecular weight standards vs. the Rf 100
Figure 20: Outer membrane protein profile of P s. a e ru g in o sa  ATCC 
15692 (PAOl) biofilm cells cultured in modified CDM and exposed to 
different treatment of antibiotics. Lane 1: molecular weights markers; 
Lane 2: P s. a eru g in o sa  planktonic cells control (776 jug protein well'1); 
Lane 3: P s. a eru g in o sa  biofilm cells control (729 pg protein well'1); Lane 
4: P s. a eru g in o sa  biofilm cells (739 pg protein well'1) with treatment of 
ampicillin at sub-MIC (8 pg mL'1); Lane 5: P s. a e ru g in o sa  biofilm cells 
(732 pg protein well'1) with treatment of nalidixic acid at sub-MIC (4 pg 
mL'1); Lane 6: P s. a eru g in o sa  biofilm cells (736 pg protein well*1) with 
treatment of streptomycin at sub-MIC (8 pg mL'1). Arrow (1) indicates 
the 37 kDa OMP. Arrow (2) indicates the 44.7 kDa OMP. 103
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Figure 21: Outer membrane protein profile of P s. a e ru g in o sa  PAOl 
eluate cells cultured in modified CDM and exposed to different treatment 
of antibiotics. Lane 1: molecular weights markers; Lane 2: P s .  
a e ru g in o sa  planktonic cells control (776 pg protein well'1); Lane 3: P s. 
a e ru g in o sa  biofilm cells control (729 pg protein well'1); Lane 4: P s .  
a e ru g in o sa  eluate cells control (752 pg protein well'1); Lane 5: P s .  
a e ru g in o sa  eluate cells (731 pg protein well’1) with treatment of 
ampicillin at sub-MIC (8 pg mL'1); Lane 6: P s. a eru g in o sa  eluate cells 
(728 pg protein well'1) with treatment of nalidixic acid at sub-MIC (4 pg 
mL'1); Lane 7: P s. a eru g in o sa  eluate cells (736 pg protein well'1) with 
treatment of streptomycin at sub-MIC (8 pg mL'1). Arrow indicates the 
71 kDa OMP.
Figure 22: Outer membrane protein profile of E sch erich ia  c o li biofilm 
cells cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weights markers; Lane 2: E. c o l i  
planktonic cells control (745 pg protein well'1); Lane 3: E. c o li biofilm 
cells control (700 pg protein well'1); Lane 4: E. c o li biofilm cells (784 pg 
protein well'1) with treatment of ampicillin at sub-MIC (2 pg mL'1); Lane 
5: E. c o li biofilm cells (794 pg protein well'1) with treatment of nalidixic 
acid at sub-MIC (2 pg mL'1); Lane 6: E. c o li biofilm cells (673 pg 
protein well'1) with treatment of streptomycin at sub-MIC (8 pg mL'1).
Arrow indicates the 37.7 kDa OMP. 110
Figure 23: Outer membrane protein profile of E sc h e r ic h ia  c o li eluate 
cells cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weight markers; Lane 2:E . c o l i planktonic 
cells control (745 pg protein well'1); Lane 3: E. c o li biofilm cells control 
(700 pg protein well'1); Lane 4: E. c o li eluate cells control (723 pg 
protein well'1); Lane 5: E. co li eluate cells (707 pg protein well'1) with 
treatment of ampicillin at sub-MIC (lpg mL'1); Lane 6: E. c o li eluate 
cells (697 pg protein well’1) with treatment of nalidixic acid at sub-MIC 
(1 pg mL'1); Lane 7: E. c o li eluate cells (702 pg protein well'1) with 
treatment of streptomycin at sub-MIC (8 pg mL'1). Arrow indicates the
21.5 kDa OMP.
Figure 24: Outer membrane protein profile of binary biofilm cells 
cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weights markers; Lane 2: P s. a e ru g in o sa  
PAOl biofilm cells control (729 pg protein well'1); Lane 3: E sc h e r ic h ia  
c o li ATCC 10000 biofilm cells control (700 pg protein well'1); Lane 4:
Binary biofilm cells control (787 pg protein well'1); Lane 5: Binary 
biofilm cells (715 pg protein well'1) with treatment of ampicillin at sub- 
MIC concentration (32 pg mL'1); Lane 6: Binary biofilm cells (705 pg 
protein well"1) with treatment of nalidixic acid at sub-MIC concentration 
(8 pg mL'1); Lane 7: Binary biofilm cells (723 pg protein well*1) with 
treatment of streptomycin at sub-MIC concentration (16 pg mL'1).
Arrow indicates the 44.7 kDa OMP. 112
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Figure 25: Outer membrane protein profile of binary eluate cells
cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weights markers; Lane 2: P s. a e ru g in o sa  
PAOl planktonic cells control (776 jug protein well'1); Lane 3: 
E sc h e r ic h ia  c o li 10000 planktonic cells control (745 pg protein well'1); 
Lane 4: P s. a e ru g in o sa  biofilm cells control (729 pg protein well'1), Lane 
5: E sc h e r ic h ia  c o li biofilm cells control (784 pg protein well'1), Lane 6: 
Binary biofilm cells control (787 pg protein well’1); Lane 7: Binary 
biofilm eluate cells control (744 pg protein well'1); Lane 8: Binary eluate 
cells (721 pg protein well'1) with treatment of ampicillin at sub-MIC 
concentration (16 pg mL'1); Lane 9: Binary eluate cells (724 pg protein 
well'1) with treatment of nalidixic acid at sub-MIC concentration (4 pg 
mL'1); Lane 10: Binary eluate cells (716 pg protein well'1) with treatment 
of streptomycin at sub-MIC concentration (4 pg mL'1). Arrow indicates 
the 22.7 kDa OMP. 112
Figure 26: Two-dimensional electrophoretic protein pattern of 2D- 
PAGE standards separated according to their molecular weight and pi. 
Protein concentration: 792 pg protein gel’1. Numbers may be to the left or 
right of protein. 117
Figure 27: Calibration curve generated by plotting the molecular weights 
of 2D-PAGE standards in Daltons vs Rf values. 118
Figure 28: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of P se u d o m o n a s  a eru g in o sa  PAOl planktonic 
cells control cultured in MCDM. The OMPs are separated by the 
isoelectric point (reading left to right) and molecular weight (top to 
bottom). Protein concentration: 793 pg protein gel'1. Numbers may be to 
the left or right of protein. 120
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Figure 29: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles o f  P se u d o m o n a s  a eru g in o sa  PAOl biofilm cells 
control cultured in MCDM. The OMPs are separated by the isoelectric 
point (reading left to right) and molecular weight (top to bottom). Protein 
concentration: 747 pg protein gel'1. Numbers may be to the left or right 
of protein. 120
Figure 30: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of P se u d o m o n a s  a e ru g in o sa  biofilm cells 
exposed to streptomycin at sub-MIC (8 pg mL'1) and cultured in MCDM. 
The OMPs are separated by the isoelectric point (reading left to right) 
and molecular weight (top to bottom). Protein concentration: 753 pg 
protein gel'1. Numbers may be to the left or right of protein. 121
Figure 31: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of binary biofilm cells control cultured in 
MCDM. The OMPs are separated by the isoelectric point (reading left to 
right) and molecular weight (top to bottom). Protein concentration: 796 
pg protein gel'1. Numbers may be to the left or right of protein. 127
Figure 32: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of binary biofilm cells exposed to ampicillin at 
sub-MIC concentration (32 pg mL'1) and cultured in modified CDM. The 
OMPs are separated by isoelectric point (reading left to right) and 
molecular weight (top to bottom). Protein concentration: 731 pg protein 
gel'1. Numbers may be to the left or right of protein. 127
Figure 33: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of binary biofilm cells exposed to nalidixic acid 
at sub-MIC (8 pg mL'1) and cultured in modified CDM. The OMPs are 
separated by isoelectric point (reading left to right) and molecular weight 
(top to bottom). Protein concentration: 712 pg protein gel'1. Numbers 
may be to the left or right of protein. 128
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Figure 34: Two-dimensional gel electrophoresis for outer membrane 
protein (OMP) profiles of binary biofilm cells exposed to streptomycin at 
sub-MIC (16 pg m l/1) and cultured in modified CDM. The OMPs are 
separated by isoelectric point (reading left to right) and molecular weight 
(top to bottom). Protein concentration: 729 pg protein gel'1. Numbers 
may be to the left or right of protein. 128
Figure 35: Silver-stained LPS-PAGE for LPS of P s. a e ru g in o sa  PAOl 
biofilm cells cultured in modified CDM and exposed to different 
treatment of antibiotics. Lane 1: molecular weight markers; Lane 2: P s. 
a e ru g in o sa  planktonic cells control; Lane 3 :P s . a e ru g in o sa  biofilm cells 
control; Lane 4: P s. a eru g in o sa  biofilm cells with treatment of ampicillin 
at sub-MIC (8 pg mL'1); Lane 5: P s. a eru g in o sa  biofilm cells with 
treatment of nalidixic acid at sub-MIC (4 pg mL'1); Lane 6: P s. 
a e ru g in o sa  biofilm cells with treatment of streptomycin at sub-MIC (8 
pg mL'1). 141
Figure 36: Silver-stained LPS-PAGE for LPS o i  P s. a e ru g in o sa  PAOl 
eluate cells cultured in modified CDM and exposed to different treatment 
of antibiotics. Lane 1: molecular weight markers; Lane 2:P s . a e ru g in o sa  
planktonic cells control; Lane 3: P s. a e ru g in o sa  biofilm cells control; 
Lane 4: P s. a e ru g in o sa  eluate cells control; Lane 5 :P s. a e ru g in o sa  eluate 
cells with treatment of ampicillin at sub-MIC (8 pg mL'1); Lane 6: P s. 
a e ru g in o sa  eluate cells with treatment of nalidixic acid at sub-MIC (4 pg 
mL'1); Lane 7: P s. aeru g in o sa  eluate cells with treatment of streptomycin 
at sub-MIC (8 pg mL'1). 142
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Figure 37: Silver-stained LPS-PAGE for LPS of E sc h e r ic h ia  c o li  
biofilm cells cultured in modified CDM and exposed to different 
treatment of antibiotics. Lane 1: molecular weight markers; Lane 2: E. 
c o li planktonic cells control; Lane 3: E. c o li biofilm cells control; Lane 4:
E. c o li biofilm cells with treatment of ampicillin at sub-MIC (2 pg mL'1);
Lane 5: E. c o li biofilm cells with treatment of nalidixic acid at sub-MIC 
(2 pg mL'1); Lane 6: E. c o li biofilm cells with treatment of streptomycin 
at sub-MIC (8 pg mL'1). 14 3
Figure 38: Silver-stained LPS-PAGE for LPS of E sc h e r ic h ia  c o li eluate 
cells cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weight markers; Lane 2 \E . c o l i planktonic 
cells control; Lane 3: E. c o li eluate cells control; Lane 4: E. c o l i eluate 
cells with treatment of ampicillin at sub-MIC (lpg mL'1); Lane 5: E. c o li  
eluate cells with treatment of nalidixic acid at sub-MIC (1 pg mL'1);
Lane 6: E. c o li eluate cells with treatment of streptomycin at sub-MIC (8
pg mL'1). 144
Figure 39: Silver-stained LPS-PAGE for LPS of binary biofilm cells 
cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weights markers; Lane 2: P s. a e ru g in o sa  
PAOl biofilm cells control; Lane 3: E sch e r ic h ia  c o li ATCC 10000 
biofilm cells control; Lane 4: Binary biofilm cells control; Lane 5: Binary 
biofilm cells with treatment of ampicillin at sub-MIC concentration (32 
pg mL'1); Lane 6: Binary biofilm cells with treatment of nalidixic acid at 
sub-MIC concentration (8 pg mL'1); Lane 7: Binary biofilm cells with 
treatment of streptomycin at sub-MIC concentration (16 pg mL'1). 146
xxi
Figure 40: Silver-stained LPS-PAGE for LPS of binary eluate cells 
cultured in modified CDM and exposed to different treatment of 
antibiotics. Lane 1: molecular weights markers; Lane 2: P s. a e ru g in o sa  
PAOl planktonic cells control; Lane 3: E sch e r ic h ia  c o li 10000 
planktonic cells control; Lane 4: P s. a e ru g in o sa  biofilm cells control, 
Lane 5: E sc h e r ic h ia  c o li biofilm cells control, Lane 6: Binary biofilm 
cells control; Lane 7: Binary biofilm eluate cells control; Lane 8: Binary 
eluate cells with treatment of ampicillin at sub-MIC concentration (16 jug 
mL'1); Lane 9: Binary eluate cells with treatment of nalidixic acid at sub- 
MIC concentration (4 pg mL'1); Lane 10: Binary eluate cells with 
treatment of streptomycin at sub-MIC concentration (4 pg mL'1).
Figure 41: Elution profile of protein fractions of Ps. a e ru g in o sa  PAOl 
planktonic cells control. 'T a n d e m ’ gel filtration of leucocidin on 
Sephadex G-100 superfine and Bio Gel P-100. 10 mL of sample was 
applied to Sephadex G-100 column (2.5 x 100 cm) equilibrated with 
phosphate buffered saline. The flow rate was 4 mL h '1 (2 mL tubes). 
Effluent was analyzed for protein at (E280nm). Fractions 209 to 213 
were combined and dialysed before further analysis.
Figure 42: SDS-PAGE profile of leucocidin fractions of P s. a e ru g in o sa  
PAOl planktonic cells. (A) Fractions 200 to 209 (lanes 1 to 10; Figure 
41). (B) Fractions 210 to 219 (lanes 11 to 20; Figure 41).
Figure 43: Elution profile of protein fractions ofPs. a e ru g in o sa  PAOl 
biofilm cells control. ‘Tandem  ’ gel filtration of leucocidin on Sephadex 
G-100 superfine and Bio Gel P-100. 10 mL of sample was applied to 
Sephadex G-100 column (2.5 x 100 cm) equilibrated with phosphate 
buffered saline. The flow rate was 4 mL h '1 (2 mL tubes). Effluent was 
analyzed for protein at (E2sonm). Fractions 209 to 213 were combined 
and dialysed.
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Figure 44: SDS-PAGE profile of leucocidin fractions o f  P s. a e ru g in o sa  
PAOl biofilm cells (control). The gel shows fractions 209 to 213 (lanes 2 
to 6; Figure 43). Lane 1 and 7 contain standard molecular weight marker 
(14.2 to 66 kDa).
Figure 45: Elution profile of protein fractions o f  P s. a e ru g in o sa  PAOl 
biofilm cells with sub-MIC of ampicillin (8 pg mL’1). ‘T a n d e m ’ gel 
filtration of leucocidin on Sephadex G-100 superfine and Bio Gel P-100. 
10 mL of sample was applied to Sephadex G-100 column (2.5 x 100 cm) 
equilibrated with phosphate buffered saline. The flow rate was 4 mL h '1 
(2 mL tubes). Effluent was analyzed for protein at (E28onm). Fractions
209 to 213 were combined and dialysed.
Figure 46: SDS-PAGE profile of leucocidin fractions ofFs\ a e ru g in o sa  
PAOl biofilm cells in the presence of sub-MIC of ampicillin (8pg mL'1). 
The gel represents fractions 209 to 213 (lanes 2 to 6; Figure 45). Lane 1 
and 7 represent standard molecular weight marker (14.2 to 66 kDa).
Figure 47: Elution profile of protein fractions o f  P s. a e ru g in o sa  PAOl 
biofilm cells with sub-MIC of nalidixic acid (4 pg mL'1). ‘T a n d e m ’ gel 
filtration of leucocidin on Sephadex G-100 superfine and Bio Gel P-100. 
10 mL of sample was applied to Sephadex G-100 column (2.5 x 100 cm) 
equilibrated with phosphate buffered saline. The flow rate was 4 mL h '1 
(2 mL tubes). Effluent was analyzed for protein at (E28onm). Fractions
210 to 213 were combined dialysed.
Figure 48: Elution profile of protein fractions o f  P s. a e ru g in o sa  PAOl 
biofilm cells with sub-MIC of streptomycin (8 pg mL'1). ‘T a n d e m ’ gel 
filtration of leucocidin on Sephadex G-100 superfine and Bio Gel P-100. 
10 mL of sample was applied to Sephadex G-100 column (2.5 x 100 cm) 
equilibrated with phosphate buffered saline. The flow rate was 4 mL h '1 
(2 mL tubes). Effluent was analyzed for protein at (E28onm). Fractions 
214 to 218 were combined dialysed.
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Figure 49: Elution profile of protein fractions of E. c o li ATCC 10000 
biofilm cells with sub-MIC of ampicillin (2 pg mL'1). ‘T an dem  ’ gel 
filtration of leucocidin on Sephadex G-100 superfine and Bio Gel P-100.
10 mL of sample was applied to Sephadex G-100 column (2.5 x 100 cm) 
equilibrated with phosphate buffered saline. The flow rate was 4 mL h '1 
(2 mL tubes). Effluent was analyzed for protein at (E28onm). No 
leucocidin fractions obtained. 158
Figure 50: Elution profile of protein fractions of binary biofilms o i P s .  
a e ru g in o sa  PAOl and E. c o li ATCC 10000 with sub-MIC of ampicillin 
(32 pg mL'1). ‘T andem  ’ gel filtration of leucocidin on Sephadex G-100 
superfine and Bio Gel P-100. 10 mL of sample was applied to Sephadex 
G-100 column (2.5 x 100 cm) equilibrated with phosphate buffered 
saline. The flow rate was 4 mL h'1 (2 mL tubes). Effluent was analyzed 
for protein at (E28onm). Fractions 212 to 216 were combined dialysed. 159
Figure 51: SDS-PAGE profile of unknown proteins of P s. a e ru g in o sa  
PAOl biofilm cells (control). A) Fractions 80 to 88 are represented in 
lanes 2 to 10 (Figure 43). B) Fractions 89 to 95 are represented in lanes 2 
to 10. Lane 1 represents standard molecular weight marker (14.2 to 66 
kDa). 160
Figure 52: SDS-PAGE profile of unknown proteins of P s. a e ru g in o sa  
PAOl biofilm cells in the presence of sub-MIC of ampicillin. A) 
Fractions 55 to 60 (lanes 1 to 7; Figure 45) and 80 to 82 (lanes 8 to 10;
Figure 45). B) Fractions 83 to 91 (lanes 2 to 10; Figure 45) Lane 1 
represents standard molecular weight marker (14.2 to 66 kDa). 160
Figure 53: SDS-PAGE profile of unknown proteins of P s. a e ru g in o sa  
PAOl biofilm cells in the presence of sub-MIC of nalidixic acid.
A) Fractions 45 to 53 (lanes 2 to 10; Figure 47). B) Fractions 54 to 60 
(lanes 2 to 8; Figure 47). Lane 1 represents standard molecular weight 
marker (14.2 to 66 kDa).
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Figure 54: SDS-PAGE profile of unknown proteins of P s. a e ru g in o sa  
PAOl biofilm cells in presence of sub-MIC of streptomycin. A) 
Fractions 64 to 72 (lanes 2 to 10; Figure 48) and B) Fractions 73 to 81 
(lanes 2 to 10; Figure 48) Lane 1 represents standard molecular weight 
marker (14.2 to 66 kDa). 161
Figure 55: SDS-PAGE profile of unknown proteins of binary biofilms of 
P s. a e ru g in o sa  PAOl and E. c o li ATCC 10000 with sub-MIC of 
ampicillin. A) Fractions 60 to 68 (lanes 2 to 10; Figure 50) and B) 
Fractions 78 to 86 (lanes 2 to 10; Figure 50). Lane 1 represents standard 
molecular weight marker (14.2 to 66 kDa).
161
Figure 56: SDS-PAGE profiles of unknown proteins of E. c o li ATCC 
10000 biofilm cells in presence of sub-MIC of ampicillin. A) Fractions 
45 to 53 (lane 2 to 10; Figure 49), B) Fractions 54 to 62 (lane 2 to 10;
Figure 49), C) Fractions 63 to 71 (lane 2 to 10; Figure 49), D) Fractions 
72 to 80 (lanes 2 to 10; Figure 49), E) Fractions 81 to 89 (lane 2 to 10;
Figure 49), and F) Fractions 90 to 95 (lane 2 to 7; Figure 49). Lane 1 
represents standard molecular weight marker (14.2 to 66 kDa). 162
Figure 57: Measurement of leucocidin activity by MTT assay at 30 
minutes and 24 hours at an optical density of 540nm; Y axis units 
1.00E+06 to 6.00E+6 corresponds to 1.0 x 106to 6.0 x 106 viable cells 
per mL, respectively. (A) leucocidin o f  P s. a e ru g in o sa  PAOl planktonic 
cells; (B) leucocidin of Ps. a eru g in o sa  PAOl biofilm cells; (C) 
leucocidin of P s. a eru g in o sa  PAOl biofilm cells with sub-MIC of 
antibiotic (ampicillin 8 pg mL'1); (D) leucocidin of E. c o l i  biofilm cells 
with sub-MIC of (ampicillin 2 pg mL'1); (E) leucocidin of binary biofilm 
cells with sub-MIC of (ampicillin 32 pg mL'1); (F) is control untreated 
cells only MTT was added on the fibroblast cells (4.4 x l ( f  mL'1). Error 
bars are calculated as the standard deviation of the individual data points, 
n = 3 replicates.
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Figure 58: Percent cells killed after treatment of leucocidin from 
different samples at 30 minutes and 24 hours; (A) leucocidin of P s. 
a e ru g in o sa  PAOl planktonic cells; (B) leucocidin of P s. a e ru g in o sa  
PAOl biofilm cells; (C) leucocidin o f  P s . a eru g in o sa  PAOl biofilm cells 
with sub-MIC of antibiotic (ampicillin 8 pg mL'1); (D) leucocidin of E. 
c o li biofilm cells with sub-MIC of (ampicillin 2 pg mL'1); (E) leucocidin 
of binary biofilm cells with sub-MIC of (ampicillin 32 pg mL'1). Error 
bars are calculated as the standard deviation of the individual data points, 
n = 3 replicates.
Figure 59: Activity of leucocidin against Sp2 cells after 30 minute 
exposure (Magnification: 400 x). (A) Sp2 cells treated with 0.2M NaCl, 
(pH 7.2; PBS; control). (B) Sp2 cells after exposure to leucocidin 
produced by planktonic P s. a eru g in o sa  PAOl cells, (C) Sp2 cells treated 
with leucocidin produced by P s. a eru g in o sa  PAOl biofilm cells; (D) Sp2 
cells exposed to leucocidin produced by P s. a e ru g in o sa  PAOl biofilm 
cells treated with sub-MIC of antibiotic (ampicillin 8 pg mL'1); (E) Sp2 
cells treated with parallel fractions to leucocidin obtained from E. c o l i  
ATCC 10000 biofilm cells treated with sub-MIC of antibiotic (ampicillin 
2 pg mL'1); (F) Sp2 cells after being exposed to leucocidin produced by 
binary biofilm cells of P s. a eru g in o sa  PAOl and E. c o l i ATCC 10000 
in the presence of sub-MIC of antibiotic (ampicillin 32 pg mL'1).
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Figure 60: Percent increase in diameter of Sp2 cells after treatment with 
leucocidin for 30 minutes; (A) percent increase in size of Sp2 cells after 
treated with leucocidin of P s. a e ru g in o sa  ATCC 15692 (PAOl) 
planktonic cells control; (B) percent increase in size of Sp2 cells treated 
with leucocidin of P s. aeru g in osa  ATCC 15692 (PAOl) biofilm cells 
control; (C) percent increase in size of Sp2 cells treated with leucocidin 
of P s. a e ru g in o sa  ATCC 15692 (PAOl) biofilm cells with sub-MIC of 
antibiotic (ampicillin 8 pg mL'1) ; (D) percent increase in size of Sp2 
cells treated with leucocidin of E. c o li ATCC 10000 biofilm cells with 
sub-MIC of antibiotic (ampicillin 2 pg mL'1) ; (E) percent increase in 
size of Sp2 cells treated with leucocidin of binary biofilm cells of P s. 
a e ru g in o sa  ATCC 15692 (PAOl) and E. c o li ATCC 10000 with sub- 
MIC of antibiotic (ampicillin 32 pg mL'1 ). Error bars are calculated as 
the standard deviation of the individual data points, n = 3 replicates.
Figure 61: Zymogram analysis of protease fractions of P s. a e ru g in o sa  
PAOl planktonic cells. (A) Lanes 1 to 10 contain fractions 240 to 249 
(Figure 41). (B) Lane 1 to 10 contains fractions 250 to 259 (Figure 41). 
Arrows indicate clearance bands corresponding to proteases.
Figure 62: Alteration of biofilm and eluate cell outer membrane proteins 
in the presence of antibiotics (ampicillin, nalidixic acid and 
streptomycin). The presence of antibiotic molecules in and around 
biofilms alters bacterial surface membrane proteins. Alteration happens 
in a subset of the outer membrane proteins in the biofilm and eluate cell 
phenotypes. While most of the proteins altered (appearance of novel 
proteins or disappearance of proteins) may not have a direct relationship 
to antibiotic resistance (i.e. some outer membrane proteins may result 
from presence of antibiotics, but may not be responsible for the resistance 
phenotype exhibited by the cell), there may be a subset of altered proteins 
that may be responsible for antibiotic resistance. This subset of 
resistance-related proteins might be similar for biofilm and eluate cell 
phenotypes due to strong similarities in their cell physiologies.
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Figure 63: Schematic representation illustrating a possible biofilm model 
of pathogenesis in presence of sub minimal inhibitory concentrations of 
antibiotics (ampicillin, nalidixic acid and streptomycin). In the absence of 
antibiotics (Figure 63A), biofilm bacteria ( A ) secrete proteases ( O  ) 
and leucocidins ( 0 ) having basal levels of virulence, and may be partly 
responsible for virulence. The ratio of damaged epithelial cells (O  ) to 
healthy epithelia ( O  ) is low. Similarly the ratio of damaged leucocytes 
or white blood cells ( q  ) to healthy ones ( ^  ) is also basal. However, 
in the presence of antibiotics ( Q )  (Figure 63B), although there is no 
significant increase in the levels of production of virulence factors 
(proteases and leucocidins), the activity of these determinants 
significantly increase causing damage to more cells.
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The Gram-negative human pathogen P se u d o m o n a s  a e ru g in o sa  is adept at 
infecting different tissues and organs. It is considered to be an opportunistic pathogen 
as it causes infections in individuals with neutropenia or whose normal immune status 
is compromised in some way. Although most infections caused by P se u d o m o n a s  
a e ru g in o sa  are hospital acquired, community acquired infections in patients have also 
been reported (Arancibia, e t a l. 2002; Weingarten, e t a l. 2003). Recent 
epidemiological statistics on nosocomial infections (Table 1) indicate significant 
frequencies of occurrence o f  P se u d o m o n a s  a e ru g in o sa  infections (Jarvis 2003).
Table 1: Nosocomial infections attributed to P s e u d o m o n a s  a e r u g in o s a .  
Adapted from Jarvis (2003)
Site of Infection Percentage caused by 
P s e u d o m o n a s  a e ru g in o sa
Rank relative to other 
bacterial causes
Respiratory tract 17%- 21% 1 or 2
Surgical site 1 1 %- 15% 4
Urinary tract 10%- 13% 3
Blood stream 4% 5
During the 1960s when effective anti-pseudomonal antibiotics were 
unavailable, mortality rates due to P se u d o m o n a s  associated bacteraemia were as high 
as 90% (Schimpf, e t  a l. 1974). With the subsequent development of effective anti- 
pseudomonal antibiotics, substantial improvement in treatment outcomes was 
observed. However, P seu d o m o n a s  a eru g in o sa  still remains a threat to public health
1
with a high rate of morbidity and mortality ranging from 16% to 61% 
(Chatzinikolaou, e t  a l. 2000; Maschmeyer & Braveny 2000).
Table 2: Antibiotics used in treatment o f  P s e u d o m o n a s  a e r u g in o s a m i^ c iio n s  





Ticarcillin disodium (Ticar) Extended spectrum penicillin
Piperacillin and tazobactam 
sodium (Zosyn)
P-Lactam + p-Lactamase inhibitor combination
Ticarcillin and clauvulanate 
potassium (Timentin)












Amikacin sulphate (Amikin) Aminoglycoside
A number of antibiotics are currently available (Table 2) to treat P se u d o m o n a s  
infections. However, there is a growing concern about different strains of 
P se u d o m o n a s  a eru g in o sa  developing resistance towards antibiotics currently 
employed. Multiple surveillance studies have demonstrated that antibiotic resistance 
is on the rise among nosocomial pathogens in significant proportions (Bonfiglio, e t  al. 
1998; Chatzinikolaou, e t al. 2000; Hauser & Sriram 2005; Henwood, e t  a l. 2001;
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Maschmeyer & Braveny 2000; Rotimi e t a l 1998; Van Eldere 2003). Susceptibility of 
P se u d o m o n a s  a eru g in o sa  to anti-pseudomonal antibiotics is reported to have 
decreased over the years in European nations (Table 3). The issue of antibiotic 
resistance of P se u d o m o n a s  a eru g in o sa  is further complicated by the fact that this 
bacterium exists in biofilms in the infective state. The biofilm mode of growth enables 
P se u d o m o n a s  to survive and thrive in hostile environments by colonizing cell 
surfaces and also induces the bacteria to increased levels of resistance towards 
antimicrobials.
Table 3: Decrease in the percent susceptibility rates of P s e u d o m o n a s  
a e ru g in o sa  as a function of time
Hauser & Sriram (2005); Van Eldere (2003)
\Y ear
Antibiotic^.
1991 1993 1995 1997 1999 2003
Ciprofloxacin 87% 82% 84% ” 70% 71%
Amikacin ” 96% 91% 74% 71%
Cefepime “ “ “ 73% 64% 50%
Meropenem “ “ 86% 81%
Ceftazidime “ * 95% 89% 78% ~
Piperacillin ” 93% “ 87% 74% ~
KEY:
- = Not determined
In the following sections, the issues of P se u d o m o n a s  a e ru g in o sa  antibiotic 
resistance within biofilms will be discussed further, in relation to virulence 
mechanisms exhibited by this organism. Introductory passages will summarise current 
knowledge on biofilms, antibiotic resistance in biofilms, virulence factors and 
virulence mechanisms of P se u d o m o n a s  a eru g in o sa . Subsequent to this general
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introduction, the results obtained as part of this thesis are presented in Chapters 3 to 5. 
The conclusions and their implications are summarised and discussed in Chapter 6 .
P s e u d o m o n a s  a e r u g in o s a  pathogenesis
Humans as targets o f  P seu d o m o n a s a e ru g in o sa  infections
P se u d o m o n a s  a eru g in o sa  is capable of transiently colonizing skin and 
mucosal surfaces, but deficient in its ability to carry out initial steps of infection. 
Hence, the normal non-specific defenses of the human body are sufficient to prevent 
P se u d o m o n a s  a e ru g in o sa  from causing infections. However, the whole issue of 
infection takes a new turn when there is a serious breach in the body’s non-specific 
defenses (e.g., bums, immunosuppressive therapy or wounds (Wenzel 1997).
Once the opportunist, P se u d o m o n a s  a eru g in o sa , overrides the primary defense 
systems, it may cause fatal systemic disease in the human body. The diseases caused 
by P s. a e ru g in o sa  are diverse; urinary tract infections, respiratory tract infections, 
dermatitis, soft tissue infections, bone and joint infections, bacteraemia, 
gastrointestinal infections and a variety of systemic infections (in patients whose 
immune system is compromised, e.g., AIDS) and depends on the site of entry and 
colonization within the body. P s. a eru g in o sa  present on catheters or in irrigation 
solutions are a major cause of urinary tract infections (Appelgren, e t  a l. 2002; 
Beckett, e t a l. 2001; Qarah, e t a l. 2004). Eye wounds or eye surgeries are responsible 
for comeal infections, while cardiac surgeries usually result in P se u d o m o n a s  
a e ru g in o sa -a sso c ia te d  endocarditis. Chronic pseudomonal respiratory tract infections 
are common in cystic fibrosis patients and the use of contaminated respirators is often 
a cause for necrotizing P s. a eru g in o sa  pneumonia. Of the different nosocomial 
infections, P s. a eru g in o sa  infections account for 10% of blood stream infections, 8% 
of surgical wound infections (Wenzel 1997), 12% of urinary tract infections (Gordon,
4
e t  a l 1998; Mandell, e t a l 1995) and 16% of pneumonia cases (Wenzel 1997). P s. 
a e ru g in o sa  has also been associated with bacteraemia and currently accounts for 15% 
of all Gram-negative bacteraemias. Mortality rates attributed to this bacterium in 
hospital acquired infections (Table 4) and patients suffering from cystic fibrosis are 
high.
Table 4: Mortality rates attributed toPs. a e ru g in o sa  in hospital acquired
infections




Pneumonia and septicaemia among 
immunocompromised patients
30 (Fergie, e t  a l. 1994)




Bum unit outbreaks 60 (Richard, e t  a l. 
1994)
Death among AIDS population 50 (Mendelson, e t  a l  
1994)
The capacity of this organism to cause such high rates of illness and death is 
primarily due to a diverse range of virulence factors. P s. a e ru g in o sa  possesses both 
cell-associated and extracellular virulence factors (Figure 1). Recent research has 
shown that the extracellular vimlence factors of this bacterium are coordinated in a 
cell density dependent manner (Smith & Iglewski 2003; Zhu, e t  a l. 2004). Thus, 
biofilms of P se u d o m o n a s a eru g in o sa  offer an excellent physiological model for in 
v iv o  bacterial cell density-dependent communication and may also act as ‘h o t s p o t s ’ 
for activation of vimlence factors and emergence of organisms with increased 












Figure 1: Cell associated and extracellular virulence factors of Pseudomonas aeruginosa. The cell associated virulence factors are flagellum, pilus, non-pilus adhesins and alginate matrix. The extracellular virulence factors include lipopolysaccharide (LPS) proteases, haemolysins, exotoxin A, exoenzyme S and pyocyanin. Adapted from Van Delden & Iglewski (1998).
P se u d o m o n a s  a eru g in o sa  virulence factors
The virulence factors (determinants) that P s. a e ru g in o sa  uses to colonize the 
immunosuppressed host are varied. Cell associated virulence factors include 
flagellum, pili, adhesins, alginate and lipopolysaccharide. Secreted or extracellular 
virulence factors include: haemolysins, proteases, lipases, Exotoxin A and cytotoxins; 
Exo S, Exo T, Exo U and Exo Y. The essential features of these virulence 
determinants are summarised in Table 5. The focus of this thesis is on three major 
virulence factors; lipopolysaccharide (LPS), proteases and cytotoxins (especially 
Leucocidin) of P s. a eru g in o sa  ATCC 15692 (PAOl).
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Table 5: Characteristics of the virulence factors of P s. a e ru g in o sa  (after Baltch & 
Smith 1994)




Protein polymer o f  15kDa 
Protein (?)
Attachment to host cells; important for 
initial colonization events 
Adherence to mucins
F lagellum
Serotype a and b Protein polymer o f  45kDa Motility exhibited during chem otaxis or 
invasion
Iron acquisition





Specifically bind iron (high affinity) help 
survive iron limited environments 
Uptake o f  siderophore- iron com plex
H aem olysin Glycolipid Has a detergent like property. It is 
ciliostatic and enhances haemolytic 






78 kDa protein 
73 kDa protein
Degradation o f  phosphatidylcholine and 
sphingomyelin causing inflammation and 
stimulation o f  mucous production 
Degradation o f  phosphatidylcholine and 
sphingomyelin causing inflammation
Exotoxin A 66 kDa protein Destrustion o f  tissues and macrophages 
due to ADP ribosylation o f  Elongation 
factor-2 and inhibition o f  protein 
synthesis
Alginate Branched polymer o f  
glucouronic and 
mannuronic acid
Physical barrier; also antiphagocytic and 





lipids with extended 
polysaccharide chains
Endotoxin causing septic shock
Leucocidin 29kDa protein Exotoxin damaging host leucocytes




Pseudomonas possesses outer membrane lipopolysaccharide (LPS) or 
endotoxin (Homma, et al. 1991). The cell envelope of Ps. aeruginosa, as with other 
Gram-negative bacteria, is composed of an external unit membrane (outer membrane, 
OM), a layer of peptidoglycan and an inner cytoplasmic membrane. The latter is 
mainly composed of phospholipids with randomly intercalated molecules of proteins 
(Schromm, et al. 2000). The outer membrane is an asymmetrical bilayer containing 
phospholipids on the inner side and lipopolysaccharide (LPS), as the major lipidic 
molecule, on the outer cell surface (Schromm, et al. 2000). The LPS of Ps. 
aeruginosa consists of three basic units: lipid A, core polysaccharide and O-specific 





Figure 2: Structure of the Gram-negative lipopolysaccharide (LPS). The LPS has three 
basic units; O antigen (exterior to the membrane) composed of oligosaccharides (varies 
according to bacteria), the core polysaccharide containing several sugars (heptoses and 
ketodeoxyoctonic acid) and Lipid A (embedded in the outer leaflet of the membrane) 
made of 0-hydroxyfatty acids. Image adapted from: (http:// www.med.sc.edu: 
85/fox/Ips.jpg) [Accessed on 02.03.20051
Disaccharide
diphosphate
The lipid A has five or six fatty acids linked to a backbone of diglucosamine 
phosphate. The core polysaccharide is covalently linked to lipid A and contains an 
unusual sugar, 2-keto-3-deoxyoctanoate (KDO), as well as a variety of heptose and 
hexose residues (Pier, e t a l  1995). The LPS of P s. a e ru g in o sa  has a lower intrinsic 
toxicity compared with that of the enterobacteriaceae (Homma, e t  a l. 1991). It plays a 
major role in protecting the cell from the complement-mediated bactericidal action of 
normal human serum (Pier, e t a l 1995). Antibodies specific for O antigens of P s. 
a eru g in o sa , particularly the high molecular-weight O polysaccharide, can protect 
against mucosal surface colonization by P s. a eru g in o sa , and this is achieved through 
circulating antibody alone rather than by induction of local antibodies (Pier, e t  a l  
1995).
Besides protection of the bacterial cell from the bactericidal activity of serum, 
the LPS is responsible for causing sepsis or septic shock in humans. The molecular 
arrangement and chemical structure of the Lipid A component of the LPS is said to be 
responsible for the biological (endotoxin) activity of LPS (Schromm, e t  a l. 2000).
P ro te a se s
Proteases are important extracellular proteolytic enzymes produced by P s. 
aeruginosa", they liquefy gelatin, dissolve elastin and fibrin, and destroy collagen 
(Matsumoto 2004; Gerald, et a l 1983). Recently some strains o f  P s . a e ru g in o sa  were 
observed to degrade mucin. This activity has also been attributed to pseudomonal 
proteases (Aristoteli & Willcox 2003). P s. a e ru g in o sa  isolates are known to produce 
proteases like elastase, alkaline protease, LasA protease, protease IV and a membrane 
protease, all of which may play important roles in the pathogenesis o f  P s . a e ru g in o sa  
(Matsumoto 2004).
9
The pseudomonal elastases are metal proteases with a molecular weight of 33 
kDa. They are often called L asB  proteases or pseudolysins. The elastases can cleave 
type I, type III and type IV collagens. Thus, they are able to cause sufficient damage 
(haemorrhage) to endothelial cells and destroy the basement membrane of blood 
vessels (Komori, e t a l 2001).
The alkaline protease is a major virulence factor produced by P se u d o m o n a s  
a e ru g in o sa . Like elastases, these proteases are also classified as metal proteases. They 
are 467 amino acids long as opposed to elastases, which are 301 amino acids in 
length. The alkaline proteases and the elastases have been reported to cleave 
components of the immune system. They are capable of degrading the human 
RANTES (Regulated upon Activation Normal T cells Expressed and Secreted); 
monocyte chemotatic protein- 1 (MCP-1), and epithelial neutrophil activating protein- 
78 (ENA-78) (Leidal, e t  a l. 2003).
L asA  protease (staphylolysin) produced by P se u d o m o n a s  a e ru g in o sa  is a 
metalloendopeptidase. It contains 182 amino acids and has a molecular weight of 20 
kDa (Kessler, e t al. 2004). LasA acts alongside elastase and alkaline protease to 
degrade elastin (Galloway 1991).
Recent studies (Caballero, e t  a l. 2004) indicate the presence of a serine 
protease (251 amino acids in length) called protease IV, produced almost exclusively 
by P se u d o m o n a s  a eru g in osa , and not other strains of the same genus. Purified 
protease IV protein is 26 kDa and is capable of cleaving the carboxyl side of lysine- 
containing peptides. Many biologically important proteins, including 
immunoglobulin, complement components, fibrinogen and plasminogen are digested 
by protease IV (Engel, e t  al. 1998).
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Fricke e t  a l. (1999) located a membrane proteinase called insulin-cleaving membrane 
proteinase (ICMP) on the outer membrane of the cell envelope inPs. a e ru g in o sa . It 
has been noted to cleave a  and p fibrinogen chains (Fricke, e t al. 1999).
C yto to x in s
Toxins produced by pathogenic bacteria play a major role in virulence of the 
bacteria. Secretory toxins (exotoxins) are capable of diffusion and cause lesions 
within the target host cell population. Cytotoxins are exotoxins produced by 
pathogens that can disrupt host cells and provide nutrients for the progress of 
infection (Popoff, 2005). P se u d o m o n a s  a eru g in o sa  produces a number of cytotoxins. 
They include the CTX protein (initially referred to as leucocidin due to its lethal 
activity towards leucocytes) and type III secretory proteins; ExoS, ExoT, ExoU and 
ExoY (Barbieri & Sun 2004).
CTX is a 29 kDa polypeptide first described by Scharmann (1976a, 1976b). 
CTX exists in a cell-bound state, in the form of a 31 kDa precursor toxin (proCTX) 
with no, or only low, toxic activity. It is converted into a 29 kDa toxin by the 
proteolytic excision (endogenous protease (elastase) of P s. a e ru g in o sa  and six other 
proteases with known specificity for peptide bonds) of 20 amino acids from the C 
terminus of proCTX, giving rise to a protein with high toxicity (Scharmann 1976a, 
1976b, Scharmann, e t a l 1976).
CTX is considered to be a member of the pore forming toxin group. It induces 
selective leakage of low molecular weight substances from target cells and also forms 
ion-channels in planar lipid membranes. The pore-forming process triggered by CTX 
takes place in three steps: binding to the membrane, alteration of membrane structure, 
and release of cytoplasmic contents. These events lead to severe tissue inflammation 
and necrosis (Baltch, e t al. 1985; Bishop, e t al. 1987). Cytotoxin causes rapid
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decrease of granulocyte function as demonstrated by phagocytosis, bactericidal 
activity and chemotaxis. However, cytotoxin has no effect on serum or complement 
(Baltch, e t a l. 1985). Its action is dependent on temperature, time, and concentration 
and completely inhibited by specific antibody.
The type III secretion system of P s. a e ru g in o sa , is part of the exoenzyme S 
regulon, which contains genes for secretion, translocation and regulation and effectors 
(Yahr, e t  al. 1997). Type III secretion is a contact dependent secretion and is triggered 
only when a pathogen comes into close contact with host cells. Four effector proteins 
of P s. a eru g in o sa  are secreted by the type III secretion pathway; ExoS, ExoT, ExoU 
and ExoY (Barbieri & Sun 2004).
ExoS and ExoT share 76% similarity in their protein primary structure. These 
effector proteins are bifunctional, as they contain Rho GTPase-Activating Protein 
(RhoGAP) domains at their N-terminus and ADP ribosylation domains at their C- 
terminus (Barbieri & Sun 2004). One of their mechanisms of cytotoxicity is due to 
their ability to rearrange actin cytoskeleton. RhoA, Rac and Cdc42 are members of 
the Rho family of proteins and control the assembly and organization of the actin 
cytoskeleton. RhoA stimulates the formation of stress fibers. Rac stimulates 
lamellopodia (membrane ruffling) and may be important for cell motility. Cdc42 
stimulates the formation of microspikes, which are essential for cell polarity. The 
RhoGAP domain of ExoS and ExoT is responsible for the inactivation of Cdc42, Rac 
and RhoA. Such inactivation results in actin cytoskeleton rearrangemert (Goehring, e t  
al. 1999; Kazmierczak & Engel 2002, Kazmierczak, e t  a l 2001). The C-terminus 
domain of ExoS and ExoT contains the ADP ribosyltransferase domain with which 
ADP ribosylates distinct host proteins, ultimately causing host cell damage. The ADP 
ribosyltransferase domain of ExoS was noted to target Ras and several Ras related 
proteins, disrupting cell signalling (Riese & Barbieri 2002; Riese, e t  a l. 2002).
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Alternately, ExoT targets the Crk-mediated phagocytosis pathway and prevents 
bacterial uptake by phagocytes (Sun & Barbieri 2003).
ExoU is a phospholipase, which is cytotoxic to epithelial cells and 
macrophages in v itro  and in v iv o  (Sato, e t al. 2003). ExoY is an adenylate cyclase, 
which causes actin cytoskeleton reorganisation by elevating intracellular cAMP levels 
in cultured mammalian cells (Yahr, e t  a l. 1998).
The P se u d o m o n a s  a eru g in o sa  infection model
Observations and evaluations of various bacterial virulence factors have shed 
light on how P se u d o m o n a s  a eru g in o sa  is able to cause disease in a wide variety of 
human organs. Such observations have led to the proposal of a three-phase infection 
model; colonization, chronic infection and acute infection.
The primary step in the infection of P se u d o m o n a s  a e ru g in o sa  is colonization. 
However, for colonization to occur, the primary line of defense should be breached. 
Trauma, surgery, bums and indwelling devices have the capacity to cause such a 
breach in the primary line of defense. Additionally, alteration of immunologic defense 
mechanisms or use of broad-spectrum antibiotics may also result in colonization by 
P s. a eru g in o sa . Cellular virulence factors like flagella (Feldman, e t  a l., 1998), type 4 
pili (De Bentzmann, e t al., 1996) and several non-pilus adhesins may play potential 
roles in this process.
Once colonization is successfully accomplished, several extracellular 
vimlence factors are secreted that cause extensive tissue damage. This results in the 
bacteria causing chronic and acute infections. Cell-to-cell signaling controls many of 
these extracellular virulence factors. Exotoxin A inactivates elongation factor 2, 
resulting in the cessation of protein biosynthesis and ultimately cell death (Wick, e t  
al., 1990). Exotoxin A may help the bacteria in its invasion process. Exoenzyme S
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ribosylates GTP binding enzymes such as Ras (Iglewski, et al., 1978) and causes 
tissue destruction and bacterial dissemination. Phospholipase C and rhamnolipid are 
two haemolysins, which break down lipids and lecithins and thus helps the bacteria 
invade tissues (De Kievit & Iglewski 2000).
GacA





- Multiple rhf- 
controlled genes
Figure 3: Quorum sensing circuit in Pseudomonas aeruginosa. The circuit is a hierarchical system wherein the las quorum sensing circuit controls the rhl circuit. The LasR/3-oxo-C12HSL (homoserine lactones) complex activates transcription of r/ilR and 
3-oxo-C12HSL blocks activation of RhlR by C4HSL (iV-butyryl homoserine lactones). 3- oxo-C12HSL has some immunomodulatory activity and is also required for biofilm development. GacA and Vfr positively controls, the las system while RsaL negatively controls it. Both the las system and the rhl system regulate numerous virulence genes. Adapted from De Kievit and Iglewski, (2000). PQS: Pseudomonas quinolone signal.
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Proteases produced by the bacterium, which include, Las A elastase, LasB 
elastase and alkaline protease, may also play a role in the invasion of tissues (De 
Kievit & Iglewski 2000).
Regulation of these extracellular virulence factors during acute and chronic 
infections is cell density dependent and therefore, quorum-sensing signaling 
mechanisms come into play during the infection process (Figure 3) (Latifi, et al., 
1996). Ps. aeruginosa signaling system is a hierarchical system, composed of two 
signaling systems, the las system and rhl system. Both these systems have their 
respective autoinducers, which activate transcriptional activator proteins. It is to be 
noted that though these autoinducers exhibit high specificity, in that they do not 
activate transcriptional activators of a different system, they are not totally 
independent of each other. The autoinducer-transcriptional activator (LasR/ 3-oxo- 
C12-HSL) complex of the las system is able to induce the expression of rhlR. This 
places the las system above the rhl system in the hierarchy (Latifi, et al., 1996).
The las system controls the expression of LasB elastase and is probably 
involved with the production of other virulence factors like, Las protease and 
exotoxin A (Passador, et al., 1993, Gambello, et al., 1991). There are two genes 
involved in this system, Iasi and lasR. The Iasi gene leads to the synthesis of an 
autoinducer called 3-oxo-C12-HSL and the lasR codes for a transcriptional activator 
protein, LasR (Pearson, et al., 1994). The LasR protein and the 3-oxo-C12-HSL form 
a complex, which binds to the /as/gene promoter and activates it.
The Iasi gene promoter is linked to the expression of the autoinducer, resulting 
in an increased production of 3-oxo-C12-HSL and eventually the LasR / 3-oxo-C12- 
HSL complex. As a critical cell density is attained and concentration of LasR / 3-oxo- 
C12-HSL complex exceeds the threshold levels, virulence genes {lasA, lasB, toxA, 
aprA, etc) are activated. The las system has also been shown to activate secretory
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pathway genes, xcpP and xcpR (Chapon, et al., 1997; Smith & Iglewski 2003). The 
autoinducer 3-oxo-C12-HSL itself has immunomodulatory activity and hence, 
contributes to virulence (Telford et al., 1998). GacA and Vfr are two genes that 
positively regulate the las signaling system. Vfr is required for the transcription of 
lasR, while RsaL is understood to inhibit transcription of the Iasi gene (Reimann, et 
al. 1997, Albus, et al. 1997, Smith & Iglewski 2003).
The second signaling system in Ps. aeruginosa is called the rhl system as it 
controls the production of rhamnolipid. Analogous to the las system, the two genes 
involved in the rhl system are rhll autoinducer synthase gene, which leads to the 
production of C4-HSL (A-butyryl homoserine lactone) and the rhlR gene, which 
codes for the transcriptional activator protein (Oschner & Reiser, 1995). The RhlR / 
C-4HSL complex is linked to the activation of rhlAB operon. As soon as a critical 
concentration of the autoinducer builds up, this operon is activated and a rhamnosyl- 
transferase that is required for the synthesis of rhamnolipid is produced. Other 
proteins that are linked to the rhl system ar eLasB elastase, Las A protease, pyocyanin, 
cyanide and alkaline protease (Pearson, et al., 1997). There is some evidence that also 
indicates that the stationary phase sigma factor-rpoS (usually involved in regulating 
stress response genes) is controlled by this system (Latifi,e/ al., 1996).
Pseudomonas aeruginosa biofilms 
The medical importance of biofilms
The concept of natural existence of most bacteria as biofilms has evolved over 
the last three decades. (Costerton et al. 1995; Costerton et al. 1999; Lazazzera & 
Stanley 2004) defines the term biofilm as “ a structured community o f bacterial cells 
enclosed in a self-produced polymeric matrix and adherent to an inert or living 
surface.” Biofilms can also develop on inert surfaces and dead tissues. In a medical
context, medical devices, dead tissues like parts of a dead bone or even living tissues
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can act as favourable surfaces for biofilm formation (Donlan 2001). The sedentary 
(biofilm) lifestyle of bacteria enables them to withstand host immune responses and 
also makes them much less susceptible to antibiotics compared to their planktonic 
counterparts. Bacterial biofilms act as bacterial sanctuaries where they are protected 
from hostile host environments (Donlan 2001).
If areas within the human body were to act as a ‘home’ for biofilm bacteria, two 
conditions would have to be fulfilled,
(1) an overlying aqueous environment with a constant flow of nutrients and
(2) a surface where bacteria could attach and colonize (Bell 2001). 
Microenvironments within the human body that satisfy these conditions are 
ubiquitous. For example, normal buccal movements cause a constant flow of saliva 
across the gingival crevices, which encourage bacteria to form oral biofilms at these 
sites.
A medical biofilm contains sessile bacteria that constantly release antigens 
into circulating blood and this eventually stimulates the production of corresponding 
antibodies. However, antibodies generated against biofilms have minimal effects 
against their target. The reason for this is that, rather than causing damage to the 
biofilms, immune complexes tend to damage host tissues immediately surrounding 
the biofilm. In the case of Pseudomonas aeruginosa biofilms, infections set in only 
when the host immune system is impaired, as the infection is opportunistic in nature. 
Hence, the immune response to Pseudomonas infections is minimal. As a result the 
only way to suppress the infection would be to resort to antibiotics (Costerton, et al
1999).
Antibiotic therapy is capable of reversing symptoms resulting from the 
adverse effects of planktonic bacteria that may detach from biofilms and could 
potentially act as the seed of infection. However, these antibiotics fail to inhibit or kill
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the biofilm. This is perhaps why medical biofilm infections show recurring infections 
and elimination of infection is futile unless the sessile bacterial population is 
surgically removed (Costerton, et al 1999).
Current antimicrobial therapies have rarely been designed with microbial 
communities like biofilms in mind. Antimicrobials that are effective in eradicating 
planktonic bacteria may not be effective against their biofilm counterparts (Stewart & 
Costerton 2001). Biofilm characteristics that are important in the infectious disease 
process include;
1. Detachment of cells or aggregates from biofilms may result in urinary tract or 
blood stream infections.
2. Horizontal transfer of antibiotic resistance plasmids may occur within 
biofilms.
3. Reduction in antimicrobial susceptibilities of biofilm bacteria.
4. Endotoxin production by biofilm associated Gram-negative organisms and
5. Increased resistance shown by biofilms towards host immune system.
Hence, a fundamental shift in perspectives is required to battle microbes capable of 
forming biofilms and causing human disease (Donlan 2002).
Developmental stages of a biofilm
A biofilm is the culmination of a series of process (Figure 4) that beginswhen 
floating (planktonic) bacteria encounter a surface. Bacteria sense environmental 
conditions triggering the transition to life on a surface (O’Toole, et al 2000; Stoodley, 
et al 1999; Watnick & Kolter 1999). These environmental signals vary among 
organisms. For example, Ps. aeruginosa and Ps. fluorescens will form biofilms under 
almost any conditions that allow growth (O’Toole & Kolter, 1998b). On the other 
hand, some strains of Escherichia coli K-12 and Vibrio cholerae will not form
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biofilms in minimal medium unless supplemented with amino acids (Pratt & Kolter 
1998, Watnick & Kolter 1999). In contrast, is. coli 0517:H7 is reported to make a 
biofilm only in low-nutrient media (Dewanti & Wong 1995). In addition to the 
nutritional content of the medium, other environmental cues that can influence biofilm 
formation include temperature, osmolarity, pH, iron availability and oxygen 
(O’Toole, et al 2000; Stoodley, et al 1999; Watnick & Kolter 1999).
Biofilm formation may occur by at least three mechanisms. The first is the 
redistribution of attached cells by surface motility (Dalton, et al. 1996). Studies on 
Pseudomonas aeruginosa suggest that type IV pili-mediated twitching motility plays 
a role in surface aggregation for this organism (O’Toole & Kolter 1998a). A second 
mechanism is from the binary division of attached cells (Heydom, et al. 2000). As 
cells divide, daughter cells spread outward and upward from the attachment surface to 
form cell clusters, in a similar manner to colony formation on agar plates. The third 
mechanism of aggregation is the recruitment of cells from the bulk fluid to the 
developing biofilm (Tolker-Nielsen & Molin 2000). The relative contribution of each 
of these mechanisms will depend on the organisms involved, the nature of the surface 
being colonized and the physical and chemical conditions of the environment.
The physical, chemical and biological dynamics of the stages of biofilm 
development normally follow an ordered sequence of events. This involves 
attachment of the bacteria to a surface, growth and polysaccharide production, 
maturation and the import of media components, usually followed by detachment as 
the whole film ‘sloughs off from its substratum (O’Toole,et al 2000).
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Figure 4: Diagram showing the development of a biofilm as a five-stage process. Stage 1: initial attachment of cells to the surface. Stage 2: production of extracellular polymeric substances (EPS) resulting in more firmly adhered “irreversible” attachment. Stage 3: early development of biofilm architecture. Stage 4: maturation of biofilm architecture. Stage 5: dispersion of single cells from the biofilm. The bottom panel (1-5) show each of the five stages of development represented by a photomicrograph of Ps. aeruginosa when grown under continuous-flow conditions on a glass substratum. (Adapted from Stoodley, et al 2002).
Bacterial attachment to surfaces
Attachment of the bacteria to a surface may occur as an active process, 
involving motility or chemotaxis by the bacteria, or due to passive encounter with a 
surface (Geesey 2001). Depending on the nature of the substrate, bacteria may show 
two types of attachment mechanisms. While initial attachment to an abiotic surface is 
mostly due to non-specific interactions (e.g., hydrophobic), adhesion to a living tissue 
is usually accomplished through specific molecular (lectin, ligand or adhesin) docking 
mechanisms. The process of attachment may be considered to take place in two 
phases: the docking phase and the locking phase (Dunne 2002). The docking phase 
involves initial attachment to the surface, largely based on attractive or repulsive 
forces and is largely reversible in nature. Electrostatic and hydrophobic forces
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influence the attachment outcome at this stage. Although electrostatic interactions 
tend to favour repulsion (Geesey 2001; Jucker, et al 1996), as both charges of the 
surface and organism are negative, the events of the second phase, the locking phase, 
overcome the negative effects of electrostatic repulsion towards attachment. In the 
locking phase the loosely bound bacteria employ specific molecular mechanisms that 
will anchor it on the surface. For example, adhesins located on bacterial cell surface 
extensions like pili are interact with the surface and cause firm attachment by 
neutralising the effects of repulsive electrostatic forces (Dunne 2002).
Exopolysaccharides and receptor-specific ligands produced at this stage by 
organisms facilitate the process of locking the bacteria on the biotic / abiotic surface. 
At the end of the attachment stage, the organisms are firmly and irreversibly attached 
to the matrix. The attachment process involving the reversible and irreversible phases 
are indicated as stage 1 and stage 2 in Figure 4.
The forces involved in the docking and locking phases of bacterial adhesion 
have been extensively researched. Three types of forces interplay in the sorption of a 
microorganism on a substrate; electrostatic or electrodynamic forces, hydrodynamic 
or aerodynamic forces and forces due to external field such as gravitational, electric or 
magnetic fields (Ho, 1986). When the organism is in close proximity to the surface it 
is the electrostatic and electrodynamic forces that play the major role in the adhesion 
process. These forces dictate two possible states for adhesion viz. reversible and 
irreversible (based on the distance or proximity of the organism to the surface). When 
the bacterium is at a distance <lnm, the cells are said tobe at a primary minimum and 
the adhesion is irreversible, while a distance >5 to lOnm from the surface, the 
bacterium is reversibly attached and the state is known to be secondary minimum. 
However, the transition from the reversible to the irreversible (docking to the locking) 
phases takes place over a distance range of 1 to 5nm from the surface, characterised
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by very high repulsive forces (energy gap). This energy gap may be overcome if 
external forces are applied to the cell e.g. motility, turbulent flow, etc. (Strevett & 
Chen, 2003; Bos et al., 1999).
The interplay of the attractive forces (mainly, Van der Waals forces) and 
repulsive electrostatic forces described above is incorporated into the DLVO theory 
elaborated by (Deijaguin & Landau, 1941; Verwey & Overbeek, 1948). Hence, 
according to this theory, the net force of interaction between a bacterial cell and a 
surface arises from a balance between the Van der Waals forces of attraction and 
electrostatic forces of repulsion. When microorganisms arrive in the vicinity of a 
surface, they are subject to short-range attraction forces (Hydrophobic and Van der 
Waals forces), which are capable of holding the microorganisms at the solid-liquid 
interface, balancing the strong electrostatic repulsive forces (Busscher & Weerkamp, 
1987; Busscher & Van der Mei, 1997). This first stage of adhesion is termed 
reversible adhesion and the cells are said to be at their “secondary energy minimum”. 
Cells at this stage have been shown to exhibit Brownian motion and can be easily 
removed from the surface by washing (Meinderse/ al., 1995). Cells may subsequently 
become firmly attached to the surface through the action of surface structures such as 
fimbriae and pili. Flagella or flagellar driven motility was found to have a role in the 
initial cell-to-surface interactions for both Pseudomonas aeruginosa and Escherichia 
coli (Pratt & Kolter, 1998; O’Toole & Kolter, 1998a; Tolker-Nielsen & Molin, 2000).
More recently microbial surface thermodynamics has been explained 
according to the extended DLVO theory developed by Van Oss (2003). They showed 
that relatively short-range forces resulting from acid-base interactions also play a key 
role in addition to electrostatic and Van der Waal’s forces (Van Oss 2003; Strevett & 
Chen, 2003; Bos et al., 1999). Transition occurring within the initial attachment stage,
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from the reversible to the irreversible stage may also be a genetically regulated event 
(Lazazzera et al., 2004).
Microcolony formation
Pseudomonas aeruginosa mutants defective in surface attachment {sad, 
surface attachment defective) have been described (O’Toole & Kolter 1998b). 
Differential expression of sad genes causes downregulation of flagellum synthesis 
genes (Garrett, et al 1999) and upregulation of type IV pili genes, responsible for 
twitching motility. Twitching motility has been implicated in the aggregation of 
organisms into microcolonies. Microcolonies are a communities of bacterial cells 
three to five layers deep which develop following the initial attachment of bacterial 
cells to a surface (Davey & O’Toole 2000) (Figure 4). Extracellular polymeric 
substances (EPS) production is critical for the ongoing development of microcolonies 
after bacterial attachment to a surface. Studies on the model organismPs. aeruginosa 
have shown that transcription of genes responsible for the production of alginate is a 
key development at this stage (Davies & Geesey 1995). The production of EPS results 
in the formation of 3-D biofilm structures and provides a safe haven for the bacteria to 
multiply (Costerton, et al 1999; Lazazzera, et al., 2004).
Maturation of biofilm
Mature biofilms are thick heterogeneous mats of bacterial cells or complex 
structures containing water channels that may also allow nutrient influx and waste 
efflux (Davey & O’Toole 2000). Quorum sensing controls the differentiation of 
mature biofilms from the microcolony stage (De Kievet & Iglewski, 2000). The 
evidence for this lies in the relatively thin and undifferentiated biofilms of LasI 
mutants. LasI directs the synthesis of a quorum sensing molecule 3-
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oxodecanoylhomoserine lactone and the observation that mature biofilms differentiate 
on the addition of this molecule in vitro, proves that quorum sensing plays a role in 
the development of mature biofilms (Costerton, et al. 1999; De Kievit & Iglewski,
2000).
The mature biofilm structure is encased in an EPS matrix and the final 
architecture is similar to the shape of a mushroom but much smaller. The shape of the 
mature biofilm may be the result of unregulated events (eg: shear forces) and 
regulated events (eg: depth and architecture of the biofilm). The depth of biofilms of 
Pseudomonas is regulated by the transcription factor RpoS (Heydom, et al. 2002; 
Whiteley, et al. 2001a). Activation of RpoS in the biofilm community directs the 
organisms into stationary phase (Venturi 2003). This would signal a nutrient 
limitation within the biofilm community and cause a reduction in the depth of Ps. 
aeruginosa biofilms (Lazazzera, et al. 2004). In Pseudomonas aeruginosa biofilms, 
the architecture of the pillar structures and water channels are maintained by the 
production of rhamnolipid surfactant and its resulting surface tension reducing 
properties. Quorum sensing regulates the production of rhamnolipid surfactant in Ps. 
aeruginosa and mutant strains have been reported to form less complex biofilm 
structures (De Kievit, et al. 2001a).
Detachment and dispersal
The process of detachment has traditionally been considered as a passive 
behaviour dependant on fluid shear or starvation (Sauer, et al. 2004). While 
hydrodynamic shear properties may catalyse the detachment of biofilm clusters, the 
detachment process may also be a programmed event that bacteria employ to colonize 
new and favourable niches (Hall-Stoodley & Stoodley 2005). The detachment process 
may be triggered by chemical cues, similar to those that control biofilm maturation.
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Alginate lyase, an enzyme that degrades alginate may play an important role in the 
sloughing of biofilms. In a recent report (Hall-Stoodley & Stoodley 2005), three 
different detachment and dispersal strategies were identified; (1) swarming dispersal, 
(2) clumping dispersal and (3) surface dispersal. In each of these strategies, dispersal 
may take place into an overlying fluid or over a solid surface. Additionally, dispersal 
may be self-propelled locomotion (swimming, sliding or twitching motility) or fluid 
driven dispersal (clumping, rippling or rolling) (Hall-Stoodley & Stoodley 2005). For 
whatever reason bacteria detach from biofilms, or whatever the strategy bacteria use 
for dispersal, the dispersal phenomenon allows pathogenic organisms living in 
biofilms, to efficiently transfer and seed infective doses and cause persistent 
infections (Greenberg, 2003 & Costerton, et al 1999).
Biofilm physiology
Bacterial cells present within biofilms, capable of attaching to surfaces, differ 
profoundly in their phenotypes from their free-living planktonic counterparts (Donlan, 
2002). The present favoured hypothesis that explains the phenotypic difference in 
planktonic and biofilm bacterial physiologies points to differential expression of 
genes in these two states (O’Toole, et al 2000).
Biofilm cells exhibit heterogeneous physiology. Bacteria produce 
exopolysaccharides, also known as glycocalyx, which assist the cell to firmly glue to 
the inert surfaces. Cell division inside the glycocalyx matrix results in the formation 
of microcolonies. Microcolonies coalesce to form layers of bacterial cells within the 
growing biofilm, and depending on the location of the particular bacterial cell within 
the biofilm, the physiological status changes (Caldwell & Lawrence 1986; Thien-Fah 
& O’Toole 2001). Cells located at the upper region of biofilms (surface biofilm cells) 
have better access to nutrients and oxygen compared to those found within. These
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cells are metabolically active, likely to have envelopes permeable to nutrients and 
may also be capable of discharging their metabolic wastes more efficiently. Their 
characteristics may be very similar to those of planktonic bacterial cells (Anwar, et al 
1992; Huang, et al. 1998; Xu, et al 2000). In contrast, cells within the thick 
glycocalyx (embedded biofilm cells) may not have as much access to nutrients and 
are more likely to be living in microaerobic conditions, increased osmotic pressure 
and pH variation (Beloin & Ghigo 2005). Core regions of the biofilm may also have a 
higher concentration of metabolic waste and the bacteria within this region are more 
likely to exhibit a physiological state similar to that of stationary phase bacteria. 
These cells may also be small, as they cannot divide efficiently and may largely lead a 
life of dormancy and low metabolic activity (Anwar, et al 1992; Xu, et al 2000).
Ample biochemical evidence supports the spatial complexity of the biofilm 
and the hypothesis that embedded biofilm bacteria face different conditions when 
compared to planktonic and surface biofilm bacterial growth. Recent gene expression 
studies have also come to similar conclusions (Beloin & Ghigo 2005). In E. coli, upto 
38% of the bacterial genome may be affected by biofilm formation (Prigent- 
Combaret, et al. 1999). These process show that bacterial biofilm physiology is 
extremely complex and there is rich heterogeneity within different locations of the 
biofilm (Beloin & Ghigo 2005).
Antibiotic resistance in Pseudomonas aeruginosa biofilms 
Antibiotic resistance in biofilms
Since the early 1950s, antimicrobial therapy has been a major tool in the 
treatment of infectious bacterial diseases. Almost all pathogenic microorganisms have 
developed some level of resistance to chemotherapeutic agents which is largely due to 
the failure to properly monitor antibiotic therapy (Madigan, et al 2003). Madigan et
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al. (2003) reported some multi-drug resistant strains of Pseudomonas aeruginosa that 
are now untreatable with any known antimicrobial drugs.
Planktonic bacteria may become antibiotic resistant through either acquired or 
intrinsic mechanisms. Mutations within the bacterial genome resulting in resistance or 
lateral transfer of resistance genes (for example via the transfer of a resistance 
plasmid) are characteristic of acquired resistance. On the other hand Intrinsic 
resistance occurs through phenotypic changes resulting from differential expression of 
existing genetic material (Hogan & Kolter 2002; Schachter 2003).
Bacteria residing within biofilms are reportedly some 10 to 1000 times less 
susceptible to a wide variety of chemotherapeutic agents compared to their planktonic 
equivalents (Davies 2003; Gilbert, et al. 2002b). Besides a variety of physical factors 
characteristic of a biofilm (e.g. EPS acting as physical barrier to macrophages, 
chemotherapeutic agents, etc.), inherent cellular mechanisms, like differential 
expression of genes giving rise to altered phenotypes, may also play a role in the 
lower levels of antimicrobial susceptibility observed (Schachter 2003).
In addition to the effect of antimicrobials themselves, the structural and 
chemical heterogeneity of the biofilms are intimately related to the rise of resistant 
phenotypes (Schachter 2003; McBain, et al, 2003). Variable thickness of biofilms and 
non-uniform distribution of cells and polymers within the matrix constitutes the 
structural heterogeneity, while local variations in the concentrations of metabolites, 
products and microbial species within the biofilms, indicate the chemical 
heterogeneity found within biofilms (Murga, et al 1994, Stewart 2003). Chemical and 
physical heterogeneity within the biofilms may trigger differential expression of genes 
resulting in resistant bacterial phenotypes (McBain, et al, 2003 & Stewart 2003).
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Reduced susceptibility of biofilms to antibiotics: Resistance mechanisms
Biofilm bacteria differ from planktonic bacteria, in their multicellularity. The 
formation of a biofilm involves a multicellular developmental process and depends on 
the ability of free-living bacteria to communicate and get together with each other 
(O’Toole, et al 2000). Within a biofilm, bacteria derive the same benefits as other 
multicellular organisms: strength in numbers, division of labour, functional 
specialization and adaptation to environmental stress. The resistance that biofilms 
employ against antibiotics may, also be a multicellular phenomenon. Hence, most of 
the hypotheses on the mechanisms of resistance exhibited by biofilm bacteria are 
inherently based on multicellular nature of the biofilm (Krasovec & Jerman 2003; 
Stewart & Costerton 2001).
There are currently four different hypothesised resistance mechanisms under 
study (Figure 5):
1. Slow penetration of the antimicrobial agent into the biofilm.
2. Altered chemical environment within biofilm, leading to zones having 
gradation in the growth rates of bacteria.
3. Adaptive stress responses.
4. Persister cells.
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Figure 5: Four possible mechanisms of antimicrobial resistance. The yellow region on the top edge of the biofilm indicates the region of slow penetration of the antimicrobial. The region coloured red at the lower edge within the biofilm is the area where there exists high heterogeneity of cells due to altered microenvironments. Cells coloured green are those that exhibit a general stress response to the antimicrobials. The violet cells represent the persisters. Adapted from image library of Centre for Biofilm Engineering http://www.erc.montana.edu/Res-Lib99-SW/Image_Library/Biofilm_Control/ [Accessed on 02.03.20051
Slow penetration o f antibiotic into biofilms
Diffusion is the predominant transport process within biofilm cell aggregates 
(Stewart 2003). One of the hypothesese explaining biofilm resistance, is that the 
surface layers of a biofilm near the biofilm-bulk fluid interface is the only area 
exposed to a lethal dose of the antibiotic due to reaction-diffusion barrier and a short 
time of antibiotic exposure that limits the penetration potential of the antimicrobial 
(Stewart 2003; McBain, et al. 2003). If the hypothesis were true, in that, it was the 
only mechanism for biofilm resistance, then the antimicrobials would be lethal to the 
biofilm if it were exposed long enough for a total diffusion. However, this is not the 
case in most observations, as there seems to be some evidence of the antimicrobial 
being neutralised as it diffuses into the biofilm (McBain, et al. 2003). Some of the
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antimicrobials that are reportedly affected by penetration limitation include chlorine 
(Stewart & Costerton 2001), hydrogen peroxide (Stewart, 2002) and p-lactam 
antibiotics (Anderl, et al 2000) and aminoglycoside antibiotics (Walters, et al. 2003).
Studies carried out with wild type strains carrying enzymes that deactivate the 
antimicrobial and mutant strains that lack these enzymes (but both strains are capable 
of forming normal biofilms), have shown that neutralization of the antibiotic as it 
diffuses into the biofilm plays a major role in its penetration potential (Anderl, et al
2000). For example, bioactive ampicillin fails to penetrate p-lactamase positive 
Klebsiella pneumoniae biofilms, as the enzyme cleaves the antibiotic faster than it 
diffuses (Anderl, et al 2000). Catalase positive strains of Ps. aeruginosa have also 
been reported to show resistance to hydrogen peroxide penetration (Stewart et al,
2000).
Recent studies have also indicated that many antimicrobials are capable of 
entering and diffusing within biofilms, without actually harming any cells. 
Antimicrobials of this nature, include ciprofloxacin (Anderl, et al 2000), 
chlorosulfamate (Stewart & Costerton 2001), rifampin (Zheng & Stewart 2002) and 
tetracycline (Stone, et al. 2002).
Altered microenvironments and slow growth
Microorganisms that have entered stationary phase are known to be generally 
resistant to antibiotics. Biofilms contain slowly growing or non-growing cells that 
exhibit similar characteristics to stationary phase planktonic cultures (Fux, et al.
2005). Such slow growth has been attributed to local depletion of nutrients within 
different layers of the biofilm. Alternatively, altered microenvironments within the 
biofilm, with respect to pH and oxygen levels may be antagonistic to the activity of 
the antimicrobial (McBain, et al. 2003).
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The growth rate of microorganisms in biofilms is slow. Experimental 
comparisons have shown that average growth rate in biofilm cells can be as low as a 
few percent of their planktonic counterparts (Walters, et al. 2003). Biofilms in which 
the average specific growth rate is half the growth rate of planktonic cells may 
actually consist of a population of cells in which half are growing rapidly and the 
other half minimal. Experiments examining growth rate related effects under 
controlled growth conditions for planktonic cultures and biofilms of Ps. aeruginosa, 
E. co li and Staphylococcus epiderm idis have shown that the sensitivities of both the 
planktonic and biofilm cells to either tobramycin or ciprofloxacin increased with 
increasing growth rates, thus supporting the suggestion that slow growth rates of 
biofilm cells protect the cells from antimicrobial action (Duguid, et al. 1992a & 
1992b; Evans et al. 1991). Overall the evidence for growlh rate being a critical factor 
in controlling antimicrobial resistance in biofilms is strong.
Stress responses
It is possible that the slow growth of microorganisms observed in biofilms is a 
direct consequence of a general stress response, rather than nutrient depletion (Brown 
& Barker 1999). Bacteria are capable of responding to numerous environmental 
stresses, like heat, cold, pH changes and chemical agents (Thien-Fah & O’Toole
2001). The molecular regulator of these responses is the stationary phase sigma factor, 
RpoS. Studies have indicated that R poS  is induced at high cell densities as judged by 
the production of trehalose (osmo-protectant) and catalase (effector of general stress 
response) (Liu, et a l 2000). As biofilms are subject to benefits of high cell density, it 
is logical to propose that these cells would express RpoS. Accordingly, the presence 
of R poS  mRNA has been shown in sputum samples of cystic fibrosis patients 
suffering from chronic Ps. aeruginosa biofilm infections (Foley, et al. 1999). Finally,
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stress responses within biofilms are implemented more effectively on antimicrobial 
challenge compared to planktonic cells (Maira-Litran e t a l, 2000a; De Kievit et al, 
2001b). Ps. aeruginosa  biofilm cells produce catalase production upon hydrogen 
peroxide treatment, while planktonic cells of the same reporter strain succumb to the 
effects of hydrogen peroxide before catalase can be produced (McBain, e t al. 2003). 
This indicates that general stress response of bacteria within a biofilm are at a state of 
alert and be rapidly activated upon challenge.
P ersisters
Regardless of the duration of treatment of biofilms with antibiotic a small 
fraction of the population remains recalcitrant (Keren, et al. 2004). This recalcitrant 
fraction of the population has been exhibited in kill versus time and kill versus 
concentration curves, as a significant tailing (residual number of cells that die slowly 
or do not die at all in presence of high concentration of antibiotics) (Keren, e t al. 
2004). The observed tailing could only be due to cells that are not affected by any 
antimicrobial challenge. The hypothetical state of these cells, where in they are 
protected from all types of antimicrobial insults, has been termed ‘p e r s is te r s ’. The 
cells in this state have been likened to dormant cells at stationary phase (Drenkard & 
Ausubel 2002; Lewis 2001; Spoering & Lewis 2001).
Presumably, antibiotics normally act against their targets in persisters as well, 
but unlike regular cells, they are not inhibited and do not die. The reason for this 
tolerance remains unknown. The suggestion that persisters are simply non-growing 
does not explain their phenotype. Indeed, fluoroquinolones kill non-growing cells, but 
leave persisters intact (Keren, et al. 2004). However, it is possible, that persisters are 
cells in a state of deep dormancy (Nystrom 2003).
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In conclusion, it may be said that all these defense mechanisms are 
multicellular in nature. Penetration-limitation of antimicrobials within biofilms occurs 
due to neutralization of the activity of the antimicrobial. Such neutralization can only 
occur if there exists a quorum of cells, as lone cell cannot deplete the antimicrobial 
agent fast enough to ensure its own safety. Considering nutrient limitation and slow 
growth; an antibiotic that requires oxygen for effective killing may not be able to 
affect the depths of a biofilm due to microorganisms in the outer layers depleting the 
oxygen and effectively creating an anaerobic environment in the layers within. A 
single planktonic cell would not be able to sufficiently deplete local oxygen levels so 
as to inactivate the antimicrobial. Stress responses are also a multicellular 
phenomenon. The stationary phase sigma factor, R poS  is activated in the presence of a 
quomm of bacteria. The multicellular nature of the biofilm ensures a quick regulation 
of stress response and better adaptation to antimicrobial agent compared to the lone 
bacterial cell. Finally the persister hypothesis suggests that these cells are capable of 
withstanding major antimicrobial assaults. However, such a benefit comes at the cost 
of being dormant. No single cell may be a persister and at the same time have a rapid 
growth (as persisters are hypothesised to be dormant cells) (Lewis 2001). However, 
within the multicellular environment of biofilms, there exists the opportunity for 
persisters. Most of the cells within the biofilm are in relatively susceptible state, in 
which they can grow, synthesize glycocalyx, and replicate their genome. A few cells 
are transformed into the ‘p ersis ter’ state. Although these cells may not be able to 
grow rapidly, they would survive and reseed the community in the event of a 
catastrophe (McBain, et al. 2003).
In summary, it has to be noted that no one of the mechanism outlined, offers 
an explanation for the persistent and tenacious resistance of a biofilm. It is more likely
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that biofilm s mount a multifaceted defense in which two or more o f  the m echanism s
outlined operate in concert.
Aims and Objectives
The pathogenic effect of Pseudom onas aeruginosa  is attributed to its virulence 
and survival factors (Fonesca et al. 2004). Common models of bacterial virulence 
analyze host-pathogen interactions under a defined set of conditions that usually do 
not include antibiotic therapy. Although the first stages of an infection usually occur 
without the presence of antibiotics, once a diagnosis is available most infectious 
diseases evolve under antibiotic treatment. Thus, besides being inhibitors of bacterial 
growth, antibiotics act as modulators of bacterial gene expression (Martinez & 
Baquero 2002).
A number of reports have indicated a general down-regulation of pathogenic 
determinants including biofilm formation of planktonic pathogenic organisms in the 
presence of sub-MICs of different antibiotics (Wilson, al. 2002; Drago e t al. 2001; 
Kim et al. 2001; Braga et al. 2000; Tateda et al. 1993) However, there exists the 
possibility that pathogenic organisms have already established biofilms and colonized 
the host before antibiotic therapy may commence. Hence, it is of prime importance to 
understand the effect of sub-MICs of antibiotics on bacteria within biofilms compared 
to their planktonic counterparts. A recent study (Fonseca et al. 2004) reported the 
inhibition of virulence factors of P seudom onas aeruginosa in the presence of 
subinhibitory concentrations of antibiotics. However, this study was performed with 
planktonic cells, and not on biofilm bacteria as usually observed in clinical conditions.
This study adopts Pseudom onas aeruginosa ATCC 15692 (PAOl), which 
displays high levels of resistance to many antimicrobials, as the model organism to 
study bacterial virulence in the presence of sub-minimal inhibitory concentrations
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(sub-MICs) selected antibiotics. Previous studies have implicated alterations within 
the outer membrane proteins (OMPs), to be a possible reason for exclusion of harmful 
molecules within the bacterial cell (Abdel Malek e t al. 2002; Al-Hmoud 2002; 
Winder et al. 2000; Brozel & Cloete 1994; Nikaido 1992). High affinities of 
antibiotics for certain OMPs may cause an import of antibiotics within the bacterial 
cell, resulting in inhibition of growth. It has been suggested that the bacteria may 
avoid such adverse growth effects due to antibiotics, by over-expression or loss of 
certain OMPs (Abdel Malek et al. 2002; Al-Hmoud 2002; Winder et al. 2000; Brozel 
& Cloete 1994; Nikaido 1992).
It is the aim of this study to investigate the effect of sub-minimal inhibitory 
concentrations (sub-MICs) of three antibiotics (ampicillin, nalidixic acid and 
streptomycin) on key pathogenic determinants (e.g. outer membrane proteins, 
leucocidin and other virulence factors) of monospecies and binary biofilms of 
Pseudom onas aeruginosa ATCC 15692 (PAOl) and E. co li ATCC 10000, 
respectively. It is hoped that sub-MICs of antibiotics will mimic subinhibitory 
chemotherapeutic doses and allow the bacteria to express pathogenic determinants 
comparable or similar to those in conditions of clinical infection.
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C h a p te r  T w o : G e n e r a l E x p e r im e n ta l M e th o d s
Introduction
The aim of this chapter is to give the experimental detail of those techniques 
associated with the routine maintenance of cultures, testing protocols and analysis of 
bacterial physiology undertaken in the subsequent experimental chapters. Whilst the 
plan of the thesis changed over the period of the project, a flow chart (below) is given 
to indicate the relationship between certain tests / procedures and the sequence in 
which they were undertaken.
Growth & antibiotic challenge of biofilms
Sacrifice of biofilms
Preparation of cell-free extracts of biofilms cells
-------------- -SDS-PAGE 2D-PAGE Lipopolysaccharide gels Gel-fi tration
Protein purification for leucocidin & protease
Leucocidin analysis Protease analysis
MTT Assay
(Human foreskin fibroblast cells)
Phase Contrast microscopy
(Spleen myeloma (Sp2) cells)
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Protocols for bacterial growth and maintenance of cultures
Maintenance and growth of cultures
P seudom onas aeruginosa ATCC 15692 (PAOl) and E scherich ia co li ATCC 
10000 were used throughout the project. The original cultures of these two bacteria 
were obtained from the National Collections of Industrial and Marine Bacteria 
(NCIMB), Aberdeen, UK. Cultures of these organisms were maintained on nutrient 
agar (Oxoid CM3) slopes in quadruplicate. The four labelled slopes were numbered 
from 1 to 4. Slope number 1 was used to inoculate overnight cultures for experimental 
purposes and slope number 2 was the backup slope in case of contamination. Slope 
number 3 was used for further subculturing and slope number 4 was kept as part of a 
stock culture collection. The maintenance of culture in quadruplicate ensured that the 
stock bacterial cultures were not ruined by a single occurrence of contamination. 
Inoculated agar slopes were maintained at room temperature, in a darkened cupboard, 
following incubation at 37°C for 24 hours. These were replaced at monthly intervals. 
E scherichia co li cultures were grown in R2A media supplemented with 1% glycerol 
(Reasoner and Geldrich, 1985) and Pseudom onas aeruginosa  cultures were grown in 
chemically defined media (CDM, replacing 0.5% succinic acid with glycerol; 
Dinning, 1995) for 24 h at 37°C in an orbital incubator (Gallenkamp, INA-305) at 190 
rpm. Culture identification was determined using the API 20NE and API 20E tests 
(Biomerieux, France).
Sigma, Poole, Dorset: Ammonium persulphate; ammonium sulphate; azocasein; 
casein; coomassie brilliant blue R-250; dithiothreitol; 5,5’-dithio-bis (2-nitrobenzoic 
acid); dimethyl sulfoxide (DMSO); ethylenediaminetetra-acetic acid; glutamine; 
glutathione; glycerol; lysostaphin; Thiazolyl blue (MTT); N-laurylsarcosine; 2-
Reagents
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mercaptoethanol; phenazine methosulphate (PMS); phenyl-methyl-sulphonyl-fluoride 
(PMSF); protease peptone number 3; proteinase K; polyethylene glycol 20000; 
Pyruvic acid; Rnase; sephadex G-100; sodium carbonate; sodium thiosulphate; 
soluble starch; Thiomersal; TEMED; N-tris (hydroxymethyl) methyl-2- 
aminoethanesulfonic acid (TES); trichloroacetic acid (TCA) Triton X-100; TRIZMA 
base; TRIZMA hydrochloride; N-P- p-tosyl-L-lysine chloromethyl ketone (TLCK); 
urea; yeast extract.
BDH Chemicals, Poole, Dorset: ammonium chloride; calcium chloride (CaCF); D- 
glucose; dipotassium orthophosphate; potassium cyanide (KCN); ethanol; ferric 
ammonium citrate; glycerol; hydrochloric acid (HC1); Igepal CA-630; magnesium 
sulphate heptahydrate (MgS0 4 .7 H2 0 ); potassium dihydrogen phosphate (KH2PO4); 
Resolyte (pH 3.5 to 10.0); Resolyte (pH 4.0 to 8.0); silver nitrate; sodium chloride 
(NaCl); sodium hydroxide (NaOH).
Fisher, Scientific UK Ltd (Loughborough, Leics): glacial acetic acid; methanol 
(HPLC).
Ampicillin (AmP), Nalidixic acid (NaL), Streptomycin (ST) Antibiotic was purchased 
from Sigma (Pool, UK). Bio Gel P-100 and (2.5x100cm) column were purchased 
from Bio Rad (UK).
Sterilisation and preparation of media
R2A medium
This medium gives excellent plate counts, but appears inadequate for 
laboratory subculture of bacterial isolates. It was prepared according to the Reasoner 
and Geldrich (1985) protocol, supplemented with 1% glycerol. It is similar to 
modified Henria medium and casein-peptone starch medium, but does not contain Fe 
as FeCb or FeSC>4. R2A medium was prepared by adding 0.5g yeast extract, 0.5g
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protease peptone, 0.5g casein acid hydrolysate, 0.5g glucose, 0.5g soluble starch, 0.3g 
sodium pyruvate, 0.3g K2HPO4 and 0.05g MgS0 4 .7 H2 0  to 900 mL deionised water. 
The volume was made up to 1L by distilled water. The pH was adjusted to 7.2 with 
either crystalline K2HPO4 (increase the pH) or KH2PO4 (decrease the pH). 1.5% 
technical agar (Oxoid number 3) was added as a gelling agent when required (pouring 
plate). This medium was sterilized by autoclaving at 121 °C, 15 psi for 15 minutes.
Chemically defined medium (CDM)
CDM was prepared according to Dinning (1995), replacing 0.5% succinic acid 
with glycerol. This medium is made up from 4 solutions; solution A, solution B, 
solution C and solution D. Solution A was prepared by adding K2HPQ1 (2.56g), 
KH2PO4 (2.08g) and NH4CI (l.OOg) to 900 mL of distilled water. The volume was 
made up to 1L with distilled water. The pH was adjusted to 6 .8  with either 1M HC1 or 
1M NaOH. The solution was sterilized by autoclaving at 121*30, 15 psi for 15 
minutes. Solution B was prepared by adding ferric ammonium citrate (l.OOg) and 
CaCl2 (O.lg) to 100 mL of distilled water. This was sterilized by filtration through a 
0.22 pm pore size cellulose acetate filter (Merck Eurolab Ltd, Lutterworth) under 
vacuum. Solution C is a 1M glycerol solution and was prepared by adding 46.45g of 
glycerol to 400 mL of distilled water. The volume was made up to 500 mL with 
deionised water. The pH was adjusted to 6.0 with the addition of either 0.1M HC1 or 
0.1M NaOH. This solution was sterilized by autodaving at 121°C, 15 psi for 15 
minutes. Finally, solution D was prepared by adding MgS0 4 .7 H2 0  (0.5g) to 900 mL 
distilled water. This was made up to 1L by distilled water. The solution was sterilized 
by autoclaving at 121°C, 15 psi for 15 minutes. The 4 solutions were prepared, and 
CDM was completed by the aseptic addition of 5 mL solution B, 15 mL solution C
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and 10 mL solution D to 1L solution A. 15.45 g L' 1 technical agar (Oxoid number 3) 
was added as a gelling agent when required.
A modified CDM (MCDM) was also used in biofilm experiments, which was 
suitable for the optimal and non-advantageous growth of both microorganisms Ps. 
aeruginosa and E. coli. In order to achieve this, CDM was modified by increasing the 
concentration of nitrogen (the concentration of nitrogen (NH4CI) in solution A (CDM) 
was 0.0187 M; in MCDM the concentration was modified to 0.0280 M) and 
decreasing the concentration of carbon (solution C: the concentration was decreased 
from 1M to 0.66 M). These modifications in the concentrations of carbon and 
nitrogen will make the doubling times for both bacteria closer to each other in this 
modified CDM (Al-Hmoud, 2002).
Chromogenic E. co li / coliform medium
Chromogenic E. coli / Coliform Medium CM956 (Oxoid LtD., Basingstoke, 
Hampshire, England) is a differential agar, which provides presumptive identification 
of E. co li and coliforms in food and environmental samples. The agar base uses two 
enzyme substrates to improve differentiation betweenE. co li and other coliforms. One 
chromogen allows specific detection of E. co li through the formation of purple 
colonies. This substrate is cleaved by the enzyme glucuronidase, which is produced 
by approximately 97% of E. co li strains. The other chromogen is cleaved by the 
enzyme galactosidase, which is produced by the majority of coliforms, resulting in 
rose / pink colonies (Sartory & Howard, 1992). This medium has been used in this 
project to differentiate between two types of bacteria: Ps. aeruginosa , which gives 
straw-coloured colonies and E. coli, which gives purple-coloured colonies (Figure 6 ). 
Aliquots (55.8 g) of this medium were in 1L of distilled water. This medium was 
sterilized by autoclaving at 121 °C, 15 psi for 15 minutes.
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Figure 6: C hrom ogenic E . coli /  Coliform  plate show ing two d ifferent coloured colonies; the 
purple ones represent E. coli ATCC 10000 and the straw ones represent Ps. aeruginosa  ATCC  
15692 (P A O l).
Validation of the flow rate in a peristaltic pump
The peristaltic pump (Autoclude model VL) is essential equipment in this 
project in order to accurately deliver known volumes and flow rates of media to 
Sorbarod biofilms. Therefore, it was necessary to undertake an accurate calibration 
procedure. Four types of silicone peristaltic pump tubes were used, each with different 
diameter. The arbitrary speed range was set between 0 and 99 and the volume of 
water throughput was measured into a volumetric cylinder. This step was repeated for 
4 tubes with 21 different speed settings. Five replicate measurements for each speed 
were made with one-minute intervals between each measurement. The volume of the 
water was plotted against the speed to produce a standard curve (Figure 7). These data 
were used to determine which combination of tube and peristaltic pump speed were 
used in subsequent biofilm experiments.
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Figure 7: The standard curve for the peristaltic pump calibration. Error bars are calculated as 
the standard deviation o f each data point, n = 5 replicates, (o) Mean o f the pumped volume (mL 
min'1). NB: SD =  0, hence error bars are inapparent.
The Sorbarod model: a simple in vitro  model for growth control of bacterial 
biofilms (Hodgson e t a t ,  1995)
Sorbarod biofilm model is composed of silicone PVC tubing containing a 
single Sorbarod (Hodgson, et al 1995). A Sorbarod filter consists of a cylindrical 
paper sleeve, encasing compacted concertina of cellulose fibres. The packed cellulose 
filling provides a large surface area for bacterial adhesion whilst the extensive inter­
fibre spaces avert system blockage. Biofilms of Ps. aeruginosa ATCC 15692 (PAOl) 
and Escherichia coli ATCC 10000 and binary biofilms (mixed) of Ps. aeruginosa 
ATCC 15692 (PAOl) and Escherichia coli ATCC 10000 were grown within 
Sorbarod filter plugs, which were perfused with modified Chemically Defined 
Medium (MCDM) (Al-Hmoud, 2002) at 37°C. An overnight culture of Ps. 
aeruginosa or E. coli grown in MCDM were used to inoculate (10 mL) from a syringe
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dropwise onto a sterile pre-wetted Sorbarod (with the addition of 5 mL 0.9% (w/v) 
sterile normal saline), held within sterile PVC tubing. The rubber plunger seal was 
withdrawn from a sterile, disposable 2 mL syringe. The syringe was introduced into 
the PVC tubing containing the Sorbarod and a sterile, disposable needle (0.8 x 40 
mm) inserted through the rubber seal (Figure 8). Media inlet tubing was attached via  
the needle and sterile MCDM was delivered into the unit at a rate of 2.2 mL min' 1 
(using peristaltic pump) at 37°C. Numbers of cells eluted (into a sterile receiving 
reservoir) from the Sorbarod filters were estimated with time by performing viable 
counts until the rate of loss of cells from the filter had decreased to a constant steady- 
state value, which was maintained for several days. Pseudo-steady states were 
established at which the growth rate of the biofilm was reproducible, measurable and 
similar to likely in vivo  growth rates (Brown & Williams, 1985). Steady state for Ps. 
aeruginosa was achieved at 102 h, forE. co li at 56 h and for binary biofilms (mixed) 
of Ps. aeruginosa  and E. coli at 126 h. Sorbarods and eluate cells were collected and 









Figure 8: Diagram o f the Sorbarod biofilm model showing silicone tubing to peristaltic pump and 
media vessel (A), rubber plunger seal (B), 2 mL disposable sterile syringe C), syringe needle (D), 
PVC tubing (E) and Sorbarod (F) (Hodgson et al., 1995)
Preparation of cell-free extract
The leakage of the cytosolic constituents (e.g. free bases, inorganic 
phosphates) from the cell into the bacterial bathing solution can be measured by 
measuring the absorbance (E260nm). This is used as an indicator of cellular 
disruption. The process of homogenisation has to be validated in order that a 
sufficient time period is applied to disrupt the Gram-negative envelope of the cells.
Sacrifice of biolfim cells
The Sorbarod was aseptically removed from the PVC tubing with the use of a 
sterile scalpel blade. The Sorbarod was then placed into a sterile plastic centrifuge 
tube (20 mL) and 5 mL of sterile PBS buffer was added. The tube was then mixed 
using a vortexer for 30 minutes, until the Sorbarod was completely broken and
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dispersed. The tube was then left to rest at room temperature for 20 minutes, until the 
components of the Sorbarod had settled out under gravity. The suspended cells were 
decanted into a sterile plastic centrifuge tube (20 mL) and centrifuged at 5000xg for 
20 minutes. The cells were washed three times with sterile PBS (5 mL) by a process 
of resuspension and centrifugation. Cells were stored in a freezer at -20°C until 
required.
Preparation of cells
Sterile MCDM medium (25 mL) was inoculated with a pure culture of 
P seudom onas aeruginosa  PAOl. The flask was incubated overnight at 37°C, 190 
osc/min in an orbital incubator (Gallenkamp INA-305). Aliquots (5mL) of the 
overnight culture were centrifuged at 5000 rpm (IEC Centra-4B) for 20 minutes. The 
pellet was washed with phosphate buffer (pH 7.2), this was repeated three times, and 
then the pellet was resuspended in 2 mL phosphate buffer. The prepared cells were 
homogenised on ice for 10 seconds, using a hand-held homogeniser (Ultra Turrax T8, 
S8N-5G, IKA labortechnic, Staufer, Germany). In order to remove any cell debris 
from the supernatant (cytosol), the cell suspension was centrifuged at 13000 rpm 
(MSE Microcentaur) for 1 minute. Using a Jenway 6105 UV/vis spectrophotometer, 
the optical density of the supernatant was measured at E260nm. A fresh phosphate 
buffer was used as a blank. The homogenisation and subsequent OD reading were 
repeated at 10-second intervals up to one minute, and every minute up to 5 minutes, 
until the optical density reading ceased increasing. By plotting homogenising time 
(Ht) against E260 nm, the minimum required time of homogenisation in order to yield 
the maximum absorbency was determined as 3 minutes for Pseudom onas aeruginosa.
The same procedure was carried out for determination of homogenization time 
(Ht) for E. coli 10000. By plotting homogenising time (Ht) against E260 nm, the
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minimum required time of homogenisation in order to yield the maximum absorbency 
was determined as 3 minutes for E. co li 10000.
Bicinchoninic acid (BCA) assay for protein estimation
Bicinchoninic acid, sodium salt (BCA-Na), is a stable, water-soluble 
compound capable of forming an intense purple complex with cuprous ions (Cu1+) in 
an alkaline environment. This reagent forms the basis of an analytical method capable 
of monitoring cuprous ion produced in the reaction of protein with alkaline Cu . The 
bicinchoninic acid assay was originally described by Smith e t al. (1985). It is 
dependent on the conversion of Cu2+ to Cu1+ under alkaline conditions and is 
therefore, similar to the traditionally used Lowry method (Lowry e t a l., 1951). 
However, the stability of the reagent (BCA) and resulting chromophore also allows 
for a simplified, one-step analysis. The assay is also considered to be more tolerant to 
a range of detergents and denaturing agents that are known to interfere with the 
Lowry assay, although it is more sensitive to reducing sugars (Smith e t a l ., 1985).
The end-point colour stability of the BCA assay was assessed by performing 
the BCA method at the incubated temperature (37°C for 30 minutes), and then 
observing absorbance at 562nm. A standard assay (detects in the range of 0.1 to 1.0 
mg protein mL'1) and a microassay (0.5 to 10 pg protein mL'1) have been described 
(Walker, 1984a).
Preparations of solutions for the BCA assay
A stock of reagent A was prepared, (BCA-Na2, 1% (w/v); sodium carbonate, 
2% (w/v); sodium tartarate, 0.16% (w/v); sodium hydroxide, 0.4% (w/v) and sodium 
bicarbonate, 0.95% (w/v) dissolved in 50 mL of distilled water). If needed, 
appropriate addition of NaOH (50% ) or solid NaHCCb was made to reagent A to
adjust the pH to 11.25. Reagent B comprises of copper sulphate 4% (w/v). Reagent A
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and B are stable indefinitely at room temperature. Directly prior to protein estimation, 
reagent C was prepared by adding 100 volumes of solution A to 2 volumes of solution 
B, ensuring an apple-green colouration developed.
Preparation of standard calibration curve
A stock of a 1 mg mL' 1 Bovine Serum Albumin (BSA) was prepared in 
deionised water. Aliquots were withdrawn from BSA stock solution and diluted with 
dH2 0  to give a total volume of 50 pL. Final BSA concentrations ranged from 0 mg 
mL' 1 to 1 mg mL' 1 of protein. An aliquot 1 mL of reagent C was added to each tube 
and incubated at 37°C for 30 minutes. The absorbance was measured at 562nm 
(Novaspec II, LKB) and plotted against known protein concentrations to produce a 
standard curve (Figure 9).
Figure 9: The standard curve for protein estimation. Error bars are calculated as the standard 
deviation o f each data point, n = 3 replicates, (o) Mean absorbency at 562 nm. NB: SD = 0, hence 
error bars are inapparent.
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A nalysis o f  samples
Aliquots of the test samples (10 pL) were diluted to a total volume of 50 pL 
with dE^O. An aliquot of reagent C (lmL) was added to those samples, which were 
incubated at 37°C for 30 minutes. Their absorbencies were measured at 562nm 
(versus a reagent blank) and compared against the standard curve (Figure 9) in order 
to estimate protein concentration.
Preparation of outer membrane proteins and sodium-dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) for biofilm and eluate cells
Outer membrane protein (OMPs) preparations
Two methods for the preparation of OMPs were used in this project. The first 
method was that described by Hodgson et al. (1995) for biofilm cells and the second 
was that of Pugsley et al. (1986) for eluate cells. However, experimentation showed 
that the Hodgson et al. (1995) method could be applied for both types of cells.
Biofilm  cells
OMPs were prepared for SDS-PAGE analysis according to Hodgson e t al.
(1995). Cultured Sorbarods were sacrificed. Cells were washed twice in 0.9% (w/v) 
sterile normal saline and harvested by centrifugation (MSE Microcentaur) at 10000 
rpm, for 10 minutes. Cells were resuspended in lmL of 0.9% (w/v) saline containing 
100 pg of lysostaphin and incubated at 37°C for 2 hours in an orbital incubator 
(Gallenkamp, INA-305) at 24 rpm. In order to inhibit proteolytic activity of bacterial 
enzymes released during lysostaphin treatment, phenylmethylsuphony fluoride 
(PMSF) and N-P-p-tosyl-L-lysine chloromethyl ketone (TLCK) were added to give 
final concentrations of 2 mmol L"1 for both. DNase and RNase were added to give
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final concentrations of O.lmg mL' 1 each. After centrifugation at 10000 rpm (MSE 
Microcentaur) for 20 minutes, the supernatant fluid was decanted and stored at -20 °C.
E luate cells
OMPs were prepared for SDS-PAGE analysis according to Pugsley et al. 
(1986). The eluate suspension was centrifuged (IEC Centra-4B) at 5000 rpm for 20 
minutes. The cells were washed three times in 25 mmol L' 1 Tris buffer (pH 7.4) 
containing 1 mmol MgCb. After homogenisation for 2.5 minutes on ice, sarcosine 
(Sigma) was added to give a final concentration of 2% (w/v), and samples were kept 
in ice for 20 minutes. The insoluble outer membrane was sedimented out at 13000 
rpm (MSE Microcentaur) for lh at 4°C. The supernatants were removed and the 
pellets were washed with lmL of distilled water. The pellets were resedimented out at 
13000 rpm (MSE Microcentaur) for lh at 4°C. Samples were stored in the freezer (- 
20°C) until required. Prior to SDS-PAGE analysis the pellet was resuspended in 100 
pL of Tris-HCl buffer (pH 6 .8). Protein samples were diluted 1:1 with sample 
(cracking) buffer (sodium dodecyl sulphate, 2% (w/v); mercaptoethanol, 5% (v/v); 
glycerol, 10% (v/v); bromophenol blue, 0.125% (w/v); Tris-HCl; 0.5M; pH 6 .8 ; made 
up to 10 mL with Tris-HCl; 0.5M; pH 6 .8) and heated at 100°C in a water bath 
(Gallenkamp, England) for 5 minutes immediately prior to loading of the gels.
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
P reparation  o f  separa ting  ge l mixture
Three stock solutions were required to prepare this mixture:
(i) Stock acrylamide solution: 73g, acrylamide and 2g, bis-acrylamide dissolved in 
250 mL distilled water.
(ii) Stock separating buffer: lg, SDS and 45.5g, Tris buffer (2-amino-
hydroxymethyl-propane-1,3-diol) dissolved in less than 250 mL of distilled
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water, the pH was adjusted to 8.8 with HC1 and then made up to 250 mL with 
distilled water.
(iii) Stock ammonium persulphate solution 10% (w/v); l.OOg, ammonium 
persulphate was dissolved in 10 mL of distilled water.
10 mL of stock acrylamide, 12 mL of distilled water and 7.5 mL of stock 
separating buffer were added together and degassed. Then, 45 pL of stock ammonium 
persulphate and 15 pL of N,N,N’,N’-tetramethyl-ethylenediamine (TEMED) were 
added to begin the polymerisation process. The mixture was mixed gently to avoid re­
gassing, and poured into a prepared gel cast (0.5 mm thick: mini-PROTEAN II, 
Biorad). Then, the gel was overlaid with water-saturated butan-2-ol, and left to set for 
approximately lh.
P reparation  o f  stacking g e l mixture
Stock stacking gel buffer: lg, SDS and 15.lg Tris buffer dissolved in less than 
250 mL distilled water, the pH was adjusted to 6.8 and the stock was made up to 250 
mL with distilled water. 750 pL, stock acrylamide; 3 mL, distilled water and 1.25 mL 
stacking gel buffer were mixed together and degassed. Then, 15 pL of ammonium 
persulphate stock solution and 5 pL of TEMED were added and mixed gently to 
avoid re-gassing. All the above stock solutions are stable for several weeks in brown 
glass vessels at 4°C.
After nearly an hour, the separating gel was set and the butan-2-ol was 
removed from the polymerised gel. In order to remove any traces of the alcohol, the 
surface was rinsed with distilled water. This was followed by pouring the stacking gel 
over the separating gel and allowing it to set for approximately 45 minutes, with a 
comb (0.5 mm, 10 wells, Biorad) in place. Once, the stacking gel had set, the comb 
was removed gently, and the wells were washed with distilled water. The polymerised
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gel was transferred to a mini-PROTEAN II system, (Biorad), which was filled with 
reservoir buffer (0.192 M, glycine (28.8g); 0.025M, Tris (6.0g); and 0.1% (w/w), SDS 
(2.0g), made up to 2L with deionised water, the pH should be at about 8.3 without 
adjustment, and the solution is freshly prepared each time), ensuring the wells were 
completely filled with the buffer.
After loading the molecular weight markers (5 pL) and the test samples (10 to 
20 pL) into the wells using a pipette (Sealpipette Jencons), a constant current (35 mA) 
was applied to the gel by a Powerpack 300 (Biorad) until the bromophenol blue in the 
cracking buffer / protein mixture reached the bottom of the gel (between lh to 1.5h). 
Once the bromophenol blue front reached the bottom, the Powerpack 300 was 
switched off and the gel was gently removed from its cast and immersed in 
Coomassie brilliant blue R250 stain or in the fixing solution (Silver stain).
Protocol for the preparation of two-dimensional gel electrophoresis for protein 
separation on the basis of isoelectric points and molecular weights
Preparation of glass tubes for the first dimensional stage
Glass tubes (1 mm diameter) were soaked in 5% Decon (BDH) overnight, 
rinsed thoroughly in distilled water and placed in fresh potassium hydroxide solution 
(KOH, 0.4g; ethanol, 20 mL). The tubes were rinsed in distilled water, placed in 
100% ethanol and then allowed to air dry. Once dried, the tubes were sealed with 
three layers of parafilm and placed in the pouring stand. The tubes were marked 5 mm 
from the top to ensure all tubes gels were the same length in order to facilitate 
reproducibility between runs.
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Preparation of tube-gel (first dimension protein separation)
An aliquot (10 mL) of the gel mixture was prepared to contain;
1. Urea (ultrapure, Sigma, Poole); 5.5g.
2. Acrylamide stock (acrylamide, 14.19g; bis-acrylamide, 0.8g in 50 mL df^O); 
1.33 mL.
3. Igepal CA-630 stock (10% (v/v); 2 mL.
4. Resolyte (BDH, Poole, pH 3.5 to 10.0); 0.3 mL.
5. Resolyte (BDH, Poole, pH 4.0 to 8.0); 0.2 mL.
6 . Distilled water; 1.97 mL.
The flask was mixed constantly at 37°C in a water bath (Gallenkamp, 
England) until the urea completely dissolved. The gel mixture was then degassed. For 
the non-equilibrium pH gradient electrophoresis (NEPHGE) method, ammonium 
persulphate (10% w/v; 20 pL) and TEMED (14 pL) were added. The solution was 
loaded into gel using a syringe with a narrow gauge hypodermic needle. The tubes 
were filled approximately 5mm from the top. The gels were overlaid with gel overlay 
solution (urea, 4.8 lg; distilled water, 10 mL; 20 pL) and allowed to polymerise for 
one hour. The tubes were removed from the pouring stand, parafilm carefully 
removed and the gel overlay solution was removed. The surface of the gel was rinsed 
three times with distilled water.
Isoelectric focusing of protein samples
The tube gels were placed in the 2D gel rig and the bottom reservoir chamber 
was filled with freshly prepared 0.02M NaOH. An aliquot (20 pL) of lysis buffer was 
added to the surface of the tube gels. This buffer was prepared as follows:
1. Urea; 9.5 M.
2. Igepal CA-630; 10% (v/v).
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3. Dithiothreitol (DTT; Sigma, Poole); 1M.
4. Resolyte (BDH, Poole, pH 3.5 to 10.0); 0.3 mL.
5. Resolute (BDH, Poole, pH 4.0 to 8.0); 0.2 mL.
6 . Dissolved in 3 mL distilled water.
An aliquot (20 juL) of the test samples containing 9M urea was added to the 
tube gels. The samples were overlaid with sample overlay (10 pL) as below:
1. Urea; 8M.
2. Resolyte (BDH, Poole, pH 3.5 to 10.0); 250 pL.
3. Dissolved in 5 mL distilled water.
The top reservoir chamber was filled with freshly prepared 0.01M H3PO4, ensuring 
the remainder of the tubes was filled and no air bubbles were present. The System was 
run at 500V for five hours. The tube gels were then removed from glass tubes, rolled 
in parafilm and placed in 5 mL SDS sample buffer, for 30 minutes. This buffer was 
prepared to contain:
1. Glycerol; 10% (w/v).
2. DTT; 15% (w/v).
3. SDS (Sodium Dodecyl Sulphate, Sigma, Poole); 2.3% (w/v).
4. Tris-HCl (pH adjusted to pH 6 .8 ); 0.0625M.
The tubes were then stored in the freezer for later analysis.
Preparation of slab gel (second dimension protein separation)
Stock acrylamide solution, 10 mL (73g, acrylamide and 2g, bis-acrylamide 
dissolved in 250 mL distilled water), stock separating buffer, 7.5 mL (lg, SDS and 
45.5g, Tris buffer (2-amino-hydroxymethyl-propane-1,3-diol) were dissolved in less 
than 250 mL of distilled water, the pH was adjusted to 8 .8  with 1M HC1 and then 
made up to 250 mL with distilled water) and 12 mL distilled water were mixed
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together and the whole solution was degassed. Stock ammonium persulphate solution 
45 pL (10% (w/v)), and N,N,N’,N’-tetramethyl-ethylenediamine (TEMED), 15 pL, 
were added to begin the polymerisation process. The mixture was mixed gently to 
avoid re-gassing, and poured into a prepared gel cast (0.5 mm thick: mini-PROTEAN 
II, Biorad). The gel was overlaid with water-saturated butan-2-ol, and left to set for 
approximately lh. The butan-2-ol was removed and the surface of the gel was rinsed 
with distilled water. The tube gel, which had previously been defrosted and placed in 
fresh SDS-sample buffer for 30 minutes, was placed on the surface of the separating 
slab gel, ensuring no air bubbles were present between the tube and slab gels. A few 
drops of 0.1% bromophenol blue were added along the surface of the tube gel. The 
gels are then placed into a vertical slab gel apparatus (a mini-PROTEAN II system, 
Biorad). The upper and lower buffer chambers were filled with reservoir buffer 
(glycine, 0.192 M; Tris-Base, 0.025 M; SDS, 0.1% (w/v). A constant current (35 mA) 
was applied to the gels by a Powerpack (LKB) for approximately 3 h, or until the 
marker dye (the bromophenol blue) front reached the bottom of the gel. The gel was 
removed from the mini-PROTEAN II system and silver stained.
Protocols for the staining of polyacrylamide gels following the separation of 
proteins
Coomassie brilliant blue R-250 staining
This is a two-step staining technique and is capable of detecting approximately 
2.33 pg of protein per band. The gel was transferred to the stain solution (0.2g, 
coomassie brilliant blue; 125 mL, methanol; 25 mL, glacial acetic acid; and 100 mL, 
distilled water). The coomassie dye was dissolved in the ethanol component first, the 
acid and water added later (if dissolved in a different order, the dye’s staining 
behaviour may alter). The gels were allowed to take up the stain for 3 to 4 h, with
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gentle agitation using an orbital shaker (Stuart Scientific, UK). De-staining of the gels 
was achieved by immersion them in the de-stain (450 mL, methanol; 100 mL, glacial 
acetic acid; 450 mL, deionised water) and mixing thoroughly. The stain and de-stain 
are best used when freshly made. After about 24 h, with gentle agitation using an 
orbital shaker (Stuart Scientific, UK) and several changes of de-staining agent, the gel 
background became colourless and left the protein bands stained blue (Smith, 1984).
Silver staining
This stain is useful when the protein concentration is low, as it can detect 
between 0.1 and 1 ng of protein per band (Walker, 1984b). The gel was immersed in 
the fixing solution (see below) for a minimum of 60 minutes; it could also be left 
overnight if desired. Then, it was transferred to wash A for 20 minutes; this step was 
repeated 3 times. The gel was placed in pretreat solution for one minute exactly, and 
then rinsed with distilled water for 20 seconds. This step was repeated 3 times. The 
gel was immersed in the impregnate solution for 2 0  minutes, and then washed twice 
with distilled water for 20 seconds each. Then, the gd was placed in the develop 
solution for as long as required (between 1 to 6 minutes), until the bands were clearly 
visible. The gel was rinsed with distilled water twice for approximately 20 seconds, 
and was transferred to stop solution for 10 minutes. Finally, the gel was placed in 
wash B for 20 minutes. The gel could be stored in this solution for 3 to 4 weeks at 4°C 
(container wrapped with foil).
The prepara tion  o f  S ilver stain solution
Fixing solu tion : (50% methanol (HPLC), 100 mL; 12% glacial acetic acid, 24 mL; 
37% formaldehyde, 100 pL. this was made up to 200 mL with distilled water).
Wash A: (50%  ethanol, 250 mL; made up to 500 mL with distilled water).
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P re trea t so lu tion : (0.04g sodium thiosulphate.5 H2O; made up to 200 mL with 
distilled water).
Im pregnate so lu tion : (0.4g of silver nitrate (anhydrous) and 37% formaldehyde, 150 
jlxL .  This made up to 200 mL with distilled water).
D evelop in g  solution: (12g of sodium carbonate (anhydrous); 37% formaldehyde, 100 
pL and 0.0008g of sodium thiosulphate.5 H2O. This was of made up to 200 mL with 
distilled water). The above solutions only last for a maximum of two weeks.
Stop so lu tion : (50% methanol, 100 mL; 12% glacial acetic acid, 24 mL and it was 
made up to 200 mL with distilled water.
Wash B / Storing solu tion : (50% methanol, 250 mL; made up to 500 mL with 
distilled water).
Reconstitution of Pharmacia low molecular weight (LMWt) markers
Low molecular weight calibration kit SDS-7 Dalton Mark VII-L (for SDS gel 
electrophoresis) is a lyophilised mixture of 7 highly purified well-characterized 
proteins, for use in molecular weight determination in the presence of the detergent 
SDS. The size range of these proteins is between 14. 2 and 66 kDa.
Albumin, Bovine : 66 kDa
Ovalbumin, chicken : 45 kDa
Glyceraldehyde-3 -phosphate 
Dehydrogenase, Rabbit :36 kDa
Carbonic Anhydrase, Bovine : 29 kDa
Trypsinogen, Bovin, PMSF treated : 24 kDa
Trypsin Inhibitor, Soybean : 20.1 kDa
a-Lactalbumin, Bovine : 14.2 kDa
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Reconstitution
(I) For Coomassie brilliant blue detection, 200 pL of lx sample buffer (0.0625 M, 
“Tris”-HCl; 2% SDS; 10% (v/v) glycerol; 0.1 M, DTT and 0.01% bromophenol 
blue) was added to the kit.
(II) For Silver staining, the aliquots were diluted by at least 50-fold in sample buffer 
and reconstituted as above.
For best reproducibility, any unused reconstituted protein solution was discarded. 
If necessary it could be stored for up to 3 months at-80°C.
D enaturation o f  pro tein s
Proteins were heated in a boiling water bath (Gallenkamp) for 5 minutes.
L oading
Proteins markers were loaded in a range of 1 to 5 pL.
Two dimensional SDS-PAGE standards
Bio-Rad’s 2D-PAGE Standards are formulated to provide a two-dimensional 
protein pattern with detection either by Silver or Coomassie staining. The standard 
proteins are defined by isoelectric point (pi) and molecular weight (M-). Added to the 
sample, they are used to determine pis and molecular weights of sample proteins or to 
serve as a marker for 2D gel matching. The characteristic pattern of main and minor 
spots of each standard protein makes them easy to identify among sample spots.
The molecular weight range is from 12.3 to 78 kDa.
Ovotransferrin (hen egg) : 76 to 78 kDa
Albumin (abovine serum) : 66.25 kDa
Ovalbumin (hen egg) : 42.7 kDa
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Carbonicanhydrase (bovine erythrocyte) : 30 kDa 
Myoglobin (equine) : 17.2 kDa
Cytochrome C (equine) : 12.3 kDa
L oading
Using silver staining 1 to 5 pL per mini gel.
Staining of LPS gels
Lipopolysaccharide gels were stained according to Preston and Penner (1987). 
Gels were immersed in fixing solution (ethanol, 400 mL; glacial acetic acid, 50 mL; 
made up to 1L with distilled water) for 16 hours. The gels transferred to oxidizing 
solution (periodic acid, 3.5 g; ethanol, 200 mL; glacial acetic acid, 25 mL; made up to 
500 mL with distilled water) for five minutes with mild agitation and then washed 
twice with distilled water for 15 minutes. The gels were immersed in freshly prepared 
staining reagent (concentrated NH4OH, 2 mL; 0.1M NaOH, 28 mL; 20% w/v AgNOj 
5 mL; distilled water, 115 mL). Gels were agitated vigorously for 10 minutes, and 
then washed three times each for 10 minutes in distilled water. Gels were transferred 
to the develop solution (citric acid, 0.05g; 37% formaldehyde, 0.5 mL;made up to 1 L 
with distilled water) for 2 to 5 minutes or until bands were seen clearly. The develop 
solution was decanted from the gels. The gels were washed twice in distilled water, 
and then stored in distilled water at 4°C in the dark for up to one week.
Protocols for protein purification and separation on the basis of size
Preparation of phosphate buffered saline pH 7.2 (Dulbecco & Vogt 1954)
The PBS was made up from three separate solutions (A, B, and C) .Solution A: 
Sodium Chloride (NaCl) 11.7g; Potassium Chloride 0.2g; Sodium phosphate dibasic
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heptahydrate 1.15g; Potassium dihydrogen phosphate 0.2g, were added and dissolved 
in 800 mL distilled water.
Solution B : Calcium chloride O.lg was added and dissolved in 100 mL distilled water. 
Solution C: Magnesium chloride O.lg was added and dissolved in 100 mL distilled 
water.
All solutions (A, B and C) were autoclaved separately, and reconstituted when cooled. 
Preparation of gel columns
Each column was packed in a vertical borosilicate glass tube (2.5 cm, internal 
diameter across; Econo column, Bio-Rad, USA) having end caps fused to a porous 
polymer bed support (28 pm) that supported the gel. Approximately 20g Sephadex gel 
filtration media G-100 (Sigma, UK) or Bio Gel P-100 (Bio-Rad, UK) were suspended 
in 500 mL of 0.2M NaCl (prepared in PBS, pH 7.2) and allowed to swell for 72 hours. 
Suspensions of the gel were deaerated (5 to 10 minutes with occasional swirling of 
suspension) in vacuo, before use.
Each column was prepared by pouring a thin slurry of appropriate (Sephadex 
G-100 or Bio Gel P-100) gel particles in buffer solution into a vertical tube (Econo 
column, Bio-Rad, UK) already partly filled with buffer, and at the same time allowing 
excess of liquid to percolate through the growing gel bed. The addition of gel was 
continued until a bed height of 95 to 97 cm. was obtained, and then a solvent reservoir 
was connected to the top of the column and the flow of the buffer maintained at a rate 
of approximately 4 mL h*1 for 6  days. Both Sephadex G-100 and Bio Gel P-100 
columns were connected tandem to each other.
Procedure for column runs
All protein purification experiments were done with columns equilibrated with
0.2M NaCl (prepared in PBS, pH 7.2), and a flow rate through the columns of
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approximately 4 mL h' 1 was maintained by using a peristaltic pump (Watson Marlow 
Ltd., Cornwall, UK) attached to the solvent reservoir. All experiments were done at 
room temperature (20 ± 4°C).
Proteins were dissolved in the equilibration buffer (10 mL) and the solution 
was applied to the top of Sephadex G-100 column by layering under the buffer 
already present. The protein solution migrated from the Sephadex G-100 gel over to 
the Bio Gel P-100 gel until they reached the end of the column. Collection of the 
column effluent in fractions with a fraction collector (BROMMA 2070 ULTRORAC, 
Pharmacia LKB, Sweden) fitted with a 30 cm siphon. Collections were made as 
fractions of 2 mL per tube. Proteins were estimated spectrophotometrically by using 1 
mL of each effluent fraction in a cuvette with a 1 cm light path. The wavelength was 
280nm.
Microculture Tetrazolium (MTT) cell proliferation assay to determine activity of 
purified leucocidin
The reduction of tetrazolium salts is now widely accepted as a reliable way to 
examine cell proliferation (Goodwin, et al, 1995; Hynes, et al, 2003). The yellow 
tetrazolium MTT (3-(4, 5- dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) is 
reduced by metabolically active cells, in part by the action of dehydrogenase 
enzymes, to generate reducing equivalents such as NADH and NADPH (Salter, e t al, 
1963; Mosmann, 1983). The resulting intracellular purple formazan can be solubilized 
and quantified by spectrophotometric means. The MTT cell proliferation assay 
measures the cell proliferation rate and conversely, when metabolic events lead to 
apoptosis or oncosis, the reduction in cell viability. For human foreskin fibroblast cell 
type, the linear relationship between cell number and signal produced is established, 
thus allowing quantification of changes in the rate of cell proliferation.
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Preparation of MTT assay solutions
The assay required preparation of four stock solutions.
Solution A: MTT (12mM in 0.2M NaCl (prepared in PBS) pH 7.2), 0.249g were 
dissolved in 50 mL buffer
Solution B : Phenazine methosulphate (PMS) ImM, 0.0153g were dissolved in 50 mL 
of buffer.
Solution C : Potassium cyanide (KCN) 100 mM, 0.325g were dissolved in 50 mL of 
buffer.
Solution D : Sorensens glycerine (optional) (0.1M glycerine in 0.1 M NaCl at pH 
10.5); 0.584g of sodium chloride were dissolved in 100 mL of distilled water; 0.37 
mL of 0.1M glycerine were added to 50 mL of 0.1M NaCl.
Thiazolyl blue (MTT), Phenazine methosulphate (PMS) and Potassium cyanide 
(KCN) stock solutions were reconstituted in 5:2.5:1 ratios immediately prior to use to 
obtain the MTT assay solution.
MTT assay protocol (Goodwin, e t a l  1995)
Human foreskin fibroblast cells were grown in a 25 cm2 cell culture flask 
containing Dulbecco MEM (Minimum Essential Medium Eagle, Sigma, UK), 100 mL 
containing (10% FCS (foetal calf serum) 11 mL; 4mM glutamine, 2 mL; 1 mL 
antibiotic (penicillin / streptomycin; 50 units mL' 1 penicillin and 50 pg mL’ 1 
streptomycin).
Culture cells from culture flask were trypsinized and were centrifuged (MSE 
MISTRAL 2000 UK) at 3500xg. The cells were washed twice in fresh buffer 0.2M 
NaCl (PBS, pH 7.2) and finally pellets were resuspended in 3 mL of Dulbecco MEM 
medium. 24-well microtiter plates containing approx. 450 pL of culture medium per 
well were seeded with the resuspended fibroblast cells at a density of 1 0 4 cells well'1.
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The plates were incubated at cell-line optimal (CLO) conditions at 37°C with 5% CQ 
for 72 h, until confluent or mat growth was observed.
In order to determine the cytotoxic activity of leucocidin, 50 pL of buffer 
0.2M NaCl (PBS, pH 7.2) containing leucocidin (3.2 to 62.4 pg mL*1) was added to 
each microtiter plate well containing fibroblast cells and incubated at 3 f C  and 5%
CO2 for either 30 min or 24 hours. The remaining viable cell number, after leucocidin 
treatment, was assayed by the addition of MTT assay solution (85 pL, 12% w/v). The 
plates were further incubated (37°C with 5% CO2) for 2 hours, after which all
supernatant from the wells were discarded.
Insoluble formazan resulting from the production of MTT within living cells 
was solubilised by the addition of 450 pL DMSO. An aliquot of 50 pL of Sorensen’s 
glycerine was added at this stage to increase sensitivity and reduce variance caused by 
medium. Cells were spun down by centrifugation (MSE Microcentaur) at 10000 rpm 
for 2 min and the optical density for supernatant was measured at 540 nm using a 
spectrophotometer (Novaspec I LKB) against a media blank (Dulbecco MEM). The 
experiment was performed in triplicate.
Viable cell numbers corresponding to optical density readings were obtained 
from calibration curves constructed for the purpose (Figure 10).
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Number of cells
Figure 10: Standard calibration curve for Microculture Tetrazolium Assay (MTT). Error bars 
are calculated as the standard deviation of each data point, n = 3 replicates, (o) Mean absorbency 
at 540 nm.
Mouse Spleen Myeloma (Sn2) cell tissue culture
Sp2 cells (Sp2/0-Agl4 ECACC NO: 85072401) were cultured in RPMI-1640 
(Sigma R0883) medium. 10 mL of a sterile medium (RPMI-1640; Sigma R0883) 
containing 10% FCS (Foetal Calf Serum) 11 mL; Glutamine 4mM 2 mL; 1 mL 
antibiotic (penicillin / streptomycin; Sigma P0906); ImM sodium pyruvate 1 mL 
(Sigma S-8636) in a 25 cm cell culture flask, was inoculated with mouse spleen 
myeloma Sp2 / 0-Agl4 (ECACC NO: 85072401) cells (1.4 x 105 cells mL'1; 300 pL). 
The cell culture flask was incubated (Heraeus instrument, Germany B5060 EK-CO2) 
for 72 h at 37°C with 5% CO2 until mat growth of Sp2 cells was observed under 
microscope (Wilovert (Germany) Inverted microscope). Cytotoxic activity of 
leucocidin on Sp2 cells was observed under phase contrast microscope (LEICA DMR, 
UK) at 400X magnification (Scharmann, et al, 1976).
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Chapter Three: The Effects of Selected Antibiotics on the Growth of 
Pseudom onas aeruginosa ATCC 15692 (PAOl) and E scherichia coli 
ATCC 10000 as both Planktonic and Bio film Cultures
Introduction
Pseudomonas aeruginosa is a Gram-negative bacterium belonging to the 
genus Pseudomonas that can be found in a variety of habitats including soil and fresh 
water streams as well as on plant and animal tissues (Hardalo & Edberg 1997; Boyd 
& Chakrabarty, 1995). Members of this genus are characterised by their ability to 
grow in water because of their simple nutritional requirements: they will even grow in 
distilled water and natural mineral water (Legnani et al., 1999). The ecological 
versatility of this organism is partly credited to its large genome size (6.3 Mbp) (Bal,
2000). Selective expression of genes required for a particular habitat, will enable the 
organism to survive in adverse circumstances (Ewing & Green, 2000). Ps. aeruginosa 
is of particular interest as a human pathogen, which rarely causes infection in the 
healthy host. In all these environments, the microbes are found predominantly 
attached to solid surfaces forming biofilms (Pollacket al., 1995).
The growth of these bacteria in natural environments is inhibited by periods of 
insufficient levels of energy and nutrients (Gilbert et al., 1990). The bacterial cultures 
undergo a series of physiological or phenotypic changes, which enable the survival of 
some of the cells (Turner et al., 2000). A series of rapid metabolic adjustments have 
also been reported during nutrient-limited conditions (Turner et al., 2000). The 
metabolic changes activate the stringent response. A similar mechanism is also 
thought to take place in stressed cells present within the biofilm.
It was suggested that the stringent response might be at least partially 
responsible for the increased resistance to antibacterial agents at slow growth rates 
(Stewart, 2002; Gilbert et al., 2002a & 2002b; Lewis, 2001; Greenway & England,
64
1999a). Also implicated are alternative sigma factors, one of which (d, encoded by 
the rpoS gene) directs gene expression during stress conditions and slows growth 
(Greenway & England, 1999b). However, it has recently been proposed that the sigma 
factors RpoS and AlgT may play a transient role in protecting thin, but not thick, 
biofilms of Ps. aeruginosa against hydrogen peroxide (Cochran et ah, 2000b).
The growth characteristics of Pseudomonas aeruginosa PAOl
In order to estimate the rate of microbial reproduction, it is necessary to 
determine the numbers of microorganisms present. The growth of Pseudomonas 
aeruginosa can be estimated by several different methods, including the total count, 
the viable count and turbidometric procedures. The viable plate count method is one 
of the most common procedures for the enumeration of bacteria. It is used to 
determine the viable population in a bacterial culture. In this procedure, serial 
dilutions of a bacterial suspension are plated onto a suitable solid growth medium in 
order to determine the number of colonies. It is assumed that each colony arises from 
an individual bacterial cell. Therefore, by counting the number of colonies that 
develop and by taking into account the dilution factors, the concentration of bacteria 
in the original sample can be determined as colony-forming units (CFU) (Salvesen & 
Vadstein, 2000). A major limitation of the viable plate count procedure is its 
selectivity. It measures only those cells that are capable of growth on the given plating 
medium under the set of incubation conditions that are used. Sometimes cells are 
viable, but nonculturable (VNC) unless steps are taken to acclimate the 
microorganisms to laboratory culture conditions (Duncan et al., 1994; Bloomfield et 
ah, 1998). Bacteria can also be enumerated by direct counting procedures (total count 
or microscopy), that is, counting without the need to first grow the cells in culture.
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However, the difficulty in establishing the metabolic status of the observed bacteria, 
that is, whether the cells are living or dead, is a major limitation of this procedure.
Measuring the amount of light that passes through a bacterial suspension with 
a spectrophotometer can be used for estimating cell mass, since the amount of light 
observed or scattered by the bacteria is proportional to the cell density (Fuchs & 
Kroger, 1999). An increase in cell mass, which can be equated with increases in the 
number of bacterial cells, is useful for establishing a growth curve for a bacterium. At 
low densities, the absorbency is roughly proportional to the cell number, but at higher 
densities, there is a significant deviation from linearity. Therefore, this procedure is 
only accurate when the absorbency at 470nm is less than 0.5, above this point the 
sample must be diluted (Lawrence & Maier, 1977).
Experimental approach
The overnight culture of Pseudomonas aeruginosa PAOl
25 mL of a sterile medium (CDM), in a 100 mL Erlenmeyer flask, was 
inoculated with a pure culture of Pseudomonas aeruginosa PAOl (single colony, 
from a streak plate). The flask was incubated overnight in an orbital incubator 
(Gallenkamp INA-305) at 37°C, 180 osc min'1.
The test culture o f Pseudomonas aeruginosa PAOl
A fresh aliquot (25 mL) of medium (CDM) was inoculated with 250 pL of 
Pseudomonas aeruginosa PAOl overnight culture. This was performed in duplicate 




1 mL of test culture was aseptically removed (from flask A) and the optical 
density (turbidity) was measured at 470 nm (E470) using a spectrophotometer 
(Novaspec I LKB) against a sterile media blank. The sample was aseptically replaced 
back into the flask so that the volume of the flask did not significantly alter, as a 
compromise in the volume may cause a corresponding compromise in nutrients and 
space availability and cause the exponentially growing bacteria to undergo an early 
shift into the stationary phase. This was performed at hourly intervals for 24 hours. If 
the absorbency was greater than 0.5, a dilution of the culture was made (1:10), 
(Lawrence & Maier, 1977). This diluted sample was discarded after reading the 
optical density. To calculate the optical density for this sample, E470 was recorded 
and multiplied by 1 0 , thus giving the actual optical density of the sample.
Viable count
An aliquot (1 mL) of the identical test culture (flask B) was aseptically 
removed and serially diluted in the range of 10' to 10'. Aliquots (100 pL) of the 
dilutions were spread plated onto appropriate agar plates (CDM agar). These plates 
were prepared in triplicate (three plates for each dilution). The plates were incubated 
overnight at 37°C. After 24 hours, colonies were counted in each plate and viable 
counts were calculated according to Equation 1:
CFU m l/1 = N (1/DF) (Equation 1)
Where; N = Mean of counts on the plates (must be in the range of 30-300 colonies per 
plate to be counted. If it was above 300, colonies cannot be distinguished as 
individual colony-forming unit, “TNTC”. Fewer than 30 colonies are not acceptable 
for statistical reasons). DF = Dilution factor.
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Results & Discussion
Figure 11 presents the growth curve of Pseudomonas aeruginosa PAOl in 
CDM. CDM is a chemically defined medium, where the nutrient supply is generally 
lower than other medium. Therefore, it was expected that the growth would be 
considerably slower. The cells in this medium were in lag phase for 1 hour before 
they entered the exponential phase. The exponential phase was very long, lasting 
between 1 and 18 hours after inoculation. Mid exponential phase was at 9.5 hours 
after inoculation. The generation time in CDM was calculated to be 110 minutes (1.7 
hours). The growth rate in CDM was slow because the nutrient sources in this 
medium were limited and it took the bacteria 1 hour to prepare for their proliferation. 
During the exponential phase bacterial growth was not rapid and increases in the 
bacterial biomass against time were slow. This result suggests CDM was sufficiently 
stringent to be used in further experimentation.
CDM is a defined medium that is a medium in which the concentrations of all 
components are known. This medium includes an organic carbon growth substrate, 
glycerol, a source of nitrogen, NH4CI, ferric ammonium citrate and water. It also 
includes potassium, magnesium, calcium, iron and chloride as trace elements (Chapter 
2). Therefore, it is relatively easy to use this medium as a nutrient limited medium by 
controlling variation of each component such that one is restrictive and the remainder 
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Figure 11: The observation of growth of Pseudomonas aeruginosa PAOl in CDM. Error bars are 
calculated as the standard deviation of the individual data points, n = 3 replicates, (o ) Iog10 viable 
count (CFU mL'1); (A) log10 OD at 470 nm.
The control experiment for Pseudomonas aeruginosa PAOl biofilm cultures
An overnight culture (OD 470nm = 1.00) of Ps. aeruginosa PAOl grown in 
Modified Chemically Defined Medium (MCDM) (Dinning, 1995) was used to 
inoculate (10 mL) a pre-wetted (with the addition of 5 mL 0.9% (w/v) sterile normal 
saline) sterile Sorbarod filter, held within sterile PVC tubing (Figure 6 ) Sorbarod 
Model System Chapter 2). This was perfused with MCDM at 37°C, using a peristaltic 
pump and tubing calibrated to give a flow rate of 2.2 mL min’1. The number of cells 
eluted (into a sterile receiving reservoir) from the Sorbarod filters were estimated with 
time by performing viable counts until the rate of loss of cells from the filter had 
decreased to a constant steady-state value, which was maintained for several days.
This experiment was performed in triplicate. Pseudo-steady states were established 
at which the growth rate of the biofilm was reproducible, measurable and significantly 
slower than in broth culture. At 102 hours after achieving steady-state, Sorbarod
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filters were removed and stored at -18 °C for later analysis. Since steady- state had 
been achieved in both the biofilm and eluate populations, growth rate could be 
calculated from knowledge of the elution-rate. The mean of the logarithm of viable 
counts for the three biofilms was plotted against time (h) to establish the growth curve 
of Ps. aeruginosa biofilm (Figure 12).
Figure 12: Graph of mean biofilm eluate counts (Ps. aeruginosa PAOl perfused with MCDM) 
over Time. Error bars are calculated as the standard deviation of the individual data points, n = 
3 replicates, (o) log10 viable count (CFU mL'1).
Viable cell number
An aliquot (100 pL) of eluate culture was aseptically removed and used for 
preparation of serial dilutions in the range of 10'2 to 10‘9. Aliquots (100 pL) were 
spread plated onto sterile CDM agar plates, in triplicate. The plates were incubated at 
37°C for 48 hours and the subsequent colonies were counted.
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The growth characteristics of Escherichia coli ATCC 10000
Escherichia coli is a Gram-negative bacterium that exhibits great tolerance 
towards many antimicrobial agents (Stone, et al., 2002). Vaara (1993) reported that 
antibiotics of natural origin showed that >90% lacked activity against E. coli. If E. 
coli cells are exposed to antibiotics (such as chloramphenicol or tetracycline), at 
concentrations slightly greater than their minimum inhibitory concentration (MIC), 
resistant derivatives are observed, which not only occur at high frequencies, but which 
also give cross-resistance to other antibiotics. This is the so-called multiple antibiotic 
resistance {mar) phenotype (George & Levy, 1983a & 1983b).
When E. coli encounters environmental stress conditions, such as nutrient 
limitation and/or the presence of antimicrobial agents, growth rate slows down and 
there is a marked alteration in gene expression. This change in gene expression is 
essential for the long-term survival of bacteria and is, in part, mediated by alternative 
sigma factors (Greenway & England, 1999b). One such sigma factor, that appears to 
be a key transcriptional factor directing gene expression during stress conditions and 
slow growth, is the stationary phase a s factor (Lange & Hengge-Aronis, 1994).
Microorganisms such as E. coli may live a lifestyle described as yeast or 
famine,'> (Schlessinger & Schaechter, 1989) and thus, the bacterium has evolved so 
that it is able to survive both extremes, which may follow each other in rapid 
succession. Adams and McLean (1999) studied E. coli biofilm formation in 
chemostats and compared strains with and without the rpoS gene. E. coli cells that 
lack rpoS are unable to form normal biofilms, whereas planktonic cells are apparently 
unaffected by the absence of this a factor. This result strongly suggests that 
conditions that elicit a slowing of bacterial growth, such as nutrient limitation or build 
up of toxic metabolites, are conducive to the formation of biofilms, at least for this 
microorganism {E. coli) (Donlan, 2000).
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The up-regulation of the mar operon results in multidrug- resistant phenotypes 
in E. coli planktonic cultures. However, Maria-Litran et al. (2000a) did not support 
the idea that the mar operon is up regulated in biofilms, as the level of mar was lower 
in biofilms compared with the level seen in equivalent stationary-phase cultures 
grown in batch. Furthermore this same group made use of mar- and acrvf^-deleted 
strains to determine if resistance of E. coli to ciprofloxacin was affected by the loss of 
these loci (AcrAB is the efflux pump, which is thought to be responsible for the 
multidrug resistant phenotypes in E. coli planktonic cells) (Maira-Litran et al., 
2000b). Loss of mar and acrAB did not adversely affect the E. coli biofilms, but 
constitutive expression of acrAB did provide a certain level of protection against 
ciprofloxacin (Maira-Litran et al., 2000b).
Experimental approach 
Test cultures
Sterile R2A medium, 25 mL in a 100 mL Erlenmeyer flasks (A, B) were 
inoculated with a pure culture of E. coli ATCC 10000 from a streak plate. The flask 
was incubated overnight at 37°C, 180 osc min"1, in an orbital incubator (Gallenkamp 
1NA-305). A fresh aliquot (25 mL) of medium (R2A) was inoculated with 250 jliL of 
E. coli overnight culture; this was performed in triplicate. The cultures were incubated 
at 37°C, 180 osc min'1, in an orbital incubator (Gallenkamp 1NA-305).
Assay for growth
At hourly intervals an aliquot (1 mL) of culture was removed aseptically from 
each flask and the optical density was measured at 470 nm using a spectrophotometer 
(Novaspec II LKB). The sample was aseptically replaced in the respective flask. If the 
optical density reading was greater than 0.5 at E^ onm, a 1 in 10 dilution of the culture
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was performed in sterile medium (Lawrence & Maier, 1977). This was not returned to 
the flask, but discarded. The OD at 470nm of this dilution was observed and the 
volume multiplied by 10  to give the actual optical density.
Viable count
1 mL of the identical test culture (flask B) was aseptically removed and 
serially diluted in the range of 10'2 to 10'8. Aliquots (100 pL) of the dilutions were 
spread plated onto appropriate agar plates (R2A agar). These plates were prepared in 
triplicate (three plates for each dilution). The plates were incubated overnight at 37°C. 
After 24 hours, colonies were counted in each plate and viable counts were calculated 
according to Equation 1.
Results & Discussion
Figure 13 presents the growth curve of Escherichia coli ATCC 10000 in R2A 
medium, where the nutrient supply is considerably when compared to the CDM 
medium used with Ps. aeruginosa. Therefore, it was expected that the growth would 
be considerably higher. The lag phase in this medium was short, lasting 1 hour before 
they entered the exponential phase. The exponential phase lasted between 5 and 6  
hours after inoculation. Mid-exponential phase was at 5.5 hours after inoculation. The 
generation time in R2A was calculated to be 18 minutes. This type of growth was 
expected in this kind of medium (R2A) is a nutrient-enriched medium and it is 
deficient in iron (Reasoner & Geldreich 1985).
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Figure 13: The observation of growth of Escherichia coli ATCC 10000 in R2A medium. Error 
bars are calculated as the standard deviation of the individual data points, n = 3 replicates, (o) 
logioOD at 470 nm; (A) logi0 viable count (CFU mL'1).
The control experiment for E. coli ATCC 10000 biofilm cultures
Establishing E. coli biofilm on a Sorbarod filter was similar to that for Ps. 
aeruginosa PAOl biofilm (Hodgson et al., 1995; Chapter 2). The Sorbarod filter was 
pre-wetted with 5 mL of 0.9% (w/v) sterile normal saline then inoculated with mid- 
logarithmic phase culture (10 mL) from a syringe dropwise onto the Sorbarod. The 
rubber plunger seal was withdrawn from a sterile, disposable 2 mL syringe. The 
syringe was introduced into PVC tubing containing the Sorbarod and a sterile, 
disposable needle (0.8 x 40 mm) inserted through the rubber seal.
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Media inlet tubing was attached via the needle and sterile modified CDM was 
delivered into the unit. Triplicates of these units were established and placed within a 
37°C incubator. Numbers of cells eluted from the Sorbarod filters were estimated with 
time by performing viable counts until achieving the steady state value. At 56 hours, 
after reaching steady-state, Sorbarod filters were removed and stored at -18 °C for 
later analysis. Since steady-state had been achieved in both the biofilm and the eluate 
populations, growth rate can be calculated from a knowledge of the elution-rate. The 
logarithm of the viable counts was calculated and plotted against time to establish the 
growth curve of E. coli biofilm (Figure 14).
Figure 14: Graph of mean biofilm eluate counts (Escherichia coli ATCC 10000, perfused with 
modified (MCDM) over Time. Error bars are calculated as the standard deviation of the 
individual data points, n = 3 replicates, (o) Iog10 viable count (CFU mL'1).
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Studies on binary biofilms (Pseudomonas aeruginosa ATCC 15692 (PAOl) and 
Escherichia coli ATCC 10000)
Many studies have focused on adhesion and biofilm formation by planktonic 
monocultures (e.g., Ps. aeruginosa’, Costerton et al., 1995). However, under natural 
conditions, true monospecies biofilms are comparatively rare and in most natural and 
industrial environments, biofilms are complex multi-species communities (Skillman 
et al., 1999). Although prominent in nature, much less information is known about 
mixed population biofilms. Bacteria do not have uniform colonization and 
physiological properties (Fletcher, 1991), a feature that enables them to utilize 
different ecological niches. Therefore, one would predict that increasing species 
diversity of planktonic bacterial communities would lead to increased species 
diversity and overall cell density within biofilms (Whiteley et al., 2001b). The 
resultant biofilms may be thicker and more stable than monospecies biofilms and this 
could further influence their susceptibly to antimicrobials (Bourion & Cerf, 1996). 
Evans et al. (1991) examined growth-rate related effects under controlled growth 
conditions for planktonic cultures and biofilms of Ps. aeruginosa and E. coli. The 
general observation was that the sensitivities of both the planktonic and biofilm cells 
towards ciprofloxacin increased with increasing growth rate, thus supporting the 
suggestion that the slow growth rate of biofilm cells protects the cells from 
antimicrobial action.
The control experiment for binary biofilms (Pseudomonas aeruginosa ATCC 
15692 (PAOl) and Escherichia coli ATCC 10000)
In order to establish a binary biofilm, the Sorbarod model was used (Hodgson 
et al., 1995; Chapter 2). The Sorbarod filter was inoculated with mid-logarithmic 
phase of E. coli culture (10 mL). This was perfused with modified chemically defined
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medium (MCDM) at 37°C. Modified CDM was suitable for the optimal and non- 
advantageous growth of both microorganisms Ps. aeruginosa and E. coli. In order to 
achieve this, CDM was modified by increasing the concentration of nitrogen (the 
concentration of nitrogen (NH4CI) in solution A (CDM) was 0.0187 M; in MCDM the 
concentration was modified to 0.0280 M) and decreasing the concentration of carbon 
(solution C: the concentration was decreased from 1M to 0.66 M) (Chapter 2). These 
modifications in the concentrations of carbon and nitrogen will make the doubling 
times for both bacteria closer to each other in this modified CDM (Al-Hmoud, 2002). 
The E. coli biofilm was run for 48 hours (steady-state) before adding an aliquot (10 
mL) of mid-logarithmic phase of Ps. aeruginosa to the Sorbarod filter. This was 
performed in order to give E. coli a “head start” in establishing itself on the Sorbarod 
filter and building the first monolayer of colonies before adding Ps. aeruginosa to the 
community. This system was run for 126 hours, in order to achieve the steady-state 
for both microorganisms. This was performed in triplicate. The eluate culture was 
collected at six-hour intervals and viable counts were performed for each eluate 
sample. The colonies were counted for each plate and the logarithm of viable counts 
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Figure 15: Graph of mean binary biofilm eluate counts for P seudom onas aeruginosa  ATCC 
15692 (PAOl) and Escherichia coli ATCC 10000 over Time. Error bars are calculated as the 
standard deviation of the individual data points, n = 3 replicates, (o) log10 viable count (CFU mL' 
') for E. co li; (A) log10 viable count (CFU mL'1) for Pseudom onas aeruginosa.
Viable cell number
An aliquot (100 pL) of eluate culture was aseptically removed and used for the 
preparation of serial dilutions in the range of 10" to 10" . Aliquots (100 pL) were 
spread plated onto sterile Chromogenic E. coli / Coliform agar plates (Oxide LTD., 
Basingstoke, Hampshire, England) in triplicate. The plates were in incubated at 37°C 
for 48 hours and the subsequent colonies were counted. Using the Chromogenic E. 
coli / Coliform agar was essential in this experiment to differentiate between both
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types of bacteria. Ps. aeruginosa gives straw colonies while E. coli gives purple 
colonies on this agar (Figure 6 Chromogenic Medium, Chapter 2).
This experiment was performed by adding both bacteria (Ps. aeruginosa and 
E. coli) on the Sorbarod filter, simultaneously. The resultant binary biofilm was 
characterised by the dominance of Ps. aeruginosa. This may be partially explained by 
the extensive piliation of Ps. aeruginosa. Pratt & Kolter (1998) revealed that the 
presence of type I pili is essential for the initial attachment of E. coli on abiotic 
surfaces, but no role in facilitating the development of mature biofilm has been 
documented. Unlike type I pili in E. coli, Ps. aeruginosa type IV pili are not essential 
for the initial attachment to abiotic surface (O’Toole & Kolter, 1998). However, it has 
been suggested that type IV pili and type IV pili-mediated twitching motility inPs. 
aeruginosa play a role in biofilm development (Pratt & Kolter, 1998). O’Toole and 
Kolter (1998) proposed that type IV pili have a direct role in stabilizing interactions 
with the abiotic surface and/or in the cell-to-cell interactions required to form a 
microcolony. Type IV pili-mediated twitching motility may also be necessary for cells 
to migrate along the surface to form the multicell aggregates characteristic of the 
wild-type strain.
Results & Discussion
The relative concentrations of Ps. aeruginosa and E. coli in binary biofilms, as 
determined by observation of eluate cell numbers (Figure 15) could not be predicted 
from their relative abundance in monospecies communities (Figure 12 & 14). The 
overall effect of growth conditions (monoculture and binary) on population size was 
shown to be significant, indicating interactions between Ps. aeruginosa and E. coli in 
binary culture. If no interactions were occurring between these two species, binary 
biofilm numbers would equal the sum of Ps. aeruginosa and E. coli monoculture
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biofilms. Differences in Logio counts between binary biofilms (8.73 ±0.1943 forPs. 
aeruginosa and 8.44 ± 0.103 for E. coli) and those for monospecies biofilms (Ps. 
aeruginosa 9.1 ± 0.065 and E. coli 8 .6 6  ± 0.325) indicate that binary biofilms are not 
simply a result of the addition of monoculture values. Therefore, the presence ofE. 
coli cells has a negative effect on Ps. aeruginosa population numbers. The numbers of 
Ps. aeruginosa decreased when grown in binary cultures, whereas the numbers ofE. 
coli in the same culture did not alter significantly. This observation once again 
reinforces the concept that planktonic population compositions may not accurately 
predict the biofilm population (Whiteley et al., 2001b).
The growth inhibitory and antimicrobial activity of selected antibiotics on the 
growth of Ps. aeruginosa ATCC 15692 (PAOl) and Escherichia coli ATCC 10000 
as both planktonic and biofilm Cultures.
Concentration and contact time are critical factors that determine the 
effectiveness of an antimicrobial agent against a particular microorganism 
(McDonnell & Russell, 1999; Russell & McDonnell, 2000). Microorganisms vary in 
their sensitivity to particular antimicrobial agents (Russell, 1999). Generally, growing 
microorganisms are more sensitive than organisms in dormant stages, such as spores 
(Turner et al., 2000). Many antimicrobial agents are aimed at blocking active 
metabolism and preventing the organism from generating the macromolecular 
constituents needed for reproduction (McManus, 1997). Because resting stages are 
metabolically dormant and are not reproducing, they are unaffected by such 
antimicrobial agents (Turner et al., 2000). Similarly, viruses are more resistant than 
other microorganisms to antimicrobial agents because they are metabolically dormant 
outside host cells (Brown, 1984).
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Antimicrobial agents used in medical practice are aimed at eliminating 
infecting microorganisms or preventing the establishment of an infection (Chen & 
Stewart, 2000). In medicine, biofilms are responsible for numerous difficult-to- 
manage infections (Costerton et al, 1999; Costerton, 2001). Antimicrobial agents are 
widely used to control biofilm formation, but they are found to be less effective 
against biofilm cells than they are against cells of the same microbial strain grown in 
conventional suspension cultures (Dodds et al, 2000). Antibiotics, which are defined 
as antimicrobial substances produced by microorganisms, were discovered by Sir 
Alexander Fleming. They have been used in medicine only since the mid-1940s 
(Barbosa & Levy, 2000). Although many of the antimicrobial compounds used today 
are in fact produced by microorganisms and therefore, are actually antibiotics, some 
are produced partly or entirely by chemical synthesis.
The biochemical differences in the cell structures of bacterial (prokaryotic) 
cells and eukaryotic cells form the basis for the effective use of antibiotics against 
bacterial infections (Lynn & Solotorovsky, 1981). The bacterial cell wall, with its 
unique peptidoglycan layer structure, and the 70s ribosome represent two major sites 
against which antimicrobial agents may be directed (Russell, et al 1997).
Most of the common antibiotics used in medicine for treating bacterial 
infections are inhibitors of cell wall, protein synthesis or DNA replication (Neu, 1992; 
Goessens, 1993). For example, cephalosporins, aminglycosides, tetracyclines and 
quinolones are used to treat endocarditis, meningitis, tuberculosis and pneumonia 
(Foley & Gilbert, 1996). However, concern is mounting in the medical field about the 
overuse of antibiotics because the undesired side effect is the selection for disease- 
causing antibiotic-resistant strains (Barbosa & Levy, 2000). The reason for concern 
about how we use antibiotics is that numerous bacterial strains have acquired the 
ability to resist the effects of some antibiotics, with some bacterial strains, generdly
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those containing R plasmids, having multiple antibiotic resistance mechanisms 
(Mulamattahil et al., 2000). Plasmid-encoded bacterial resistance has emerged to 
various antibiotics such as (3-lactams, aminoglycosides, aminocyclitols, tetracyclines, 
macrolides and chloramphenicol (Russell, 1997).
It has been proposed that intrinsic resistance in Gram-negative bacteria has the 
greatest significance (Russell, 1997). Resistance to antibiotics in Gram-negative 
bacteria is more likely, where less specific mechanisms are involved (e.g. the outer 
membrane may act as a non-specific exclusion barrier, thereby preventing the uptake 
of chemically unrelated molecules; Russell et al., 1997; Russell et al., 1998). Cell 
envelope changes have been observed microscopically, implicating the outer 
membrane as being involved in this reduced susceptibility. However, in bacteria 
grown planktonically, it is now known to be the combined action of multidrug 
resistance (CDR) efflux pumps and decreased OM permeability that confers this 
resistance (Masuda etal., 1995).
The intrinsic resistance of Ps. aeruginosa to numerous antimicrobial agents is 
even more pronounced when this microorganism is found growing as a biofilm. 
Antimicrobial resistance is a trait typical of most biofilm microorganisms and it has 
been speculated that biofilms are the causative agent of up to 65% of bacterial 
infections (Potera, 1999). The mechanisms by which microorganisms in a biofilm 
evade killing by antibiotics are of obvious practical interest and are just beginning to 
be discovered. It is now clear that there must be multiple resistance mechanisms (Mah 
& O’Toole, 2001).
There are three types of hypothesised mechanisms of reduced biofilm 
susceptibility to antimicrobial agents. The first of these is faibre of the antimicrobial 
agent to penetrate the full depth of the biofilm. This is due to the presence of a 
polysaccharide matrix enveloping the biofilm community. However, the inherent
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mobility of antimicrobial agents within the biofilm is unlikely to be restricted enough 
to account for the profoundly reduced susceptibility of biofilm microorganisms 
(Dodds et al., 2000). It is only when the antimicrobial agent is reactively neutralized 
in the surface layers of the biofilm, faster than it diffuses into thebiofilm interior that 
penetration limitations occurs (Dodds et al., 2000). Studies have shown that many 
antibiotics diffuse completely through the biofilm, but with a reduced rate of transfer 
(Stewart, 1996). The ability of these agents to penetrate depends on their not being 
prone to deactivation in the biofilm. Therefore, penetration is most viable as a 
resistance mechanism when dealing with thick biofilms and highly reactive 
antimicrobials. Even when the antimicrobial agent is not particularly reactive or when 
the biofilm is very thin, biofilm bound microorganisms can display remarkable 
resistance to killing. In these cases, some other resistance mechanism must be at work 
because penetration-limitation is not a tenable theory under these conditions (Dodds 
et al., 2000).
A second mechanism of biofilm reduced susceptibility requires that at least 
some of the cells within a biofilm experience a nutrient limitation that causes them to 
enter a slow growing or starved state (Desai et al., 1998). It is well known that the 
physiology of biofilm cells is remarkably heterogeneous and varies according to the 
location of individual cells within the biofilm (Sternberg e/ al., 1999). Cells located at 
the biofilm surface presumably have adequate supplies of nutrients and are 
metabolically active, while deeply embedded cells are likely to be metabolizing more 
slowly due to potential nutrient and oxygen limitations (Huang et al., 1998). Because 
many antimicrobial agents require actively metabolizing cells to be effective, the 
presence of slow growing or dormant cells is thought to represent a resistant 
population (Stewart 2002; Gilbert, et al. 2002b).
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The third mechanism of reduced biofilm susceptibility suggests that bacteria 
growing in a biofilm undergo distinct phenotypic changes associated with surface- 
attached growth that render them more resistant (Cochran et al., 2000a). At present, 
very little is known about the genotypic and/or phenotypic changes that occur as cells 
transition from planktonic to the biofilm mode of growth (De Kievit et al., 2001). 
Brooun et al., (2000) showed that cells liberated from slP s . aeruginosa  PAOl biofilm 
into growth medium were considerably more resistant to tobramycin than planktonic 
cells. This experiment suggested that cells become intrinsically more resistant when 
growing in the biofilm and retain part of this resistance even outside the biofilm. 
Therefore, one can suggest that biofilms are probably protected by multiple resistance 
mechanisms (Stewart, 2001). Mah & O’Toole (2001) suggest the possibility that 
multiple resistance mechanisms operate in concert within a single biofilm community.
Antimicrobial susceptibility testing
Determination of the antimicrobial susceptibility of a pathogen is important in 
aiding the clinician to select the most appropriate agent for treating this disease. The 
most common approach to antimicrobial susceptibility testing is to determine the 
minimum inhibitory concentrations (MIC) using tube dilution procedures (Ceri et al.,
1999). The MIC measures the actions of antibiotics against planktonic 
microorganisms and serves as an important reference in the treatment of many acute 
infections.
Application of MICs in the treatment of chronic or device-related infections 
involving bacterial biofilms is often ineffective (Costerton et al., 1995). MIC is, in 
effect, a range of concentrations depending on the dilution series used. Measurement 
of the MIC should be used as an indicator of activity rather than something of real 
substantive value (Lambert & Pearson, 2002).
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A useful definition of the MIC is “the lowest concentration, which results in
maintenance or reduction of inoculum viability” (Carson et al., 1995). The 
determination of the MIC involves a semi-quantitative test procedure, which gives an 
approximation to the lowest concentration of an antimicrobial needed to prevent 
microbial growth. In the recent past, the method used tubes of growth broth 
containing a test level of preservative, into which an inoculum of microbes was 
added. The end result of the test was the minimum concentration of antimicrobial, 
which gave a clear solution (i.e. no visible growth) (Davidson & Parish, 1989).
The aims of these experiments were to determine the Minimum Inhibitory 
Concentration (MIC) of selected antibiotics (ampicillin (AmP), nalidixic acid, (NaL) 
and streptomycin (ST)) against both monoculture and binary biofilms of Ps. 
aeruginosa ATCC 15692 (PAOl) and Escherichia coli ATCC 10000. In particular, 
the determination of the planktonic MIC was undertaken in order to allow for an 
estimate of in-use MIC for subsequent biofilm experiments to be carried out. Besides 
yielding a set of MIC values forPs\ aeruginosa and E. coli grown as pure cultures in 
planktonic, biofilm and eluate forms, MIC determination also allowed selection of 
suitable sub-MICs of antibiotics. Additionally, mixed or binary biofilms of Ps. 
aeruginosa and E. coli were established and the MIC of these cultures and their eluate 
cells were also determined.
The antibiotics were selected from a broad range of classes, which include 13- 
lactams (ampicillin), quinolones (Nalidixic acid) and aminoglycosides 
(Streptomycin), respectively. The mode of action and targets of these different classes 
of antibiotics differ. While the 13-lactams, target the disruption of peptidoglycan 
synthesis due to competitive inhibition of the transpeptidation process; the quinolones 
(Nalidixic acid) and the aminoglycosides (streptomycin) disrupt internal processes of 
the bacterial cell. The quinolones bind the DNA gyrase and inhibit supercoiHng of the
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bacterial DNA, while the aminoglycosides inhibit protein synthesis by forming 
complexes with bacterial ribosomes. As indicated in Table 2 (Chapter 1), a number of 
antibiotics that fall within these general classes are currently being used for treatment 
against Pseudomonas infections.
Over the last 15 years, trends have indicated a decrease in susceptibility ofPs. 
aeruginosa towards these antibiotics (Hauser & Sriram 2005). Hence, there is reason 
to believe that this may be due to differential gene expression or adaptive mutations, 
leading to the expression of an unique set of outer membrane proteins responsible for 
the resistant phenotype. Hence, experiments were designed using sub-MICs of 
antibiotics to qualitatively visualise the changes in the outer membrane proteins 
(resulting from differential gene expression or adaptive mutations due to antibiotic 
influence) using SDS-PAGE and 2D-PAGE.
Monospecies and binary biofilms ofPs. aeruginosa ATCC 15692 (PAOl) and 
Escherichia coli ATCC 10000 were subjected to sub-minimum inhibitory 
concentrations (MIC/16) of ampicillin, nalidixic acid and streptomycin respectively. 
Although the use of sub-MICs had a negative effect on the growth rate of 
Pseudomonas aeruginosa and E. coli, biofilm formation was not hampered. Such 
biofilms were used for further investigation regarding the development of tolerance or 
resistance towards the selected antibiotics.
Minimum Inhibitory Concentrations (MICs) were determined for 
Pseudomonas aeruginosa and E. coli cultures in the planktonic, eluate and biofilm 
states. Separately MICs were also determined for binary biofilms. Determination of 
the MIC values would reflect the capacity of the bacteria to tolerate antibiotics. 
Changes in MIC values should indicate corresponding organismal changes in 
antibiotic susceptibility. For example, a positive increase in MIC values would 
suggest that the bacteria are more resistant to antibiotics, while a decrease would
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indicate the opposite. In a different perspective, an increase in the MIC values may 
also indicate a corresponding increase in the pathogenic potential of the organism. 
This may be so as the organism is now capable of tolerating and causing disease in the 
presence of antibiotics. Although as indicated previously, a number of studies (Wilson 
et al. 2002; Drago et al. 2001; Kim et al. 2001; Braga et al. 2000) have reported a 
decrease in the pathogenic potential of the organism in the presence of antibiotics, this 
study aims to investigate this hypothesis in sub-MIC exposed biofilms.
Experimental approach
MIC determination for planktonic culture ofPs. aeruginosa PAOl
Aliquots (9 mL) of sterile Modified CDM medium (MCDM) were prepared 
and doubling increases of antibiotics (lpg mL'1 to 512 pg mL'1) were added in 1 mL 
aliquots. Tubes were inoculated with 100 pL of a 16 h (overnight) culture of Ps. 
aeruginosa PAOl grown at 37°C, 180 osc min’1 and vortexed (Rotamixer, Hook and 
Tucker). The tubes were incubated at 37°C and observed for growth after 48 h. The 
MIC was determined as the lowest concentration of the antibiotic showing no visible 
growth after 48 hours (Bloomfield, 1991; Figure 16).
MIC determination for biofilm and eluate culture ofPs. aeruginosa PAOl
A biofilm of Ps. aeruginosa PAOl was established on a Sorbarod filter 
(Chapter 2; Hodgson et al., 1995). This biofilm was perfused with MCDM at 37°C. 
This was only run for 102 hours (to reach steady-state). At 102 hours, the Sorbarod 
filters were sacrificed (the adherent cells were removed and resuspended in 0.9% 
(w/v) sterile normal saline) and the MICs for three selected antibiotics (ampicillin 
(AmP), nalidixic acid (NaL) and streptomycin (ST)) were determined according to the
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tube dilution method (Bloomfield, 1991) using a standard inoculum (100 pL). This





Figure 16: Summary of MIC results obtained against Ps. aeruginosa  ATCC 15692 (PAOl)
planktonic, biofllm and eluate cells cultured in modified CDM. Error bars are calculated as the 
standard deviation of the individual data points, n = 3 replicates. NB: SD = 0, hence error bars 
are inapparent.
MIC determination for planktonic culture o f Escherichia coli ATCC10000
Aliquots (9 mL) of sterile MCDM prepared and doubling increases of 
antibiotics (lpg mL'1 to 512 pg mL'1) were added in 1 mL aliquots (Figure 17). Tubes 
were inoculated with 100 pL of a 16 h (overnight) culture of Escherichia coli grown 
at 37°C, 180 osc min'1 and vortexed (Rotamixer, Hook and Tucker; UK). The tubes 
were incubated at 37°C and observed for growth after 48 h. The MIC was determined 
as the lowest concentration of the antibiotic showing no visible growth after 48 hours 
(Figure 17).
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Figure 17: Summary of MIC results obtained against E. coli ATCC 10000 planktonic, biofilm 
and eluate cells cultured in modified CDM. Error bars are calculated as the standard deviation 
of the individual data points, n = 3 replicates. NB: SD = 0, hence error bars are inapparent.
MIC determination for biofilm and eluate culture o f Escherichia coli ATCC 10000
A biofilm of Escherichia coli was established on a Sorbarod filter (Chapter 2; 
Hodgson et al., 1995). This biofilm was perfused with MCDM at 37°C. This was only 
run for 56 hours (to reach steady-state). At 56 hours, the Sorbarod filters were 
sacrificed (the adherent cells were removed and resuspended in 0.9% (w/v) sterile 
normal saline) and the MICs for three selected antibiotics (ampicillin (AmP), nalidixic
acid (NaL) and streptomycin (ST)) were determined according to the tube dilution
method (Bloomfield, 1991) using a standard inoculum (100 pL). This was performed 
for the eluate and attached cells (Figure 17).
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MIC determination for binary biofilm cells and eluate cells ofPs. aeruginosa ATCC 
15692 (PA01) and Escherichia coli ATCC 10000
In order to establish a binary biofilm, the Sorbarod model was used (Hodgson 
et al., 1995; Al-Hmoud, 2002; Chapter 2). The Sorbarod filter was inoculated with 
mid-logarithmic phase of E. coli culture (10 mL). This was perfused with modified 
chemically defined medium (MCDM) at 37°C. Modified CDM was suitable for the 
optimal and non-advantageous growth of both microorganisms Ps. aeruginosa and E. 
coli. In order to achieve this, CDM was modified by increasing the concentration of 
nitrogen (the concentration of nitrogen (NH4CI) in solution A (CDM) was 0.0187 M; 
in MCDM the concentration was modified to 0.028M, Al-Hmoud, 2002) and 
decreasing the concentration of carbon (solution C: the concentration was decreased 
from 1M to 0.66M, Al-Hmoud, 2002) (Chapter 2).
These modifications in the concentrations of carbon and, nitrogen will make 
the doubling times for both bacteria closer to each other in this modified CDM (Al- 
Hmoud, 2002). The E. coli biofilm was run for 48 hours (steady-state) before adding 
an aliquot (10 mL) of mid-logarithmic phase of Ps. aeruginosa to the Sorbarod filter. 
This was performed in order to give E. coli a “head start” in establishing itself on the 
Sorbarod filter and building the first monolayer of colonies before adding Ps. 
aeruginosa to the community. This system was run for 126 hours, in order to achieve 
the steady-state for both microorganisms. At 126 hours, the Sorbarod filters were 
sacrificed and the MIC (Bloomfield, 1991) against these selected antibiotics AmP, 
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Figure 18: Summary of MIC results obtained against binary biofilm and eluate cells of Ps. 
aeruginosa  ATCC 15692 (PAOl) and E. coli ATCC 10000 cultured in modified CDM. Error bars 
are calculated as the standard deviation of the individual data points, n = 3 replicates. NB: SD = 
0, hence error bars are inapparent.
Results & Discussion
Minimal inhibitory concentration (MIC) analysis was carried out on Ps. 
aeruginosa PAOl strains, in three states; planktonic, biofilm and eluate. The results 
show varying MIC values for antibiotics for each of these states, suggesting a change 
in the physiology of the organisms and their behaviour towards antibiotics. It can be 
seen that MIC values of biofilm and the eluate states of the bacteria were several 
times higher to that of the planktonic state (Table 6). Although it has been established 
elsewhere in this thesis that mechanisms involved with biofilm resistance to 
antibiotics are inherently due to the multicellular nature of the biofilm, a serious 
distinction has to be made at this stage regarding the nature of the resistance reported 
in this thesis. While measuring MICs using the tube dilution method, the biofilms 
were sacrificed and the cells were resuspended in media. This process eliminates 
some of the key proposed benefits of multicellular biofilm resistance and forces the
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bacteria into a planktonic form. However, due to the abrupt nature of this 
experimental transition from biofilm to the planktonic form, it is highly unlikely that 
the biofilm cell has adopted a planktonic physiology. This is surmised from the fact 
that MIC values of biofilm cells are several times higher than their planktonc 
counterparts. Furthermore, as resistance due to the multicellular nature of biofilm is 
compromised in the experimental protocol, the resulting increase in the MIC can only 
be explained by an inherent cellular mechanism. It is proposed to investigate the 
possibility that the resistance seen is a result of outer membrane protein shifts and 
changes in the cell wall structure of the bacterial cell.
The eluate cells studied here are probably cells that detach from the biofilm 
and have undergone a physiological reversion back to the planktonic state. However, 
the increased tolerance exhibited towards selected antibiotics as concluded from the 
MIC values show that these cells haven’t lost all their biofilm characteristics.
Table 6 : Summary of MIC results obtained against binary biofilm, eluate and 
planktonic cells of (Ps. aeruginosa ATCC 10000 (PAOl) and Escherichia coli 
(ATCC 10000) and monospecies biofilms cultured in modified CDM.

















Planktonic Cells 8 16 nd
Biofilm Cells 128 32 512
Eluate Cells 64 16 256
Nalidixic
acid
Planktonic Cells 32 8 nd
Biofilm Cells 64 32 128
Eluate Cells 32 16 64
Streptomycin
Planktonic Cells 2 64 nd
Biofilm Cells 128 128 256
Eluate Cells 64 128 64
nd = Not determined
What is indeed interesting from the results indicated in Figure 18 is that binary 
biofilms have an increased antibiotic tolerance to that observed with monospecies
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biofilms (in binary biofilm cells the MIC value with ampicillin was 512 pg mL'1, with 
nalidixic acid 128 pg mL'1 and with streptomycin 256 pg mL'1, while in the 
monospecies biofilms (in Ps. aeruginosa PAOl the MIC value with ampicillin was 
128 pg mL'1, with nalidixic acid was 64 pg mL'1 and with streptomycin was 128 pg 
mL'1 while (in E. coli ATCC 10000 the MIC value with ampicillin was 32 pg mL'1, 
with nalidixic acid was 32 pg mL'1 and with streptomycin the MIC was 128 pg mL'1). 
The practical significance of this observation is heightened, when considering the fact 
that in medical and environmental contexts, biofilms exist as mixed communities and 
that they may offer a synergistic resistance to antimicrobials. The results in these 
analyses reveal that bacteria living in biofilms can be up to 7-fold more resistant to 
antibiotics than the corresponding planktonic population of the same single or mixed 
species.
The increase in the MIC values provides ample ground to investigate the 
hypothesis that post-biofilm formation, the virulence and resistance of the organism 
increases. Although it is known that antibiotic resistance of the organism increases 
after biofilm formation (Davies 2003; Gilbert, et al. 2002a), there is no current 
evidence of virulence of the organism increasing post-biofilm formation. Based on the 
initial MIC results, studies to determine the activity of the vimlence factors before and 
after biofilm formation were designed. In order to investigate the inherent cellular 
resistance exhibited by the biofilm cells against antibiotics, the cell envelope 
characteristics were probed for the presence or absence of OMPs that may shed a clue 
to their increased resistance.
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Chapter Four: Studies of the Outer Membrane Proteins of 
Planktonic and Biofilm Cultures of Pseudom onas aeruginosa  ATCC 
15692 (PAOl) and Escherichia coli ATCC 10000 Challenged with 
sub-MICs of Selected Antibiotics
Introduction
Pseudomonas aeruginosa is one of the most antibiotic resistant of the non­
spore-forming bacteria. Intrinsic resistance exhibited by this organism is higher than 
any other Gram-negative bacteria (Hancock, 1997). Although three main mechanisms 
of intrinsic resistance has been attributed to Pseudomonas aeruginosa (outer 
membrane impermeability, drug efflux mechanisms and antibiotic degrading 
enzymes; McDonnell & Russell 1999, Jo et al., 2003), low outer membrane 
permeability is the property that distinguishes Ps. aeruginosa from other Gram­
negative bacteria (McDonnell & Russell 1999). Hence, antibiotic resistance has been 
primarily proposed to be due to cell envelope characteristics (Yoshihara & Nakae,
1989).
The outer cell envelope of Pseudomonas aeruginosa is composed mainly of 
proteins (outer membrane proteins, OMPs) and lipopolysaccharide (LPS) (Backhed et 
al., 2003). Alterations in the outer membrane proteins (OMPs) and the integrity of the 
LPS influence the permeability of the outer membrane to antimicrobial agents 
(Koebnik et al 2000). The presence of LPS in the outer membrane confers very low 
permeability for hydrophobic antibiotics (Koebnik et al 2000; Hogan and Kolter,
2002). However, the overall permeability of the outer membrane depends upon the 
number and properties of pore-forming proteins, generally called porins (Trias & 
Nikaido, 1990). Porins are proteins that form pores in the outer membrane by the 
clustering of three protein subunit molecules (trimeric) (Koebnik et aL, 2000), by
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fo ld in g  in to  P -p le a te d  sh e e ts  to  fo rm  a  c lo s e d  b a rre l. Ps. aeruginosa  a ls o  e x h ib its  
r e s is ta n c e  to  sm a ll h y d ro p h ilic  a n tib io tic s , lik e  te tra c y c lin e s  a n d  p - la c ta m s . Ps. 
aeruginosa  h a s  12- to  1 0 0 -fo ld  lo w e r  o u te r  m e m b ra n e  p e rm e a b i li ty  th a n  E scherichia  
coli (R u sse ll &  C h o p ra  1996; H a n c o c k  19 98 ). R ecen tly , th e  Ps. aeruginosa  g e n o m e  
w a s  p u b lis h e d  a n d  th re e  la rg e  p a ra lo g o u s  fa m ilie s  o f  o u te r  m e m b ra n e  p ro te in s  h a v e  
b e e n  id e n tif ie d  (S to v e r, et a l 2 0 0 0 ). T h e  O p rD  fa m ily  o f  s p e c if ic  p o r in s  (1 9  g e n e s), 
th e  T o n B -fa m ily  o f  g a te d  p o rin s  a n d  th e  O p rM  fa m ily  o f  o u te r  m e m b ra n e  p ro te in s  
in v o lv e d  in  e f f lu x  o r  s e c re tio n  (18  g e n e s )  (S to v e r , e t a l  2 0 0 0 ). M o s t  p o r in s  o iP s .  
aeruginosa  a re  sp e c if ic  fo r  c e r ta in  su b s tra te s  (e .g . fo r  b a s ic  a m in o  a c id s  (O p rD ), o r  
fo r  p h o s p h a te  (O p rP ); H a n c o c k  et al., 19 90 ). T h e se  p o r in s  p e rm it  e n try  o f  s tru c tu ra l 
a n a lo g u e s  (eg : O p rD , w h ic h  is  th e  p ro te in  b y  w h ic h  th e  a n tib io t ic  im ip e n e m  e n te rs  
th ro u g h  th e  o u te r  m e m b ra n e  o f  Ps. aeruginosa  (N ik a id o , 1 9 9 2 )). O n  th e  o th e r  h a n d  
O p rF  (3 8  k D a ) , w h ic h  is th e  m a jo r  n o n -sp e c if ic  O M P , h a s  p o o r  e f f ic ie n c y  in  tra n s p o r t  
(H a n c o c k  19 98 ), a lth o u g h  it  fo rm s  b o th  la rg e  a n d  s m a ll p o r in s . D e s p ite  th e se  
v a r ia t io n s  in  m e m b ra n e  p e rm e a b ility  in  th e  p la n k to n ic  fo rm s  o f  P seudom onas  
aeruginosa, th e  p e r ip la s m ic  c o n c e n tra tio n s  o f  m a n y  a n tib io t ic s  c a n  re a c h  5 0 %  o f  th e ir  
e x te rn a l c o n c e n tra tio n s  w ith in  2 0  se c o n d s  (G re e n w a y  &  E n g la n d , 1 9 9 9 a ). T h u s , th e  
p re s e n c e  o f  th e  o u te r  m e m b ra n e  a lo n e  c a n n o t e x p la in  th e  e x te n t o f  in tr in s ic  re s is ta n c e . 
I t is  n o w  w e ll u n d e rs to o d  th a t o u te r  m e m b ra n e  im p e rm e a b ili ty  m u s t  b e  c o u p le d  w ith  a  
s e c o n d a ry  a n tib io tic  re s is ta n c e  m e c h a n ism , lik e  a c tiv e  d ru g  e ff lu x , fo r  e f fe c tiv e  
re s is ta n c e  a g a in s t  a n tib io tic s  (Jo  et al., 2 0 0 3 ).
A lth o u g h  it  m a y  be  sa id  th a t m u lti d ru g  e f f lu x  sy s te m s  a c t  a s  a  m a jo r  
re s is ta n c e  m e c h a n ism  in  p la n k to n ic  Ps. aeruginosa, e v id e n c e  in d ic a te s  th e  c o n tra ry  
w ith in  b io f ilm s . R e c e n tly , D e  K ie v i te t  al. (2 0 0 1 b ) re v e a le d  th a t  th e  e x p re s s io n  o f  th e  
fo u r  w e ll-c h a ra c te r is e d  m u ltid ru g  r e s is ta n t (M D R ) p u m p s  (M e x A B -O p rM , M ex C D - 
O p rJ , M e x F E -O p rN , a n d  M e x X Y ) is  n o t  in c re a se d  in  Ps. aeruginosa  b io f i lm s . T h is
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su g g e s ts  th a t  th e  o th e r  fac to rs , su c h  a s  d e c re a se d  m e m b ra n e  p e rm e a b i l i ty  re su lt in g  
fro m  sp e c if ic  m o le c u la r  o rg a n isa tio n  o f  l ip o p o ly sa c c h a r id e s  a n d  p o r in s  m a y  b e  
re sp o n s ib le  fo r  th e  in n a te  re s is ta n c e  to  a n tib io tic s  b y  th is  p o p u la t io n  o f  b a c te r ia  
(T a tta w a sa ra t, et al. 2 0 0 0 ).
P seudom onas aeruginosa  g ro w s  as  b io f ilm s  in  n a tu re  a n d  is  a lso  a s s o c ia te d  
w ith  c h ro n ic  lu n g  in fe c tio n s  in  p a t ie n ts  w i th  cy s tic  f ib ro s is  (C F ) (H o ib y , 2 0 0 2 ). 
C h ro n ic i ty  o f  in fe c tio n s  h a s  b e e n  re c e n tly  a ttr ib u te d  to  a n tib io t ic  r e s is ta n c e  o f  
b io f ilm s  (C o s te r to n , 2 0 0 1 , H a ll-S to o d le y  &  S to o d le y , 2 0 0 5 , F u x  et a l., 2 0 0 5 ) . T h is  
c h a p te r  a im s  to  in v e s tig a te  a lte ra tio n  o f  o u te r  m e m b ra n e  p ro te in s  (O M P s )  a s  a  
p o s s ib le  so u rc e  fo r  s tru c tu ra l e n v e lo p e  m o d if ic a tio n s  re sp o n s ib le  fo r  a n tib io tic  
re s is ta n c e . A c c o rd in g ly , m o n o sp e c ie s  a n d  b in a ry  b io f ilm s  o f  Pseudom onas  
aeruginosa  w e re  te s te d  fo r  a lte ra tio n s  o f  o u te r  m e m b ra n e  p ro te in s  in  th e  p re s e n c e  o f  
su b -m in im a l in h ib ito ry  c o n c e n tra tio n s  o f  s e le c te d  a n tib io t ic s  (a m p ic il l in , n a l id ix ic  
a c id  a n d  s tre p to m y c in ) .
Experimental approach
In  th is  s tu d y , o u te r  m e m b ra n e  p ro te in s  o f  m o n o s p e c ie s  a n d  b in a r y  b io f ilm s , 
e lu a te  a n d  p la n k to n ic  ce lls  o f  Ps. aeruginosa  a n d  E scherichia co li in  th e  p re s e n c e  o f  
th e  M I C /16 o f  a n tib io tic s  A m P -, N a L -  a n d  S T -se n s itiv e  a n d  r e s is ta n t  ce lls  w e re  
a n a ly z e d  u s in g  S D S -P A G E , in  o rd e r  to  e x a m in e  a n y  a lte ra tio n s  in  p ro te in  p ro f ile s . 
T w o  d if fe re n t m e th o d s  fo r  p re p a ra tio n  o f  O M P s  w e re  u s e d  (o n e  fo r  th e  b io f i lm  c e lls  
a n d  a n o th e r  fo r  th e  e lu a te  ce lls). B io f ilm  O M P s  w e re  p re p a re d  fo r  S D S -P A G E  an d  
2 D -P A G E  a n a ly s is  a c c o rd in g  to  H o d g s o n  et al., (1 9 9 5 ; C h a p te r  2 ) . E lu a te  O M P s  
w e re  p re p a re d  fo r  th e  sam e  a n a ly se s  b y  th e  m e th o d  o f  P u g s le y e ^  al., (1 9 8 6 ; C h a p te r  
2 ). H o w e v e r , b e fo re  O M P s  c o u ld  b e  is o la te d  f ro m  b a c te r ia l  c e ll w a lls , b io f i lm s  h a d  to  
b e  g ro w n  o n  S o rb a ro d  f ilte rs  a s  d e sc r ib e d  b e lo w .
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Growth of monospecies and binary biofilms of Ps. aeruginosa ATCC 15692 (PAOl)
a n d  E scherichia coli A T C C  10000
M o n o s p e c ie s  b io f ilm s  o f  Ps. aeruginosa  A T C C  15692 ( P A O l)  a n d  
E scherichia co li A T C C  10000 w e re  e s ta b lis h e d  o n  S o rb a ro d  f ilte rs  (C h a p te r  2 ; 
H o d g so n  et al., 19 95 ). T h e  S o rb a ro d  a d h e re n t c e lls  (Ps. aeruginosa  a n d E. co li) w e re  
in it ia lly  p e r fu s e d  w ith  M C D M  (m o d if ie d  c h e m ic a lly  d e f in e d  m e d iu m )  in  th e  p re s e n c e  
o f  th e  M IC /1 6  o f  se le c te d  a n tib io tic s  (a m p ic il l in  (A m P ); n a l id ix ic  a c id  (N a L )  a n d  
s tre p to m y c in  (S T )) a t  3 7 °C  fo r  102 h o u rs  a n d  56  h o u rs  re sp e c tiv e ly , u n ti l  b io f ilm  
s te a d y  s ta te  w a s  a c h ie v e d  fo r b o th  o rg a n ism s . S u b se q u e n t to  th e  fo rm a tio n  o f  m a tu re  
b io f ilm s  ( i.e . a f te r  s te a d y  s ta te  w a s  a c h ie v e d )  th e  S o rb a ro d  f ilte rs  w e re  s a c r if ic e d  a n d  
th e  a d h e re n t c e lls  w e re  re m o v e d  a n d  re su s p e n d e d  in  s te r ile  n o rm a l s a lin e  (0 .9 %  N a C l 
in  d is ti l le d  w a te r  (w /v )) . C o n tro l a n d  a n tib io tic  tr e a te d  b io f ilm  a n d  e lu a te  c e lls  w e re  
s to re d  s e p a ra te ly  a t - 2 0 ° C  fo r la te r  a n a ly s is .
I n  o rd e r  to  e s ta b lish  a b in a ry  b io f ilm , th e  m o d if ie d  S o rb a ro d  m o d e l w a s  u s e d  
(A l-H m o u d , 2 0 0 2 ; C h a p te r  2 ). T h e  S o rb a ro d  f i l te r  w a s  in o c u la te d  w i th  m id -  
lo g a r ith m ic  p h a se  o f  E. coli c u ltu re  (1 0  m L ), a n d  s u p p le m e n te d  w ith  m o d if ie d  
c h e m ic a lly  d e f in e d  m e d iu m  (M C D M ) in  th e  p re se n c e  o f  th e  M IC /1 6  o f  se le c te d  
a n tib io tic s  (a m p ic il lin  (A m P ), n a l id ix ic  a c id  (N aL ) a n d  s tre p to m y c in  (S T ))  a t 3 7 °C . 
T h e  E. co li b io f ilm  w a s  ru n  fo r  4 8  h o u rs  (a p p ro a c h in g  b io f ilm  s te a d y -s ta te )  b e fo re  
a d d in g  a n  a liq u o t (10  m L ) o f  m id - lo g a r ith m ic  p h a se  o f  Ps. aeruginosa  to  th e  S o rb a ro d  
f ilte r. T h is  w a s  p e rfo rm e d  in  o rd e r  to  g iv e  E. co li a “h ead s ta r t” in  e s ta b lis h in g  i t s e l f  
o n  th e  S o rb a ro d  f i l te r  an d  b u ild in g  th e  f irs t m o n o la y e r  o f  c e lls  b e fo re  in tro d u c in g  Ps. 
aeruginosa  to  th e  co m m u n ity . T h e  sy s te m  w a s  ru n  fo r  126 h o u rs  u n ti l  a  c o m b in e d  
b io f ilm  s te a d y  s ta te  re su ltin g  f ro m  th e  p re se n c e  o f  b o th  b a c te r ia  w a s  a c h ie v e d . T h e  
S o rb a ro d  f ilte rs  w e re  sa c r if ic e d  (th e  a d h e re n t ce lls  w e re  re m o v e d  a n d  r e s u s p e n d e d  in  
s te r ile  n o rm a l sa lin e )  an d  b o th  b io f ilm  a n d  e lu a te  c e lls  w ere c o lle c te d  a n d  c e n tr ifu g e d
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(IE C  C e n tra -4 B )  a t  5 0 0 0  g  fo r 2 0  m in u te s . C e ll p e l le ts  w e re  c o lle c te d  a n d  s to re d  a t -  
2 0 °C  fo r  a ll  su b se q u e n t a n a ly s is .
M o d if ie d  C D M  w a s  su ita b le  fo r  th e  o p tim a l a n d  n o n -a d v a n ta g e o u s  g ro w th  o f  
b o th  m ic ro o rg a n is m s , Ps. aeruginosa  a n d  E. coli. T h e  c o n c e n tra t io n  o f  n i tro g e n  
(N H 4C I) in  C D M  (so lu tio n  A ) w a s  in c re a s e d  f ro m  0 .0 1 8 7 M  to  0 .0 2 8 M  a n d  th e  
c o n c e n tra t io n  o f  c a rb o n  (so lu tio n  C ) w a s  d e c re a se d  f ro m  1M  to  0 .6 6 M  (A l-H m o u d , 
2 0 0 2 ). T h e s e  m o d if ic a tio n s  in  th e  c o n c e n tra t io n s  o f  c a rb o n  a n d  n i tro g e n  a l lo w e d  th e  
d o u b lin g  t im e s  fo r b o th  b a c te r ia  to  a p p ro x im a te  e a c h  o th er.
S D S -p o ly a c ry la m id e  g e l e le c tro p h o re s is  (S D S -P A G E )
S D S -P A G E  is  p ro b a b ly  th e  m o s t  w id e ly  u s e d  te c h n iq u e  fo r  a n a ly s in g  m ix tu re s  
o f  p ro te in s . In  th is  te c h n iq u e , p ro te in s  a re  t re a te d  w ith  th e  a n io n ic  d e te rg e n t , so d iu m  
d o d e c y ls u lp h a te  (S D S ) o r  so d iu m  la u ry l su lp h a te  (S L S ) to  fo rm  n e g a tiv e ly  c h a rg e d  
c o m p le x e s . T h e  a m o u n t o f  S D S  b o u n d  b y  a  p ro te in , a n d  so  th e  c h a rg e  o n  th e  
c o m p le x , is  ro u g h ly  p ro p o r tio n a l to  its  s iz e . R o u g h ly , a b o u t 1 ,4 g  S D S  is  b o u n d  p e r  
g ra m  o f  p ro te in , a lth o u g h  th e re  a re  e x c e p tio n s  to  th is  ru le  (D e y l, 1 9 7 9 ). T h e  p ro te in s  
a re  g e n e ra l ly  d e n a tu re d  a n d  s o lu b iliz e d  w h e n  b o u n d  to  S D S , a n d  th e  c o m p le x  a d o p ts  
th e  fo rm  o f  a  n e g a tiv e ly  c h a rg e d  p ro la te  e ll ip so id  o r  ro d  o f  le n g th  ro u g h ly  
p ro p o r tio n a l to  th e  p ro te in ’s m o le c u la r  w e ig h t. T h u s , p ro te in s  o f  a c id ic  o r  b a s ic  p i  
( iso e le c tr ic  p o in t)  fo rm  n e g a tiv e ly  c h a rg e d  c o m p le x e s  th a t  c a n  b e  s e p a ra te d  o n  th e  
b a s is  o f  d iffe re n c e s  in  c h a rg e  a n d  s ize  b y  e le c tro p h o re s is  th ro u g h  a  s ie v e -lik e  m a tr ix  
o f  p o ly a c ry la m id e  g e l (S m ith , 19 84 ). S a m p le  p re p a ra tio n  fo r  S D S -P A G E  a n d  th e  
s y s te m  o f  b u ffe rs  u s e d  in  the  g e l sy s te m  (d e sc rib e d  in  C h a p te r  2 )  is th a t  o f  L a e m m li 
(1 9 7 0 ) . A  p o ly a c ry la m id e  gel o f  s lab  sh a p e  is  u se d  in  th is  te c h n iq u e . T h is  fo rm a l lo w s  
s im u lta n e o u s  e le c tro p h o re s is  o f  m o re  th a n  o n e  s a m p le  a n d  th u s , is  id e a l fo r  
c o m p a ra t iv e  p u rp o se s .
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P re p a ra t io n  o f  s e p a ra tin g  a n d  s ta c k in g  ge l m ix tu re s , w e re  u n d e r ta k e n  a s  
d e s c r ib e d  in  C h a p te r  2 . O u te r  m e m b ra n e  p ro te in  p ro f ile s  w e re  o b ta in e d  u s in g  a  P o w e r  
P a c k  3 0 0  (c o n s ta n t c u r re n t o f  35  m A  fo r  1.5 h )  an d  th e n  s ta in e d  w ith  C o o m a s s ie  
b r i l l ia n t  b lu e  R 2 5 0  o r  S ilv e r  s ta in in g  (d e s c r ib e d  in  d e ta il in  C h a p te r  2 ).
T h e  a n a ly s is  o f  O M P  p ro f ile s
T h e  f irs t s ta g e s  in  a n a ly s in g  th e  g e ls  ( im a g e  c a p tu re )  w e re  p e r fo rm e d  u s in g  
P h o re t ix  im a g in g  a n a ly s is  so f tw a re  (n o n -L in e a r  D y n a m ic s  L td , N e w c a s t le  u p o n  T y n e , 
E n g la n d ) . H o w e v e r , th is  so f tw a re  w a s  fa u lty  a n d  h e n c e , th e  m o le c u la r  w e ig h ts  a n d  Rf 
(R e ta rd a tio n  fa c to r)  v a lu e s  o f  a ll  th e  o u te r  m e m b ra n e  p ro te in s  in  th e  s a m p le s  w e re  
e s tim a te d  m a n u a lly . T h is  w a s  p e r fo rm e d  in  o rd e r  to  o b se rv e  a n y  p o s s ib le  d if fe re n c e s  
b e tw e e n  th e  se n s itiv e  a n d  re s is ta n t c u l tu re s  fo r  b o th  b io f ilm  a n d  e lu a te  c e lls . L a n e  1 in  
e a c h  g e l d e m o n s tra te s  th e  s ta n d a rd  m o le c u la r  w e ig h ts  (M r) m a rk e rs  fo r  th a t  g e l. T h e se  
(M r) m a rk e rs  a re  g iv e n  b e lo w  in  T a b le  7.
B y  p lo ttin g  m o le c u la r  w e ig h ts  o f  m a rk e rs  a g a in s t  th e ir  Rf v a lu e s , a  s ta n d a rd  
c a lib ra tio n  c u rv e  w a s  c o n s tru c te d  (F ig u re  19). H o w e v e r , Rf v a lu e s  fo r  th e s e  s ta n d a rd  
m o le c u la r  w e ig h ts  m a y  v a ry  s lig h tly  fro m  o n e  g e l to  a n o th e r . T h is  s ta n d a rd  
c a lib ra tio n  c u rv e  w a s  u s e d  to  d e te rm in e  th e  m o le c u la r  w e ig h ts  o f  a ll  th e  p ro te in s  o n  
th e  g e l. T h e  Rf fo r  e a c h  b a n d  w a s  e s tim a te d  a c c o rd in g  to  E q u a tio n  2:
R f=  distance migrated by protein/distance migrated by dye (Equation 2)
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Table 7: Standard molecular weight ladder for SDS Polyacrylamide Gel 
Electrophoresis (14.2 to 66 kDa)
Protein Mr (kDa) Rf
Albumin, Bovine 66 0.34
Ovalbumin, chicken 45 0.49
Glyceraldehyde-3- phosphate 36 0.52
Dehydrogenase, Rabbit
Carbonic Anhydrase, Bovine 29 0.62
Trypsinogen, Bovin, PMSF treated 24 0.77
Trypsin Inhibitor, Soybean 20.1 0.86
a-Lactalbumin, Bovine 14.2 0.98
Figure 19: The standard calibration curve generated by plotting the molecular weight (Mr) of the low range molecular weight standards vs. the Rf.
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Results & Discussion
U p o n  e x p o su re  o f  Ps. aeruginosa  P A O l b io f ilm  a n d  e lu a te  c e lls  to  su b -M IC s 
o f  a n tib io tic s  (A m P , N a L  a n d  S T ) so m e  d is tin c t v a r ia t io n s  in  th e  n u m b e r  o f  o u te r  
m e m b ra n e  p ro te in s  (O M P s)  b e tw e e n  th e  p la n k to n ic , b io f ilm  a n d  e lu a te  c e lls  w e re  
o b se rv e d . In  p a r tic u la r , i t  w a s  p o s s ib le  to  o b se rv e  th e  p re s e n c e  o f  ‘n o v e l ’ p ro te in s  
w ith in  su b -M IC  a n tib io tic -e x p o se d  tre a tm e n ts  (N B : fo r  th e  p u rp o s e s  o f  th is  re se a rc h , 
a  n o v e l p ro te in  is  d e f in e d  a s  o n e  w h ic h  h a s  a  g re a te r  th a n  1 k D a  sh if t  f ro m  a  p ro te in  in  
a  s im ila r  p o s i t io n  o n  a  c o n tro l g e l, b u t  w h ic h  is  n o  lo n g e r  p r e s e n t  in  th e  t r e a te d  g e l) .
O M P  sh ifts  in Ps. aeruginosa  P A O l b io f ilm  a n d  e lu a te  c e lls  e x p o s e d  to  s u b -M IC s  o f  
a m p ic il l in  (A m P ), n a l id ix ic  a c id  (N a L ) a n d  s tre p to m y c in  (S T )
A  4 4 .7  k D a  o u te r  m e m b ra n e  p ro te in  p re s e n t  in  c o n tro l (c e lls  u n e x p o s e d  to  
a n tib io tic s )  ( la n e  3 , F ig u re  2 0 ), w a s  n o t  a p p a re n t a f te r  c e lls  w e re  e x p o s e d  to  su b - 
M IC s  o f  a n t ib io t ic s  o f  A m P , N a L  a n d  S T  ( la n e s  4 , 5 &  6 re sp e c tiv e ly , F ig u re  20 ). 
S im ila r ly  a  3 7  k D a  O M P  p re se n t in  c o n tro l ( la n e  3 , F ig u re  2 0 )  w a s  n o t  p re s e n t  in  
( la n e s  4  a n d  5 ), a f te r  c e lls  w e re  e x p o se d  to  su b -M IC s  o f  a n t ib io t ic s  A m P  a n d  N a L . 
H o w e v e r , th is  O M P  a p p e a re d  in  c e lls  e x p o se d  to  su b -M IC s o f  s tre p to m y c in  ( la n e  6 , 
F ig u re  20 ; T a b le  8). F o r  th e  p u rp o se  o f  th is  s tu d y , O M P  sh ifts  o r  m o v e m e n ts  
in d ic a tin g  th e  a b se n c e  a n d /o r  p re s e n c e  o f  p ro te in  in  a n y  g iv e n  lan e , c o u p le d  w i th  th e  
c o rre sp o n d in g  p re s e n c e  a n d /o r  a b se n c e  o f  p ro te in  o f  r e la tiv e ly  s im ila r  m o le c u la r  
w e ig h t h a s  b e e n  a s su m e d  to in d ic a te  a  sm a ll a p p a re n t m o le c u la r  w e ig h t  c h a n g e  in  a  
s in g le  p ro te in  ra th e r  th a n  th e  c o u p le d  d isa p p e a ra n c e / a p p e a ra n c e  o f  tw o  p ro te in s .
A  71 k D a  o u te r  m e m b ra n e  p ro te in  w a s  a b s e n t in  b o th  sub -M IC  
c o n tro ls  o f  p la n k to n ic  a n d  e lu a te  c e lls  ( la n e s  2 a n d  4 , F ig u re  2 1 ), b u t  a p p e a re d  a f te r  
c e lls  w e re  e x p o se d  to  su b -M IC s  o f  a n tib io tic s  A m P , N a L  a n d  S T  (L a n e  5, 6 &  7, 
F ig u re  21 ). T w o  o u te r  m e m b ra n e  p ro te in s  o f  43  k D a  a n d  4 0 .2  k D a  w e re  a b s e n t  f ro m
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c o n tro l sa m p le s  o f  b o th  p la n k to n ic  a n d  e lu a te  c e lls  ( la n e s  2  a n d  4 , F ig u re  2 1 ) , b u t  
a p p e a re d  a f te r  c e lls  w e re  e x p o se d  to  su b -M IC  o f  a n tib io tic s  w i th  n a l id ix ic  a c id  ( la n e  
6 , F ig u re  2 1 ; T a b le  9).
A ll s u b s e q u e n t an a ly s is  o f  re su lts  f ro m  b io f ilm  a n d  e lu a te  s a m p le s  o f E. co li 
a n d  b in a ry  c u ltu re s  w e re  c a rr ie d  o u t in  a  s im ila r  fa sh io n  a s  in d ic a te d  b e lo w  (T a b le  8 , 
p a r ts  1 a n d  2; T a b le  9, p a r ts  1, 2  a n d  3). T h e se  a n a ly se s  (g e ls  w e re  a n a ly s e d  
m a n u a lly )  a re  n o t  g iv e n  h e re  fo r  th e  p u rp o s e s  o f  b re v ity .
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Figure 20: O uter m em brane protein profile o f Ps. aeruginosa  A T C C  15692 (P A O l) biofilm  cells 
cultured in m odified CDM  and exposed to d ifferent treatm ent o f  antibiotics. Lane 1: m olecular 
w eights m arkers; Lane 2: Ps. aeruginosa  p lanktonic cells control (776 pg protein w e l l1); Lane 3: 
Ps. aeruginosa  biofilm  cells control (729 pg protein w ell'1); Lane 4: Ps. aeruginosa  b iofilm  cells 
(739 pg protein w ell'1) w ith treatm ent o f  am picillin at sub-M IC  (8 pg m L'1); Lane 5: Ps. 
aeruginosa  biofilm  cells (732 pg protein well'1) w ith treatm ent o f nalidixic acid at sub-M IC  (4 pg 
mL'1); Lane 6: Ps. aeruginosa  biofilm  cells (736 pg protein well'1) w ith  treatm ent o f  streptom ycin  





Figure 21: O uter m em brane protein profile o f  Ps. aeruginosa  P A O l eluate cells cultured in 
m odified CDM  and exposed to different treatm ent o f antibiotics. Lane 1: m olecular weights 
m arkers; Lane 2: Ps. aeruginosa  planktonic cells control (776 pg protein w ell'1); Lane 3: Ps. 
aeruginosa  biofilm  cells control (729 pg protein w ell'1); Lane 4: Ps. aeruginosa  eluate cells control 
(752 pg protein w ell'1); Lane 5: Ps. aeruginosa  eluate cells (731 pg protein w ell'1) w ith  treatm ent 
o f am picillin at sub-M IC  (8 pg mL'1); Lane 6: Ps. aeruginosa  eluate cells (728 pg protein  w ell'1) 
with treatm ent o f nalidixic acid at sub-M IC (4 pg m L'1); Lane 7: Ps. aeruginosa  eluate cells (736 
pg protein well"1) with treatm ent of streptom ycin at sub-M IC (8 pg m L'1). A rrow  indicates the 71 
kDa OM P.
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T a b le  8 ( p a r t  1 ): M e a su re m e n t d a ta  in d ic a tin g  B a n d  n u m b e r , M o le c u la r  w e ig h t  (M ) 
a n d  R e ta rd a tio n  fa c to r  (Rf) fo r O u te r  M e m b ra n e  P ro te in s  o f  Ps. aeruginosa  P A O l 
b io f i lm  c e lls  e x p o se d  to  d iffe re n t t r e a tm e n t o f  a n tib io tic s  a n d  c u l tu re d  in  m o d if ie d  
C D M  (B a n d  no : b a n d  n u m b e r; C o : c o r re sp o n d in g  p ro te in  to  L a n e  3 (N B : o n ly  th e  te s t  
la n e s  4 , 5 &  6 a re  c o m p a re d  to  la n e  3); N : n o v e l p ro te in ) .
L a n e  1
(m o le c u la r  w e ig h t 
m a rk e rs )
L a n e  2
(Ps. aeruginosa  p la n k to n ic  
c e lls  c o n tro l)
L a n e  3
(Ps. aeruginosa  b io f ilm  
c e lls  c o n tro l)
Band M r Rf Co Band M r Rf Co Band M r Rf Co
no. (kDa) no. (kDa) no. (kDa)
1 66 0.34 - 1 (72.2) (0.11) - 1 (73.7) (0.09) -
2 45 0.49 - 2 (71) (0.13) - 2 (68.7) (0.16) -
3 36 0.52 - 3 (68.2) (0.17) - 3 (66) (0.20) -
4 29 0.62 - 4 (66) (0.20) - 4 (63.2) (0.24) -
5 24 0.77 - 5 (64) (0.23) - 5 (61.2) (0.27) -
6 20.1 0.86 - 6 (62.5) (0.25) - 6 (59.7) (0.29) -
7 14.2 0.98 - 7 (60.5) (0.28) - 7 57.7 0.32 -
- - - - 8 (57.7) (0.32) - 8 53 0.35 -
- - - - 9 51 0.36 - 9 48 0.38 -
- - - - 10 48 0.38 - 10 44.7 0.41 -
- - - - 11 44.7 0.41 - 11 41.7 0.44 -
- - - - 12 41.7 0.34 - 12 38.7 0.47 -
- - - - 13 37 0.50 - 13 37 0.50 -
- - - - 14 33.5 0.55 - 14 36 0.52 -
- - - - 15 30.5 0.60 - 15 33 0.56 -
- - - - 16 28.2 0.64 - 16 29.5 0.63 -
- - - - 17 26.7 0.67 - 17 26.7 0.67 -
- - - - 18 23.7 0.74 - 18 22.7 0.78 -
- - - - 19 21.7 0.79 - 19 19.5 0.85 -
- - - - 20 19.2 0.86 - 20 17.5 0.90 -
- - - - 21 17 0.91 - - - - -
- - - - 22 15.7 0.95 - - - - -
KEY:
():  Molecular weights estimated from linear equation derived from standard calibration curve (F ig 19)
- :  N o data for that cell
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T a b le  8  ( p a r t  2 ): M e a su re m e n t d a ta  in d ic a tin g  B a n d  n u m b e r , M o le c u la r  w e ig h t  (M ) 
a n d  R e ta rd a tio n  fa c to r  (Rf) fo r O u te r  M e m b ra n e  P ro te in s  o f  Ps. aeru gin osa  b io f ilm  
c e lls  e x p o s e d  to  d iffe re n t tr e a tm e n t o f  a n tib io tic s  a n d  c u ltu re d  in  m o d if ie d  C D M  
(B a n d  n o : b a n d  n u m b e r; C o : c o r re sp o n d in g  p ro te in  to  L a n e  3 (N B : o n ly  th e  te s t  lan es  
4 , 5 &  6 a re  c o m p a re d  to  la n e  3); N : n o v e l  p ro te in ) .
L a n e  4
(Ps. aeruginosa  b io f ilm  
c e lls  w i th  tre a tm e n t o f  
a m p ic il l in  a t su b -M IC  (8 
p g  m L '1).
L a n e  5
(Ps. aeruginosa  b io f ilm  
c e lls  w i th  tr e a tm e n t o f  
n a l id ix ic  a c id  a t  su b -M IC  
(4  p g  m L '1).
L a n e  6
(Ps. aeruginosa  b io f i lm  
c e lls  w i th  tr e a tm e n t  o f  
s tr e p to m y c in  a t  su b -M IC  
(8 p g  m L '1).
Band Mr Rf Co Band Mr Rf Co Band Mr Rf Co
no. (kDa) no. (kDa) no. (kDa)
1 (59.7) (0.29) 6 1 (59.2) (0.30) 6 1 (59.2) (0.30) 6
2 49.5 0.37 N 2 49.5 0.37 N 2 46.7 0.39 N
3 45.7 0.40 N 3 45.7 0.40 N 3 44.7 0.41 10
4 41.7 0.44 11 4 43.7 0.42 10 4 41.7 0.44 11
5 41 0.45 11 5 41.7 0.44 11 5 41 0.45 11
6 40.2 0.46 N 6 41 0.45 11 6 37 0.50 13
7 33 0.56 15 7 33 0.56 15 7 32.2 0.57 15
8 32.2 0.57 15 8 32.2 0.57 15 8 30.5 0.60 16
9 30.5 0.60 16 9 30.5 0.60 16 9 29 0.62 16
10 29.5 0.63 16 10 29.5 0.63 16 10 27.7 0.65 17
11 27.7 0.65 17 11 27.7 0.65 17 11 25 0.71 N
12 26.2 0.68 17 12 26.2 0.68 17 12 23.7 0.75 18
13 24.5 0.72 N 13 25 0.71 N 13 20.2 0.83 19
14 22.5 0.77 18 14 23 0.76 18 14 17.5 0.90 20
15 19.7 0.84 19 15 20.2 0.83 19 - - - -
16 17.5 0.90 20 16 17.5 0.90 20 - - - -
KEY:
():  Molecular weights estimated from linear equation derived from standard calibration curve (Fig 19)
- :  No data for that cell
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T a b le  9  ( p a r t  1 ): M e a su re m e n t d a ta  in d ic a tin g  B a n d  n u m b e r , M o le c u la r  w e ig h t  (M ) 
a n d  R e ta rd a tio n  fa c to r  (Rf) fo r O u te r  M e m b ra n e  P ro te in s  o f  Ps. aeruginosa  P A O l 
e lu a te  c e lls  e x p o se d  to  d iffe re n t tr e a tm e n t o f  a n tib io tic s  a n d  c u ltu re d  in  m o d if ie d  
C D M  (B a n d  no : b a n d  n u m b e r; C o : c o r re sp o n d in g  p ro te in  to  L a n e  4  (N B : o n ly  th e  te s t  
la n e s  5 , 6 &  7 a re  c o m p a re d  to  la n e  4 ); N : n o v e l p ro te in ) .
L a n e  1
(m o le c u la r  w e ig h t 
m a rk e rs )
L a n e  2
(Ps. aeruginosa  p la n k to n ic  
ce lls  c o n tro l)
L a n e  3
(Ps. aeruginosa  b io f ilm  
c e lls  c o n tro l)
Band Mr Rf Co Band Mr Rf Co Band Mr Rf Co
no. (kDa) no. (kDa) no. (kDa)
1 66 0.34 - 1 (72.2) (0.11) - 1 (73.7) (0.09) -
2 45 0.49 - 2 (68.2) (0.17) - 2 (68.7) (0.16) -
3 36 0.52 - 3 (66) (0.20) - 3 (66) (0.20) -
4 29 0.62 - 4 (64) (0.23) - 4 (63.2) (0.24) -
5 24 0.77 - 5 (62.5) (0.25) - 5 (61.2) (0.27) -
6 20.1 0.86 - 6 (60,5) (0.28) - 6 (59.7) (0.29) -
7 14.2 0.98 - 7 (58.5) (0.31) - 7 57,7 0.32 -
- - - - 8 51 0.36 - 8 53 0.35 -
- - - - 9 48 0.38 - 9 48 0.38 -
- - - - 10 44.7 0.41 - 10 44.7 0.41 -
- - - - 11 41.7 0.34 - 11 41.7 0.44 -
- - - - 12 37 0.50 - 12 38.7 0.47 -
- - - - 13 33.5 0.55 - 13 37 0.50 -
- - - - 14 30.5 0.60 - 14 36 0.52 -
- - - - 15 28.2 0.64 - 15 33 0.56 -
- - - - 16 26.7 0.67 - 16 29.5 0.63 -
- - - - 17 23.7 0.74 - 17 26.7 0.67 -
- - - - 18 21.7 0.79 - 18 22.7 0.78 -
- - - - 19 19.2 0.86 - 19 19.5 0.85 -
- - - - 20 17 0.91 - 20 17.5 0.90
- - - - 21 15.7 0.95 - - - - -
- - - - - - - - - - - -
KEY:
( ): Molecular weights estimated from linear equation derived from standard calibration curve (F ig 19)
- :  No data for that cell
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T a b le  9  ( p a r t  2 ) : M e a s u re m e n t d a ta  in d ic a tin g  B a n d  n u m b e r , M o le c u la r  w e ig h t  (M ) 
a n d  R e ta rd a tio n  fa c to r  (Rf) fo r O u te r  M e m b ra n e  P ro te in s  o f  Ps. aeruginosa  e lu a te  
c e lls  e x p o se d  to  d if fe re n t tr e a tm e n t o f  a n tib io tic s  a n d  c u ltu re d  in  m o d if ie d  C D M  
(B a n d  no : b a n d  n u m b e r; C o : c o rre sp o n d in g  p ro te in  to  L a n e  4  (N B : o n ly  th e  te s t  la n e s  
5 , 6 &  7  a re  c o m p a re d  to  la n e  4 ); N : n o v e l p ro te in ) .
L a n e  4
(Ps. aeruginosa  e lu a te  
c e lls  c o n tro l) .
(Ps. aer  
w i1 
ampi<
L a n e  5
uginosa  e lu a te  ce lls  
h  tre a tm e n t o f  
cillin  a t su b -M IC  
;8 p g  m L '1).
L a n e  6
(Ps. aeruginosa  e lu a te  c e lls  
w i th  tr e a tm e n t o f  n a l id ix ic  
a c id  a t  su b -M IC  
(4  p g  m L '1).
Band M r Rf Co Band M r Rf Co Band M r Rf Co
no. (kDa) no. (kDa) no. (kDa)
1 (73.7) (0.09) - 1 (73) (0.10) 1 1 (73.7) (0.09) 1
2 (66.7) (0.19) - 2 (71) (0.13) N 2 (71) (0.13) N
3 38.7 0.47 - 3 (67.5) (0.18) 2 3 (66.7) (0.19) 2
4 37.7 0.49 - 4 (59.7) (0.29) N 4 (64.7) (0.22) N
5 36 0.52 - 5 57 0.33 N 5 (61.7) (0.26) N
6 32.2 0.57 - 6 48 0.38 N 6 (61.2) (0.27) N
7 29.5 0.63 - 7 45.7 0.41 N 7 (59.7) (0.29) N
8 26.2 0.68 - 8 41.7 0.44 N 8 57 0.33 N
9 24.5 0.72 - 9 38.7 0.47 3 9 44.7 0.41 N
10 23.5 0.75 - 10 37.7 0.49 4 10 43 0.43 N
11 21.7 0.79 - 11 36 0.52 5 11 40.2 0.46 N
12 20.5 0.82 - 12 33.5 0.55 N 12 36 0.52 4
13 19.5 0.85 - 13 32.2 0.57 6 13 36 0.52 5
14 18 0.89 - 14 30.5 0.60 7 14 33 0.56 6
15 15.7 0.95 - 15 26.7 0.67 8 15 30.5 0.60 7
- - - - 16 24 0.73 10 16 29.5 0.63 7
- - - - 17 23.5 0.75 10 17 26.7 0.67 8
- - - - 18 21 0.81 11 18 25 0.71 9
- - - - 19 19.5 0.85 13 19 23.5 0.75 10
- - - - 20 18.2 0.88 14 20 21.5 0.80 11
- - - - - - - - 21 19.7 0.84 13
- - - - - - - - 22 18.2 0.88 14
KEY:
():  Molecular weights estimated from linear equation derived from standard calibration curve (Fig 19)
- :  N o data for that cell
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T a b le  9  ( p a r t  3 ): M e a su re m e n t d a ta  in d ica tin g  
B a n d  n u m b e r , M o le c u la r  w e ig h t (Mr) a n d  
R e ta rd a tio n  fa c to r  (Rf) fo r  O u te r  M e m b ra n e  P ro te in s  
o f  Ps. aeruginosa  e lu a te  ce lls  e x p o se d  to  d iffe re n t 
t r e a tm e n t o f  a n tib io tic s  a n d  c u ltu re d  in  m o d if ie d  
C D M  (B a n d  n o : b a n d  n u m b e r; C o: c o r re sp o n d in g  
p ro te in  to  L a n e  4  (N B : o n ly  th e  te s t  la n e s  5, 6 &  7 
a re  c o m p a re d  to  la n e  4 ); N : n o v e l p ro te in ) .
L a n e  7
(Ps. aeruginosa  e lu a te  c e lls  w i th  t r e a tm e n t o f  
s tre p to m y c in  a t  su b -M IC  (8 p g  m L ’1)
Band M r (kDa) Rf Co
no.
1 (73.7) (0.09) 1
2 (71) (0.13) N
3 (67.5) (0.18) N
4 (66.7) (0.19) 2
5 (65.2) (0.21) N
6 (63.2) (0.24) N
7 57 0.33 N
8 45.7 0.40 N
9 43.7 0.42 N
10 41.7 0.44 N
11 38.7 0.47 3
12 37.7 0.49 4
13 36 0.52 5
14 33 0.56 6
15 30.5 0.60 7
16 29 0.62 7
17 27.2 0.66 8
18 25.7 0.69 8
19 24 0.73 10
20 23.7 0.74 10
21 21.7 0.79 11
22 19.7 0.84 13
23 18.2 0.88 14
KEY:
( ): Molecular weights estimated from linear equation derived
from standard calibration curve (Fig 19)
- :  No data for that cell
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OMP shifts in Escherichia coli ATCC 10000 biofilm and eluate cells exposed to sub-
M IC s  o f  a m p ic il l in  (A m P ), n a lid ix ic  a c id  (N a L ) a n d  s tre p to m y c in  (S T )
I n  E. coli b io f ilm  ce lls  tw o  o u te r  m e m b ra n e  p ro te in s  w ith  m o le c u la r  w e ig h ts  
o f  3 7 .7  k D a  a n d  3 6  k D a  w e re  p re s e n t  in  c o n tro l ( la n e  3, F ig u re  2 2 ) , b u t  w e re  
u n d e te c ta b le  in  c e lls  e x p o se d  to  su b -M IC s  o f  N a L  a n d  S T  ( la n e s  5 a n d  6 , F ig u re  2 2 ). 
A f te r  tr e a tm e n t w ith  su b -M IC s  o f  A m P  a n d  n a lid ix ic  a c id  ( la n e s  4  a n d  5 , F ig u re  2 2 ), 
a  2 3 .5  k D a  O M P  w a s  n o  lo n g e r  a p p a re n t.
In  E. co li e lu a te  ce lls , a  2 1 .5  k D a  o u te r  m em b ra n e  p ro te in  a b s e n t  f ro m  c o n tro l 
s a m p le s  ( la n e  4 , F ig u re  2 3 ), a p p e a re d  in  c e lls  e x p o se d  to  su b -M IC s o f  n a l id ix ic  a c id  
( la n e  6 , F ig u re  2 3 ). T w o  p ro te in s  w ith  m o le c u la r  w e ig h ts  o f  2 2 .7  k D a  a n d  2 3 .5  k D a  
w e re  a b s e n t f ro m  c o n tro l a n tib io tic  u n e x p o s e d  c e lls  ( la n e  4 , F ig u re  2 3 ) , b u t  b o th  
O M P s  w e re  p re s e n t  in  c e lls  e x p o se d  to  su b -M IC s o f  A m P , N a L  a n d  S T  r e s p e c tiv e ly  
( la n e s  5 , 6 , &  7 , F ig u re  23 ). A  36 .5  k D a  O M P  w a s  o n ly  p re s e n t  in  c o n tro l  s a m p le s , 
b u t  in a p p a re n t in  c e lls  e x p o se d  to  su b -M IC s  o f  A m P  a n d  S T  ( la n e s  5 a n d  7 , F ig u re  
23 ).
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Figure 22: O uter m em brane protein profile o f E scherichia coli b iofilm  cells cultured in m odified  
CDM  and exposed to different treatm ent o f  antibiotics. Lane 1: m olecular w eights m arkers; 
Lane 2: E. coli planktonic cells control (745 pg protein w ell'1); Lane 3: E. coli biofilm  cells control 
(700 pg protein w ell'1); Lane 4: E. coli b iofilm  cells (784 pg protein w ell'1) w ith treatm ent of  
am picillin at sub-M IC (2 pg mL'1); Lane 5: E. co li b iofilm  cells (794 pg protein well"1) with 
treatm ent o f nalidixic acid at sub-M IC (2 pg mL'1); Lane 6: E. co li b iofilm  cells (673 pg protein  









Figure 23: O uter m em brane protein profile o f E scherichia coli eluate cells cultured in m odified  
CDM  and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eight m arkers; Lane 
2: E. coli planktonic cells control (745 pg protein w ell'1); Lane 3: E. coli b iofilm  cells control (700 
pg protein w ell'1); Lane 4: E. coli eluate cells control (723 pg protein w ell'1); Lane 5: E. coli eluate 
cells (707 pg protein w ell'1) w ith treatm ent o f  am picillin at sub-M IC  ( lp g  m L'1); Lane 6: E. coli 
eluate cells (697 pg protein well'1) w ith treatm ent o f  nalidixic acid at sub-M IC  (1 pg mL'1); Lane 
7: E. coli eluate cells (702 pg protein well"1) w ith treatm ent o f streptom ycin at sub-M IC  (8 pg mL' 
!). Arrow  indicates the 21.5 kDa OM P.
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OMP shifts in sub-MIC of AmP, NaL and ST exposed cells of binary biofilm cells
a n d  e lu a te  ce lls  o f  Ps. aeruginosa  P A O l a n d  E. co li A T C C  10 0 0 0 .
In  b in a ry  b io f ilm s  (m ix e d )  c e lls  a  4 4 .7  k D a  O M P  o b s e rv e d  in  c o n tro l c e lls  w a s  
in a p p a re n t in  c e lls  e x p o se d  to  su b -M IC  o f  a n tib io tic s  o f  A m P  a n d  S T  (c o m p a re  la n e  4  
to  la n e s  5 a n d  7, F ig u re  24 ). H o w e v e r , th is  O M P  w a s  a p p a re n t  in  c e lls  t r e a te d  w ith  
su b -M IC s  o f  n a lid ix ic  a c id  ( la n e  6 , F ig u re  2 4 ). T w o  o th e r  O M P s  w i th  m o le c u la r  
w e ig h ts  o f  66  k D a  a n d  2 3 .7  k D a  w e re  p re s e n t in  c o n tro l c e lls  ( la n e  4 , F ig u re  2 4 ) ,b u t  
w e re  in a p p a re n t in  c e lls  e x p o se d  to  su b -M IC s  o f  A m P , N a L  a n d  S T  ( la n e  5, 6 , &  7, 
F ig u re  2 4 ).
A  4 8  k D a  w a s  a p p a re n t in  c e lls  e x p o se d  to  s u b -M IC s  o f  a n t ib io t ic s  o f  A m P  
a n d  N a L  (c o m p a re  la n e  4  to  la n e s  5 a n d  6 , F ig u re  24 ). A n o th e r  O M P  w i th  a  m o le c u la r  
w e ig h t o f  3 8 .7  k D a  w a s  p re s e n t in  c o n tro l s a m p le s  ( la n e  4 , F ig u re  2 4 ), b u t  in a p p a re n t 
in  c e lls  e x p o se d  to  su b -M IC s  o f  a n tib io tic s  o f  A m P  a n d  N a L  ( la n e s  5 a n d  6 , F ig u re  
2 4 ). S im ila r ly  a  35 k D a  O M P  w a s  p re s e n t  in  c o n tro ls , a n d  in a p p a re n t in  c e lls  tr e a te d  
w ith  su b -M IC s  o f  a n tib io tic s  o f  A m P , N a L  a n d  S T  (la n e  5 , 6 &  7 , F ig u re  2 4 ) .
F ig u re  2 5  il lu s tra te s  S D S -P A G E  O M P  p ro f ile s  o f  b in a ry  e lu a te  c e lls . A n  o u te r  
m e m b ra n e  p ro te in  w ith  a  m o le c u la r  w e ig h t o f  2 2 .7  k D a  w a s  a b s e n t  in  c o n tro ls  (c e lls  
th a t  h a v e  n o t  b e e n  tre a te d  w ith  a n tib io tic s ) , b u t  w a s  p re s e n t  a f te r  c e lls  w e re  e x p o s e d  
to  su b -M IC s  o f  a m p ic ill in  (c o m p a re  lan e  7 to  lan e  8 , F ig u re  2 5 ). A n o th e r  6 6 .7  k D a  
o n ly  a p p e a re d  in  ce lls  e x p o se d  to  su b -M IC s  o f  A m P  a n d  S T  (c o m p a re  la n e  7  to  la n e s  
8 a n d  10). T w o  O M P s  w ith  m o le c u la r  w e ig h ts , 61 .7  k D a  a n d  2 4  k D a  w e re  in d u c e d  
o n ly  a f te r  c e lls  w e re  e x p o se d  to  su b -M IC s o f  A m P , N a L  a n d  S T  (c o m p a re  la n e  7 to  
la n e s  8 , 9 a n d  10, F ig u re  25). A  7 0 .2  k D a  O M P  w a s  o n ly  p re s e n t  in  c o n tro l s a m p le s  
( la n e  7, F ig u re  25 ) a n d  a n o th e r  51 k D a  O M P  w a s  in a p p a re n t in  th e  p re s e n c e  o f  su b - 
M IC s  o f  a n tib io tic s  o f  A m P  a n d  n a lid ix ic  a c id  ( la n e s  8 a n d  9 , F ig u re  2 5 ).
I l l
Figure 24: O uter m em brane protein profile o f  binary biofilm  cells cultured in m odified CDM  
and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eights m arkers; Lane 2: Ps. 
aeruginosa  P A O l biofilm  cells control (729 pg protein w ell'1); Lane 3: E scherich ia  co li ATCC  
10000 biofilm  cells control (700 pg protein w ell'1); Lane 4: Binary biofilm  cells control (787 pg 
protein w ell'1); Lane 5: Binary biofilm  cells (715 pg protein w ell'1) w ith treatm ent o f  am picillin at 
sub-M IC concentration (32 pg mL'1); Lane 6: Binary biofilm  cells (705 pg protein well"1) with 
treatm ent o f nalidixic acid at sub-M IC concentration (8 pg mL'1); Lane 7: Binary biofilm  cells 
(723 pg protein w ell'1) w ith treatm ent o f streptom ycin at sub-M IC  concentration (16 pg m L'1). 
A rrow indicates the 44.7 kDa OM P.







Figure 25: O uter m em brane protein profile o f  binary eluate cells cultured in m odified CDM  
and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eights m arkers; Lane 
2; Ps. aeruginosa  P A O l planktonic cells control (776 pg protein  w ell'1); Lane 3: Escherichia  
coli 10000 planktonic cells control (745 pg protein w ell'1); Lane 4: Ps. aeruginosa  b iofilm  cells 
control (729 pg protein w ell'1), Lane 5: E scherich ia  coli b iofilm  cells control (784 pg protein  
w ell'1), Lane 6: Binary biofilm  cells control (787 pg protein w ell'1); Lane 7: Binary biofdm  
eluate cells control (744 pg protein well'1); Lane 8: Binary eluate cells (721 pg protein  w e l l1) 
with treatm ent o f  am picillin at sub-M IC concentration (16 pg m L'1); Lane 9: Binary eluate  
cells (724 pg protein w ell'1) with treatm ent o f  nalidixic acid at sub-M IC  concentration (4 pg 
m L'1); Lane 10: Binary eluate cells (716 pg protein w ell'1) w ith treatm ent o f streptom ycin at 
sub-M IC concentration (4 pg m L'1). Arrow indicates the 22.7 kD a O M P.
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V a ria t io n s  in  o u te r  m e m b ra n e  p ro f ile s  b e tw e e n  Ps. aeruginosa  a n d  E. coli 
m o n o s p e c ie s  a n d  b in a ry  b io f ilm  a n d  e lu a te  c e lls  fo llo w in g  e x p o su re  to  s u b -M IC s  o f  
a n tib io tic s , a m p ic ill in , n a lid ix ic  a c id  a n d  s tre p to m y c in  a re  a p p a re n t. S o m e  o u te r  
m e m b ra n e  p ro te in s  a p p e a re d  in  b o th  s e n s itiv e  a n d  tre a te d  c e lls , w h ile  o th e rs  a p p e a re d  
w ith  s lig h t  a lte ra tio n s  in  th e ir  m o le c u la r  w e ig h ts . I t  is  a lso  e v id e n t th a t  so m e  O M P s  
w e re  lo s t  f ro m  th e  ce lls  fo llo w in g  a n tib io t ic  tre a tm e n ts . O th e rs  a p p e a re d  a s  n o v e l 
p ro te in s  in  th e  tre a te d  ce lls . T h e se  re su lts  in d ic a te  a  c o m p le x  s e r ie s  o f  in te rn a l 
m e ta b o lic  a n d  e x te rn a l o u te r  m e m b ra n e  a s so c ia te d  c h a n g e s  in d u c e d  b y  th e  p re s e n c e  
o f  su b -M IC s  o f  a n tib io tic s . S u c h  c h a n g e s  a re  in d ic a tiv e  o f  a n tib io tic  a c tin g  a t a  
d iv e rs ity  o f  s ite s  in te rn a l to  th e  b a c te r ia l  ce ll.
T h e  m o d e  o f  g ro w th  (b io film , e lu a te  o r  p la n k to n ic )  a ffe c ts  th e  s e n s i t iv ity  o f  
th e  b a c te r ia l sp e c ie s  to w a rd s  a n tib io tic s . I t  m a y  b e  n o te d  th a t  v a r ia t io n s  in  th e  O M P  
p ro f ile s  m a y  a lso  b e  c h a ra c te r is t ic  to  th e  m o d e  o f  g ro w th . S ig n if ic a n t v a r ia t io n s  in  th e  
O M P  p ro f ile s  fo llo w in g  e x p o su re  to  d if fe re n t a n tib io tic s  m a y  le a d  to  e p ito p ic  c h a n g e s  
in  th e  b a c te r ia l  m e m b ra n e . O u te r  m e m b ra n e  p ro te in s  (O M P s)  im p la n te d  w i th in  th e  
b a c te r ia l  m e m b ra n e  a re  c a p a b le  o f  se le c tiv e  in ta k e  o f  so lu te s  ( in c lu d in g  
a n tim ic ro b ia ls ) . O v e r-e x p re ss io n  o r  lo s s  o f  c e r ta in  O M P s  m a y  le a d  to  e p ito p ic  
c h a n g e s  in  th e  b a c te r ia l m e m b ra n e , le a d in g  to  su b se q u e n t re s is ta n c e  o r  lo s s  o f  
se n s i t iv ity  (A b d e l M a le k , 20 02 ).
O n e -d im e n s io n a l S D S -P A G E , w h ile  c a p a b le  o f  p ro v id in g  v a lu a b le  
in fo rm a tio n  th a t c o u ld  b e  u se d  fo r  in itia l a n a ly s is  o f  O M P s , is  n o t  c o n s id e re d  a  
d e f in itiv e  a p p ro a c h  to  th e ir  p ro te o m ic  a n a ly s is . I n  o rd e r  to  id e n tify  th e s e  O M P s , m a s s  
s p e c tro sc o p ic  a n a ly s is  h a s  to  b e  c a r r ie d  o u t a n d  2 D -P A G E  a n a ly s is  o f  th e s e  p ro te in s  
w o u ld  n a tu ra lly  p re c e d e  it. H e n c e , 2 D -P A G E  a n a ly s is  o f  th e s e  p ro te in s  (O M P s )  w a s  
u n d e r ta k e n .
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T w o - d im e n s io n a l  p o ly a c r y la m id e  g e l e le c t r o p h o r e s i s  (2 D -P A G E )  o f  o u t e r  
m e m b r a n e  p r o t e in s  is o la te d  f r o m  m o n o s p e c ie s  a n d  b i n a r y  b io f i lm s  o f  Ps. 
aeru g in osa  A T C C  15 69 2  ( P A O l )  a n d  E sch erich ia  co li A T C C  1 0 0 0 0
T h e  re su lts  o b ta in e d  f ro m  S D S -P A G E  a n a ly s is  i l lu s t ra te d  s ig n if ic a n t  
d if fe re n c e s  in  th e  o u te r  m e m b ra n e  p ro te in s . A lth o u g h  S D S -P A G E  a n a ly s is  o f  
a n tib io t ic  tr e a te d  a n d  co n tro l s a m p le s  in d ic a te d  sh ifts  in  p ro te in  p a t te r n s ,  fu r th e r  
a n a ly s is  u s in g  2 D -P A G E  w as  u n d e r ta k e n . S u c h  a n a ly s is , b e s id e s  g u a ra n te e in g  
s e p a ra tio n  o f  a ll  o u te r  m e m b ra n e  p ro te in s  b e in g  a n a ly se d , w o u ld  a ls o  e n s u re  c o r re c t 
in te rp re ta tio n  o f  re su lts . F o r  in s ta n c e , a  th ic k  p ro te in  b a n d  v is u a lis e d  o n  S D S -P A G E  
m a y  b e  in te rp re te d  as o v e r-e x p re s s io n  o f  a  s in g le  p ro te in . H o w e v e r , th e o r e t ic a l ly  th is  
m a y  a lso  b e  d u e  to  tw o  p ro te in s  h a v in g  s im ila r  m o le c u la r  w e ig h ts  c o - lo c a l iz in g  a t  th e  
sa m e  p o s i t io n  o n  th e  gel. I n  o rd e r  to  d is c o u n t  th e  la tte r  p o s s ib i l i ty  2 D -P A G E  a n a ly s is  
w a s  p e r fo rm e d  o n  a ll te s t  sa m p le s . L ik e w is e , n o v e l p ro te in  b a n d s  p r e s e n t  w ith in  
a n tib io tic  tre a te d  sa m p le s  (3 7  k D a  p ro te in  b a n d  in  s tre p to m y c in  tr e a te d  Ps. 
aeruginosa  b io f ilm  ce lls , 4 4 .7  k D a  p ro te in  b a n d  v isu a lis e d  in  n a l id ix ic  a c id  tre a te d  
b in a ry  b io f ilm  sa m p le , 2 2 .7  k D a  p ro te in  b a n d  in  th e  a m p ic il l in  t r e a te d  e lu a te  c e ll 
s a m p le s , e tc .)  w e re  in v e s tig a te d  u s in g  2 D -P A G E  so a s  to  a s c e r ta in  th e  a c tu a l  n u m b e r  
o f  p ro te in s  th a t m a k e  u p  th e  b a n d .
E x p e r im e n ta l a p p ro a c h
S in ce  O ’F a rre ll (1 9 7 5 ) in tro d u c e d  th e  im p ro v e d  te c h n iq u e  fo r  h ig h -re s o lu t io n  
tw o -d im e n s io n a l p o ly a c ry la m id e  ge l e le c tro p h o re s is  (2 D -P A G E ). I t  h a s  b e c o m e  o n e  
o f  th e  m o s t  p o w e rfu l to o ls  fo r  th e  s e p a ra tio n  a n d  c h a ra c te r is a t io n  o f  p ro te in s  fro m  
c o m p le x  m ix tu re s  ( O ’F a rre ll , 19 75 ). T h is  fo rm  o f  s e p a ra tio n  d e p e n d s  o n  th e  
m o le c u la r  w e ig h ts  o f  p o ly p e p tid e s  a n d  a lso  o n  th e ir  o v e ra ll c h a rg e , w h ic h  in  tu rn  
d e p e n d s  o n  th e  a m in o  a c id  c o m p o s it io n  o f  th e  p ro te in , th e  p re s e n c e  o r  a b s e n c e  o f
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d e te rg e n ts  a n d  th e  p H  o f  th e  so lu tio n . In  th is  te c h n iq u e , th e  p ro te in s  a re  s e p a ra te d  in  
th e  f irs t  d im e n s io n  a c c o rd in g  to  th e ir  iso e le c tr ic  p o in ts  a n d  su b s e q u e n tly  a c c o rd in g  to  
m o le c u la r  w e ig h t in  th e  se c o n d  d im e n s io n . C o n se q u e n tly , i t  h a s  su f f ic ie n t re s o lu t io n  
to  s e p a ra te  in d iv id u a l p ro te in s  as  d isc re te  sp o ts  o n  th e  g e l ( O ’F a rre ll , 1 9 7 5 ). T h e re  a re  
tw o  d if fe re n t m e th o d s  fo r  p e r fo rm in g  th e  f irs t-d im e n s io n a l s ta g e  ( iso e le c tr ic  fo c u s in g ; 
IE F ). T h e  f irs t  m e th o d  is b y  p re -ru n n in g  th e  f irs t  d im e n s io n a l g e l ( tu b e  g e l)  w i th o u t 
th e  s a m p le  to  e s ta b lish  th e  p H  g ra d ie n t. In  th e  s e c o n d  m e th o d , s a m p le s  a re  lo a d e d  
d ire c t ly  o n to  th e  tu b e -g e ls  a n d  th e  p H  g ra d ie n t e s ta b lish e d  d u rin g  th e  is o e le c tr ic  
fo c u s in g  s ta g e  (th e  n o n -e q u ilib r iu m  p H  g ra d ie n t e le c tro p h o re s is  te c h n iq u e ; N E P H G E ; 
O ’F a rre ll , et al. 1977 ). T h e  se c o n d  d im e n s io n  re m a in s  th e  sa m e  a s  th a t  o r ig in a l ly  
d e v e lo p e d  b y  L a e m m li (197 0 ). B y  c o m b in in g  IE F  o r  N E P H G E  in  th e  f ir s t  d im e n s io n  
w ith  so d iu m  d o d e c y l su lp h a te  (S D S ) g e l e le c tro p h o re s is  in  th e  s e c o n d  d im e n s io n , th is  
p ro c e d u re  (IE F -S D S ) c a n  re so lv e  o v e r  10 00  p ro te in s  (C e lis  &  B ra v o  19 8 3 ).
P re p a ra t io n  o f  tu b e -g e ls  ( f irs t d im e n s io n  p ro te in  s e p a ra tio n ) , is o e le c tr ic  
fo c u s in g  o f  p ro te in  sa m p le s  a n d  p re p a ra tio n  o f  s la b  g e ls  (se c o n d  d im e n s io n  p ro te in  
se p a ra tio n )  w e re  p e r fo rm e d  as d e sc r ib e d  in  C h a p te r  2.
F o r  2 D -P A G E  a n a ly s is , b io f ilm s  w e re  g ro w n  o n  S o rb a ro d  f ilte rs  a s  d e s c r ib e d  
e a r lie r  in  th is  c h a p te r  (P ag e  9 7 ). B io f ilm  O M P s  w e re  e x tra c te d  a c c o rd in g  to  th e  
m e th o d  d e sc r ib e d  b y  H o d g so n  e t al. (1 9 9 5 ) a n d  e lu a te  O M P s  w e re  e x tra c te d  
a c c o rd in g  to  P u g s le y  et al. (1 9 8 6 ) s a m p le s  w e re  s to re d  a t  -2 0 °C  fo r  la te r  a n a ly s is . 
O u te r  m e m b ra n e  p ro te in  (O M P ) s a m p le s  u s e d  fo r  2 D -P A G E  a n a ly se s  w e re  th o s e  o f  
P seudom onas aeruginosa  m o n o s p e c ie s  b io f ilm s  tre a te d  w ith  s u b -M IC s  o f  
s tre p to m y c in  a n d  b in a ry  b io f ilm s  {Pseudom onas aeruginosa  a n d  E sch erich ia  co li) 
tr e a te d  w ith  a ll th re e  a n tib io tic s  (A m P , N a L  a n d  S T ).
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A n alysis o f  OM P pro files
F ig u re  2 6  i l lu s tra te s  th e  tw o -d im e n s io n a l e le c tro p h o re tic  p ro te in  p a t te rn  o f  
2 D -P A G E  m a rk e rs  se p a ra te d  a c c o rd in g  to  th e ir  m o le c u la r  w e ig h ts  a n d  p i ’s 
( iso e le c tr ic  p o in ts ; p o in ts  a t  w h ic h  th e  p ro te in s  h a v e  a  n e t  n e u tra l  c h a rg e ) . T h e  IE F  
ra n g e  is  b e tw e e n  p H  3 .5  a n d  p H  10; th e  p i  fo r  e a c h  p ro te in  w a s  e s t im a te d  m a n u a lly  
a n d  c o m p a re d  to  th e  s ta n d a rd  p i  (T a b le  10) in  o rd e r  to  d e te rm in e  th e  m o le c u la r  
w e ig h t  fo r  e a c h  sp o t. T h e  Rf v a lu e  fo r  e a c h  s ta n d a rd  p ro te in  w a s  c a lc u la te d  a c c o rd in g  
to  E q u a tio n  2  (P ag e  99). B y  p lo t t in g  th e  m o le c u la r  w e ig h ts  (M r; D a l to n s )  a g a in s t  Rf 
v a lu e s , a  c a lib ra tio n  c u rv e  w as  c o n s tru c te d  (F ig u re  2 7 ). F o r  th e  s a m p le  g e ls  (F ig u re s  
2 8 , 2 9  &  3 0 ) th e  Rf v a lu e  o f  p ro te in s  w e re  e s tim a te d  f ro m  E q u a tio n  2  a n d  th e n  
e x tra p o la te d  o n to  th e  c a lib ra tio n  c u rv e , in  o rd e r  to  d e te rm in e  th e  m o le c u la r  w e ig h t. 
T h e  in d iv id u a l n u m b e re d  p ro te in s  (o n  e a c h  sa m p le  g e l)  a n d  th e ir  c o r re sp o n d in g  
e s tim a te d  m o le c u la r  w e ig h ts , Rf a n d  p i  ( a n a ly se d  m a n u a lly )  a re  s h o w n  in  T a b le  10.
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Figure 26: T w o-dim ensional electrophoretic protein pattern o f  2D -PA G E  standards separated  
according to their m olecular weight and p i. Protein concentration: 792 pg protein gel"1. Num bers 
may be to the left or right o f  protein, but not above or below.
T a b le  10 : Standard Molecular Weights and Isoelectric points (pi).
P r o te in M o le c u la r p i
W e ig h t  (k D a ) (p H )
Ovotransferrin (hen egg) 76- 78 3.9
Albumin (a bovine serum) 66.25 3.9
Ovalbumin (hen egg) 42.7 8.7
Carbonicanhydrase (bovine 30 6.6
erythrocyte)
Myoglobin (equine) 17.2 N
Cytochrome C (equine) 12.3 6.0
N: Not detected due to manufacturers error.
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Table 11: Measurement data indicating Protein number, Molecular weight (Mr), 
Retardation factor (R f )  and Isoelectric point (pi) o f the proteins identified in the 
2D-PAGE standard proteins gel.
Protein no. Mr (kDa) R f p i (pH)
1 76 0.35 3.9
2 66.2 0.42 3.9
3 42.7 0.56 8.7
4 30 0.68 6.6
5 12.3 0.82 6
Figure 27: Calibration curve generated by plotting the molecular weights of 2 0-  
PAGE standards in Dalton’s vs Rf values.
Results & Discussion
One o f the primary aims of carrying out SDS-PAGE and 2D-PAGE analyses 
on outer membrane proteins of Pseudomonas aeruginosa biofilms was to isolate those 
potential proteins that may be responsible for a common mechanism o f antibiotic 
resistance. Hence, three different antibiotics were chosen (AmP, NaL and ST) and
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S D S -P A G E  e n a b le d  th e  id e n tif ic a tio n  o f  c o m m o n  n o v e l p ro te in s  th a t  b e c a m e  
a p p a re n t a n d  th o se  th a t b e c a m e  in a p p a re n t, fo r  a ll d if fe re n t a n t ib io t ic  tr e a tm e n ts . In  
o rd e r  to  fu r th e r  in v e s tig a te  th is  su b se t o f  p ro te in s  d e r iv e d  f ro m  c o m p a r is o n  o f  a ll  
th re e  a n tib io tic  tre a tm e n ts  (d a ta  n o t  g iv e n  h e re ) , 2 D -P A G E  o f  o n ly  o n e  a n tib io t ic  
t r e a te d  sa m p le  w a s  n e c e ssa ry , a n d  so  s tre p to m y c in  w a s  c h o s e n  as  th e  r e p re se n ta t iv e  
c o m p o u n d .
T h e  o u te r  m e m b ra n e  p ro te in s  o f  Ps. aeruginosa  b io f ilm  c e lls  e x p o s e d  to  th e  
a n tib io t ic  s tre p to m y c in  a t su b -M IC  (8 jug m L '1) w e re  a n a ly s e d  a n d  c o m p a re d  a g a in s t  
p ro te in s  o f  b io f ilm  c u ltu re  c o n tro l (T a b le  12). K e y  p ro te in s , th a t  w e re  v is ib le  in  th e  
b io f ilm  c o n tro l a n d  w ith  tre a te d  b io f ilm  c e lls , w e re  id e n tif ie d  a n d  c o m p a re d , s u c h  th a t 
th e  m o le c u la r  w e ig h t a n d  iso e le c tr ic  p o in ts  o f  p ro te in s  f ro m  tre a te d  b io f i lm  c e lls  
c o u ld  b e  e s tim a te d  a g a in s t th o se  o f  th e  c o n tro l ce lls . T h e  m o s t  p r o m in e n t  d if fe re n c e  
b e tw e e n  th e  ge ls  c o n ta in in g  p ro te in s  f ro m  p la n k to n ic  c o n tro l c e lls  (F ig u re  2 8 )  a n d  
b io f ilm  c o n tro l ce lls  (F ig u re  2 9 ) c o m p a re d  to  th o se  tre a te d  w ith  s tre p to m y c in  a t  su b - 
M IC  (8 p g  m L '1) (F ig u re  30 ), is  th e  d is a p p e a ra n c e  o f  v a r io u s  h ig h  m o le c u la r  w e ig h t  
p ro te in s  (8 0  k D a  to  98  k D a ) a n d  th e  p re s e n c e  o f  O M P s w ith  b a s ic  is o e le c tr ic  p o in ts  
a f te r  e x p o su re  to  su b -M IC  o f  s tre p to m y c in . A n  o u te r  m e m b ra n e  p r o te in  w i th  a  
m o le c u la r  w e ig h t o f  59 .2  k D a  (p i 8 .1 ) a p p e a re d  fo llo w in g  e x p o su re  o fP s. aeruginosa  
b io f ilm  c e lls  to  su b -M IC  o f  s tre p to m y c in  (8 p g  m L '1) , b u t  w a s  n o t  fo u n d  in  b io f i lm  
c o n tro l ce lls . T h is  p ro te in  a p p e a rs  to  b e  th e  s a m e  O M P  (5 9 .2  k D a ) , w h ic h  a p p e a re d  
u p o n  th e  e x p o su re  o f  b io f ilm  c e lls  to  su b -M IC  o f  s tre p to m y c in  (8 p g  m L '1) in  S D S - 
P A G E  g e ls  ( la n e  6 , F ig u re  20 ). S im ila r ly  a n o th e r  3 6 .7  k D a  (p i 4 .1 )  O M P  a p p e a re d  
fo llo w in g  th e  e x p o su re  o f  th e  b io f ilm  c e lls  to  su b -M IC  o f  s tre p to m y c in  (8  p g  m L '1), 
w h ic h  c o u ld  b e  th e  sam e  p ro te in  fo u n d  in  s im ila r  c o n d itio n s  o n  S D S -P A G E  g e ls  
(L a n e  6 , F ig u re  20 ). F in a lly  a  98 k D a  (p i 4 .5 )  O M P  w a s  p re s e n t  in  b io f i lm  con tro l 
sa m p le s , b u t  d is a p p e a re d  a f te r  e x p o su re  to  th e  sub -M IC  o f  s tre p to m y c in  (8  p g  m L '1).
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Figure 28: Tw o-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
Pseudom onas aeruginosa  PA O l planktonic cells control cultured in M C D M . The O M Ps are 
separated by the isoelectric point (reading left to right) and m olecular w eight (top  to bottom ). 
Protein concentration: 793 pg protein gel'1. Num bers may be to the left or right o f  protein .
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Figure 29: Two-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
Pseudom onas aeruginosa  P A O l biofilm  cells control cultured in M C D M . The O M Ps are 
separated by the isoelectric point (reading left to right) and m olecular w eight (top to bottom ). 
Protein concentration: 747 pg protein gel"1. Num bers may be to the left or right o f  protein.
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Figure 30: Tw o-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
Pseudom onas aeruginosa  b iofilm  cells exposed to streptom ycin at sub-M IC  (8 fig m L'1) and 
cultured in M CDM . The O M Ps are separated by the isoelectric point (reading left to right) and 
m olecular w eight (top to bottom ). Protein concentration: 753 pg protein  gel'1. N um bers may be to 
the left or right o f protein.
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T a b le  12  ( p a r t  1 ): M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  Ps. aeruginosa  b io f ilm  c e lls  e x p o s e d  to  
s tre p to m y c in  a t su b -M IC  (8 p g  m L '1) a n d  c o m p a re d  a g a in s t  Ps. aeruginosa  b io f ilm  
c e lls  ( c o n tro l) , c u ltu re d  in  m o d if ie d  C D M , (C o : c o r re sp o n d in g  p ro te in  to  F ig u re  29  
(N B : o n ly  F ig u re  30 is  c o m p a re d  to  F ig u re  2 9 ); N : n o v e l p ro te in ) .
F ig u r e  2 6 F ig u r e  28
S ta n d a rd  m o le c u la r  w e ig h t Ps. aeruginosa  p la n k to n ic  c e lls  c o n tro l
Protein Mr Rf Pi Co. Protein Mr Rf Pi Co.
no. (kDa) no. (kDa)
1 76 0.35 3.9 - 1 96 0.19 4.5 “
2 66.2 0.42 3.9 " 2 92 0.22 5.6
3 42.7 0.56 8.7 3 88 0.25 3.9 “
4 17.2 0.81 6.6 4 85 0.27 4 “
5 12.3 0.83 6.0 - 5 81 0.30 4.5
- “ “ “ 6 77 0.33 4.6
- “ 7 76 0.35 4.9 “
" “ 8 70.2 0.38 3.9 “
" " * 9 70.2 0.38 4.8 “
- “ “ “ “ 10 64 0.43 5.3
■ " 11 59.2 0.46 4.3
“ “ • “ 12 55.2 0.49 5.1
“ “ * “ 13 55.2 0.49 3.9 ”
“ " “ “ “ 14 55.2 0.49 4.5
“ “ “ ” 15 51.2 0.52 5.1
" “ " “ 16 51.2 0.52 3.9
“ “ “ “ 17 48.5 0.54 4.2
“ “ “ * 18 42 0.56 5.1
“ ” “ “ 19 42 0.56 4.5
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T a b le  12  ( p a r t  2 ) : M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  I so e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  Ps. aeruginosa  b io f ilm  c e lls  e x p o s e d  to  
s tre p to m y c in  a t su b -M IC  (8  p g  m L '1) a n d  c o m p a re d  a g a in s t  Ps. aeruginosa  b io f ilm  
c e lls  (c o n tro l) , c u l tu re d  in  m o d if ie d  C D M , (C o: c o r re sp o n d in g  p ro te in  to  F ig u re  29  
(N B : o n ly  F ig u re  30 is  c o m p a re d  to  F ig u re  29 ); N : n o v e l p ro te in ) .
F ig u r e  26 F ig u r e  28
S ta n d a rd  m o le c u la r  w e ig h t Ps. aeruginosa  p la n k to n ic  c e lls  c o n tro l
Protein Mr Rf pi Co. Protein Mr Rf Pi Co.
no. (kDa) no. (kDa)
- - “ 20 39.5 0.61 4.8
- - - " 21 39.5 0.61 4.3
- - “ “ 22 39.5 0.61 4.6 “
- “ “ “ " 23 39.5 0.61 5.1 “
- " " 24 34.2 0.65 5.4 “
- - - " 25 30 0.68 4.2 “
“ “ “ 26 30 0.68 4.2
“ “ " “ “ 27 30 0.68 4.6 “
- “ " - “ 28 27.5 0.70 5.8
" “ “ " 29 27.5 0.70 6.2
“ “ " “ ■ 30 20.5 0.75 4.2 "
“ " “ “ " 31 20.5 0.75 5.3 “
“ “ " “ 32 20.5 0.75 5.4 “
“ " ■ “ " 33 19 0.76 4.6
“ " ” “ " 34 12.3 0.82 4.2 "
" * “ 35 7.2 0.85 5.3 -
“ “ “ ” 36 3 0.88 4.2 -
- :  N o data for that cell
123
T a b le  12 ( p a r t  3 ): M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
fro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  P s . a e r u g in o s a  b io f ilm  c e lls  e x p o s e d  to  
s tre p to m y c in  a t su b -M IC  (8  p g  m L '1) a n d  c o m p a re d  a g a in s t  P s , a e r u g in o s a  b io f ilm  
c e lls  (c o n tro l) , c u l tu re d  in  m o d if ie d  C D M , (C o : c o r re sp o n d in g  p ro te in  to  F ig u re  29  
(N B : o n ly  F ig u re  30  is  c o m p a re d  to  F ig u re  2 9 ); N : n o v e l p ro te in ) .
F ig u r e  29
P s. a eru g in o sa  b io film  ce lls  (con tro l)
F ig u r e  30
P s. a eru g in o sa  b io film  ce lls  treated w ith  sub- 










1 98.7 0.17 4.5 1 81 0.30 4.1 N
2 96 0.19 5.4 " 2 59.2 0.46 6.2 N
3 92 0.22 3.6 “ 3 59.2 0.46 7.2 N
4 89.2 0.24 3.9 “ 4 59.2 0.46 8.1 N
5 88 0.25 3.6 “ 5 55.2 0.49 4.1 20
6 77 0.34 3.6 6 48.5 0.54 4.1 23
7 77 0.34 3.7 “ 7 48.5 0.54 4.8 23
8 77 0,34 4.1 “ 8 48.5 0.54 5.2 23
9 73 0.36 4.7 9 48.5 0.54 6.2 23
10 73 0.36 5.4 10 48.5 0.54 7.2 23
11 73 0.36 6 11 48.5 0.54 8.1 23
12 68.7 0.39 3.9 “ 12 37 0.63 4.1 N
13 66.2 0.42 4.3 " 13 27.5 0.70 4.1 N
14 66.2 0.42 5 “ 14 21.7 0.74 4.1 N
15 66.2 0.42 5.4 “ 15 16.5 0.78 4.1 N
16 66.2 0.42 5.8 “ 16 16.5 0.78 5.7 N
17 62 0.44 3.7 " 17 1 0.91 8.8 N
- :  No data for that cell
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T a b le  12  ( p a r t  4 ): M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  Ps. aeruginosa  b io f ilm  c e lls  e x p o s e d  to  
s tre p to m y c in  a t  su b -M IC  (8  p.g m L ’1) a n d  c o m p a re d  a g a in s t  Ps. aeruginosa  b io f ilm  
c e lls  (c o n tro l) , c u l tu re d  in  m o d if ie d  C D M , (C o : c o r re sp o n d in g  p ro te in  to  F ig u re  2 9  
(N B : o n ly  F ig u re  3 0  is c o m p a re d  to  F ig u re  2 9 ); N : n o v e l p ro te in ) .
F ig u r e  29 F ig u r e  30
Ps. aeruginosa  b io f ilm  ce lls  (c o n tro l) . Ps. aeruginosa  b io f ilm  c e lls  t r e a te d  w ith  










18 58 0.47 3.9 " " “
19 58 0.47 4.3 “ “ “
20 55.2 0.49 3.6 " “ “ “
21 52.5 0.51 3.9 “ " “ “ “
22 49.7 0.53 5 “ “ “ "
23 48.5 0.54 4.5 “ “
24 42 0.56 3.7 “ “ “ “ "
25 35 0.64 9.5 “ “ “ "
26 31 0.67 5.4 “ “ “ •
27 26.2 0.71 3.7 “ “ ■ “
28 15 0.79 4.7 " “ "
29 13 0.81 3.6 “ " “ “
30 5.7 0.86 4.5 “ * " “
- :  No data for that cell
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F ig u re s  31 , 32 , 33 &  3 4  d e m o n s tra te  th e  o u te r  m e m b ra n e  p ro te in  p ro f ile s  o f  
b in a ry  b io f ilm  ce lls  (co n tro l a n d  th o se  tre a te d  w ith  th e  su b -M IC  o f  an tib io tic s-  
a m p ic ill in , n a lid ix ic  a c id  a n d  s tre p to m y c in , r e sp e c tiv e ly ) , s e p a ra te d  b y  tw o - 
d im e n s io n a l ge l e le c tro p h o re s is . A  c o m p a riso n  o f  th e  o u te r  m e m b ra n e  p ro f i le s  o f  
b io f ilm  c e lls  (c o n tro l an d  a n tib io tic  tre a te d )  is  sh o w n  in  T a b le  13.
F ig u re  32  d e m o n s tra te s  th e  o u te r  m e m b ra n e  p ro te in s  o f  b in a ry  b io f i lm  c e lls  
e x p o s u re  to  th e  su b -M IC  o f  a m p ic il l in  a t  (3 2  jug m L '1). T h e  s ig n if ic a n t  d if fe re n c e  
b e tw e e n  b io f ilm  c o n tro l g e l (F ig u re  3 1 ) a n d  b io f ilm  tre a te d  g e l (F ig u re  3 2 )  is  th e  
a p p e a ra n c e  o f  v a r io u s  p ro te in s  w ith  h ig h  m o le c u la r  w e ig h ts  (1 0 0  k D a  to  111 k D a ) 
a n d  a lso  th e  o b se rv a tio n  o f  O M P s w ith  a lk a lin e  iso e le c tr ic  p o in ts . A n  o u te r  m e m b ra n e  
p ro te in  w ith  a  m o le c u la r  w e ig h t 31 k D a  (p i 7 .6 )  w a s  a p p a re n t in  a n t ib io t ic  t re a te d  
b io f ilm  c e lls , b u t  th is  O M P  w a s  a b s e n t in  th e  b io f ilm  c o n tro l c e lls . T h is  p r o te in  c o u ld  
b e  th e  s a m e  O M P  (30  k D a), w h ic h  a p p e a re d  u p o n  th e  e x p o su re  o f  b io f i lm  c e lls  to  
su b -M IC  o f  a m p ic ill in  (32  p g  m L '1) in  S D S -P A G E  g e ls  (L a n e  4 , F ig u re  2 4 ).
C o m p a riso n  o f  th e  2 D -P A G E  O M P  p ro f ile s  o f  b in a ry  b io f ilm s , c o n tro l (F ig u re  
3 1 ) a n d  tre a te d  ce lls  (F ig u re  3 3 ), in d ic a te  m a rk e d  d iffe re n c e s  b e tw e e n  th e  tw o  g e ls . A
4 8 .5  k D a  (p i 5 .2 ) p ro te in , a b se n t f ro m  c o n tro l sa m p le s , w a s  a p p a re n t in  c e lls  e x p o s e d  
to  su b -M IC  o f  n a lid ix ic  a c id  (8 jug m L '1). T h is  p ro te in  a p p e a rs  to  b e  th e  s a m e  O M P  
(4 8  k D a )  th a t a p p e a re d  in  S D S -P A G E  sa m p le s  tre a te d  w ith  su b -M IC  o f  n a l id ix ic  a c id  
(8 p g  m L '1) ( la n e  6, F ig u re  2 4 ). In  b in a ry  b io f ilm s  e x p o s e d  to  s u b -M IC s  o f  
s tre p to m y c in  (16  p g  m L '1) (F ig u re  3 4 ), a  73 k D a  (p i 5 .0 )  a n d  9 2  k D a  ( p i  3 .5 )  p ro te in  
w e re  a p p a re n t. A g a in , O M P s w ith  m o le c u la r  w e ig h ts  o f  41 k D a  (p i  5 .0 )  a n d  35  k D a  
( p i  4 .7 )  w e re  p re se n t in  b in a ry  b io f ilm  c o n tro l c e lls , b u t  a b s e n t in  c e ll  s a m p le s  
e x p o s e d  to  th e  su b -M IC  o f  s tre p to m y c in  (16  p g  m L '1).
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Figure 31: Tw o-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
binary biofilm  cells control cultured in M CDM . The O M Ps are separated by the isoelectric point 
(reading left to right) and m olecular w eight (top to bottom ). Protein concentration: 796 pg 
protein gel'1. Num bers may be to the left or right o f  protein.






12.3 to 78 
kDa
Figure 32: Tw o-dim ensional gel electrophoresis for outer m em brane protein  (O M P) profiles o f  
binary biofilm  cells exposed to am picillin at sub-M IC concentration (32 pg m L'1) and cultured in 
m odified CDM . The O M Ps are separated by isoelectric point (reading left to right) and 
m olecular w eight (top to bottom ). Protein concentration: 731 pg protein gel'1. N um bers may be to 
the left or right o f protein.
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12.3 to 78 
kDa
Figure 33: T w o-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
binary biofilm  cells exposed to nalidixic acid at sub -M IC  (8 pg m L'1) and cultured in m odified  
C D M . The O M Ps are separated by isoelectric point (reading left to right) and m olecular w eight 
(top to bottom ). Protein concentration: 712 pg protein  gel'1. N um bers may be to the left or right 
o f  protein.







12.3 to 78 
kDa
Figure 34: T w o-dim ensional gel electrophoresis for outer m em brane protein (O M P) profiles o f  
binary biofilm  cells exposed to streptom ycin at sub-M IC  (16 pg m L'1) and cultured in m odified  
CDM . The O M Ps are separated by isoelectric point (reading left to right) and m olecular w eight 
(top to bottom ). Protein concentration: 729 pg protein  gel'1. N um bers may be to the left or right 
o f  protein.
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T a b le  13 ( p a r t  1 ): M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  b in a ry  b io f ilm  c e lls  e x p o s e d  to  d if fe re n t 
tr e a tm e n t o f  a n tib io tic s  a n d  c o m p a re d  a g a in s t  b in a ry  b io f ilm  c e lls  (c o n tro l) , c u l tu re d  
in  m o d if ie d  C D M , (C o : c o rre sp o n d in g  p ro te in  to  F ig u re  31 ; N : n o v e l p ro te in ) .
F ig u r e  31
B in a ry  b io f ilm  c e lls  co n tro l.
F ig u r e  3 2
B in a ry  b io f ilm  c e lls  w i th  th e  tr e a tm e n t  o f  










1 92 0.20 4.3 1 86 0.25 4.1 3
2 91 0.21 3.6 “ 2 82.5 0.28 5.1 4
3 87 0.24 4.0 3 81 0.29 4.1 5
4 82 0.28 4.0 4 81 0.29 5.1 5
5 82 0.28 5.3 “ 5 77.5 0.32 . 4.7 7
6 80 0.30 4.7 ~ 6 72.5 0.36 9.0 9
7 77.5 0.32 4.9 “ 7 72.5 0.36 9.4 9
8 76 0.33 5.3 “ 8 66.5 0.41 6.0 11
9 73.5 0.35 4.6 “ 9 62 0.44 8.6 13
10 70 0.38 3.6 " 10 57 0.48 4.7 16
11 67 0.40 3.9 “ 11 57 0.48 9.0 16
12 65 0.42 4.9 “ 12 52 0.52 5.1 19
13 62 0.44 5.3 “ 13 52 0.52 5.5 19
14 61.5 0.45 4.7 " 14 48 0.57 6.0 N
15 61.5 0.45 5.5 “ 15 37.5 0.63 4.1 22
16 57 0.48 4.2 " 16 37.5 0.63 4.9 22
17 57 0.48 3.6 " 17 37.5 0.63 5.5 22
18 56 0.49 4.0 - 18 31 0.68 7.6 28
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T a b le  13 ( p a r t  2 ): M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l ge l a n a ly s is  o f  b in a ry  b io f ilm  c e lls  e x p o s e d  to  d if fe re n t 
t r e a tm e n t o f  a n tib io tic s  a n d  c o m p a re d  a g a in s t  b in a ry  b io f ilm  c e lls  (c o n tro l) , c u ltu re d
in  m o d if ie d  C D M , (C o : c o r re sp o n d in g  p ro te in  to  F ig u re  31 ; N : n o v e l p ro te in ) .
F ig u r e  31 F ig u r e  32
B in a ry  b io f ilm  c e lls  co n tro l. B in a ry  b io f ilm  c e lls  w i th  th e  t r e a tm e n t o f
a m p ic ill in  a t su b -M IC  (3 2  p g  m L '1).
Protein M r Rf Pi Co. Protein M r Rf pi Co.
no.
(kDa) no. (kDa)
19 52.5 0.51 5.2 “ 19 29 0.69 8.4 28
20 52.5 0.51 4.5 “ 20 7.2 0.85 6.8 31
21 41.5 0.61 5.2 “ " * “ “ -
22 36.5 0.65 5.9 “ " " “ " “
23 35 0.66 3.6 “ “ ” “ ”
24 35 0.66 4.0 “ * “ "
25 35 0.66 4.5 “ “ "
26 33 0.67 5.7 “ " “ “ “
27 33 0.67 7.0 “ " ~ " "
28 30 0.68 4.9 “ “ “ “
29 27.5 0.70 5.8 “ “ “ “ “ “
30 13 0.81 5.7 “ “ “ - “
31 8.2 0.84 4.0 “ “
32 5.7 0.86 4.0 “ “ - - -
- :  No data for that cell
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T a b le  13 ( p a r t  3 ) : M e a su re m e n t d a ta  in d ic a tin g  P ro te in  n u m b e r , M o le c u la r  w e ig h t 
(M r) a n d  R e ta rd a tio n  fa c to r  (Rf) a n d  Iso e le c tr ic  p o in t (p i)  o f  th e  p ro te in s  id e n tif ie d  
f ro m  th e  T w o -D im e n s io n a l g e l a n a ly s is  o f  b in a ry  b io f ilm  c e lls  e x p o s e d  to  d if fe re n t 
tr e a tm e n t o f  a n tib io tic s  a n d  c o m p a re d  a g a in s t  b in a ry  b io f ilm  c e lls  (c o n tro l) , c u ltu re d  
in  m o d if ie d  C D M , (C o : c o rre sp o n d in g  p ro te in  to  F ig u re  31 ; N : n o v e l p ro te in ) .
F ig u r e  33
B in a ry  b io f ilm  c e lls  w ith  th e  tr e a tm e n t o f  
n a l id ix ic  a c id  a t su b -M IC  (8 p g  m L "1).
F ig u r e  3 4
B in a ry  b io f ilm  c e lls  w i th  th e  t r e a tm e n t o f  










1 90 0.22 5.6 2 1 107 0.11 3.5 N
2 81 0.29 6.4 4 2 92 0.20 3.5 1
3 81 0.29 7.2 4 3 83 0.28 3.5 4
4 78 0.31 5.1 7 4 81 0.30 9.4 5
5 74 0.34 5.6 9 5 79.7 0.31 4.4 6
6 71 0.37 5.4 10 6 77 0.33 3.5 7
7 67 0.40 5.6 11 7 77 0.33 3.9 7
8 67 0.40 7.5 11 8 77 0.33 9.4 7
9 67 0.40 8.5 11 9 73 0.36 5 9
10 56 0.49 4.9 18 10 73 0.36 5.4 9
11 49 0.55 5.2 N 11 68.7 0.39 4.1 N
12 36.5 0.65 8.5 22 12 67 0.40 3.9 11
13 32.5 0.68 9.8 26 13 55.2 0.49 4.6 18
14 20.5 0.78 5.4 N 14 51.2 0.52 4.1 N
15 13 0.81 5.6 30 15 47.5 0.58 3.5 N
“ * * - 16 29 0.69 3.8 28
“ “ * * 17 3 0.88 4.1 N
- :  N o data for that cell
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T h e  re su lts  o b ta in e d  f ro m  S D S -P A G E  a n d  2 D -P A G E  a n a ly s is  s h o w e d  
s ig n if ic a n t d iffe re n c e s  b e tw e e n  b io f ilm  a n d  e lu a te  c e lls , o n  o n e  h a n d  a n d  c o n tro l a n d  
c e lls  t re a te d  w ith  su b -M IC s  o f  a n tib io tic s  o n  th e  o th e r  h a n d . W h ile  m a n y  o u te r  
m e m b ra n e  p ro te in s  w e re  c o m m o n  in  b o th  c o n tro l a n d  tre a te d  c e ll s a m p le s , o th e rs  
a p p e a re d  to  b e  n o v e l (p ro te in s  th a t a re  n o t  p re s e n t  in  th e  c o n tro l, b u t  p r e s e n t  in  th e  
tr e a te d  sa m p le s ) . F u r th e rm o re , so m e  o u te r  m e m b ra n e  p ro te in s  d is a p p e a re d  f ro m  c e lls  
fo llo w in g  e x p o su re  to  su b -M IC s  o f  a n tib io tic s . T h e se  s ig n if ic a n t a lte ra t io n s  in  o u te r  
m e m b ra n e  p ro f ile s  a f te r  e x p o su re  to  a n tib io tic s  m a y  le a d  to  a  b a c te r ia l  su rfa c e  
p h e n o ty p e  th a t  m in im ise s  a n tib io tic  e n try  in to  c e lls  o r  m a y  e v e n  r e s u l t  in  a n  o v e r  
e x p re s s io n  o f  su rfa c e  p ro te in s  th a t  p u m p -o u t a c c u m u la tin g  c o n c e n tra tio n s  o f  
a n tib io tic s  in to  th e  e x te rn a l e n v iro n m e n t.
A lth o u g h  i t  is  o u ts id e  th e  sc o p e  o f  th is  w o rk  to  id e n tify  th e  p ro te in s  th a t  a re  
re sp o n s ib le  fo r  th e  o b se rv e d  re s is ta n c e , so m e  c lu e s  m a y  b e  d e r iv e d  f ro m  p r im a ry  
p ro te o m ic  a n a ly s is  c a r r ie d  o u t in  th is  s tudy  b y  a  p ro c e s s  o f  p ro te in  e lim in a tio n . A n  
S D S -P A G E  a n d  2 D -P A G E  a n a ly s is  o f  c o n tro l an d  a n tib io t ic  tr e a te d  c e lls  in  th e  
b io f ilm  s ta te  h a s  in d ic a te d  a  su b se t o f  u n iq u e  p ro te in s  (n o v e l p ro te in s  a n d  p ro te in s  
th a t  h a v e  d isa p p e a re d )  to  th e  se le c te d  a n tib io tic  tre a tm e n t. A  s im ila r  a n a ly s is  c a r r ie d  
o u t w ith  e lu a te  c e lls  a lso  re su lte d  in  u n iq u e  p ro te in  su b se ts  (d a ta  n o t  g iv e n  h e re ) . 
H o w e v e r , a  c o m p a riso n  o f  th e se  tw o  su b se ts  o f  p ro te in s  (d e r iv e d  f ro m  b io f i lm  a n d  
e lu a te  sa m p le s )  sh o u ld  y ie ld  a  fe w  c o m m o n  p ro te in s  th a t  m a y  b e  re s p o n s ib le  fo r  th e  
re s is ta n c e  o ffe re d  b y  th e  o rg a n ism  a g a in s t  th e  a n tib io tic . T h e  p ro te in s  th a t  a re  n o t 
s im ila r  m a y  h a v e  n o  re la tio n  (m a y  b e  o u te r  m e m b ra n e  p ro te in s  th a t  a re  p ro d u c e d  as a  
d ire c t c o n se q u e n c e  o f  a d d itio n  o f  th e  a n tib io tic , b u t  h a v e  n o  ro le  in  re s is ta n c e )  o r  o n ly  
a  s e c o n d a ry  re la tio n  to  a n tib io tic  re s is ta n c e . F o r  e x a m p le  th e  d is a p p e a ra n c e  o f  a  3 8 .7  
k D a  p ro te in  fro m  b io f ilm  an d  e lu a te  c e lls  t re a te d  w ith  N a L  (T a b le  8 , P a r ts  1 &  2 ; 
T a b le  9 , P a r t  2) m a y  b e  re sp o n s ib le  fo r  th e  n a lid ix ic  a c id -re s is ta n t p h e n o ty p e . S u c h  a
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c o m p a riso n  b e tw e e n  o u te r  m e m b ra n e  p ro te in  p ro f ile s  o f  d if fe re n t s ta te s  (b io f i lm  s ta te  
a n d  e lu a te  c e ll  s ta te )  is  a tte m p te d  o n  th e  a s s u m p tio n  th a t  th e  p h y s io lo g ie s  o f  th e s e  tw o  
s ta te s  a re  v e ry  s im ila r , as c o n c lu d e d  f ro m  re la tiv e ly  s im ila r  M IC  re su lts  (C h a p te r  3 , 
T a b le  6). I f  th e  c e ll p h y s io lo g ie s  a re  g ro ss ly  d if fe re n t  a s  in  b io f ilm  a n d  p la n k to n ic  
s ta te s , th e re  e x is t  th e  p o s s ib ility  th a t  th e  b a c te r ia  m a y  e x h ib it  d if fe re n t r e s is ta n t  
p h e n o ty p e s  fo r  th e  sa m e  a n tib io tic , a n d  th e  a b o v e  c o m p a riso n  w o u ld  n o t  h a v e  b e e n  
p o s s ib le . A  s im ila r  lo g ic  a p p lie d  to  th e  p ro te in  su b se ts  d e r iv e d  f ro m  o th e r  a n tib io t ic  
tr e a tm e n ts  (a m p ic il l in  an d  s tre p to m y c in ; d a ta  n o t  g iv e n  h e re )  d id  n o t  y ie ld  a n y  s im ila r  
p ro te in s . H o w e v e r , th is  m a y  b e  d u e  to  m a n u a l e r ro r  in  e s tim a tio n  o f  m o le c u la r  
w e ig h ts  o f  p ro te in s . F o r  in s ta n c e , a  4 5 .7  k D a  p ro te in  o b s e rv e d  in  N a L - tre a te d  b io f ilm  
c e lls  b y  S D S -P A G E  (T a b le  8, P a rts  1 &  2 ), m ig h t  a c tu a lly  b e  th e  4 4 .7  k D a  p ro te in  
o b se rv e d  in  th e  c o rre sp o n d in g  e lu a te  sa m p le s  (T a b le  9 , P a r t  2 ) . H o w e v e r , th is  c a n n o t  
b e  c o n f irm e d  u n le s s  fu r th e r  a n a ly s is  (e .g . M A L D I-T O F  m a s s  sp e c tro m e tr ic  a n a ly s is )  
o f  th e se  p ro te in s  is  d o n e .
I t  is  in te re s tin g  to  n o te  th a t th e  4 5 .7  k D a  p ro te in  (S D S -P A G E ) a p p e a rs  to  b e  
p re s e n t  in  a ll  a n tib io tic  (a m p ic illin , s tre p to m y c in  a n d  n a l id ix ic  a c id )  t r e a te d  s a m p le s  
(T a b le  8, P a r t  2 ; T a b le  9 , P a rts  2  &  3). T h is  o b s e rv a tio n  m a y  in d ic a te  a  c o m m o n  
m o d e  o f  re s is ta n c e  fo r  a ll th re e  d iffe re n t a n tib io tic s . T h e  p re s e n c e  o f  c o m m o n  p ro te in  
p ro f ile s  o b s e rv e d  in  c o m p a riso n s  o f  th e  b io f ilm  a n d  e lu a te  s ta te s  o f  P seudom onas  
aeruginosa  fu r th e r  s tre n g th e n s  th e  h y p o th e s is , th a t  th e  re s is ta n c e  a g a in s t  a n t ib io t ic s  is  
a n  in h e re n t c e llu la r  b a se d  m e c h a n ism .
T h e re  is  n o  d e f in itiv e  e v id e n c e  a s  to  h o w  sh if ts  in  o u te r  m e m b ra n e  p ro te in s  in  
re sp o n se  to  a n tib io tic  tre a tm e n ts  a f fe c t th e  o v e ra ll p a th o g e n ic ity  o f  th e  o rg a n ism . 
H o w e v e r , so m e  lo g ic a l c o n c lu s io n s  m a y  b e  m a d e . O M P  sh if ts  m a y  r e s u l t  in  e p ito p ic  
c h a n g e s  o f  th e  b a c te r ia l m e m b ra n e . B e s id e s  a n  in c re a se  in  re s is ta n c e  to  a n tib io t ic s , 
e p ito p ic  f lu c tu a tio n s  b y  b a c te r ia  ( re su ltin g  f ro m  O M P ) sh if ts  m a y  le a d  to  a n tig e n ic
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sh ifts  a n d  s u b s e q u e n t e v a s io n  o f  th e  im m u n e  re sp o n s e  m o u n te d  a g a in s t  it . S u c h  
in c re a se s  in  th e  re s is ta n c e  an d  b a c te r ia l  e v a s io n  ta c tic s  w ill  p o s i t iv e ly  in f lu e n c e  th e  
su rv iv a l o f  th e s e  p a th o g e n s  in vivo , a n d  in d ire c tly  in c re a se  th e  p a th o g e n ic  p o te n t ia l  o f  
th e s e  o rg a n ism s , p ro v id e d  v iru le n c e  o f  th e se  o rg a n ism s  is  n o t  h a m p e re d  b y  th e  
p re s e n c e  o f  th e  an tib io tic . H e n c e , w h e n  c o n s id e re d  as  a  d e te rm in a n t o f  p a th o g e n ic ity , 
in c re a se s  in  b a c te r ia l  a n tib io tic  re s is ta n c e  m a y  e q u a te  to  a  c o n c u r re n t in c re a s e  in  
p a th o g e n ic ity  o f  Pseudom onas aeruginosa.
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C h a p te r  F iv e : S tu d ie s  o f  th e  E ffe c ts  o f  s u b -M I C s  o f  S e le c te d  
A n tib io t ic s  o n  P a th o g e n ic  F a c to r s  o f  Pseudom onas aeruginosa  A T C C  
1 5 6 9 2  ( P A O l)  a n d  Escherichia coli A T C C  1 0 0 0 0  G r o w n  a s B io f i lm s
Introduction
T h e  te rm  ‘v iru le n c e ’ is  d e s c r ib e d  a s  th e  re la tiv e  c a p a c ity  o f  a  m ic ro b e  to  c a u se  
d is e a se  o r  a  re d u c tio n  in  h o s t f itn e s s  (P o u lin  &  C o m b e s , 1999 ; C a s s a d e v a l &  P iro fsk i, 
2 0 0 2 ). A t p re s e n t , th e  c o n c e p t o f  v iru le n c e  h a s  a lso  b e e n  u s e d  a s  a  c h a ra c te r is t ic  th a t 
d is tin g u ish e s  p a th o g e n ic  b a c te r ia  f ro m  n o n -p a th o g e n ic  o n e s  (C a s s a d e v a l &  P iro fsk i,
2 0 0 1 ). D e sp ite  th e  tra d itio n a l c o n c e p t o f  v iru le n c e , th e re  is  a  d e g re e  o f  u n c e r ta in ty  
re g a rd in g  th e  e x a c t d e f in itio n  o f  th e  te rm . T h e  p ro b le m  re su lts  f ro m  th e  v a r ia b ili ty  
p re s e n t  in  th e  d ise a se  c a u s in g  a b ili ty  o f  a  m ic ro b ia l sp e c ie s  in  d if fe re n t h o s ts . F o r  
e x a m p le , v iru le n c e  c a n  o n ly  b e  to ta lly  e x p re s s e d  in  a  s u sc e p tib le  h o s t  a n d  n o t  in  a 
h e a l th y  h o s t. A g a in , th e  d e g re e  o f  h o s t  s u s c e p tib il ity  c a u se s  a  v a r ia t io n  in  th e  d e g re e  
o f  v iru le n c e . In  sho rt, p h e n o ty p ic  e x p re s s io n  o f  v iru le n c e  is  d e p e n d e n t  o n  h o s t-  
m ic ro b e  in te ra c tio n s , d esp ite  b e in g  a n  in h e re n t m ic ro b ia l c h a ra c te r  (C a s s a d e v a l  &  
P iro fsk i, 2 0 0 1 ).
I f  d ise a se  is th e  p h e n o ty p ic  re su lt  o f  v iru le n c e  e x p re s s io n , th e n  th e  fa c to rs  th a t 
o rg a n ism s  p o s s e s s  th a t  c a n  c au se  d ise a se  a re  te rm e d  virulence factors. T h u s , v iru le n c e  
fa c to rs  a re  d e te rm in a n ts  o f  p a th o g e n ic ity  a n d  th e y  h a v e  b e e n  d e f in e d  a s  “ com ponents 
that im pair virulence when deleted, but not v ia b ility ’ (C a s sa d e v a l &  P iro fs k i, 1999; 
2 0 0 1 ). V iru le n c e  fac to rs  m a y  h a v e  d if fe re n t fu n c tio n a l ro le s , e i th e r  d i re c t ly  o r  
in d ire c tly  re la te d  to  re d u c in g  h o s t  f itn e ss . T h e y  m a y  in c lu d e  fa c to rs  th a t  h e lp  b a c te r ia  
a tta c h  to  c e ll su rfa c e s  (a d h e s in s , p i l i ,  e tc .) , e sc a p e  a n d  e v a d e  h o s t  im m u n e  d e te c tio n  
(f la g e lla , c a p su le ) , d e s tro y  h o s t c e lls  (c y to to x in s , L P S ) a n d  su rv iv e  in  th e  h o s t  (e .g ., 
le u c o c id in )  (W ilso n  et al., 20 0 2 ).
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T h e  su c c e ss  o f  a b a c te r ia l p a th o g e n  w ith  re g a rd  to  c o lo n iz a tio n , s u rv iv a l an d  
g ro w th  w ith in  th e  h o s t d e p e n d s  o n  its  a b ility  to  se n se  a n d  re sp o n d  to  d if f e re n t  h o s t 
e n v iro n m e n ts  d u rin g  th e  in fe c t io n  p ro c e s s  (C a ssa d e v a l &  P iro fsk i, 2 0 0 3 ) . V iru le n c e
r
fa c to rs  p la y  a  m a jo r  ro le  in  th is  c o n te x t a n d  in  th e  r e sp o n s e  s tra te g y  e m p lo y e d  b y  
b a c te r ia  d u r in g  th e  p ro c e s s  o f  h o s t  in fe c tio n . H e n c e , r e g u la t io n  o f  th e s e  v iru le n c e  
fa c to rs  in vivo  is  c r itic a l fo r  su c c e s s fu l in fe c tio n . B a c te r ia l  p a th o g e n s  re g u la te  
v iru le n c e  u s in g  c o m m o n  re g u la to ry  m e c h a n ism s  th a t in c lu d e  a lte rn a te  s ig m a  fa c to rs  
a n d  tw o -c o m p o n e n t s ig n a l t ra n s d u c tio n  sy s te m s  (W ilso n  et al., 2 0 0 2 ). W h ile  a lte rn a te  
s ig m a  fa c to rs  h a v e  b e e n  sh o w n  to  re g u la te  g e n e  e x p re s s io n  in  s tre s s fu l c o n d itio n s  
( s ta tio n a ry  p h a se , n u tr ie n t lim ita tio n , o x id a tiv e  s tre s s , o sm o tic  s tre s s , e tc .)  tw o - 
c o m p o n e n t s ig n a l tra n sd u c tio n  sy s te m s  o f te n  d e p e n d  o n  c e ll d e n s ity  (e .g . q u o ru m  
se n s in g )  (W ilso n  et al., 2 0 0 2 ). B o th  th e se  fac to rs : (1 ) s tre s s  c o n d itio n s  a n d  (2 ) h ig h  
c e ll d e n s itie s  a re  p re s e n t w ith in  b a c te r ia l  b io f ilm s , a n d  th u s , m a y  b e  id e a l fo r 
v iru le n c e  g e n e  e x p re ss io n . A lth o u g h  i t  is  e v id e n t th a t  b a c te r ia l  b io f i lm s  are  
re sp o n s ib le  fo r  c h ro n ic  in fe c tio n s  a n d  as  su ch , m a y  h a v e  a  b a s a l  le v e l o f  v iru le n c e  
(C ry e r  et al., 2 0 0 4 ), th is  se c tio n  p re s e n ts  th e  e ffe c ts  o f  s e le c te d  a n tib io t ic  s tre ss  
(a m p ic il lin , n a lid ix ic  a c id  a n d  s tre p to m y c in )  o n  Pseudom onas  m o n o s p e c ie s  an d  
b in a ry  b io f ilm  v iru le n c e .
T h e  l ip o p o ly sa c c h a rid e  (L P S ) in  G ra m -n e g a tiv e  o rg a n is m s  ( e .g .,  Ps. 
aeruginosa  a n d  E. coli) is  lo c a te d  w ith in  th e ir  o u te r  m e m b ra n e s . T h e y  a re  o f te n  
re fe r re d  to  a s  e n d o to x in s , a s  th e ir  r e le a se  fro m  b a c te r ia l  s u r fa c e s  c a ta ly s e s  
p a th o g e n e s is  a n d  o th e r  m a n ife s ta tio n s  o f  G ra m -n e g a tiv e  in fe c t io n s  (e .g . s e p tic  sh o c k )  
(G u tsm a n n  et al., 2 0 0 0 ). T he  b io lo g ic a l e f fe c ts  o f  L P S -re la te d  p a th o g e n e s is  a re  o f te n  
a  re su lt  o f  a c tiv a tio n  o f  a s ig n a ll in g  c a sc a d e  th a t le a d s  to  a  d is e a s e  p h e n o ty p e  
fo llo w in g  tra n s p o r t-p ro te in -m e d ia te d  o r  h y d ro p h o b ic  in te ra c tio n s  w i th  a  sp e c if ic  
s ig n a l p ro te in  o n  h o s t ce ll m e m b ra n e s  (G u tsm a n n  et a l., 2 0 0 0 ).
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M a n y  c la s s e s  o f  a n tib io tic s  a re  k n o w n  to  in d u c e  re le a s e  o f  v a r io u s  a m o u n ts  o f  
L P S  in vitro, a n d  th u s , a re  th o u g h t to  c o n tr ib u te  to  in c re a se s  in  v iru le n c e  p o te n tia l  o f  
G ra m -n e g a tiv e  p a th o g e n s  d u rin g  a n tib io tic  tre a tm e n t (T su ji e t al., 2 0 0 3 ). H o w e v e r , 
c lin ic a l in v e s tig a t io n s  o f  th e  p h e n o m e n o n  o f  a n t ib io t ic - in d u c e d  e n d o to x in  re le a s e  in  
in fe c tio n s  h a v e  ra is e d  c o n flic tin g  re p o r ts . S im p so n  et al. (2 0 0 0 ) h a v e  s h o w n  th a t 
p a t ie n ts  t re a te d  w ith  th e  a n tib io tic  c e f ta z m id e  h a d  s ig n if ic a n tly  h ig h e r  sy s te m ic  
e n d o to x in  c o n c e n tra tio n s  a f te r  th e  f irs t  d o se . O th e r  in v e s tig a to rs  h a v e  re p o r te d  n o  
s ig n if ic a n t d iffe re n c e s  in  re le a se  o f  e n d o to x in  (T su ji et al., 2 0 0 3 ).
A s  n o  c o n se n su s  c o u ld  b e  d e d u c e d  o n  L P S -re la te d  p a th o g e n e s is  o r  v iru le n c e  
p o te n tia l  o f  p a th o g e n s  in  th e  p re se n c e  o f  a n tib io tic s , th e  p re s e n t  s tu d y  w a s  d e s ig n e d  
a n d  a im s  to  c irc u m v e n t th is  p ro b le m  b y  in v e s tig a t in g  v iru le n c e  b a s e d  o n  re la tiv e  
p ro d u c tio n  o f  th e  in d iv id u a l c o m p o n e n ts  o f  L P S . T h e  r a tio n a le  b e h in d  th is  is  th e  
u n d e rs ta n d in g  th a t, c h a n g e s  o b se rv e d  in  L P S  p a tte rn s  o f  b io f ilm  p a th o g e n s  in  
p re s e n c e  o f  a n tib io tic s  a re  lin k e d  to  in c re a se s  in  a n tib io tic  re s is ta n t p h e n o ty p e s  a n d  
h e n c e , th e  o v e ra ll v iru le n c e  p o te n tia l o f  th e  m ic ro o rg a n ism .
L e u c o c id in  a n d  p ro te a se s  p ro d u c e d  b y  Pseudom onas aeruginosa  c o n tr ib u te  
d ire c tly  to  its  v im le n c e  p o te n tia l . L e u c o c id in s  h a v e  c y to to x ic  a c tiv ity  (H ira y a m a  et 
al., 1984; O h n ish i et al., 1994). T h e y  a re  c a p a b le  o f  a t ta c k in g  a n d  d e s tro y in g  h o s t 
c e lls , e sp e c ia lly  th o se  o f  th e  im m u n e  sy s te m  (e .g ., le u k o c y te s  o r  w h ite  b lo o d  c e lls  
(W B C s) (O h n ish i et a l., 19 94 ). T h is  w ill e n a b le  th e  b a c te r ia  ( in  th is  c a se , 
P seudom onas) to  su rv iv e  a n d  m a y  e v e n  th r iv e  in  h o s tile  h o s t  e n v iro n m e n ts . W h ile  a  
n u m b e r  o f  Pseudom onas  c y to to x in s  h a v e  b e e n  d e sc r ib e d  in  re c e n t  t im e s , th is  th e s is  
w ill fo c u s  o n  v iru le n c e  s tu d ie s  c a r r ie d  o u t o n  th e  e a r lie s t  c y to to x in  ( le u c o c id in )  
c h a ra c te r ise d . F u r th e rm o re , a s  c y to to x in s  p ro d u c e d  b y  P seudom onas  e x h ib i t  th e ir  
a c tiv ity  b y  o n c o s is  (d e a th  o f  h o s t  c e ll c h a ra c te r ise d  b y  sw e llin g ) , f lu c tu a tio n s  in  
v iru le n c e  (a f te r  m o n o sp e c ie s  a n d  b in a ry  b io f ilm s  o f  Pseudom onas  w e re  c h a lle n g e d
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w ith  a n tib io tic s )  w e re  d ire c tly  a s sa y e d  a s  a  m e a su re  o f  le u c o c id in  a c tiv ity  (o n c o s is )  
(D a c h e u x  et al., 2 0 0 0 )  o n  S p le e n -m y e lo m a  c e ll lin e  (S p 2  c e lls ) , u s in g  p h a s e  c o n tra s t  
m ic ro sc o p y .
P ro te a s e s  p ro d u c e d  b y  Pseudom onas aeruginosa  b r e a k  d o w n  sp e c if ic  h o s t 
p ro te in s  le a d in g  to  so m e  o f  th e  c h a ra c te r is t ic  c lin ic a l m a n ife s ta t io n s  o f  d ise a se  
(W ilso n  et a l., 2 0 0 2 ). E x a m p le s  o f  P seudom onas  p ro te a se s  in c lu d e  e la s ta s e  (LasB ), 
a lk a lin e  p ro te a se , Las A  p ro te a se  a n d  p ro te a s e  IV  (M a tsu m o to , 2 0 0 4 ). W h ile  e la s ta se  
is  a b le  to  c le a v e  ty p e  I, I I I  an d  IV  c o lla g e n , a lk a lin e  p ro te a s e  o f Pseudom onas  is  m o re  
sp e c if ic  to  ty p e  I c o lla g e n  (H e c k e f  al., 1986 ; M a tsu m o to , 2 0 0 4 ). P ro te a s e  IV  h a s  a lso  
b e e n  re c e n tly  a ttr ib u te d  to  d e g ra d e  c e llu la r  m a tr ix  p ro te in s  (C a b a lle ro  e t al., 2 0 0 4 ). 
B e s id e s  b re a k d o w n  o f  c e llu la r  m a tr ix  p ro te in s  a  n u m b e r  o f  o th e r  h o s t  im m u n e  
re sp o n se  fa c to rs  (p la sm a  p ro te in s , im m u n o g lo b in s , c o a g u la tio n  a n d  c o m p le m e n t 
fa c to rs )  a re  re p o r te d ly  a ffe c te d  b y  p ro te a s e s  (C a b a lle ro  e t al., 2 0 0 4 ). T h e  a c t iv i ty  o f  
p ro te a s e s  is  k n o w n  to  a id  in  th e  p a th o g e n e s is  o f  tis s u e  in v a s io n  a n d  h e m o rrh a g ic  
tis su e  n e c ro s is  o f te n  o b se rv e d  in  Ps. aeruginosa  in fe c t io n s  (e .g ., k e ra ti t is )  
(M a tsu m o to , 2 0 0 4 ). A z o c a se in  p ro te a se  a s sa y s  w e re  u s e d  to  m e a su re  c h a n g e s  in  th e  
v iru le n c e  o f  P seudom onas aeruginosa  ( a f te r  a n tib io tic  c h a lle n g e  o f  b io f ilm s ) , a s  a  
re su lt  o f  p ro te a s e  ac tiv ity .
Pseudom onas aeruginosa  b io f ilm s  (m o n o sp e c ie s  a n d  b in a ry  b io f i lm s  o f  Ps. 
aeruginosa  A T C C  15692  (P A O l)  a n d  E. co li A T C C  1 0 0 0 0 ) w e re  s u b je c te d  to  su b - 
M IC s  o f  th e  a b o v e -m e n tio n e d  a n tib io tic s  a n d  f lu c tu a tio n s  in  v iru le n c e  le v e ls  w e re  
a s sa y e d  fo r  th re e  m a jo r  v iru le n c e  fac to rs : (1 ) lip o p o ly sa c c h a r id e  (L P S ), (2 ) le u c o c id in  
a n d  (3 ) p ro te a s e s  (d e sc rib e d  a lso  in  C h a p te r  1).
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Experimental approach
M o n o s p e c ie s  a n d  b in a ry  b io f ilm s  o f  Ps. aeruginosa  A T C C  1 5 6 9 2  ( P A O l)  a n d  
E scherichia co li A T C C  10000 w e re  e s ta b lis h e d  o n  a  S o rb a ro d  f ilte rs  (C h a p te r  2 ; A l-  
H m o u d , 2 0 0 2 ; H o d g so n  et al., 19 95 ). T h e  b io f ilm s  w e re  p e r fu s e d  w i th  M C D M  
c o n ta in in g  M IC /1 6  o f  se le c te d  a n tib io tic s  (a m p ic il lin  (A m P ), n a l id ix ic  a c id  (N a L ) a n d  
s tre p to m y c in  (S T ) a t 37 °C . T h e  c o n tro l a n d  su b -M IC  a n tib io tic  t r e a te d  b io f i lm s  w e re  
s a c r if ic e d  a f te r  sp e c ific  tim e  in te rv a ls  (c o r re sp o n d in g  to  d e v e lo p m e n t o f  m o n o s p e c ie s  
a n d  b in a ry  b io f ilm  s tead y  s ta te s ; 102 h o u rs  fo r  TV  aeruginosa  A T C C  1 5 6 9 2  ( P A O l) ,  
56  h o u rs  fox E scherichia coli A T C C  10 00 0  a n d  126 h o u rs  fo r  b in a ry  b io f ilm s ) . L P S  
w a s  e x tra c te d  a n d  p ro te a se s  a n d  le u c o c id in  w e re  p u r i f ie d  f ro m  s a c r if ic e d  b io f ilm  
c e lls , e lu a te  c e lls  a n d  p la n k to n ic  c e lls  a f te r  ly s is .
L ip o p o ly sa c c h a r id e  (L P S ) e x tra c tio n s
L ip o p o ly sa c c h a r id e  w a s  e x tra c te d  f ro m  b io f ilm , e lu a te  a n d  p la n k to n ic  c e lls  
a c c o rd in g  to  P re s to n  a n d  P e n n e r  (1 9 8 7 ). B io f ilm  c e lls  (d e v e lo p e d  o n  S o rb a ro d  f ilte rs ) , 
e lu a te  c e lls  a n d  p la n k to n ic  ce lls  w e re  h a rv e s te d  in  5 m L  o f  c o ld  p h o s p h a te  b u ffe re d  
s a lin e  (P B S ). C u ltu re s  w e re  c o lle c te d  in  tu b e s  a n d  c e ll d e n s ity  w a s  m e a s u re d  a t  E6oo. 
C e ll s u sp e n s io n s  w e re  d ilu te d  in  P B S  to  a n  E6oo o f  0 .6 . A n  a liq u o t (1 .5  m L )  o f  th e  
d i lu te d  c e ll su sp e n s io n  w a s  c e n tr ifu g e d  fo r  1.5 m in u te s  a t  5 0 0 0 x g  ( IE C  C e n tra -4 B ). 
T h e  s u p e rn a ta n t w a s  d isc a rd e d . T h e  p e l le ts  w e re  so lu b ilise d  in  0 .2  m L  o f  ly s is  b u f fe r  
(G ly c e ro l, 2 0 % ; 2 -P -m e rc a p to e th a n o l, 5 % ; S D S , 4 .6 % ; 0 .1 2 5 M  T ris  H C 1 (p H  6 .8 ) , 
b ro m o p h e n o l b lu e , 0 .0 0 4 % ) a n d  h e a te d  a t  100°C  fo r  10 m in . T h e  s a m p le s  w e re  
c o o le d  to  ro o m  te m p e ra tu re . A n  a liq u o t (0 .0 4  m L ) o f  ly s is  b u f fe r  c o n ta in in g  2 .5  m g  
m L '1 p ro te in a se  K  w a s  ad d ed  to  th e  c o o l ly sa te s . T h e  sa m p le s  w e re  in cu b a ted  a t  6 0 °C  
fo r  o n e  h o u r , fo llo w e d  b y  in c u b a tio n  in  a  b o il in g  w a te r  b a th  fo r  5 m in u te s . S a m p le s  
w e re  c o o le d  a n d  u se d  fo r L P S -P A G E .
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Determination o f  lipopolysaccharide profiles
T h e  L P S  p ro f ile s  w e re  p re p a re d  u s in g  a  12%  s e p a ra to r  g e l a n d  a  5 %  s ta c k e r  
g e l a s  d e s c r ib e d  in  (C h a p te r  2 ) w i th o u t th e  a d d itio n  o f  S D S . A n  a liq u o t (1 0  to  2 0  p L )  
o f  th e  sa m p le s  w e re  a d d e d  to  th e  w e lls  a n d  th e  g e ls  w e re  ru n  a t  3 5  m A  fo r  
a p p ro x im a te ly  1.5 h o u rs  o r  u n til th e  le a d in g  sa m p le s  h a d  re a c h e d  th e  e n d  o f  th e  gel. 
T h e  g e ls  w e re  f ix e d  a n d  s ta in e d  a c c o rd in g  to  th e  m e th o d  o f  P re s to n  &  P e n n e r  (1 9 8 7 ; 
C h a p te r  2 ).
L P S  sh ifts  in  Ps. aeruginosa  P A O l b io f ilm  a n d  e lu a te  c e lls  e x p o s e d  to  s u b -M IC s  o f  
a m p ic ill in , n a lid ix ic  a c id  an d  s tre p to m y c in
F ig u re  35 il lu s tra te s  th e  L P S  p ro f ile  o f  Ps. aeruginosa  b io f ilm  c e l ls  (c o n tro l 
a n d  tre a te d  w ith  th e  su b -M IC  o f  a n tib io t ic s  (A m P , N a L  a n d  S T )). L P S  b a n d s  a re  
k n o w n  to  m ig ra te  a c c o rd in g  to  th e ir  m o le c u la r  w e ig h t. H o w e v e r , u n lik e  n e g a tiv e ly  
c h a rg e d  p ro te in  m o le c u le s  (u n d e r  th e  in f lu e n c e  o f  S D S ), th e re  m ay  b e  m o le c u la r  
w e ig h t a n o m a lie s  in  L P S  m ig ra tio n  p a t te rn s , d u e  to  c h a rg e  a n d  to  m a s s  d if f e re n c e s  o f  
in d iv id u a l L P S  m o le c u le s . T he  g e l sh o w s  g e n e ra l d iffe re n c e s  in  b a n d in g  p a t te rn s .  T h e  
ra n g e  o f  L P S  b a n d s  c o rre sp o n d in g  to  th e  h ig h  m o le c u la r  w e ig h t p ro te in  m a rk e rs  (27  
k D a  to  74  k D a ; la n e  1) sh o w  m a rk e d  d iffe re n c e s  w ith  r e sp e c t to  s p a c in g  a n d  in te n s i ty  
o f  b a n d s . W h ile  c o n tro l (w ith o u t a n tib io tic  tre a tm e n t)  s a m p le s  o f  th e  b io f i lm  c e lls  
sh o w e d  a  n u m b e r  o f  b a n d s  in  th is  re g io n  (3 6  k D a  to  72  k D a ; la n e  3; F ig u re  3 5 )  a n d  
p la n k to n ic  ce lls  sh o w e d  b a n d s  in  tw o  d if fe re n t re g io n s  (6 4  k D a  to  7 4  k D a  a n d  3 2  k D a  
to  45  k D a ; la n e  2 ), a f te r  ce lls  w e re  e x p o s e d  to  su b -M IC s  o f  a n t ib io t ic s  (A m P , N a L  
a n d  S T ) tre a te d  b io f ilm  sa m p le s  ( la n e s  4 , 5 a n d  6 re sp e c tiv e ly )  e x h ib i te d  fe w  b a n d s  
ra n g in g  b e tw e e n  (44  k D a  to  65 k D a ). F u r th e rm o re , th e  fe w  b a n d s  s e e n  a ls o  sh o w e d  
d im in ish e d  s ta in in g  (in d ic a tiv e  o f  lo w e r  c o n c e n tra tio n s  o f  L P S ) . T h e  L P S  m o le c u le s  
th a t  b a n d  a t  h ig h  m o le c u la r  w e ig h t re g io n s  a re  th e  O  a n tig e n s . H e n c e , a  d e c re a s e  in
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number of bands in antibiotic treated samples within this region would mean there are 
either short O chains (lower Mr) or there are none at all.






Figure 35: Silver-stained LPS-PAG E for LPS o f Ps. aeruginosa  P A O l biofilm  cells cultured in 
m odified CDM  and exposed to different treatm ent o f antib iotics. Lane 1: m olecular weight 
m arkers; Lane 2: Ps. aeruginosa  planktonic cells control; Lane 3: Ps. aeruginosa  biofilm  cells 
control; Lane 4: Ps. aeruginosa  biofilm  cells with treatm ent o f am picillin  at sub-M IC  (8 pg m L'1); 
Lane 5: Ps. aeruginosa  biofilm  cells w ith treatm ent o f nalidixic acid at sub-M IC  (4 pg m L 1); 
Lane 6: Ps. aeruginosa  biofdm  cells with treatm ent o f  streptom ycin at sub-M IC  (8 pg m L'1).
Figure 36 demonstrates the LPS of Ps. aerug inosa  eluate cells (control and 
treated with sub-MIC of antibiotics (AmP, NaL and ST)). As observed in the previous 
gel (Figure 35), general differences in banding patterns between control and treated 
cells could be seen in the range of LPS bands corresponding to the O antigen region. 
High molecular weight LPS bands observed in biofilm control samples (32 kDa to 71 
kDa; Lane 4; Figure 35), some bands (35 kDa to 66 kDa) were inapparent after cells 
were exposed to sub-MICs of antibiotics (AmP, NaL and ST) (lane 5, 6 and 7 
respectively). A thick band was apparent in eluate control with a molecular weight 
about (32 kDa; lane 4; Figure 36), but inapparent after cells were exposed to sub- 
MICs of NaL and ST (lanes 6 and 7 respectively). The antibiotic response of eluate 
cells (as judged by their LPS profiles) is very similar to that of biofilm cells. This
141
gives further credence to previous observations made, of relatively high MIC values 
for both biofilm and eluate cells towards selected antibiotics.
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Figure 36: Silver-stained LPS-PAG E for LPS o f Ps. aeruginosa  P A O l eluate cells cu ltured in 
m odified CDM  and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eight 
m arkers; Lane 2: Ps. aeruginosa  planktonic cells control; Lane 3: Ps. aeruginosa  b iofilm  cells 
control; Lane 4: Ps. aeruginosa  eluate cells control; Lane 5: Ps. aeruginosa  eluate cells with  
treatm ent o f  am picillin at sub-M IC (8 pg m L'1); Lane 6: Ps. aeruginosa  eluate cells with 
treatm ent o f nalidixic acid at sub-M IC (4 pg m L'1); Lane 7: Ps. aeruginosa  eluate cells with 
treatm ent o f streptom ycin at sub-M IC (8 pg m L'1).
E. co li biofilm cells (control; lane3; Figure 37) and cells treated with sub-MIC 
of antibiotics, AmP (lane 4), NaL (lane 5) and ST (lane 6) showed few bands (if any) 
corresponding to O antigen (high molecular weight bands; see Figure 37). However, 
significant differences in high molecular weight bands (O antigen) were observed 
when compared to planktonic cells (28 kDa to 68 kDa; lane 2; Figure 37). This 
indicates that E. co li cells down-regulate O antigen production as they shift to the 
biofilm state from the planktonic state. 26 kDa to 29 kDa bands were present in 
biofilm control cells (lane 3; Figure 37), but inapparent after cells were exposed to 
sub-MICs of AmP, NaL and ST (lanes 4, 5 and 6 respectively). These low molecular 
weight bands correspond to the Lipid A region of LPS. Banding pattern changes in
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this region would indicate changes in the epitopic nature of the endotoxin. The 
reflection of such changes on endotoxin (Lipid A) towards virulence of the organism 







Figure 37: Silver-stained LPS-PAG E for LPS o f E scherichia coli biofilm  cells cu ltu red  in 
m odified CDM  and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eight 
m arkers; Lane 2: E. coli planktonic cells control; Lane 3: E. coli biofilm  cells control; Lane 4: E. 
coli b iofilm  cells w ith treatm ent o f am picillin at sub-M IC (2 pg m L'1); Lane 5: E. co li b iofilm  cells 
with treatm ent o f nalidixic acid at sub-M IC  (2 pg m L 1); Lane 6: E. coli biofilm  cells with 
treatm ent o f streptom ycin at sub-M IC (8 pg m L'1).
LPS profiles of E. co li eluate cells show marked differences from their biofilm 
counterparts. While E. coli biofilm cells down regulate O antigens, the eluate cells 
(control, lane 3, Figure 38) express O antigens. 26 to 74 kDa bands were present in 
control cells (lane 3; Figure 38), but some bands were inapparent in the range of 42 
kDa to 62 kDa after cells were exposed to sub-MIC of antibiotics Amp, NaL and ST 
(lanes 4, 5 and 6 respectively). The presence of sub-MICs of antibiotics seems to 
cause suppression of O antigens (decrease in the number and intensity of high 
molecular weight bands within antibiotic treated samples). Two thick bands were 
present in control cells (lane 3; Figure 38) with low molecular weights (14 kDa to 20 
kDa). These bands were inapparent after cells were exposed to sub-MIC of antibiotic
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(AmP, NaL and ST; lanes 4, 5 and 6 respectively). The presence of antibiotics also 
caused changes in the banding patterns of the lipid A (lower Mr) region of LPS.
Figure 38: Silver-stained LPS-PAGE for LPS o f  E scherich ia  coli eluate cells cu ltured in  m odified  
CDM  and exposed to different treatm ent o f  antibiotics. Lane 1: m olecular w eight m arkers; Lane 
2: E. coli planktonic cells control; Lane 3: E. coli eluate cells control; Lane 4: E. co li e lu ate cells 
with treatm ent o f am picillin at sub-M IC ( lp g  m L'1); Lane 5: E. coli eluate cells w ith  treatm en t of 
nalidixic acid at sub-M IC (1 pg m L 1); Lane 6: E. coli eluate cells w ith treatm ent o f strep tom ycin  
at sub-M IC (8 pg m L'1).
Biofilms formed by P seudom onas aeruginosa  and E. coli in the presence of 
each other (binary biofilms, lane 4, Figure 39) indicated LPS profile pattern 
similarities to those obtained from individual species at a time (monospecies biofilms, 
lanes 2 and 3 respectively). 26 to 68 kDa bands patterns were present in control binary 
biofilm cells (lane 4; Figure 39), but some bands in the range of 52 kDa to 64 kDa 
were inapparent after cells were exposed to sub-MIC of antibiotics (AmP, NaL and 
ST; lanes 5, 6 and 7 respectively). Two thick bands with lower molecular weights (14 
kDa to 18 kDa) were present in control cells (lane 4; Figure 39), but inapparent after 
cells were exposed to sub-MIC of antibiotics (AmP, NaL and ST; lanes 5, 6 and 7 
respectively). A 26 kDa band was absent in control cells (lane 4; Figure 39), but 
apparent after treatment with sub-MIC of ST (lane 6; Figure 39). However, it is
144
o b s e rv e d  th a t  th e  L P S  p ro file  p a t te rn s  o f  b in a ry  b io f ilm s  w e re  s ig n if ic a n tly  d if fe re n t  
f ro m  th e  m o n o sp e c ie s  b io f ilm s  w h e n  tre a te d  w ith  a n tib io tic s . A  n u m b e r  o f  L P S  b a n d s  
c o r re sp o n d in g  to  O  a n tig e n  (52  k D a  to  64  k D a )  d is a p p e a re d  in  su b -M IC  a n tib io t ic  
t r e a te d  c e lls  (A m P  ( la n e  5), N a L  ( la n e  6 ) a n d  S T  ( la n e  7 ; F ig u re  3 9 )  a n d  tw o  th ic k  
b a n d s  w ith in  lip id  A  re g io n s  (1 4  k D a  to  18 k D a )  w e re  p re s e n t  in  c o n tro l c e lls  ( la n e  4 ; 
F ig u re  3 9 ), w e re  in a p p a re n t a f te r  c e lls  w e re  e x p o se d  to  su b -M IC  o f  a n t ib io t ic s  tr e a te d  
s a m p le s  (A m P  (la n e  5 ), N a L  ( la n e  6) a n d  S T  ( la n e  7; F ig u re  3 9 ).
F ig u re  4 0  il lu s tra te s  th e  L P S  o f  b in a ry  e lu a te  c e lls  (c o n tro l; la n e  7 )  a n d  c e lls  
t re a te d  w ith  su b -M IC  o f  a n tib io tic s  (A m P , N a L  a n d  S T ; la n e s  8, 9 a n d  10 
re sp e c tiv e ly ) . In te re s tin g ly , su b -M IC  a n tib io tic  tre a te d  sa m p le s  o f  b in a ry  b io f ilm  
e lu a te  c e lls  e x h ib it  a n  in c re a se  in  th e  p ro d u c t io n  o f  lip id  A , a s  c a n  b e  s e e n  f ro m  th e  
s tro n g  lo w  m o le c u la r  w e ig h t b a n d s  in  th e  r e g io n  b e tw e e n  14 .2  k D a  to  2 7  k D a  (F ig u re  
4 0 ; la n e s  8 , 9 a n d  10 re sp e c tiv e ly )  a n d  m a in ta in  a  d e c re a se  o f  O  a n t ig e n  p ro d u c t io n  
w h e n  c o m p a re d  to  th e ir  b in a ry  b io f ilm  c o u n te rp a rts  ( la n e s  5 , 6 a n d  7, F ig u re  3 9 ).
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Figure 39: Silver-stained LPS-PAGE for LPS o f binary biofilm  cells cultured in m odified CDM  
and exposed to different treatm ent o f antibiotics. Lane 1: m olecular w eights m arkers; Lane 2: Ps. 
aeruginosa  P A O l biofilm  cells control; Lane 3: E sch erich ia  coli A TC C  10000 biofilm  cells 
control; Lane 4: Binary biofilm  cells control; Lane 5: Binary biofilm  cells w ith treatm ent of  
am picillin at sub-M IC  concentration (32 pg m L'1); Lane 6: Binary biofilm  cells w ith  treatm ent of 
nalidixic acid at sub-M IC concentration (8 pg m L'1); Lane 7: Binary biofilm  cells w ith  treatm ent 
o f streptom ycin at sub-M IC concentration (16 pg m L'1).




Figure 40: Silver-stained LPS-PAGE for LPS o f binary eluate cells cultured in m odified CDM  
and exposed to different treatm ent o f  antibiotics. Lane 1: m olecular w eights m arkers; Lane 2: Ps. 
aeruginosa  PA O l planktonic cells control; Lane 3: E scherich ia  co li 10000 planktonic cells
control; Lane 4: Ps. aeruginosa  biofilm  cells control, Lane 5: E scherich ia  co li biofilm  cells 
control, Lane 6: Binary biofilm  cells control; Lane 7: Binary biofilm  eluate cells control; Lane 8: 
Binary eluate cells w ith treatm ent o f  am picillin at sub-M IC  concentration (16 pg m L'1); Lane 9: 
Binary eluate cells w ith treatm ent o f nalidixic acid at sub-M IC  concentration (4 pg m L'1); Lane 
10: Binary eluate cells with treatm ent o f streptom ycin at sub-M IC  concentration (4 pg mL ').
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Results & Discussions
T h e  e x p re s s io n  o f  L P S  c o m p o n e n ts  (p a r tic u la r ly  O  an tig en ) a p p e a rs  to  b e  
e n v iro n m e n ta l ly  re g u la te d  (M a k in  &  B e v e rid g e , 19 9 6 a  &  19 9 6 b ; R o c c h e t ta  e t al., 
1999 ; N o rm a n  et al., 2 0 0 2 ). A c c o rd in g ly , th e  p a t te rn  o f  L P S  m o le c u le s  w ith in  L P S -  
P A G E  m a y  v a ry . C o m p a riso n s  o f  L P S  fro m  th e  p la n k to n ic  a n d  b io f ilm  c e lls  e x h ib it  a  
g e n e ra l d e c re a se  in  O  a n tig e n  p ro d u c tio n  in  th e  la t te r  p h e n o ty p e  a n d  h e n c e , a  
t r a n s i t io n  f ro m  th e  sm o o th  to  th e  ro u g h  p h e n o ty p e  (G iw e rc m a n  et a l., 19 92 ). 
A lth o u g h  th is  is  th e  c a se  fo r E. co li (F ig u re  37 , la n e s  2  a n d  3 ), th e  re su lts  o b ta in e d  fo r  
P seudom onas aeruginosa  (F ig u re  3 5 , la n e s  2  a n d  3) in d ic a te  n o  c h a n g e  in  L P S  
p a tte rn s . N e v e r th e le s s , th e  p re se n c e  o f  a n tib io tic s  c a u se d  a  d e c re a se  in  th e  p ro d u c t io n  
o f  O  a n tig e n s  in  b o th  E. coli a n d  Pseudom onas aeruginosa  sa m p le s . A  s h i f t  f ro m  th e  
p la n k to n ic  s ta g e  to  th e  b io f ilm  s ta g e  c o r re sp o n d s  to  a  s im ila r  tr a n s i t io n  f ro m  a c u te  to  
c h ro n ic  in fe c t io n  (G o ld b e rg  a n d  P ie r , 19 96 , R o c c h e tta  et al., 19 99 , S a b ra  e t a l., 2 0 0 3 ). 
L o s s  o f  O  a n tig e n s  in  th e  b io f ilm  p h a se  w ill  th u s , h e lp  th e  c e lls  e v a d e  h o s t  im m u n e  
re sp o n s e  a n d  a d a p t to  th e  c h ro n ic  in fe c t io n  life s ty le . T h e  lo s s  o f  O  a n t ig e n s  m a y  re s u lt  
f ro m  in te rn a l b io f ilm  s tre ss  (S a b ra  et al., 2 0 0 3 ). T h e  p re s e n c e  o f  a n t ib io t ic s  in  th e  
im m e d ia te  b io f ilm  e n v iro n m e n t m ig h t c o n s titu te  fu r th e r  s tre s s  a n d  m a y  p o s s ib ly  c a u se  
fu r th e r  d o w n  re g u la tio n  o f  O  a n tig e n s .
P e rh a p s  d e v e lo p m e n t o f  re s is ta n c e  to  a n tib io tic s  b y  re d u c e d  p e rm e a b i l i ty  m a y  
b e  a n o th e r  re a so n  fo r  th e  o b se rv e d  d e c re a se  in  th e  p ro d u c tio n  o f  O  a n t ig e n s  in  th e  
p re s e n c e  o f  an tib io tic s . A lth o u g h  th e  e x a c t m e c h a n is m  o f  re s is ta n c e  to  d if fe re n t 
c la s se s  o f  a n tib io tic s  a t th e  p re s e n t  t im e  is  o u ts id e  th e  sc o p e  o f  th is  s tu d y , 
g e n e ra lis a tio n s  m a y  b e  m ad e . A  d e c re a se  o f  O  a n tig e n  in  a m p ic il l in  t r e a te d  s a m p le s  
( la n e  4 , F ig u re  35 ; lan e  5, F ig u re  3 6  a n d  la n e  4 , F ig u re  3 7 ) w ill in c re a s e  th e  re la tiv e  
p ro p o r tio n  o f  h y d ro p h o b ic  lip id  A  p o r t io n s  o f  L P S . T h is  w i ll  u n d o u b te d ly  in c re a s e  th e  
h y d ro p h o b ic i ty  o f  th e  o u te r  m e m b ra n e . H y d ro p h ilic  a n tib io tic s  l ik e  p - la c ta m s
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(a m p ic il lin )  a n d  a m in o g ly c o s id e s  ( s tre p to m y c in )  w ill f in d  th e  m e m b ra n e  m o re  
h y d ro p h o b ic  a n d  a n  e ffe c tiv e  b a r r ie r  to  c ro ss  (L a m b e rt, 2 0 0 2 ). F u r th e rm o re , an  
in c re a s e  in  c e ll m e m b ra n e  h y d ro p h o b ic i ty  m a y  a lso  a ttra c t  m o d e ra te ly  h y d ro p h o b ic  
e n z y m e s , lik e  (3 -lactam ases, to w a rd s  i t  a n d  re le a se  th e m  in to  th e  e x te rn a l 
e n v iro n m e n t, c a u s in g  a  n e u tra lis a t io n  o f  (3-lactam s o u ts id e  th e  c e ll (G iw e rc m a n  et a l ,
1992).
P seudom onas aeruginosa  P A O l p o s se s se s  tw o  d is tin c t ty p e s  o f  L P S  O 
p o ly s a c c h a r id e s  (A  b a n d  a n d  B  b a n d  L P S ). P re v io u s  s tu d ie s  h a v e  s h o w n  th a t 
a m in o g ly c o s id e s  b in d  m a x im a lly  to  th e  L P S  c o n ta in in g  b o th  A  a n d  B  b a n d s  (A+B +), 
m o d e ra te ly  to  L P S  c o n ta in in g  e ith e r  o n e  o f  th e se  b a n d s  (A+B 7  A 'B * ) a n d  le a s t  to  L P S  
c o n ta in in g  n o  O  a n tig e n  (A FT ) (K a d u ru g a m u w a , et a l , 1993 ; M a k in  a n d  B e v e r id g e , 
19 96 b ). T h e  n e a r  a b se n c e  o f  a n y  b a n d s  e ith e r  c o r re sp o n d in g  to  th e  A  b a n d  a n d  B  b a n d  
in  P seudom onas aeruginosa  s tre p to m y c in - tre a te d  b io f ilm  a n d  e lu a te  s a m p le s  (F ig u re  
35 , la n e  6 a n d  F ig u re  36 , la n e  7 re sp e c tiv e ly )  in d ic a te s  th a t  th e  L P S  p h e n o ty p e  is  
re sp o n s ib le  fo r  th e  re d u c tio n  in  a tta c h m e n t o f  s tre p to m y c in  to  the m e m b ra n e .
Q u in o lo n e s  (esp . n a lid ix ic  a c id )  a re  h y d ro p h o b ic  a n tib io t ic s  ( J a in  an d  
R a je sh w a r i, 2 0 0 2 ; H ira i e t a l ,  19 86 ). G e n e ra lly , a  c o m p le te  L P S  (p re se n c e  o f  b o th  A  
a n d  B  b a n d s  o r  c o m p le te  O  a n tig e n )  is  re sp o n s ib le  fo r  c re a tin g  a  p e rm e a b i l i ty  b a r r ie r  
fo r  th e se  a n tib io tic s  a n d  a lso  p re v e n ts  th e m  fro m  a c c u m u la tin g  in s id e  c e lls  (H ira i et 
a l ,  1986 ). A n  a b se n c e  o f  h y d ro p h o b ic  B  b a n d s  m a y  a lso  r e s u lt  in  a  re s is ta n t 
p h e n o ty p e  as th e  re la tiv e ly  h y d ro p h il ic  A  b a n d s  m a y  re p e l h y d ro p h o b ic  a n tib io tic s . 
In d e e d , th e  o b se rv a tio n s  (F ig u re  35 , la n e  5; F ig u re  36 , la n e  6 a n d  F ig u re  3 7 , la n e  5) 
s e e m  to  in d ic a te  a  g e n e ra l d o w n -re g u la tio n  o f  B  b a n d s .
In  c lin ic a l co n d itio n s , m u ltisp e c ie s  b io f ilm s  m a y  b e  th e  n o rm  r a th e r  th a n  
m o n o sp e c ie s  b io f ilm s  (D o n la n , 2 0 0 1 ). A n a ly s is  o f  L P S  p a tte rn s  in  b in a r y  b io f ilm s  
sh o w  re su lts  s im ila r  to  th o se  o f  m o n o s p e c ie s  b io f ilm s . In  g e n e ra l, th e  p re s e n c e  o f  su b -
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M IC s  o f  a n tib io tic s , h ig h e r  m o le c u la r  w e ig h t re g io n s  o f  O  a n tig e n s  a re  d o w n  
re g u la te d . D o w n  re g u la tio n  is  fu r th e r  a c c e n tu a te d  in  th e  c a s e  o f  e lu a te  c e lls  fro m  
b in a ry  b io f ilm s  tre a te d  w ith  su b -M IC s  o f  a n tib io tic s . T h e s e  c h a n g e s  in  th e  su rfa c e  
m e m b ra n e  m a y  re su lt  in  e p ito p ic  c h a n g e s  o f  c e lls  r e su lt in g  in  e f fe c tiv e  h o s t- im m u n e  
e v a s io n  m e c h a n ism s  (G o ld b e rg  a n d  P ie r , 1996).
A  c u rso ry  g la n c e  o f  th e  d if fe re n t L P S  p ro f ile s  g e n e ra te d  fo r  e lu a te  a n d  b io f ilm  
c e ll p h y s io lo g ie s  in d ic a te s  a  d e c re a se  in  th e  n u m b e r  a n d  in te n s i ty  o f  b a n d s  in  th e  
p re s e n c e  o f  a n tib io tic s  w ith  r e sp e c t to  c o n tro l sa m p le s . H o w e v e r , in te rp re t in g  th is  
o b s e rv a tio n  to  m e a n  a  d e c re a se  in  v iru le n c e  in  th e  p re s e n c e  o f  s u b - M I C s  o f  
a n tib io tic s  m a y  b e  m is le a d in g . In  th e  p re s e n t s tu d y  d e ta ile d  a n a ly s is  sh o w s  a  p a t te rn  
o f  e v id e n c e  su g g e s tin g  a d a p ta t io n  o f  c e lls  to  a  n e w  e n v iro n m e n t (n a m e ly , in  th e  
p re s e n c e  o f  a n tib io tic s )  ra th e r  th a n  a  d e c re a se  in  v iru le n c e . In d e e d , th e  e v id e n c e  m a y  
p o in t  to  in c re a se s  in  th e  o v e ra ll v iru le n c e  p o te n tia l  o f  th e  b io f i lm  p a th o g e n  
(Pseudom onas aeruginosa ) in  th e  p re s e n c e  o f  a n tib io tic s . H o w e v e r , th e  e a r lie r  
s u p p o s it io n  th a t a n tib io tic  re s is ta n c e  re su lt in g  fro m  L P S  p a t te rn  c h a n g e s  m a y  le a d  to  
in c re a se s  in  v iru le n c e  h a s  to  b e  te s te d  w ith  o th e r  v iru le n c e  fa c to rs . H e n c e , th e  s tu d y  o f  
c y to to x in s  ( le u c o c id in )  a n d  p ro te a s e s  o f  P seudom onas aeruginosa  w a s  su b s e q u e n tly  
a tte m p te d .
Purification of Leucocidin and Protease from monospecies and binary biofilms 
of Ps. aeruginosa  ATCC 15692 (PAOl) and E. co li ATCC 10000 as control and 
challenged with sub-MIC of selected antibiotics (ampicillin, nalidixic acid and 
streptomycin).
P re v io u s ly , S c h a rm a n n  a n d  c o -w o rk e rs  (1 9 7 6 ) h a v e  d e s c r ib e d  p u r i f ic a t io n  o f  
le u c o c id in  fro m  Pseudom onas aeruginosa  s tra in  I 58 u s in g  a m m o n iu m  su lp h a te  
p re c ip ita t io n  (2 0 %  sa tu ra tio n )  a n d  g e l f iltra tio n  te c h n iq u e s . S im ila r  p ro to c o ls  w e re
149
e m p lo y e d  in  th is  s tu d y  to  p u rify  a n d  iso la te  le u c o c id in  f ro m  Ps. aeruginosa  A T C C  
15 69 2  ( P A O l) .  In  o rd e r  to te s t  f lu c tu a tio n s  in  v iru le n c e  p o te n tia l  o f  le u c o c id in  
p ro d u c e d  b y  Ps. aeruginosa  b io f ilm  c e lls , w h e n  c h a lle n g e d  w ith  a n tib io t ic s  a n d  in  th e  
p re s e n c e  o f  o th e r  o rg a n ism s  lik e  E. co li (b in a ry  b io f ilm s  a re  a  g o o d  s im u la t io n  o f  
m u ltis p e c ie s  b io f ilm s  p re s e n t in  n a tu re  a n d  c e r ta in  in fe c tio u s  c o n d itio n s ) , i t  is  c r itic a l 
to  c h e c k  fo r  fu n c tio n a lly  s im ila r  c y to to x ic  m o le c u le s  p ro d u c e d  b y  E. co li  th a t  m a y  c o ­
p re c ip ita te  a n d  b e  p u r if ie d  a lo n g  w ith  f ra c tio n s  o f  p s e u d o m o n a l- le u c o c id in . 
U n d e te c te d  c o -p u r if ic a tio n  o f  fu n c tio n a lly  s im ila r  m o le c u le s  w o u ld  c e r ta in ly  in d ic a te  
e rro n e o u s  f lu c tu a tio n s  o f  v iru le n c e  p o te n tia l  th a t  m a y  b e  a ttr ib u te d  to  th e  ta rg e t 
m o le c u le . H e n c e , f ra c tio n s  s im ila r  to  th o se  c o n ta in in g  p s e u d o m o n a l- le u c o c id in s  w e re  
iso la te d  f ro m  E. co li a n d  te s te d  fo r  ac tiv ity . A  s im ila r  lin e  o f  re a s o n in g  w a s  a p p lie d  to  
p se u d o m o n a l-p ro te a se s  iso la te d  f ro m  f ra c tio n s  th a t  e lu te d  la te r  th a n  th o s e  o f  
Pseudomonas-lQucoci&m  in  th e  p u r if ic a tio n  p ro c e s s . P ro te in s  p r e s e n t  w i th in  th e se  
f ra c tio n s  w e re  d e te c te d  a n d  c o n firm e d  u s in g  S D S -P A G E  a n d  w e re  s to re d  a t  - 2 0 ° C  fo r  
fu r th e r  a n a ly s is .
P u r if ic a tio n  o f  le u c o c id in  an d  p ro te a se  fro m  p la n k to n ic  c e lls  o f Ps. aeruginosa  A T C C  
15692 ( P A O l)  (C o n tro l) .
P reparation  o f  autolysate
2 5 0  m L  o f  a  s te r ile  m e d iu m  (C D M ), in  a 10 00  m L  E r le n m e y e r  f la sk , w a s  
in o c u la te d  w ith  a  p u re  c u ltu re  o f  Pseudom onas aeruginosa  P A O l (s in g le  c o lo n y , 
f ro m  a  s tre a k  p la te ) . T h e  f la sk  w a s  in c u b a te d  o v e rn ig h t in  a n  o rb i ta l  in c u b a to r  
(G a lle n k a m p  IN A -3 0 5 )  a t 37°C , 180 o sc  m in ’1. A f te r  2 2  h  c u ltiv a tio n  Ps. aeruginosa  
c e lls  w e re  w a s h e d  o n ce  w ith  P h o sp h a te  b u ffe re d  s a lin e  (p H  7 .2 ; P B S ; D u lb e c c o  &  
V o g t, 19 54 ), th e n  c e lls  w ere  re su s p e n d e d  in  P B S  to  o n e - te n th  o f  th e  o r ig in a l c u ltu re  
v o lu m e  a n d  s h a k e n  fo r  73 h  a t 37°C . T h e  su p e rn a ta n t o f  th e  a u to ly s a te  w a s  c o lle c te d
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b y  c e n tr ifu g a tio n  (M S E  S u p e rsp e e d  50 , U K ; 3 7 0 0 0 x g , 4 0  m in ; S c h a rm a n n , 1 9 7 6 a). 
A ll p u r i f ic a tio n  s te p s  w e re  c a rrie d  o u t a t  4°C .
Ammonium su lphate fractionation
T h e  s u p e rn a ta n t f lu id  f ro m  a u to ly se d  Ps. aeruginosa  c u ltu re s  (1 5 0  m L )  w a s  
c o o le d  to  4°C  a n d  37 .5  m L  o f  a  s a tu ra te d  a m m o n iu m  su lp h a te  s o lu t io n  (2 0 %  
sa tu ra tio n , p H  7 .2 ) w a s  a d d e d  d ro p w ise  w ith  s tirr in g . S tir r in g  w a s  c o n tin u e d  o v e r ­
n ig h t a n d  th e  p re c ip ita te  c o lle c te d  b y  c e n tr ifu g a tio n  (M S E  S u p e rsp e e d  5 0 , U K )  a t 
2 2 0 0 0 x g  fo r  15 m in . T h e  p re c ip ita te  w a s  d is s o lv e d  in  (1 0  m L )  P B S  c o n ta in in g  0 .2 M  
N a C l (p H  7 .2 ) , s tir re d  o v e rn ig h t, a n d  th e  so lu b le  f ra c tio n  o b ta in e d  b y  c e n tr i fu g a tio n  
(M S E  S u p e rsp e e d  50 , U K ; 2 2 0 0 0 x g , 15 m in ; S c h a rm a n n , 19 76 ).
G el filtra tion
T h e  s u p e rn a ta n t f lu id  fro m  s te p  1 (1 0  m L ) w as a p p lie d  to  a  c o lu m n  (2 .5  x  100 
cm ) o f  S e p h a d e x  G -1 0 0  su p e rf in e  p re v io u s ly  e q u ilib ra te d  w ith  P B S  c o n ta in in g  0 .2  M  
N a C l (p H  7 .2 ), a n d  e lu te d  w ith  th e  sa m e  b u ffe r . T h e  f lo w  ra te  w a s  4  m L  h '1 (2  m L  p e r  
tu b e ) . F ra c t io n s  w e re  c o lle c te d  ( f irs t 97  f ra c tio n s  f ro m  th e  S e p h a d e x  G -1 0 0  c o lu m n  
a lo n e )  a n d  th e  o p tic a l d e n s ity  fo r  a ll f ra c tio n s  w a s  m e a su re d  a t  2 8 0 n m . S h o r t ly  b e fo re  
th e  le u c o c id in  a c tiv ity  w a s  e x p e c te d  to  a p p e a r  in  th e  e lu a te , th e  e f f lu e n t  w a s  
tra n s fe rre d  to  a  s e c o n d  c o lu m n  (2 .5  x  100 cm ) o f  B io  G e l P-100 e q u il ib ra te d  w ith  
P B S  c o n ta in in g  0 .2 M  N a C l (p H  7 .2 ). T h is  tra n s fe r  w a s  m a d e  b y  c o n n e c t in g  th e  
d ra in in g  tu b e  o f  th e  S e p h ad ex  c o lu m n  to  th e  a d a p te r  o f  th e  B io  G e l c o lu m n  ( f ra c tio n s  
f ro m  98  to  2 7 0  w e re  c o lle c te d  f ro m  b o th  c o lu m n s  (F ig u re  4 1 ; F ra c t io n s  1 to  4 0  w e re  
n o t c o n s id e re d  fo r  an a ly s is ) . T h is  tandem  g e l f iltra tio n  (S c h a rm a n n , 1 9 7 6 a )  w a s  u s e d  
to  s e p a ra te  le u c o c id in  a n d  p ro te a se  f ro m  m o n o sp e c ie s  a n d  b in a ry  b io f i lm s  o f  Ps. 
aeruginosa  A T C C  15692 ( P A O l)  a n d  E. co li A T C C  10000 .
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Figure 41: Elution profile o f  protein fractions o f Ps. aeruginosa  P A O l planktonic cells control. 
‘Tandem  ’ gel filtration o f leucocidin on Sephadex G -100 superfine and Bio Gel P-100. 10 mL of  
sam ple was applied to Sephadex G -100 colum n (2.5 x 100 cm ) equilibrated w ith phosphate 
buffered saline. The flow rate was 4 mL h'1 (2 mL tubes). Effluent was analyzed for protein at 
(E280nm ). Fractions 209 to 213 were com bined and dialysed before further analysis.
SD S-P A G E  p ro file  o f  leucocidin fro m  Ps. aerug inosa  A T C C  15692 (P A O l)  
p la n k to n ic  cells
Elution profiles from previous studies carried out by Scharmann (1976b), 
showed the 27.5 kDa protein, leucocidin to fractionate between fractions 120 to 140 
(flow rate used 5.4 mL h'1). In this study, peaks corresponding to proteins in and 
around fractions 200 to 220 on elution profiles (flow rate used 4 mL h'1; Figure 41) 
were analysed using SDS-PAGE, to confirm the presence of leucocidin.
SDS-PAGE profiles of leucocidin fractions were prepared using a 10% 
separator and 5% stacker gel SDS-PAGE as described in Chapter 2. Aliquots (10 to 
20 pL) of the samples were added to the wells and the gels were run at 35 mA for 
approximately 1.5 hours or until the leading samples had reached the end of the gel. 
The gels were stained in Silver stain as described in Chapter 2.
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Figure (42A and 42B) illustrate leucocidin fractions of Ps. aerug inosa  PAOl 
planktonic cells between fractions 200 to 219. Leucocidin protein appeared as a single 
band on the SDS-PAGE gel with a molecular weight of 29 kDa (lanes 10 to 14).
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Figure 42: SD S-PA G E profile o f leucocidin fractions o f  Ps. aeruginosa  P A O l p lanktonic cells. (A) 
Fractions 200 to 209 (lanes 1 to 10; Figure 41). (B) Fractions 210 to 219 (lanes 11 to 20; Figure 
41).
Purification of leucocidin and protease from biofilm cells of Ps. a eru sin o sa  ATCC 
15692 fPAOl)
SDS-PAGE analysis of 20% ammonium sulphate protein precipitated fractions 
of planktonic P seudom onas cell lysates, indicated the presence of leucocidin in 
fractions 200 to 219. However, the aim of the current investigation was to analyse 
changes in the virulence potential of leucocidin produced by biofilms of Ps. 
aeruginosa. Investigations to identify the leucocidin fractions in biofilm 
P seudom onas cells were therefore undertaken.
Biofilms of Ps. aeruginosa  ATCC 15692 (PAOl) were established on 
Sorbarod filters (Chapter 2; Hodgson et al., 1995). These biofilms were perfused with 
MCDM at 37°C. Biofilm steady state was achieved within 102 hours. The Sorbarod 
filters were sacrificed (the adherent cells were removed and washed once with 
phosphate buffered saline, pH 7.2, PBS; Dulbecco & Vogt, 1954) and resuspended in
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PBS to one-tenth of the original culture volume. Autolysis of cells was carried out in a 
shaker set at 37°C for 73 hours. The supernatant of the autolysate was collected by 
centrifugation (MSE Superspeed 50, UK; 37000xg, 40 min; Scharmann, 1976a). 
Ammonium sulphate precipitation and gel filtration of the biofilm derived autolysate 
was carried-out in a fashion similar to that for planktonic cells. The elution profile is 
exhibited below (Figure 43). A similar purification strategy was used to collect target 
fractions (containing leucocidin and proteases) from all samples (with different 
variables). The leucocidin fraction profiles were analysed by SDS-PAGE, using a 
10% separating and 5% stacking gel as described in Chapter 2. An aliquot (10 to 20 
pL) of the samples were added to the wells and the gel was run at 35 mA for 
approximately 1.5 hours or until the sample reached the end of the gel. The gels were 
stained in Silver stain as described in Chapter 2.
Figure 43: Elution profile o f protein fractions o f  Ps. aeruginosa  P A O l biofilm  cells contro l. 
‘Tandem ’ gel filtration o f leucocidin on Sephadex G-100 superfine and Bio Gel P-100. 10 m L  of 
sam ple was applied to Sephadex G-100 colum n (2.5 x 100 cm ) equilibrated w ith phosphate  
buffered saline. The flow rate was 4 mL h'1 (2 mL tubes). E ffluent was analyzed for protein  at 
(E280nm). Fractions 209 to 213 were com bined and dialysed.
Figure 44 illustrates SDS-PAGE analysis of leucocidin fractions of Ps. 
aeruginosa  PAOl biofilm cells. Lanes 1 and 7 show standard molecular weight
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protein markers (14.2 to 66 kDa, Dalton mark VII-L, Sigma-Aldrich Company Ltd., 
Gillingham, UK). Leucocidin protein fractions (column fractions 209 to 213) 
appeared as a single band on the gel with a molecular weight of 29 kDa (lanes 2, 3, 4, 
5 and 6). The molecular weight of leucocidin determined at present (29 kDa) appears 
to be slightly at variance to previous results published by Scharmann (1976b), 27.5 







Figure 44: SDS-PAG E profile of leucocidin fractions o f Ps. aeruginosa  P A O l b io film  cells 
(control). The gel shows fractions 209 to 213 (lanes 2 to 6; Figure 43). Lane 1 and 7  contain  
standard m olecular w eight m arker (14.2 to 66 kDa).
The elution profile and initial SDS-PAGE analysis of leucocidin proteins of 
P seudom onas aeruginosa  PAOl may be compared to those samples treated with the 
antibiotic ampicillin (Figure 45 and 46). Ampicillin was chosen as the representative 
antibiotic used to challenge P seudom onas biofilms and to study virulence, due to its 
functional significance as a broad-spectrum antibiotic.
The elution profile (Figure 45) indicated peaks corresponding to leucocidin as 
analysed by SDS-PAGE (Figure 46) within similar fractions to those obtained in the 
control samples {Pseudom onas aeruginosa  biofilm samples without sub-MIC 
ampicillin treatment). Both control and antibiotic challenged samples showed the
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29kDa leucocidin protein. This indicates no significant modifications of leucocidin 
protein occurred in the presence of ampicillin.
Figure 45: Elution profile o f protein fractions o f  Ps. aeruginosa  P A O l biofilm  cells w ith  sub-M IC  
o f  am picillin (8 pg mL'1). ‘Tandem ’ gel filtration o f leucocidin on Sephadex G -100 su p erfin e and 
Bio Gel P-100. 10 mL o f sam ple was applied to Sephadex G -100 colum n (2.5 x 100 cm) 
equilibrated with phosphate buffered saline. The flow  rate was 4 mL h'1 (2 m L tu b es). Effluent 









Figure 46: SD S-PA G E profile o f  leucocidin fractions o f Ps. aeruginosa  P A O l b iofilm  cells in the 
presence o f sub-M IC o f am picillin (8 pg m L'1). The gel represents fractions 209 to 213  (lanes 2 to 
6; Figure 45). Lane 1 and 7 represent standard m olecular w eight m arker (14.2 to 66 kD a).
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Elution profiles for all remaining samples (monospecies and binary biofilms of 
Ps. aerug inosa  ATCC 15692 (PAOl) and E. co li ATCC 10000; control and antibiotic 
treated) are represented below (Figures 47, 48, 49 and 50). While the process of 
purification was similar to that outlined above, the steady state of biofiilm 
development for E. co li biofilms varied to those of P seudom onas aeruginosa . E. co li  
biofilms reached a steady state within 56 hours as opposed to 102 hours of 
P seudom onas  biofilms. Again, binary biofilms reached steady state only after 126 
hours. P seudom onas aeruginosa  biofilms were grown in chemically defined medium 
(CDM). However, CDM had to be modified (MCDM) with respect to their C:N ratios 
for better growth of E. coli monospecies and binary biofilms. These modifications in 
the concentrations of carbon and nitrogen will make the doubling times for both 
bacteria closer to each other in this modified CDM (Al-Hmoud, 2002).
Figure 47: Elution profile o f protein fractions o f Ps. aeruginosa  PA O l biofilm  cells w ith  sub-M IC  
o f nalidixic acid (4 pg mL'1). ‘Tandem  ’ gel filtration o f leucocidin on Sephadex G -100 sup erfine  
and Bio Gel P-100. 10 mL o f sam ple was applied to Sephadex G -100 colum n (2.5 x 100 cm ) 
equilibrated with phosphate buffered saline. The flow rate was 4 mL h 1 (2 mL tubes). E fflu ent 
was analyzed for protein at (E28onm). Fractions 210 to 213 w ere com bined dialysed.
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Figure 48: Elution profile o f protein fractions o f Ps. aeruginosa  P A O l biofilm  cells w ith  sub-M IC  
o f  streptom ycin (8 jig mL'1). ‘Tandem ’ gel filtration o f leucocidin on Sephadex G -100  superfine 
and Bio Gel P-100. 10 mL o f sam ple was applied to Sephadex G -100 colum n (2.5 x  100 cm) 
equilibrated w ith phosphate buffered saline. The flow  rate was 4 mL h'1 (2 m L tu b es). Effluent 
was analyzed for protein at (E280nm). Fractions 214 to 218 w ere com bined dialysed.
Figure 49: Elution profile o f protein fractions o f  E. coli A TCC 10000 biofilm  cells w ith  sub-M IC  
o f am picillin (2 pg mL'1). ‘Tandem  ’ gel filtration o f leucocidin on Sephadex G -100 su p erfin e  and 
Bio Gel P-100. 10 mL o f sam ple w as applied to Sephadex G -100 colum n (2.5 x  100 cm) 
equilibrated with phosphate buffered saline. The flow rate w as 4 mL h'1 (2 m L tu b es). Effluent 
was analyzed for protein at (E280nm). No leucocidin fractions obtained.
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Figure 50: Elution profile o f protein fractions o f binary biofilm s o f Ps. aeruginosa  P A O l and E. 
coli A TCC 10000 with sub-M IC of am picillin (32 pg mL'1). ‘T an dem ’ gel filtration o f leucocidin  
on Sephadex G-100 superfine and Bio Gel P-100. 10 mL o f sam ple w as applied to  Sephadex G- 
100 colum n (2.5 x 100 cm) equilibrated with phosphate buffered saline. The flow  rate was 4 mL 
h'1 (2 mL tubes). Effluent was analyzed for protein at (E2gonm). Fractions 212 to 216 w ere  
com bined dialysed.
Twin peaks of leucocidin and protease were visible in all elution profiles, 
except those of E. coli biofilms wherein only a single protease peak appeared. 
Leucocidin generally appeared between fractions 210 to 220, while protease peaks 
were found between fractions 250 to 260 in all samples.
Interestingly, protein peaks obtained corresponding to fractions preceding 
leucocidin (40 to 100), shifted significantly when challenged with antibiotics. The 
shift in peaks was also observed when monospecies biofilms were converted to binary 
biofilms. Although it is not intended at present to determine the nature of these 
proteins, a preliminary analysis using SDS-PAGE was performed. The results are 
indicated in Figures 51 to 56.
Investigation of proteins in column fractions preceding leucocidin
The fractions visualised in the elution profiles (40 to 100; all samples), 
preceeding those of leucocidin contained unrecognised proteins. The principle applied 
during gel filtration of protein mixtures is one of size. The gel beads act as a sieve
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through which smaller molecular weight protein molecules are trapped (due to high 
diffusibility), while the high molecular weight proteins are pulled down by 
gravitational forces more easily and thus, are collected as fractions earlier in the 
purification process. Accordingly, the fractions collected before those of leucocidin 
were expected to have molecular weights greater than that of leucocidin (29 kDa). 
Initial characterisation of the proteins present in the highly variable region was 
attempted and the results are shown below (Figures 51 to 56).














Figure 51: SD S-PA G E profile of unknown proteins o f Ps. aeruginosa  PA O l b iofilm  cells 
(control). A) Fractions 80 to 88 are represented in lanes 2 to 10 (F igure 43). B) F ractions 89 to 95 
are represented in lanes 2 to 10. Lane 1 represents standard m olecular w eight m arker (14.2 to 66 
kDa).











Figure 52: SDS-PAG E profile o f  unknown proteins o f  Ps. aeruginosa  P A O l b iofilm  cells  in the 
presence o f sub-M IC o f am picillin. A) Fractions 55 to 60 (lanes 1 to 7; Figure 45) and 80 to 82 
(lanes 8 to 10; Figure 45). B) Fractions 83 to 91 (lanes 2 to 10; F igure 45) Lane 1 represents 
standard m olecular w eight marker (14.2 to 66 kDa).
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Figure 53: SD S-PA G E profile o f  unknown proteins o f  Ps. aeruginosa  P A O l biofilm  cells in the 
presence o f sub-M IC  o f nalidixic acid. A) Fractions 45 to 53 (lanes 2 to 10; F igure 47). 
B) Fractions 54 to 60 (lanes 2 to 8; Figure 47). Lane 1 represents standard m olecular w eigh t  
m arker (14.2 to 66 kDa).
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Figure 54: SD S-PA G E profile of unknown proteins o f Ps. aeruginosa  P A O l b iofilm  ce lls  in 
presence o f  sub-M IC o f streptom ycin. A) Fractions 64 to 72 (lanes 2 to 10; Figure 48) an d  B) 
Fractions 73 to 81 (lanes 2 to 10; Figure 48) Lane 1 represents standard m olecular w eight m ark er  
(14.2 to 66 kDa).












Figure 55: SD S-PA G E profile o f unknown proteins o f binary biofilm s o f Ps. aeruginosa  P A O l 
and E. coli ATCC 10000 with sub-M IC o f am picillin. A) Fractions 60 to 68 (lanes 2 to 10; F igure  
50) and B) Fractions 78 to 86 (lanes 2 to 10; Figure 50). Lane 1 represents standard m olecular  
w eight m arker (14.2 to 66 kDa).
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Figure 56: SDS-PAG E profiles o f unknown proteins o f  E. coli A TC C  10000 b iofilm  cells in 
presence o f sub-M IC o f am picillin. A) Fractions 45 to 53 (lane 2 to 10; F igure 49), B) Fractions 54 
to 62 (lane 2 tolO; Figure 49), C) Fractions 63 to 71 (lane 2 to 10; Figure 49), D ) Fractions 72 to 
80 (lanes 2 to 10; Figure 49), E) Fractions 81 to 89 (lane 2 to 10; Figure 49), and F) F ractions 90 
to 95 (lane 2 to 7; Figure 49). Lane 1 represents standard m olecular w eight m arker (14.2 to 66 
kDa).
Surprisingly, some of the fractions (Figure 54A; lanes 6, 7, 8, 9 and 10 and 
Figure 54B; lanes 2, 3, 4, 5, 6, 7, 8 and 9) indicated proteins having lower molecular 
weights than that of leucocidin (29 kDa). The molecular weights of the proteins from
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th e  h ig h ly  v a r ia b le  re g io n  ( fra c tio n s  4 0  to  100) w e re  a n a ly s e d  u s in g  S D S -P A G E  an d  
th e  re su lts  a re  ta b u la te d  b e lo w  (T a b le  14).
T a b l e  14 : P r o te in s  a p p ea r in g  in  e lu t io n  fr a c t io n s  th a t c o r r e sp o n d  to  th e  h ig h ly  v a r ia b le  
r e g io n  ( fr a c t io n  4 0  to  100) p r e c e d in g  le u c o c id in  fr a c t io n  ( fr a c t io n s  2 0 9 -2 1 3 ) . 
M o le c u la r  w e ig h t s  o f  p r o te in s  w e r e  c a lc u la te d  m a n u a lly  a n d  e x p r e s s e d  a s  k i lo d a lto n s  
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I t  is  n o t  e n tire ly  c le a r  a s  to  w h y  lo w  m o le c u la r  w e ig h t  p ro te in s  c o - f ra c tio n a te d  
w ith  h ig h  m o le c u la r  w e ig h t p ro te in s . H o w e v e r , th e re  m a y  b e  tw o  p o s s ib le  
e x p la n a tio n s  fo r  th is  p h e n o m e n o n
1. S o m e  lo w  m o le c u la r  w e ig h t p ro te in s  m a y  b e  v e ry  lo o se ly  p a c k e d  a n d  h e n c e , 
h a v e  a n  e ffe c tiv e  la rg e  3 -D  size . S in c e  g e l f iltra tio n  s ie v e s  p ro te in s  b a s e d  o n  
s iz e , th e se  lo o se ly  p a c k e d  lo w e r  m o le c u la r  w e ig h t p ro te in s  m a y  b e  le ss  
d iffu s ib le  a n d  s lip  th ro u g h  a lo n g  w ith  p ro te in s  o f  h ig h  m o le c u la r  w e ig h t.
2 . I t  m a y  a lso  b e  th a t a  fe w  lo w  m o le c u la r  w e ig h t p ro te in s  m a y  h a v e  a  re la tiv e ly  
lo w  d iffu s io n  ra te  o r  s o lu b ili ty  ra te , h e n c e  th e y  m a y  b e  a b le  to  c o m p e te  w ith  
th e ir  h ig h e r  m o le c u la r  w e ig h t  c o u n te rp a r ts  a n d  f ra c tio n a te  s im u lta n e o u s ly .
I t  is  p ro b a b le  th a t b o th  th e se  fa c to rs  p la y  a  ro le  in  th e  c o lu m n  p u r i f ic a t io n  o f  p ro te in s , 
r e su lt in g  in  lo w  m o le c u la r  w e ig h t  p ro te in s  c o -fra c tio n a tin g  w ith  h ig h  m o le c u la r  
w e ig h t p ro te in s .
A lth o u g h  it  m a y  b e  o b se rv e d  th a t  a  n u m b e r  o f  p ro te in s  w ith  v a ry in g  s iz e s  a re  
p re s e n t  w ith in  th is  h ig h ly  v a r ia b le  re g io n , S D S -P A G E  a n a ly s is  p ro v e s  th a t  th e  m o s t 
a b u n d a n t p ro te in s  a re  o f  lo w  m o le c u la r  w e ig h ts . T h e y  m a y  b e  a n y  p ro te in  f ro m  th e  
to ta l p ro te in  p ro f ile  o f  P seudom onas aeruginosa  th a t a re  c a p a b le  o f  p re c ip i ta t in g  a t 
2 0 %  s a tu ra t io n  o f  a m m o n iu m  su lp h a te . In  a ll p ro b a b ili ty  th e  lo w  m o le c u la r  w e ig h ts  
m a y  in d ic a te  th a t th e y  a re  s id e ro p h o re s  o r  s id e ro p h o re -lik e  p ro te in s . I t  m a y  a ls o  b e  
n o te d  th a t fo r  a  su b se t o f  th e  lo w  m o le c u la r  w e ig h t p ro te in s , th e  f ra c tio n a tin g  p a t te rn  
c h a n g e s  w h e n  c h a lle n g e d  w ith  th e  a n tib io tic s . F o r  in s ta n c e , a  14 .2  k D a  p ro te in  
p re s e n t w ith in  fra c tio n s  85  to  95  (T a b le  14) o f P ^ .  aeruginosa  b io f ilm  c o n tro l  c e lls , 
f ra c tio n a te s  in  sam p le s  55 to  75 , w h e n  th e se  c e lls  a re  tr e a te d  w ith  s tre p to m y c in  a t  
su b -M IC  (8 p g  m L '1). T h is  in d ic a te s  th a t  so lu b ili ty  o f  th a t p a r t ic u la r  p ro te in  h a s  
d e c re a se d  w h e n  th e  ce lls  are  t re a te d  w ith  s tre p to m y c in  o r  in  o th e r  w o rd s  th e  p ro te in  
m a y  h a v e  m is - fo ld e d  re su ltin g  in  a n  in a c tiv e  p ro te in . H o w e v e r , fu r th e r  in v e s t ig a t io n
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(e .g ., M A L D I sp e c tro p h o to m e tr ic  a n a ly s is  to  d e te rm in e  p ro te in  id e n tity )  o f  su c h  
p ro te in s  is  n e e d e d  to  p ro v id e  a n y  d e f in itiv e  c o n c lu s io n s .
D eterm in ation  o f leucocid in  activ ity  on fib rob last cells b y  M icrocu ltu re  
T etrazoliu m  A ssays (M T T  assay)
M ic ro c u ltu re  te tra z o liu m  a s sa y s  (M T T ) a re  w id e ly  u s e d  to  in v e s tig a te  th e  
m e c h a n ism s  o f  b o th  c e ll a c tiv a tio n  a n d  c e ll d a m a g e  (G o o d w in , e t a l , 19 9 5 ). T h e y  a re  
c o lo u r im e tr ic  a s sa y s , w h ic h  a re  b a s e d  u p o n  th e  b io re d u c tio n  o f  a  te tra z o liu m  s a lt to  an  
in te n se ly  c o lo u re d  fo rm azan . B io re d u c tio n  o c c u rs  w h e n  a c tiv a te d  c e lls  c a u se  
te tra z o liu m  sa lt  to  c h a n g e  in to  so lu b le  fo rm a z a n  (G o o d w in , et a l, 19 9 5 ). Id e a l 
c o lo r im e tr ic  a s sa y s  s h o u ld  u t iliz e  c o lo u rle ss  su b s tra te s  th a t  m a y  b e  m o d if ie d  to  
c o lo u re d  p ro d u c ts  b y  a n y  liv in g  c e ll a n d  n o t  d e a d  c e lls  o r  t is s u e  c u ltu re  m e d iu m . T h e  
a c tiv ity  o f  b a c te r ia l  d e h y d ro g e n a se  e n z y m e s , p re s e n t  o n ly  w ith in  a c tiv e  m ito c h o n d ria , 
c a u se s  c le a v a g e  o f  th e  te tra z o liu m  r in g  b y  a  re d u c tio n  p ro c e s s , g iv in g  r is e  to  a  
c o lo u re d  p ro d u c t. A s  ac tiv e  m ito c h o n d ria  m a y  o n ly  b e  s e e n  in  v ia b le  c e lls , M T T  
a ssa y s  a re  h ig h ly  sp e c ific  and  se n s itiv e  a s sa y s  fo r  m e a s u r in g  liv e  c e lls  (M o sm a n n , 
1983).
L e u c o c id in  p ro d u c e d  b y  P seudom onas aeruginosa  e x h ib its  c y to to x ic  a c tio n  
a g a in s t  e u k a ry o tic  ce lls . C y to to x ic ity  is  c h a ra c te r is e d  b y  a b n o rm a l c e ll s w e llin g  
fo llo w e d  b y  m e m b ra n e -ru p tu re  a n d  ce ll d ea th . A s  th e  b io - re d u c tio n  o f  M T T  b y  liv e  
e u k a ry o tic  c e lls  is  d ire c tly  p ro p o r tio n a l to  th e ir  c e ll c o n c e n tra t io n  a n d  e x h ib its  a  lin e a r  
re la tio n sh ip  (F ig u re  10; C h a p te r  2 ), a n y  c h a n g e  in  th e  n u m b e r  o f  v ia b le  c e lls  is  
im m e d ia te ly  re f le c te d  u p o n  th e  re d u c tio n  o f  M T T  a n d  its  c o lo u re d  e n d -p ro d u c t. 
H e n c e , a  d e c re a se  in  th e  c o n c e n tra t io n  o f  v ia b le  e u k a ry o tic  c e lls  o n  a d d it io n  o f  a c tiv e  
p se u d o m o n a l- le u c o c id in  m a y  b e  a c c u ra te ly  q u a n tif ie d  a s  a  fu n c tio n  o f  th e  l iv e  c e lls  
re m a in in g  a f te r  tre a tm e n t. T he  n u m b e r  o f  c e lls  k i l le d  b y  th e  a c tio n  o f  le u c o c id in  is
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d ire c t ly  p ro p o r tio n a l to  its  c o n c e n tra tio n . A c tiv ity  o f  le u c o c id in  w a s  d e te rm in e d  a s  
a  m e a su re  o f  its  e f f ic ie n c y  and  a b ility  to  k ill  e u k a ry o tic  t is su e -c u ltu re  c e lls .
E x p e r im e n ta l a p p ro a c h
10 m L  o f  s te r ile  m e d iu m  (D u lb e c c o  M in im u m  E s s e n tia l  M e d iu m  E a g le -  
D u lb e c c o  M E M ; S ig m a  M 2 2 7 9 ; a lso  d e sc r ib e d  in  C h a p te r  2 ), c o n ta in in g  1 0 %  F C S  
(F o e ta l C a l f  S e ru m ) 11 m L ; G lu ta m in e  (4 m M ) 2  m L ; 1 m L  a n tib io t ic  (p e n ic il l in  /  
s tre p to m y c in ; S ig m a  P 0 9 0 6 ; d e sc r ib e d  in  C h a p te r  2 ) in  a  2 5  c m  c e ll c u ltu re  f la sk , 
w a s  in o c u la te d  w ith  3 0 0  jliL  h u m a n  fo re sk in  f ib ro b la s t  c e lls  (1 .4  x  105 c e lls  m L ’1). 
T h e  c e ll c u ltu re  f la sk  w a s  in c u b a te d  in  a n  in c u b a to r  (E le raeu s In s tru m e n ts , G e rm a n y  
B 5 0 6 0 , E K -C O 2) fo r  72  h  a t 3 7 °C  w ith  5 %  C O 2 u n ti l  c o n f lu e n t g ro w th  o f  f ib ro b la s t  
c e lls  w a s  o b se rv e d  u n d e r  m ic ro sc o p e  (W ilo v e r t  (G e rm a n y )  In v e r te d  m ic ro s c o p e ) . T h e  
a c tiv ity  o f  le u c o c id in  (3 .2  to  6 2 .4  p g  m L ’1) o n  t is s u e -c u ltu re d  f ib ro b la s t  c e l ls  w a s  
a n a ly se d  u s in g  M T T  a s s a y  (d e sc rib e d  in  C h a p te r  2)
Colourim etric M T T  (tetrazolium ) assay  (M o sm a n n , 1983 ; G o o d w in , e i a l, 19 9 5 ).
1 m L  o f  th e  M T T  assay  s u p e rn a ta n t w a s  re m o v e d  ( fro m  2 4  w e l l  p la te s )  a n d  
th e  o p tic a l d e n s ity  w a s  m e a su re d  a t 5 4 0  n m  u s in g  a  s p e c tro p h o to m e te r  (N o v a s p e c  I 
L K B ) a g a in s t  a  m e d ia  b la n k  (D u lb e c c o  M E M ). T h is  w a s  p e r fo rm e d  a t  tw o  tim e  p o in ts  
(30  m in u te s  a n d  2 4  h o u rs ) . I f  th e  a b so rb e n c y  w a s  g re a te r  th a n  0 .5 , a  d i lu t io n  o f  th e  
a s sa y  su p e rn a ta n t w a s  m a d e  (1 :1 0 ; L a w re n c e  a n d  M a ie r , 19 77 ). In  o rd e r  to  c a lc u la te  
th e  a c tu a l o p tic a l d e n s ity  fo r th e  sa m p le , E540 w a s  m u ltip lie d  b y  a  f a c to r  10. C e ll 
n u m b e rs  c o r re sp o n d in g  to  o b se rv e d  o p tic a l d e n s itie s  w e re  o b ta in e d  f ro m  a  s ta n d a rd  
c a lib ra tio n  c u rv e  c o n s tru c te d  fo r  th e  p u rp o s e  (p re se n te d  in  C h a p te r  2 ).
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R e s u l t s  &  D is c u s s io n
Ps. aeruginosa  le u c o c id in , so m e tim e s  re fe r re d  to  a s  c y to to x in  (C T X ), is  a  2 9 -  
k D a  p ro te in  e n d o w e d  w ith  c y to ly tic  a c tiv ity  to w a rd s  le u c o c y te s  a n d  o th e r  ty p e s  o f  
c e lls  (O h n ish i et al., 1994 ). I t  is  in it ia lly  sy n th e s iz e d  as a  31 k D a  p r e c u r s o r  p ro te in  
(p ro -C T X ) a n d  c o n v e r te d  in to  ac tiv e  to x in  o n ly  o n  th e  p ro te o ly tic  c le a v a g e  o f  2 0  
a m in o  a c id  re g io n  fro m  its  C - te rm in u s  (H a y a sh i et al., 1 9 89 ; O h n ish i e t a l., 19 94 ). 
T h e  p re s e n t  s tu d y  iso la te d  an d  p u r i f ie d  th e  2 9  k D a  a c tiv e  c y to to x in  f ro m  m o n o s p e c ie s  
a n d  b in a ry  b io f ilm s  o f  Ps. aeruginosa  P A O l a n d  p ro b e d  its  v iru le n c e  p o te n tia l  w h e n  
c h a lle n g e d  w ith  su b -M IC  o f  a m p ic il l in  (8 p g  m L '1).
T h e  a c tiv ity  o f  le u c o c id in  w a s  d e te rm in e d  b y  M T T  a ssa y . A s  th e  a s s a y  w a s  
sp e c if ic  fo r  v ia b le  ce lls , ce lls  k i l le d  a s  a  re su lt  o f  c y to to x ic  a c tiv ity  o f  le u c o c id in  
c o u ld  b e  a c c u ra te ly  e s tim a te d . F ig u re  57  i l lu s tra te s  th e  m e a s u re m e n t o f  le u c o c id in  
a c tiv ity  b y  M T T  a ssa y  a f te r  30  m in u te s  a n d  2 4  h o u rs  a t a n  o p tic a l d e n s i ty  o f  5 4 0 n m . 
I t  m a y  b e  n o te d  th a t le u c o c id in  a c tiv ity  c o u ld  b e  o b s e rv e d  w ith in  3 0  m in u te s  o f  
a d d it io n  in to  f ib ro b la s t c u ltu re s . A n a ly s is  o f  th e  d a ta  (F ig u re  57 ) i l lu s t ra t in g  th e  
n u m b e r  o f  v ia b le  ce lls  a f te r  th e  a d d it io n  o f  p u r if ie d  a c tiv e  le u c o c id in  sh o w s  a  d is t in c t  
p a t te rn  o f  e v e n ts  a lso  re f le c te d  w h e n  a n a ly s in g  v iru le n c e  p o te n tia l  o f  m o n o s p e c ie s  
a n d  b in a ry  P se u d o m o n a l-p ro te a se s  c h a lle n g e d  w ith  su b -M IC  o f  a m p ic ill in .
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□ Test samples 
(30 mins)
□ Test samples 
(24 h)
Test Samples
Figure 57: M easurem ent o f Ieucocidin activity by M TT assay at 30 m inutes and 24 hours at an 
optical density o f 540nm; Y axis units 1.00E+06 to 6.00E +6 corresponds to 1.0 x 106 to 6.0 x 106 
viable cells per mL, respectively. (A) leucocidin o f Ps. aeruginosa  P A O l planktonic cells; (B) 
leucocidin o f Ps. aeruginosa  PAO l biofdm  cells; (C) leucocidin o f Ps. aeruginosa  P A O l biofilm  
cells w ith sub-M IC  o f antibiotic (am picillin 8 pg m L'1); (D) leucocidin o f E. coli b iofilm  cells with  
sub-M IC o f (am picillin 2 pg mL"1); (E) leucocidin o f  binary biofilm  cells w ith sub-M IC  of  
(am picillin 32 pg mL'1); (F) is control untreated cells only M TT w as added on the fibrob last cells 
(4.4 x 106 m L'1). Error bars are calculated as the standard deviation o f  the individual data points, 
n = 3 replicates.
The most active leucocidin was purified from Pseudomonas aeruginosa 
biofilm cells treated with sub-MIC of ampicillin (8 pg mL"1). Parallel E. coli biofilm 
fractions, treated with sub-MIC of ampicillin (2 pg mL’1) showed minimal 
cytotoxicity. This indicates there is no active cytotoxin within E. coli fractions similar 
to those of Ps. aeruginosa leucocidin. This could also be confirmed from elution 
profiles of E. coli (challenged with ampicillin) lacking any peaks within the target 
fractions (fractions 200 to 219, Figure 49).
It is also noted that planktonic and biofilm cells of Pseudomonas devoid of 
treatment of ampicillin showed significant cytotoxic activity. While it may be usual 
for planktonic cells to exhibit cytotoxic activity, it is surprising to find an increase in 
leucocidin activity in biofilm cells due to the relatively dormant nature of bacterial 
cells within biofilms and also because of the chronic nature of biofilm infection.
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F in a lly , a c tiv ity  o f  le u c o c id in  is o la te d  f ro m  b in a ry  b io f ilm s  c h a l le n g e d  w ith  
a m p ic ill in , w a s  se c o n d  o n ly  to  c o r re sp o n d in g  m o n o sp e c ie s  b io f ilm  o f  P seudom onas  
aeruginosa. T h is  in d ic a te s  th a t  e v e n  in  c lin ic a l s e tt in g s  (w h e re  th e  p ro b a b i l i ty  o f  
f in d in g  m u ltis p e c ie s  o r  b in a ry  b io f ilm  in fe c tio n s  is  h ig h )  t r e a tm e n t w i th  a n tib io t ic s  
m a y  a c tu a lly  w o rse n  p ro g n o s is  r a th e r  th a n  im p ro v e  it.
I t  is  a lso  n o te d  th a t th e  a b o v e  a n a ly s is  o f  th e  a c tiv it ie s  o f  le u c o c id in  fro m  
d if fe re n t s a m p le s  (c o n tro l an d  a n tib io tic  tre a te d )  w e re  c a r r ie d  o u t a t  c o n s ta n t v o lu m e s , 
b u t  n o t  c o n s ta n t le u c o c id in  p ro te in  c o n c e n tra tio n s . T h u s , a  h ig h  a c tiv ity  in  o n e  s a m p le  
re la tiv e  to  a  lo w e r  a c tiv ity  in  a n o th e r  m a y  b e  d u e  to  h ig h e r  le u c o c id in  c o n c e n tra t io n s  
in  th e  fo rm e r  a n d  m a y  n o t  c o n s titu te  a  s ig n if ic a n t in c re a se  in  v iru le n c e  p o te n tia l  d u e  
to  le u c o c id in . In  o rd e r  to  n o rm a lis e  th e  d a ta  w ith  re s p e c t  to  le u c o c id in  p ro te in  
c o n c e n tra tio n , q u a n tita t iv e  e s tim a te s  o f  le u c o c id in  p re s e n t  w ith in  ta rg e t f ra c tio n s  w e re  
d e te rm in e d  sp e c tro sc o p ic a lly  a n d  th e  v iru le n c e  p o te n tia l  r e a n a ly se d . A l th o u g h  s lig h t 
v a r ia t io n s  in  p ro te in  c o n c e n tra tio n s  w e re  o b s e rv e d  w ith in  c o n s ta n t  f ra c tio n  v o lu m e s , 
th e  p a t te rn  o f  a c tiv ity  o f  th e  d if fe re n t sa m p le s  d e s c r ib e d  a b o v e  r e m a in e d  th e  sa m e . 
T h e  re su lts  a re  sh o w n  in  F ig u re  58 as  p e rc e n t  ce lls  k i l le d  d u e  to  le u c o c id in  a c tiv ity . 
A s  n o te d  p re v io u s ly , in c re a se d  c y to to x ic ity  o f  f ib ro b la s t  w a s  o b s e rv e d  fo r  
m o n o sp e c ie s  a n d  b in a ry  b io f ilm s  c h a lle n g e d  w ith  a m p ic ill in . T h e se  re su lts  s h o w  th a t  
p re s e n c e  o f  sub  M IC s  o f  a n tib io tic s  c a u se  a n  in c re a se  in  v iru le n c e  p o te n tia l  o f  
Pseudom onas aeruginosa  b io f ilm s.
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□ Test samples 
(30 minutes)
□  Test samples 
(24 hours)
Test samples
Figure 58: Percent cells killed after treatm ent o f  leucocidin from  d ifferent sam ples at 30 m inutes 
and 24 hours; (A) leucocidin o f Ps. aeruginosa  PA O l planktonic cells; (B) leucocid in o f  Ps. 
aeruginosa  PA O l biofilm  cells; (C) leucocidin o f Ps. aeruginosa  PA O l biofilm  cells w ith  sub-M IC  
o f antibiotic (am picillin 8 pg m L 1); (D) leucocidin o f E. coli biofilm  cells w ith  sub-M IC  of  
(am picillin 2 pg mL'1); (E) leucocidin o f binary biofilm  cells w ith sub-M IC  o f  (am picillin  32 pg 
m L'1). Error bars are calculated as the standard deviation o f the individual data points, n = 3 
replicates.
P h a s e  c o n t r a s t  m ic ro s c o p ic  a n a ly s is  o f  th e  c y to to x ic  a c t io n  o f  le u c o c id in  o f  
P seu dom on as aeruginosa  P A O l  o n  S p le e n - m y e lo m a  c e ll l in e  (S p 2 )  c e lls  (S p 2 /0 -  
A g l4  E C  A C C  N O : 8 5 0 7 2 4 0 1 )
Pseudomonal-leucocidins are cytotoxic to different human cells. Scharmann 
and colleagues (1976) have shown these proteins to be active against human 
leucocytes of various cell types (hence the name, leucocidins). Cells killed due to the 
action of leucocidin, showed signs characteristic to accidental death or oncosis (death 
characterised by swelling of the target cell). Subsequently, they were found to be 
active against different host cells. In an earlier experiment, cytotoxic activity of 
leucocidin against human foreskin fibroblast cells was demonstrated using MTT 
assay. In order to discount the possibility of natural death of cells (apoptosis) in 
presence of leucocidin, phase contrast microscopy was performed on tissue cultured
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S p le e n  m y e lo m a  ce lls . P h a se  c o n tra s t  m ic ro s c o p y  w o u ld  h e lp  d e te rm in e  th e  
m o rp h o lo g ic a l c h a ra c te r is t ic s  o f  th e  p o p u la tio n  o f  c e lls  ta rg e te d  b y  le u c o c id in , a n d  
th u s  h e lp  d e te rm in e  th e  c au se  o f  d e a th , e ith e r  b y  a p o p to s is  o r  o n c o s is . F u r th e rm o re , 
th e  d e g re e  o f  o n c o s is  (sw e llin g )  m a y  a lso  b e  a  re lia b le  m e a su re  fo r  q u a n tify in g  th e  
a c tiv ity  o f  th e  to x in  ( le u c o c id in ) .
E x p e r im e n ta l a p p ro a c h
10 m L  o f  a  s te r ile  m e d iu m  (R P M I-1 6 4 0 ; S ig m a  R 0 8 8 3 ; d e s c r ib e d  in  C h a p te r  
2 ), c o n ta in in g  (1 0 %  F C S  (F o e ta l C a l f  S e ru m ) 11 m L ; G lu ta m in e  (4 m M ) 2  m L ; 1 m L  
a n tib io tic  (p e n ic il l in  /  s tre p to m y c in ; S ig m a  P 0 9 0 6 ); I m M  so d iu m  p y ru v a te  in  a  25  
c m 2 c e ll c u ltu re  f la sk , w a s  in o c u la te d  w ith  S p le e n -m y e lo m a  c e ll lin e  S p 2  /  0 - A g l4  
(E C A C C  N O : 8 5 0 7 2 4 0 1  ce lls  (1 .4  x  105 c e lls  m L '1; 3 0 0  p L ) . T h e  c e ll c u l tu re  f la s k  
w a s  in c u b a te d  in  a n  in c u b a to r  (H e ra e u s  in s tru m e n t, G e rm a n y  B 5 0 6 0  E K -C O 2) fo r  72  
h  a t 3 7 °C  w ith  5%  C O 2 u n ti l  m a t  g ro w th  o f  (S p 2 ) c e lls  w a s  o b s e rv e d  u n d e r  
m ic ro s c o p e  (W ilo v e r t  (G e rm a n y ) In v e r te d  m ic ro sc o p e ) . M o rp h o lo g ic a l a lte ra t io n s  o f  
th e  S p2  c e lls  a f te r  le u c o c id in  tre a tm e n t w a s  o b se rv e d  b y  u s in g  p h a s e  c o n tra s t  
m ic ro s c o p y  (L E IC A  D M R ) a t 4 0 0 x  o n  a  g la s s  s lid e  w ith  a  c o v e r  g la s s .
P reparation  o f  Sp2 cells on g lass slide
A n  a liq u o t (1 0  p L )  o f  S p2  c e lls  w a s  ta k e n  a n d  m ix e d  w ith  5 p L  o f  le u c o c id in  
s o lu tio n  o r  w i th  5 p L  o f  P B S  c o n ta in in g  0 .2 M  N a C l (p H  7 .2 ) a s  c o n tro l o n  a  g la s s  
s lid e . T h is  w a s  p e r fo rm e d  at tw o  tim e  p o in ts  (3 0  m in u te s  a n d  2 4  h o u rs ) . A  c o v e r  g la s s  
w a s  a d d e d  a n d  th e  o b se rv a tio n s  o n  th e  p h a s e  c o n tra s t  m ic ro s c o p e  (L E IC A  D M R ) a t 
4 0 0 x  w e re  m a d e  a t ro o m  te m p e ra tu re .
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R esu lts & D iscu ssion
E u k a ry o tic  ce ll d e a th  m a y  b e  c la s s if ie d  in to  tw o  d is tin c t ty p e s  b a s e d  o n  
m o rp h o lo g ic a l a n d  b io c h e m ic a l c h a n g e s . S u ic id a l ce ll d e a th  o r  p ro g ra m m e d  c e ll  d e a th  
(a lso  c a l le d  a p o p to s is )  is  c h a ra c te r is e d  m o rp h o lo g ic a lly  b y  ‘h a lf  m oon ’ l ik e -  
c o n d e n s e d  c h ro m a tin )  s tru c tu re s  w ith in  sh ru n k e n  n u c le i. A p o p to s is  is  a ls o  o f te n  
c h a ra c te r is e d  b y  d e g ra d a tio n  o f  c h ro m a tin  le a d in g  to  th e  re le a se  o f  2 0 0 b p  D N A  
o lig o m e rs . T h e  s e c o n d  ty p e  o f  c e ll d e a th  c h a ra c te r is e d  b y  c e llu la r  a n d  n u c le a r  
sw e llin g , v a c u o liz a tio n  a n d  ce ll m e m b ra n e  d is in te g ra tio n  is  d e s c r ib e d  a s  ‘a c c id e n ta l ' 
c e ll d e a th  o r  o n c o s is  (D a c h e u x  et a i ,  2 0 0 0 ).
M ic ro sc o p ic  a n a ly s is  o f  m o rp h o lo g y  o f  S P 2  c e lls  a f te r  le u c o c id in  tr e a tm e n t 
(p u r if ie d  f ro m  d iffe re n t sa m p le s )  re v e a ls  c e ll d e a th  b y  o n c o s is  (F ig u re  5 9 ). T h e se  
re su lts  a lso  in d ic a te  th a t d e a th  o f  f ib ro b la s t c e lls  o b se rv e d  in  p re v io u s  M T T  a s s a y s  
a f te r  tr e a tm e n t w ith  le u c o c id in  fra c tio n s  w e re  n o t  d u e  to  n a tu ra l  c a u s e s  ( a p o p to s is ) , 
b u t  w e re  a c c id e n ta l  o r  in d u c e d  b y  th e  p re s e n c e  o f  th e  le u c o c id in .
A lth o u g h  a ll fra c tio n s  c o n ta in in g  le u c o c id in  w e re  a b le  to  c a u s e  o n c o s is , th e  
d e g re e  v a r ie d . L e u c o c id in s  fro m  a n tib io tic -e x p o se d  c e lls  w e re  m o re  a c tiv e  a n d  w e re  
a b le  to  c a u se  m u c h  m o re  sw e llin g  o f  S p 2  c e lls  th a n  th e ir  le s s  a c tiv e  n o n -a n tib io tic -  
e x p o s e d  c o n tro ls  c o u n te rp a rts . T h e  d e g re e  o f  s w e llin g  m a tc h e d  th e  v iru le n c e  p o te n tia l  
o f  le u c o c id in . A c c o rd in g ly  F ig u re  59  sh o w s  m a x im u m  d e g re e  o f  o n c o s is  (d e a th  o f  
c e ll c h a ra c te r is e d  b y  sw e llin g )  to  Pseudom onas aeruginosa  b io f ilm  c e lls  e x p o s e d  to  
a m p ic il l in  (sa m p le  C , F ig u re  60 ). L e u c o c id in  p u r if ie d  f ro m  b in a ry  b io f i lm s  o f  
P seudom onas  sh o w e d  a t le a s t 10%  d e c re a se  in  a c tiv ity  w h e n  c o m p a re d  to  th e ir  
m o n o s p e c ie s  c o u n te rp a rts , y e t r e m a in e d  s ig n if ic a n tly  h ig h e r  th a n  c o n tro l s a m p le s  (A , 
p la n k to n ic  Pseudom onas  ce lls ; B , b io f ilm  P seudom onas  c e lls )  th a t  w e re
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Figure 59: A ctivity o f  leucocidin against Sp2 cells after 30 m inute exposure (M agnification: 400 
x). (A) Sp2 cells treated with 0.2M NaC l, (pH 7.2; PBS; control). (B) Sp2 cells after exposure to 
leucocidin produced by planktonic Ps. aeruginosa  P A O l cells, (C) Sp2 cells treated with  
leucocidin produced by Ps. aeruginosa  P A O l biofilm  cells; (D) Sp2 cells exposed to leucocidin  
produced by Ps. aeruginosa  PAOl biofdm  cells treated w ith sub-M IC o f antib iotic (am picillin 8 
pg m L'1); (E) Sp2 cells treated with parallel fractions to leucocidin obtained from  E. coli ATCC  
10000 biofilm  cells treated with sub-M IC o f  antibiotic (am picillin 2 pg m L'1); (F) Sp2 cells after 
being exposed to leucocidin produced by binary biofdm  cells o f Ps. aeruginosa  P A O l and E. coli 
ATCC 10000 in the presence of sub-M IC o f antibiotic (am picillin  32 pg m L'1).
not exposed to ampicillin. Although parallel fractions collected from E. coli biofilms
exposed to ampicillin, did not show any significant cytotoxic activity, this does not
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discount the possibility of E. coli producing some molecules that may quench the 
activity of Pseudomonal-leucocidin, thus explaining the decrease of leucocidin 
activity of binary biofilms. Alternatively, this observed decrease in leucocidin activity 
may be the result of a simple dilution of leucocidin production within the binary 
biofilm structure. The morphological results obtained (Figure 59 and 60) yielded 
leucocidin activities that were in agreement with previous results from MTT assay
T est sam ples
Figure 60: Percent increase in diam eter o f  Sp2 cells after treatm ent w ith leucocid in for 30 
minutes; (A) percent increase in size o f Sp2 cells a fter treated w ith leucocidin o f  Ps. aeruginosa  
ATCC 15692 (P A O l) planktonic cells control; (B) percent increase in size o f Sp2 cells treated  
with leucocidin o f Ps. aeruginosa  ATCC 15692 (P A O l) biofilm  cells control; (C) percent increase  
in size o f Sp2 cells treated with leucocidin o f  Ps. aeruginosa  A TC C  15692 (P A O l) biofilm  cells 
with sub-M IC  o f antibiotic (am picillin 8 pg m L'1) ; (D) percent increase in size o f  Sp2 cells 
treated w ith leucocidin of E. coli ATCC 10000 b iofilm  cells w ith sub-M IC  o f antib iotic (am picillin  
2 pg mL'1) ; (E) percent increase in size o f Sp2 cells treated with leucocidin o f  binary biofilm  cells 
o f Ps. aeruginosa  ATCC 15692 (P A O l) and E. co li  ATCC 10000 w ith sub-M IC  o f  antibiotic 
(am picillin 32 pg mL’1 ), Error bars are calculated as the standard deviation o f  the individual 
data points, n =  3 replicates.
In summary, it may be noted that activities of leucocidin (virulence factor) 
produced by Pseudomonas aeruginosa PAOl biofilm cells, increase in the presence 
of sub-MICs of antibiotics. This has been elegantly demonstrated using MTT assay 
and phase contrast microscopy. The results of these experiments are tabulated below
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(T a b le  15). T h e  ta b le  sh o w s  p e rc e n t re d u c tio n  (k illin g )  o f  c e lls  p e r  m L  p e r  m ic ro g ra m  
o f  le u c o c id in  a n d  p e rc e n t in c re a se  in  th e  m e a n  d ia m e te r  o f  S p 2  c e lls . F ro m  th e se  
re su lts , i t  m a y  b e  c o n c lu d e d  th a t th e  in c re a se  in  v iru le n c e  o f  m o n o s p e c ie s  a n d  b in a ry  
b io f ilm s  o f  Pseudom onas aeruginosa  P A O l in  th e  p re s e n c e  o f  s u b -M IC  a n tib io t ic s  
w o u ld  in c re a se  th e  o b v io u s  e ffec ts  o f  p a th o g e n ic ity .
T a b le  15 : M e a s u re s  o f  th e  c y to to x ic  e f fe c t o f  le u c o c id in  o n  h u m a n  f ib ro b la s t  c e lls  
a n d  S p2  c e lls














% Cells killed 








A 0.5 64.5 35 .5 62 .4 1.03 55
2 4 72.7 27 .3 1.16
B 0 .5 69.3 3 0 .7 32 2 .1 6 81
2 4 90 .6 9.4 2 .83
C 0 .5 92.5 7.5 2 5 .6 3.61 150
2 4 93.9 6.1 3 .6 6
D 0.5 5.7 94 .3 3 .2 1.78 3 .4 4
2 4 0.15 99 .8 5 0 .0 4 8
E 0.5 86.3 13 .7 2 4 3 .5 9 132
2 4 87.2 12.8 3 .63
KEY:
A - purified leucocidin o f Ps. aeruginosa planktonic cells (control)
B- purified leucocidin o f  Ps. aeruginosa biofilm cells (control)
C- purified leucocidin o f Ps. aeruginosa biofilm cells with sub-MIC o f ampicillin (8 pg m L'1)
D- purified leucocidin o f E.coli 10000 biofilm cells with sub-MIC o f  ampicillin (2 pg m L'1)
E- purified leucocidin o f  binary biofilm cells o f  Ps. aeruginosa  and E. coli with sub-MIC o f  
ampicillin (32 pg mL'1)
F- Untreated cells (Fibroblast cells with MTT). Final concentration o f cells was 4.4 x 106 cells per 
mL
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Iso la tion , id en tification  and assay o f  p rotease  activ ity  from  m on osp ec ies and  
b in ary  b io film s o f  Ps. aeruginosa A T C C  15692 (P A O l) and is. coli A T C C  10000
In v e s t ig a t io n s  o f  Ps. aeruginosa  b io f ilm s  in d ic a te  a n  in c re a s e  in  v iru le n c e  
p o te n tia l  o f  le u c o c id in  (v iru le n c e  d e te rm in a n t)  in  th e  p re se n c e  o f  s u b -M IC s  o f  
a n tib io tic s . I t  w a s  d e c id e d  to in v e s tig a te  w h e th e r  th is  o b s e rv a tio n  w a s  tru e  fo r  o th e r  
v iru le n c e  fa c to rs  (p ro te a se s )  p ro d u c e d  b y  Ps. aeruginosa  b io f ilm s .
P ro te a s e s  a re  a s su m e d  to  p la y  a  m a jo r  ro le  d u rin g  a c u te  in fe c t io n s . P u lm o n a ry  
h a e m o rrh a g e s , w h ic h  o c c u r  d u rin g  in v a s iv e  in fe c t io n  o f  Pseudom onas aeruginosa, 
h a v e  b e e n  tra d it io n a lly  a ttr ib u te d  to  h y p e ra c tiv ity  o f  its  p ro te a s e s  (V a n  D e ld e n  a n d  
Ig le w sk i, 19 9 8 ). T h e  h u m a n  lu n g  tis su e  is  c o m p o se d  o f  e la s t in  th a t  h e lp s  i t  e x p a n d  
a n d  c o n tra c t. E la s tin  is  a lso  re sp o n s ib le  fo r  th e  re s i l ie n c e  o f  b lo o d  v e s s e ls .  T h e  
sy n e rg is tic  e la s to ly tic  a c tiv ity  o f  tw o  Pseudom onas  p ro te a s e s , L a s  A  a n d  L a s  B , 
d e g ra d e s  e la s t in  a n d  is  re sp o n s ib le  fo r  th e  g ra d u a l d e s tru c tio n  o f  lu n g  e p i th e l ia  in  
c y s tic  f ib ro s is  p a tie n ts  (G a llo w ay , 19 91 ). L a s  B  e la s ta se  a lso  d e g ra d e s  f ib r in  a n d  
c o lla g e n  (H e c k  et al., 1986). T h e  in v o lv e m e n t o f  a lk a lin e  p ro te a s e  p ro d u c e d  b y  
P seudom onas  in  c o m e a l in fe c tio n s  is  sa id  to  b e  s u b s ta n tia l (V a n  D e ld e n  a n d  Ig le w s k i,
1998).
E x p e r im e n ta l a p p ro a c h
P re v io u s ly  it h a s  b e e n  o b se rv e d  th a t  p ro te a se s  in te r fe re  w ith  th e  p u r i f ic a t io n  
o f  le u c o c id in s  as  th e y  c o -p re c ip ita te  in  2 0 %  a m m o n iu m  s u lp h a te  a n d  h a v e  s im ila r  
m o le c u la r  w e ig h ts  (S ch a rm a n n , 1 9 76 b ). A c c o rd in g ly , f ra c tio n s  o b ta in e d  n e a r  to  th o se  
o f  le u c o c id in  w e re  p ro b e d  fo r  p ro te a s e s  u s in g  z y m o g ra p h y . Z y m o g ra p h y  is a n  
e le c tro p h o re tic  m e th o d  fo r  m e a s u r in g  p ro te o ly tic  a c tiv ity . I t  is  b a s e d  o n  so d iu m  
d o d e c y l su lp h a te  ge l im p re g n a te d  w ith  a  p ro te in  su b s tra te  (u su a lly  c a s e in ) , w h ic h  is  
d e g ra d e d  b y  th e  p ro te a se s  d u rin g  th e  in c u b a tio n  p e r io d  (L e b e r  &  B a lk w ill ,  1 9 9 7 ). T h e
176
p ro te a s e  a c tiv ity  o n  th e  ge l is  v is u a lis e d  as  a  z o n e  o f  c le a ra n c e . B a c k g ro u n d  
C o o m a ss ie  b lu e  s ta in in g  re v e a ls  s ite s  o f  p ro te o ly s is  a s  w h ite  b a n d s  o n  a  d a rk  b lu e  
b a c k g ro u n d . T h e  b a n d  in te n s ity  c a n  b e  l in e a r ly  re la te d  to  th e  a m o u n t o f  p ro te a s e  
lo a d e d  (T h a n g a m  &  R a jk u m a r , 2 0 0 2 ).
O n c e  sa m p le s  c o n ta in in g  p ro te a s e s  w e re  id e n tif ie d , th e ir  a c tiv it ie s  w e re  
d e te rm in e d  b y  a z o c a se in  a ssay . A z o c a s e in  is  a  c h e m ic a lly  m o d if ie d  p ro te in  c o m p o s e d  
o f  c a s e in  (a  m ilk  p ro te in )  to  w h ic h  a n  o ra n g e  su lp h a n ila m id e  g ro u p  h a s  b e e n  a tta c h e d . 
P ro te o ly s is  re le a se s  th e  s u lp h a n ila m id e  g ro u p  re su lt in g  in  a n  o ra n g e -re d  c o lo u r  
(C h a n ta w a n n a k u l, et a l  2 0 0 2 ; T o m a re ll i , et al. 19 49 ). T h e  in te n s i ty  o f  th e  c o lo u r  is  
d ire c t ly  p ro p o r tio n a l to  th e  a c tiv ity  o f  p ro te a s e s  (C h a n ta w a n n a k u l , e t a l  2 0 0 2 ).
Zym ography assay  (L e b e r  &  B a lk w ill, 1997)
T h e  p ro te a se  p ro f ile s  w e re  v is u a lis e d  o n  n o n -d e n a tu r in g  10%  s e p a ra t in g  g e ls  
c o n ta in in g  0 .5  m g  m L '1 c a se in  a n d  4 %  s ta c k in g  g e l (d e sc rib e d  in  C h a p te r  2 ). S a m p le  
a liq u o ts  (1 0  to  2 0  p L )  w ere  lo a d e d  to  th e  w e lls  a n d  th e  g e l w a s  ru n  a t  35  m A  fo r  
a p p ro x im a te ly  1.5 h o u rs  o r  u n til th e  le a d in g  sa m p le s  h a d  re a c h e d  th e  e n d  o f  th e  gel. 
G e ls  w e re  so a k e d  fo r  1 h  in  2 .5 %  T r i to n  X -1 0 0  o n  a  sh a k e r  fo llo w e d  b y  tw o  b r ie f  
w a sh e s  in  c o lla g e n a se  b u ffe r  (5 0 m M  T ris-H C l (p H  7 .6 ) , 0 .2 M  N a C l, 5 m M  C a C b , 
0 .2 5  (v /v ) T r i to n  X -10 0  (K in g  et al, 1996) a n d  f in a lly  in c u b a te d  fo r  18 h  a t  37 °C  
w ith in  c o lla g e n a se  b u ffe r. P rio r  to  s ta in in g , g e ls  w e re  b r ie f ly  r in s e d  in  d is t i l le d  w a te r. 
T h e  g e ls  w e re  f ix e d  a n d  s ta in e d  in  C o o m a ss ie  b r i l l ia n t  b lu e  R -2 5 0  fo r  3 h  a n d  th e n  
d e s ta in e d  in  d e s ta in in g  so lu tio n  as  (d e sc rib e d  in  C h a p te r  2 )  u n til c le a r  r e g io n s  o f  
su b s tra te  d e g ra d a tio n  w e re  v isu a liz e d .
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A zocasein  assay  (C h a n ta w a n n a k u l, et al. 2 0 0 2 )
A n  a liq u o t (20  p L ) o f  th e  p ro te a s e s  w e re  in c u b a te d  a t 37 °C  in  a  m ix tu re  (4 0 0  
p L )  c o n ta in in g  2 %  a z o c a se in  (2 3 0  p L ) , a n d  0 .2  M  N - tr is  (h y d ro x y m e th y l)  m e th y l-2 -  
a m in o e th a n e su lfo n ic  a c id  (T E S ) b u f fe r  p H  7 .0  (1 5 0  p L )  fo r  2  h . In  o rd e r  to  te rm in a te  
th e  re a c tio n , 1.2 m L  o f  10%  tr ic h lo ro a c e tic  a c id  (T C A ) w a s  a d d e d . A ll  s a m p le s  w e re  
a llo w e d  to  s ta n d  fo r  15 m in  a n d  th e  su p e rn a ta n t (1 .4  m L ) w a s  c o l le c te d  a f te r  
c e n tr ifu g a tio n  (1 0 ,0 0 0 x g ; 5 m in ). A n  e q u iv a le n t v o lu m e  o f  1 M  N a O H  w a s  th e n  
a d d e d  a n d  th e  so lu tio n  w a s  m ix e d  th o ro u g h ly  p r io r  to  m e a s u r in g  th e  a b s o rb a n c e  a t 
4 4 0 n m  (B ro c k  et al, 1982).
P ro te a se  a c tiv ity  w a s  m e a s u re d  in  te rm s  o f  e n z y m e  u n its . O n e  u n i t  p ro te a s e  
a c tiv ity  c o rre sp o n d s  to  a  c h a n g e  in  a b so rb a n c e  (4 4 0 n m ) o f  0 .0 0 1  p e r  m in u te . T h e  
a m o u n t o f  a z o c a se in  c a p a b le  o f  b e in g  h y d ro ly se d  p e r  m in u te  p e r  u n i t  a c t iv i ty  o f  
p ro te a s e  w a s  p re v io u s ly  d e te rm in e d  to  b e  1.3 p g  (W o lz  a n d  B o n d , 19 9 5 ).
R e s u l t s  &  D is c u s s io n
E lu tio n  p ro f ile s  o f  a ll sa m p le s  in d ic a te d  a  p ro te in  p e a k  im m e d ia te ly  a f te r  
le u c o c id in . F ra c tio n s  c o rre sp o n d in g  to  th e  o b se rv e d  p e a k  (2 4 0  to  2 5 9 )  w e re  a n a ly s e d  
u s in g  z y m o g ra p h y  fo r  th e  p re s e n c e  o f  p ro te a se s . F ig u re  6 1 A  a n d  6 1 B  sh o w  
z y m o g ra m s  p ro d u c e d  fro m  p ro te a s e  f ra c tio n s  o f  p la n k to n ic  Ps. aeruginosa  P A O l 
c e lls . A lth o u g h  fra c tio n s  24 0  to  2 4 9  d id  n o t c o n ta in  a n y  p ro te a s e  (a s  a n a ly s e d  f ro m  
z y m o g ra m s , F ig u re  61 A ), z y m o g ra m s  c o n ta in in g  f ra c tio n s  2 5 0  to  2 5 9  (F ig u re  6 IB )  
sh o w e d  v e ry  g o o d  c le a ra n c e  b a n d s  in d ic a tiv e  o f  s tro n g  p ro te a s e s . A s  s im ila r  p e a k s  
w e re  v isu a lis e d  in  th e  e lu tio n  p ro f ile s  o f  a ll s a m p le s  c o r re sp o n d in g  to  f ra c t io n s  2 4 0  to  
2 6 0 , i t  w a s  a s su m e d  th a t  th e  p e a k s  c o r re sp o n d e d  to  p ro te a se s .
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Figure 61: Z ym ogram  analysis o f  protease fractions o f Ps. aeruginosa  P A O l p lanktonic cells. (A) 
Lanes 1 to 10 contain fractions 240 to 249 (F igure 41). (B) Lane 1 to 10 contains fractions 250 to 
259 (F igure 41). Arrows indicate clearance bands corresponding to proteases.
Fraction samples containing proteases were used for azocasein activity assays. 
The rationale behind conducting protease activity assays was to check for activity 
fluctuations similar to those observed for leucocidin. The results of the assay are 
tabulated below (Table 16).
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T a b le  16 : P ro te a se  a c tiv it ie s  o f  m o n o sp e c ie s  a n d  b in a ry  b io f ilm s  o f  Ps. aeruginosa  
A T C C  15 69 2  ( P A O l)  a n d  E. co li A T C C  10 00 0 , w e re  te s te d  w ith  a z o c a se in .
T e s t A b s o r b e n c y P r o te a s e U n its  p g '1 o f A z o c a s e in
s a m p le s (4 4 0 n m ) a c t iv i ty p r o t e a s e p g  m L '1 m i n '1
p r o t e a s e (E U )
A 0 .6 8 2 14 .22 0 .0 7 0 0 .0 9 1
B . 0 .7 7 5 16 .14 0 .0 6 0 0 .0 7 8
C 1 .424 2 9 .6 6 0 .1 3 0 0 .1 6 9
D 0 .3 5 5 7 .4 0 0 .0 4 5 0 .0 5 8
E 0 .913 19 .02 0 .1 3 0 0 .1 6 9
KEY:
A - Proteases o f  Ps. aeruginosa  planktonic cells (control)
B- Proteases o f  Ps. aeruginosa  biofilm cells
C- Proteases o f  Ps. aeruginosa  biofilm cells in presence o f sub-MIC o f  ampicillin (8 pg m L'1) 
D - Proteases o f  E. coli 10000 biofilm cells in presence o f  sub-MIC o f  ampicillin (2 pg m L'1) 
E- Proteases o f  binary biofilm cells o f  Ps. aeruginosa  and E. coli in presence o f  sub-MIC o f  
ampicillin (32 pg mL'1)
I t  m a y  b e  n o te d  th a t a c tiv ity  o f  p ro te a s e s  w e re  a n a ly s e d  f ro m  a l l  s a m p le s  (b o th  
c o n tro l a n d  a n tib io tic -  (a m p ic illin )  c h a l le n g e d  sa m p le s  o f  Ps. aeruginosa  a n d  E. co li 
b io f ilm s) . T h e  m o s t ac tiv e  p ro te a s e s  w e re  fo u n d  f ro m  m o n o s p e c ie s  a n d  b in a ry  
b io f ilm s  o f  Pseudom onas aeruginosa  tr e a te d  w ith  su b -M IC s  o f  a m p ic il l in . E. co li 
b io f ilm s  tre a te d  w ith  su b -M IC s  o f  a m p ic il l in  (2  p g  m L '1) s h o w e d  th e  le a s t  a c tiv ity . 
In te re s tin g ly , n o  sy n e rg is tic  p ro te a se  a c tiv ity  e ffe c ts  w e re  o b s e rv e d  in  b in a ry  b io f i lm s  
tre a te d  w ith  a m p ic illin . P la n k to n ic  c e lls  o f  Pseudom onas aeruginosa  p ro d u c e d  
p ro te a se s  th a t w e re  m o re  a c tiv e  th a n  b io f ilm  ce lls . T h is  m a y  b e  e x p e c te d  as  c e lls  
w ith in  b io f ilm s  a re  sa id  to  b e  in  a  d o rm a n t s ta g e  a n d  h e n c e , m a y  n o t  p ro d u c e  a c tiv e  
p ro te a se s . H o w e v e r , f ro m  th e  re su lts , w e  m a y  c o n c lu d e  th a t th e  a c tiv ity  o f  p ro te a s e s  
s ig n if ic a n tly  in c re a se s  in  th e  p re se n c e  o f  su b -M IC s  o f  a m p ic ill in .
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C onclusion
T h e  c o n c e p t th a t  v iru le n c e  fa c to rs  a re  m ic ro b ia l  c h a ra c te r is t ic s  th a t  d e te rm in e  
th e  c a p a c ity  fo r  c a u s in g  d ise a se  (p a th o g e n e s is )  h a s  le d  to  th e  in v e s t ig a t io n  a n d  
id e n tif ic a tio n  o f  m ic ro b ia l tra its  th a t e f fe c t a n d  m e d ia te  v iru le n c e  (C a s a d e v a ll  &  
P iro fsk i, 2 0 0 1 ). A c c o rd in g ly , b a c te r ia l L P S  p a t te rn  c h a n g e s  m a y  b e  c la s s i f ie d  a s  
‘m ediators o f  v iru len ce’ (ch an g es  in  th e  L P S  p re s e n t  w ith in  th e  o u te r  b a c te r ia l  
e n v e lo p e  m a y  in d ire c tly  re su lt  in  e v a s io n  o f  b a c te r ia  f ro m  h o s t im m u n e  sy s te m ) , a n d  
p ro te a s e s  a n d  c y to to x in s  ( le u c o c id in s )  m a y  b e  d e n o te d  ‘effectors o f  v iru len ce ’ 
(p ro te a se s  a n d  c y to to x in s  are  c a p a b le  o f  d ire c t ly  d e s tro y in g  o r  d a m a g in g  h o s t  ce ll 
ta rg e ts ) .
T h e  re su lts  p re se n te d  in  th is  c h a p te r  in d ic a te  s ig n if ic a n t r e a r ra n g e m e n t o f  L P S  
s tru c tu re  o f  b io f ilm  ce lls  o f  Pseudom onas aeruginosa  in  th e  p re s e n c e  o f  a n t ib io t ic s  
(a m p ic il lin ) . T h is  w a s  a c c o m p a n ie d  b y  a n  in c re a se  in  a n tib io t ic  r e s is ta n c e  (T a b le  6; 
C h a p te r  3). S u c h  in c re a se s  in  re s is ta n c e  w ill e n a b le  th e  b a c te r ia  to  s u rv iv e  in  a n  
a n tib io tic  c o n ta in in g  e n v iro n m e n t a n d  m a y  b e  an  in d ic a to r  o f  in c re a s e  in  o v e ra ll 
v iru le n c e  p o te n tia l  o f  th e  o rg an ism . S im ila r  in c re a se s  in  v iru le n c e  w e re  o b s e rv e d  fo r  
le u c o c id in  a n d  p ro te a se s  p ro d u c e d  b y  th e  b io f ilm  c e lls . W h ile  th e  a c t iv i ty  o f  
le u c o c id in  w a s  o b se rv e d  to in c re a se  b y  a t  le a s t 5 0 % , p ro te a s e  a c tiv ity  in c re a s e d  
10 0 % , in  th e  p re s e n c e  o f  sub -M IC  a n tib io tic s  (a m p ic il lin ) . T h e  in c re a s e  in  v iru le n c e  
a c tiv ity  o f  b io f ilm  p h e n o ty p e s  re p o r te d  h e re in  h a s  n o t b e e n  p re v io u s ly  p re d ic te d  o r  
e v e n  e x p e c te d , a s  b io f ilm  c e lls  a re  sa id  to  h a v e  a  c h ro n ic  in fe c t io n  p h e n o ty p e , 
in d ic a tin g  lo n g -te rm  in fe c tio n  c h a ra c te r is e d  b y  lo w  le v e ls  o f  p a th o g e n ic i ty  (F u x  e t al., 
2 0 0 5 ).
M o d e ra te ly  v iru le n t m ic ro o rg a n ism s  p ro d u c in g  c lin ic a l sy m p to m s  a re  m o re  
f re q u e n tly  tre a te d  w ith  a n tib io tic s  th a n  n o n -v iru le n t o n e s  (M a rt in e z  a n d  B a q u e ro ,
2 0 0 2 ). S e le c tiv e  a n tib io tic  p re s su re  a g a in s t  th e se  in te rm e d ia te ly  v iru le n t  fo rm s  m a y
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r e s u lt  in  e ith e r  d e c re a se  in  p a th o g e n ic ity  (su b -v iru le n t fo rm s)  o v e r  s e v e ra l b a c te r ia l  
c e ll d iv is io n s , o r  in c re a se  in  p a th o g e n ic ity  (h y p e r-v iru le n t fo rm s), in  th e  f irs t  in s ta n c e  
b e c a u s e  th e y  a re  n o t  a lw a y s  d e te c te d  a n d  th u s  n o t  a lw a y s  tre a te d , a n d  in  th e  se c o n d , 
b e c a u s e  th e  h o s t  d ie s  w ith o u t g iv in g  th e m  e n o u g h  tim e  to  b e  in  c o n ta c t w i th  in h ib ito ry  
c o n c e n tra t io n s  o f  a n tib io tic s  (M a rt in e z  a n d  B a q u e ro , 2 0 0 2 ). T h e  re su lts  o b ta in e d  in  
th e  p re s e n t  w o rk  su g g e s t th e  la t te r  p o s s ib i l i ty , w h e re in  b io f ilm s  p r e s e n t  in  s u b M IC  
a n tib io t ic  e n v iro n m e n ts  in c re a se  th e ir  v iru le n c e , p o s s ib ly  to  e sc a p e  th e  se le c t iv e  
p re s s u re  a n d  in h ib ito ry  e ffe c ts  o f  a n tib io tic s .
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C h a p te r  S ix : G e n e r a l D isc u ss io n
In d iv id u a ls  w h o se  n a tu ra l d e fe n se s  a re  s e v e re ly  im p a ire d  a re  a t  a  r is k  o f  
c o n tra c tin g  o p p o rtu n is tic  in fe c tio n s  (M a rie  et al., 2 0 0 5 ). W h ile  it  w a s  th e  n o rm a l 
m ic ro f lo ra  a s so c ia te d  w ith  th e  h u m a n  b o d y  th a t w a s  re sp o n s ib le  fo r  o p p o r tu n is tic  
in fe c t io n s  in  th e  p re a n tib io tic  e ra , m o re  re c e n tly , e n v iro n m e n ta l p a th o g e n s  h a v e  b e e n  
o b s e rv e d  to  p la y  a  m a jo r  ro le  in  c a u s in g  in fe c tio n s  (M a rt in e z  a n d  B a q u e ro , 2 0 0 2 ). 
T h e  re a s o n  fo r  su c h  a  tra n s itio n  h a s  b e e n  h y p o th e s is e d  to  b e  d u e  to  th e  ex ce ss iv e  u se  
o f  a n t ib io t ic s  in  c lin ic a l se ttin g s  (D a n c e r , 2 0 0 4 ).
A n tib io tic s  e lim in a te  su sc e p tib le  h u m a n  m ic ro f lo ra , p r e v e n t  in fe c t io n s  a n d  
th u s , a c t  a s  a  ‘se c o n d  lin e  o f  d e fe n s e ’ w h e n  th e  b o d y ’s n a tu ra l  im m u n e  r e sp o n s e  is  
lo w . H o w e v e r , e n v iro n m e n ta l m ic ro o rg a n ism s  w ith  a n  in h e re n tly  h ig h  le v e l o f  
r e s is ta n c e  a re  c a p a b le  o f  e ff ic ie n tly  ta c k lin g  a n tib io tic s  ( th e  s e c o n d  lin e  o f  d e fe n se )  
a n d  m a y  c o n v e r t in to  h u m a n  p a th o g e n s , e s p e c ia lly  in  th e  c a s e  o f  a n  
im m u n o c o m p ro m ise d  p a tie n t (Q u in n , 19 98 ). P e rh a p s  i t  is  th is  a b i l i ty  o f  
e n v iro n m e n ta l p a th o g e n s  (h a v in g  n o  p a th o g e n ic  d e te rm in a n ts  to  ta c k le  h u m a n  
im m u n e  re sp o n se s , sav e  a n tib io tic  to le ra n c e )  th a t  a llo w s  th e m  to  in fe c t  th e  
im m u n o c o m p ro m ise d  h o s t (M a rt in e z  a n d  B a q u e ro , 2 0 0 2 ). F o r  in s ta n c e , th e  
o p p o rtu n is tic  h u m a n  p a th o g e n  P seudom onas aeruginosa  is  u b iq u ito u s  in  n a tu re  a n d  is  
n o t  a b le  to  c a u se  in fe c tio n  in  a  h u m a n  h o s t  u n le s s  th e  im m u n e  s y s te m  is  im p a ire d . I t  
is  th is  in h e re n t re s is ta n c e  to w a rd s  a n tib io tic s  o ffe re d  b y  Ps. aeruginosa  ( b y  v ir tu e  o f  
its  la rg e  g e n o m e  a n d  re p e r to ire  o f  a n tib io tic  r e s is ta n t g e n e s  a c c u m u la te d  in  
e v o lu tio n a ry  tim e ) th a t e n a b le s  th e  b a c te r iu m  to  p e rs is t  in  th e  im m o u n o c o m p ro m is e d  
h o s t  d u rin g  a n tib io tic  tre a tm e n t (M a rt in e z  a n d  B a q u e ro , 2 0 0 2 ).
In  re c e n t y e a rs , th e  r e p la c e m e n t o f  tra d itio n a l o p p o rtu n is tic  p a th o g e n s  w ith  
m o re  re s is ta n t o n es  h a s  b e e n  o b se rv e d . S u sc e p tib ili ty  ra te s  h a v e  s te a d ily  b e e n  sh o w n  
to  d e c re a se  o v e r  tim e , a n d  th is  tr e n d  h a s  b e e n  a ttr ib u te d  to  s e le c t iv e  a n tib io t ic
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p re s s u re s  re su lt in g  in  b a c te r ia l a d a p ta t io n  w ith in  th e  h u m a n  b o d y  (V a n  E ld e re , 2 0 0 3 ; 
H e n w o o d  e t a l., 2 0 0 1 ). In d e e d  f ro m  a  b a c te r ia l s ta n d p o in t, th e  a c q u is it io n  o f  
re s is ta n c e  to  a n tib io tic s  m u s t b e  a  fa ir ly  s im p le  p ro c e s s  w h e n  c o n s id e r in g  th e  
tre m e n d o u s  a n tib io tic  s tre ss  b a c te r ia l  p a th o g e n s  u n d e rg o  (b a c te r ia  a s s o c ia te d  w ith  
h u m a n s  u n d e r ta k in g  a n tib io tic  c h e m o th e ra p y  h a v e  e n c o u n te re d  a t  le a s t  1 0 11 
m o le c u le s  o f  a n tib io tic ) , th e  in c re d ib le  b io c h e m ic a l v e rs a ti l i ty  th e y  p o s s e s s  ( th e y  are  
c a p a b le  o f  liv in g  in  a  w id e  ra n g e  o f  p H  a n d  te m p e ra tu re s )  a n d  th e  k in d  o f  l i fe  s ty le  
th e y  lead , w h e re in  th e y  h a v e  f re q u e n t e x c h a n g e s  o f  g e n e tic  m a te r ia l  in c lu d in g  
a n tib io tic  re s is ta n c e  g en es  (H a m ilto n -M ille r , 2 0 0 4 ).
Is the p ro c e ss  o f  acqu ired  resistance to an tib io tics reversib le?
W h ile  i t  is  tru e  th a t a c q u ire d  re s is ta n c e  to  a n tib io t ic s  r e s u lts  f ro m  th e ir  
e x c e ss iv e  u se , th e  q u e s tio n  re m a in s  as  to  th e  p o s s ib i l i ty  o f  th e se  r e s is ta n t  s tra in s  
re v e r tin g  to  th e ir  su sc e p tib le  fo rm s . S e v e ra l s tu d ie s  h a v e  in d ic a te d  a  b io lo g ic a l f itn e ss  
c o s t  e n d u re d  b y  th e  b a c te r iu m  th a t a c c e p ts  re s is ta n c e  p la s m id s  o r  m u ta tio n s  re su lt in g  
in  a n tib io t ic  re s is ta n c e  (B jo rk m a n  &  A n d e rs so n , 2 0 0 0 ; A n d e rs s o n  &  L e v in , 1999 ). 
T h u s , th e o re tic a lly  i f  th e  u se  o f  th e  a n tib io tic  is  w ith d ra w n , th e  s u s c e p tib le  fo rm s  o f  
th e  b a c te r ia  sh o u ld  o u tg ro w  th e  re s is ta n t fo rm s  an d  th e  p ro c e s s  m a y  b e  re v e rs ib le  
(A n d e rs so n , 2 0 0 3 ). H o w e v e r, th is  is  n o t  th e  c a se  in  re a l i ty  a s  m u ta t io n s  in  th e  
re s is ta n t  s tra in  c o m p e n sa te  th e ir  la c k  o f  b io lo g ic a l f itn e s s , m a k in g  th e  a c q u is it io n  o f  
re s is ta n c e  in  b a c te r ia  a n  ir re v e rs ib le  p ro c e s s  (K u g e lb e rg  et al., 2 0 0 5 ) . T h e  p ra c tic a l  
im p lic a tio n s  o f  a n tib io tic  re s is ta n c e , a s  n o te d  a b o v e , fo rm  th e  b a s is  o f  th e  p re s e n t  
in v e s tig a t io n  c o n d u c te d  a n d  th e  in te rp re ta tio n s  p re s e n te d  w ith in  th is  se c tio n .
T h e  p r im a ry  a im  o f  th is  th e s is  is  to  u n d e rs ta n d  th e  e f fe c t o f  su b -m in im a l 
in h ib ito ry  c o n c e n tra tio n s  (su b -M IC s) o f  se le c te d  a n tib io tic s  (a m p ic il l in , n a l id ix ic  a c id  
a n d  s tre p to m y c in )  o n  Pseudom onas aeruginosa  b io f ilm s  (b o th  m o n o s p e c ie s  a n d
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b in a ry  b io f ilm s) . T h e  e ffe c ts  w e re  a n a ly se d  w ith  r e s p e c t  to  p ro te in  p ro f ile  p a t te rn  
c h a n g e s  a n d  a c tiv ity  d iffe re n c e s  in  o u te r  m e m b ra n e  p ro te in s  a n d  v iru le n c e  fa c to rs ; 
l ip o p o ly sa c c h a r id e  (L P S ) , c y to to x in s  ( le u c o c id in )  a n d  p ro te a s e s  re sp e c tiv e ly .
C lin ical im portance o f  sub-m inim al in h ib itory  con cen tration s (su b -M IC s) o f  
antib iotics
S u b -m in im a l in h ib ito ry  c o n c e n tra tio n s  (su b -M IC s)  o f  a n t ib io t ic s  h a v e  m u c h  
p ra c tic a l  im p lic a t io n  in  a  c lin ic a l se ttin g . A n tib io tic s  c re a te  c o n c e n tra t io n  g ra d ie n ts  
w ith in  th e  h u m a n  b o d y  d u rin g  c h e m o th e ra p y  (B a q u e ro , 2 0 0 1 ). S u c h  c o n c e n tra t io n  
g ra d ie n ts  a r is e  la rg e ly  d u e  to  p h a rm a c o k in e tic  fa c to rs  su c h  a s  d if fe re n t  d i f fu s io n  ra te s  
in to  v a r io u s  t is su e s , m e ta b o lism , lo c a l in a c tiv a tio n  o r  d if fe re n c e s  in  th e  e lim in a tio n  
ra te s  fro m  v a r io u s  b o d y  s ite s . H e n c e , in h ib ito ry  c o n c e n tra t io n s  o f  a n t ib io t ic s  m a y  n o t  
r e a c h  ta rg e t b a c te r ia l p a th o g e n s  in  in fe c t io n  s ite s . R a th e r , m o s t  b a c te r ia  a re  in  c o n ta c t 
w i th  su b -M IC s  o f  a n tib io tic s  (B a q u e ro , 2 0 0 1 ). A lth o u g h  i t  is  n o w  k n o w n  th a t  b a c te r ia  
in  th e ir  p la n k to n ic  s ta te  a re  o f te n  v u ln e ra b le  to  c h a n g e s  e lic ite d  b y  s u b -M IC s  o f  
a n tib io tic s , th e re  a re  n o  cu rre n t s tu d ie s  in d ic a tin g  th e  e f fe c ts  o f  s u b -M IC s  o f  
a n tib io tic s  o n  th e  v iru le n c e  o f  b a c te r ia  in  th e  b io f ilm  s ta te . T h e  p re s e n t  s tu d y  o f  Ps. 
aeruginosa  b io f ilm s  in  p re se n c e  o f  su b -M IC s  o f  a n t ib io t ic s , a s s u m e s  c r itic a l 
im p o rta n c e  in  th e  lig h t o f  th e  fa c t th a t  P seudom onas  in fe c t io n s  a re  o f te n  fo u n d  in  th e  
fo rm  o f  b io f ilm s .
B acteria l outer m em brane protein  sh ifts m ay b e in volved  in  an tib io tic  resistan ce
D e te rm in a tio n  o f  M IC s  o f  s e le c te d  a n tib io tic s  (a m p ic il lin , n a l id ix ic  a c id  a n d  
s tre p to m y c in )  in  th e  p la n k to n ic  s ta te  a n d  b io f ilm  s ta te s  o f  Pseudom onas aeruginosa  
sh o w e d  s ig n if ic a n t d iffe re n c e s  (F ig u re  16; T a b le  6). M IC  le v e ls  e x h ib ite d  w e re  7 -fo ld  
h ig h e r  in  b io f ilm  c e lls  tre a te d  w ith  a n tib io tic s  c o m p a re d  to  th e ir  p la n k to n ic
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c o u n te rp a r ts  (T a b le  6). C e lls  th a t  d e tach  f ro m  th e  b io f ilm s  (e lu a te  c e lls )  h a d  a n  o v e ra ll 
le s s e r  M IC  w h e n  c o m p a re d  to  b io f ilm  M IC s  (T a b le  6). H o w e v e r , th e  e lu a te  M IC s  
w e re  m u c h  g re a te r  th a n  th o se  o f  th e  c o r re sp o n d in g  p la n k to n ic  fo rm s . T h is  m a y  b e  
b e c a u s e  th e  d e ta c h e d  c e lls  a re  u n d e rg o in g  p h y s io lo g ic a l r e v e r s io n  to  th e  p la n k to n ic  
s ta te . A lth o u g h  so m e  li te ra tu re  a sc r ib e s  m u ltic e l lu la r i ty  a s  th e  ro o t  c a u s e  o f  b io f i lm  
re s is ta n c e  (K ra so v e c  &  Je rm a n , 2 0 0 3 ), th e  e v id e n c e  s u g g e s te d  in  th is  th e s is  in d ic a te s  
so m e  fo rm  o f  in h e re n t c e llu la r  m e c h a n ism , th u s , m a k in g  r e s is ta n c e  m o re  
in d iv id u a lis tic . I t  is  h y p o th e s is e d  th a t  th e  c e llu la r  r e s is ta n c e  o b s e rv e d  is  d u e  to  
c h a n g e s  in  th e  o u te r  m e m b ra n e  p ro te in s  (F ig u re  62).
In  F ig u re  62 , a  g e n e ra l u n d e rs ta n d in g  o f  th e  h y p o th e s is  (p ro p o s e d  a b o v e )  is 
il lu s tra te d . P la n k to n ic  c e lls  a p p ro a c h in g  a  su rfa c e  a d h e re  to  i t  a n d  f in a l ly  fo rm  a  
b io f ilm  (D a v e y  a n d  O ’T o o le , 2 0 0 0 ; S to o d le y  et al., 2 0 0 2 ) . B io f ilm  c e lls  d if fe r  
s ig n if ic a n tly  in  th e ir  p h y s io lo g ie s  to  p la n k to n ic  ce lls  (B e lo in  a n d  G h ig o , 2 0 0 5 ) . M a n y  
o f  th e ir  o u te r  m e m b ra n e  p ro te in s  m a y  b e  s ig n if ic a n tly  d if fe re n t f ro m  th o s e  p r e s e n t  in  
th e ir  p la n k to n ic  s ta te  (lan es  2  a n d  3 , F ig u re  2 0 ; C h a p te r  4 ). H o w e v e r , w h e n  th e s e  
b io f ilm  c e lls  e n c o u n te r  a n tib io tic s , th e y  fu r th e r  a lte r  th e  e x p re s s io n  o f  th e ir  o u te r  
m e m b ra n e  p ro te in s  so  a s  to  u l t im a te ly  p re v e n t  in tra c e llu la r  a c c u m u la tio n  o f  le th a l 
le v e ls  o f  a n tib io tic s  (c o m p a re  la n e  3 to  la n e s  4 , 5 a n d  6, F ig u re  2 0 ; C h a p te r  4 ). 
B io f ilm  c e ll c lu s te rs  th a t d e ta c h  f ro m  b io f ilm s  (e lu a te  c e lls )  m a y  re v e r t  to  th e ir  
p la n k to n ic  fo rm s  (H o ib y , 2 0 0 1 ). H o w e v e r , th e y  m a y  re ta in  o u te r -m e m b ra n e  p ro te in s  
th a t  m a y  b e  re la te d  to  th e  a n tib io tic  r e s is ta n t p h e n o ty p e  (c o m p a re  T a b le  8 (p a r t  2 )  to  
T a b le  9 (p a r t 2  a n d  3); C h a p te r  4 ) ( s ig n if ic a n tly  h ig h e r  M IC  v a lu e s  o f  e lu a te  c e lls  to  
th o se  o f  p la n k to n ic  fo rm s , a lso  su p p o rt th is  su g g e s tio n ) . T h e  h y p o th e s is  (F ig u re  6 2 ) 
a b o v e  a s su m e s  c r itic a l im p o rta n c e  in  l ig h t o f  th e  fa c t th a t  o u te r  m e m b ra n e  p ro te in s  
(O M P s)  p re s e n t  w ith in  the  o u te r  e n v e lo p e  o f  b a c te r ia  p la y  im p o r ta n t ro le s  in  
e x c lu d in g  h a rm fu l m o le c u le s  f ro m  th e  c e ll (A b d e l M a le k  et a l ., 2 0 0 2 ) . M a n y
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antimicrobial agents enter the cell through OMPs. Over-expression or loss of certain 
OMPs may lead to an increase in resistance towards antimicrobials (Winder et al., 
2000).
Key:
( ^ 3 )  -  P lanktonic cell phenotype
( C 3 l )  -  Eluate cell phenotype with altered outer m em brane proteins (in response to antibiotics) 
(1... I ) -  Biofilm  cell phenotype
m  ) -  Biofilm  cell phenotype with altered outer m em brane proteins (in response to antibiotics) 
( ) - A ntibiotic molecules
(,«s£2) -  B iofilm  matrix
Figure 62: A lteration o f biofilm  and eluate cell outer m em brane proteins in the presence o f  
antibiotics (am picillin, nalidixic acid and streptom ycin). The presence o f antib iotic m olecules in 
and around biofilm s alters bacterial surface m em brane proteins. A lteration happens in a subset 
o f the outer m em brane proteins in the biofdm  and eluate cell phenotypes. W hile m ost o f  the 
proteins altered (appearance o f  novei proteins or d isappearance o f  proteins) may not have a 
direct relationship to antibiotic resistance (i.e. som e outer m em brane proteins may result from  
presence o f antibiotics, but may not be responsible for the resistance phenotype exhibited by the 
cell), there may be a subset o f altered proteins that may be responsible for antibiotic resistance. 
This subset o f  resistance-related proteins m ight be sim ilar for biofilm  and eluate cell phenotypes 
due to strong sim ilarities in their cell physiologies.
In order to identify proteins that may be involved in resistance, SDS-PAGE 
and 2D-PAGE analysis of outer membrane proteins was performed. The approach
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in v o lv e d  in v e s tig a t in g  o u te r  m e m b ra n e  p ro te in  p ro f ile s  o f  Ps. aeruginosa  in  tw o  
s ta te s , b io f ilm  a n d  e lu a te . A s th e  re s is ta n c e  sh o w n  b y  th e  e lu a te  fo rm s  (a d ju d g e d  b y  
M IC s )  w e re  m u c h  c lo se r  to  th a t o f  th e  b io f ilm  s ta te  c e lls , i t  w a s  s u g g e s te d  th a t  th e  
p h y s io lo g y  a n d  th e  m e c h a n ism  o f  re s is ta n c e  in  th e se  tw o  s ta te s  m ig h t  a ls o  b e  s im ila r . 
T h u s , a  c o m p a riso n  o f  a n tib io tic  tr e a te d  a n d  c o n tro l s a m p le s  in  e a c h  o f  th e s e  s ta te s  
(b io f ilm  a n d  e lu a te )  w o u ld  re v e a l c a n d id a te  o u te r  m e m b ra n e  p ro te in s  re s p o n s ib le  fo r  
r e s is ta n c e  to w a rd s  a  se le c te d  a n tib io tic  a n d  a  c o m p a riso n  b e tw e e n  th e  c a n d id a te  
p ro te in s  d e r iv e d  f ro m  th e se  tw o  s ta te s  w o u ld  fu r th e r  se le c t c o m m o n  p ro te in s  th a t  m a y  
b e  re sp o n s ib le  fo r  a n tib io tic  re s is ta n c e  to  s e le c te d  a n tib io tic s  in  th e s e  tw o  s ta te s . 
A c c o rd in g ly  a  3 8 .7  k D a  p ro te in , a p p a re n t in  c o n tro l c e lls  w a s  in a p p a re n t  in  th e  
p re s e n c e  o f  n a lid ix ic  a c id  tre a tm e n t o f  b io f ilm s  a n d  e lu a te  c e lls . F u r th e rm o re , th e  
p re s e n c e  o f  th is  p ro te in  in  c o n tro l s a m p le s  o f  b o th  b io f ilm  a n d  e lu a te  c e lls  su g g e s ts  
th a t i t  m a y  p la y  a  m a jo r  ro le  in  th e  re s is ta n c e  e x h ib ite d  b y  Pseudom onas  b io f ilm  
in fe c tio n s . I t  is  to  b e  n o te d  th a t th e  a n tib io tic  tr e a tm e n t w a s  p e r fo rm e d  M I C /16 a n d  
th u s , th e  d is a p p e a ra n c e  o f  th e  3 8 .7  k D a  p ro te in  in  re sp o n s e  to  th e  p re s e n c e  o f  
n a l id ix ic  a c id  m a y  a c tu a lly  h a v e  c lin ic a l s ig n if ic a n c e .
C hanges in L P S structure contribute to antib iotic  resistan ce in Ps. aeruginosa
M o s t a n tib io tic s  u se d  fo r  tr e a tm e n t o f  P seudom onas  in fe c t io n s  h a v e  to  f irs t  
p e n e tra te  th e  o u te r  m e m b ra n e , c e ll w a ll a n d  in n e r  m e m b ra n e , in  o rd e r  to  r e a c h  th e ir  
ta rg e ts . T h e  in n a te  re s is ta n c e  e x h ib ite d  b y  P seudom onas aeruginosa  a g a in s t  
a n tib io tic s  h a s  b e e n  a ttr ib u te d  to  th e  lo w  p e rm e a b ili ty  o f  th e  c e ll e n v e lo p e  (H a u s e r  
a n d  S rira m , 2 0 0 5 ). L P S  is  a m a jo r  c o n s ti tu e n t o f  th e  G ra m -n e g a tiv e  o u te r  m e m b ra n e  
a n d  h e n c e , c h a n g e s  o b se rv e d  in  its  s tru c tu re  m a y  r e s u lt  in  h e ig h te n e d  a n tib io t ic  
p e rm e a b ili ty  b a rr ie rs .
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In  th e  p re s e n t  s tu d y , h ig h  m o le c u la r  w e ig h t L P S  b a n d in g  p a t te rn s  w e re  s e e n  to  
d if fe r  in  b in a ry  a n d  m o n o sp e c ie s  Pseudom onas aeruginosa  b io f ilm s  (F ig u re  35  a n d  
F ig u re  39 ). H ig h  m o le c u la r  w e ig h t L P S  b a n d s  h a v e  g e n e ra l ly  b e e n  a t t r ib u te d  to  th e  O 
c h a in  o f  th e  L P S  s tru c tu re . D isa p p e a ra n c e  o f  th e se  b a n d s  in  th e  su b -M IC  a n tib io t ic  
t re a te d  s a m p le s  in d ic a te s  a p h e n o ty p ic  sw itc h  f ro m  th e  m o re  v iru le n t  S -fo rm  
(re sp o n s ib le  fo r  a c u te  in fe c tio n s)  to  th e  le s s  v iru le n t R -fo rm  ( in v o lv e d  in  c h ro n ic  
in fe c tio n s ) . T h u s , i t  m a y  b e  th a t  th e  b io f ilm  b a c te r ia  a re  g e a r in g  u p  fo r  a  c h ro n ic  
in fe c t io n  li fe s ty le  w h e n  e x p o se d  to  su b -M IC s  o f  a n tib io tic s .
I t  h a s  b e e n  p re v io u s ly  re p o r te d  th a t  o u te r  m e m b ra n e  p h o s p h o l ip id  c o n te n t 
in c re a se s  in  p a ra lle l  w ith  the  sw itc h  f ro m  th e  S to  th e  R  fo rm  (G iw e rc m a n  e t al., 
19 92). A  d o w n  re g u la tio n  o f  th e  h ig h  m o le c u la r  w e ig h t f ra c tio n  o f  th e  L P S  (O  c h a in )  
w ill th u s  r e s u lt  in  a n  in c re a se  in  th e  ra tio  o f  c o re  L ip id  A  c o n te n t to  O  a n tig e n . T h u s , 
th e  b a c te r ia l  o u te r  m e m b ra n e  b e c o m e s  m o re  h y d ro p h o b ic . H y d ro p h il ic  a n t ib io t ic  
m o le c u le s  w ill  a s  a  re su lt  f in d  i t  m o re  d if f ic u lt  to  p e n e tra te  th e  h y d ro p h o b ic  o u te r  
m e m b ra n e . B e s id e s  th is  g e n e ra l o u te r  m e m b ra n e -re p e llin g  a c tio n , th e  in c re a s e  in  th e  
h y d ro p h o b ic i ty  o f  th e  o u te r  m e m b ra n e  m a y  a lso  c a u se  m o d e ra te ly  h y d ro p h o b ic  
p ro te in s , lik e  p - la c ta m a se s , to  escap e  in to  th e  o u te r  m ilie u  (G iw e rc m a n  et a l ., 1992 ). 
S u c h  a  le a k a g e  m a y  re su lt  in  n e u tra lis a t io n  o f  a n tib io tic s  b e fo re  th e y  h a v e  a  c h a n c e  to  
in te ra c t w i th  th e  b a c te r ia l ce ll.
V iru le n c e  h a s  b e e n  d e f in e d  a s  th e  re la tiv e  c a p a c ity  o f  a  m ic ro b e  to  c a u s e  
d a m a g e  in  a  h o s t (C a sa d e v a ll &  P iro fsk i, 2 0 0 0 ). W h ile  m e c h a n is m s  o f  a n t ib io t ic  
re s is ta n c e  h e lp  b a c te r ia  to  a d a p t to  a n  a n tib io tic -c o n ta in in g  e n v iro n m e n t, v i ru le n c e  
m e c h a n is m s  h e lp  th e  b a c te ria  to  e v a d e  o r  re s is t  th e  h o s t  im m u n e  sy s te m . T h u s , i t  m a y  
b e  a s su m e d  th a t b o th  an tib io tic  re s is ta n c e  and  v iru le n c e  a re  s im ila r  a d a p tiv e  
m e c h a n ism s  in d u c e d  in  o rd e r  to  su rv iv e  s tre s s  (e ith e r  h o s t  in v a s io n  o r  a n t ib io t ic  
tre a tm e n t)  (M a rtin e z  &  B aq u e ro , 2 0 0 2 ).
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T h e re  e x is t  m a n y  e x a m p le s  w h e re  b a c te r ia l  v iru le n c e  a n d  a n tib io t ic  r e s is ta n c e  
d e te rm in a n ts  c o n tr ib u te  to  in vivo  in fe c t iv e  v e rsa ti l i ty  o f  th e  b a c te r iu m . F o r  in s ta n c e , 
v iru le n c e  d e te rm in a n ts  o f  the  p a th o g e n  Legionella  pneum ophilla  a l lo w  i t  to  tra v e l 
in tra c e llu la r ly  f ro m  o n e  c e ll to  a n o th e r  w ith o u t m u c h  p o te n tia l  a n tib io tic  c o n ta c t . T h e  
p o o r  p e rm e a b ili ty  o ffe re d  b y  m a m m a lia n  c e lls  a g a in s t  v a r io u s  fa m ilie s  o f  a n t ib io t ic s , 
a llo w s  th is  p a th o g e n  to  e sc a p e  d e tr im e n ta l e f fe c ts  o f  a n t ib io t ic s  (B a rk e r  e t a l., 19 95 ). 
A g a in  m u ltid ru g  re s is ta n c e  (M D R ) e f f lu x  p u m p s  p r im a r ily  u s e d  b y  b a c te r ia  to  
e x c lu d e  d if fe re n t a n tib io tic s  f ro m  b u ild in g  h ig h  c o n c e n tra tio n s  w ith in  th e  c e ll , h a s  
a lso  b e e n  re p o r te d  to  ex tru d e  b i le  sa lts , a l lo w in g  th e  p a th o g e n  to  c o lo n iz e  in te s tin a l 
tra c ts  (T h a n a s s i e t aL, 1997). T h u s , v iru le n c e  a n d  a n tib io t ic  re s is ta n c e  d e te rm in a n ts  
c o n tr ib u te  to  e a c h  o th e r ’s e ffec ts . A s  s u g g e s te d  ab o v e , e v o lu tio n a ry  a n d  e c o lo g ic a l 
lin k s  m a y  b e  e s ta b lish e d  b e tw e e n  b a c te r ia l v im le n c e  a n d  a n tib io t ic  re s is ta n c e . 
H o w e v e r , li tt le  is k n o w n  a b o u t th e  n a tu re  o f  b a c te r ia l  v iru le n c e  w h e n  c h a l le n g e d  w ith  
su b -M IC s  o f  a n tib io tic s , e sp e c ia lly  v iru le n c e  re sp o n se s  o f  b io f ilm  b a c te r ia .
In  a  r e c e n t in v e s tig a tio n , F o n s e c a  a n d  c o -w o rk e rs  (2 0 0 4 ) s h o w e d  th a t  su b - 
M IC  c o n c e n tra tio n s  o f  p ip e ra c il l in  /  ta z o b a c ta m  c o m b in a tio n  h a d  p ro fo u n d  n e g a tiv e  
im p a c t o n  v iru le n c e  p a ra m e te rs  o f  P seudom onas aeruginosa. T h e ir  r e s u lts  in d ic a te d  
s ig n if ic a n t d e c re a se  in  a d h e s io n  v a lu e s , b io f ilm  fo rm a tio n , f la g e l lu m  m e d ia te d  
sw im m in g  a n d  ty p e  IV  m e d ia te d  tw itc h in g  m o tili ty , a n d  le d  to  th e  c o n c lu s io n  th a t  
su b -M IC s  o f  p ip e ra c il l in  /  ta z o b a c ta m  c o u ld  in te rfe re  w ith  p a th o g e n ic  p o te n tia l  o f  
c lin ic a l iso la te s  o f  Pseudom onas aeruginosa. H o w e v e r , i t  m a y  b e  n o te d  th a t  th e ir  
in v e s tig a t io n  w a s  p e rfo rm e d  o n  p la n k to n ic  fo rm s  o f  P seudom onas, r a th e r  th a n  th e ir  
m o re  c o m m o n  c lin ic a l m a n ife s ta tio n s  as  b io f ilm s . T h e  p re s e n t  w o rk  o u t l in e d  in  th is  
th e s is  a s su m e s  c r itic a l im p o rta n c e , in  th a t  th e  s tu d ie s  w e re  c a r r ie d  o u t o n  m o n o s p e c ie s  
a n d  b in a ry  b io f ilm s  o f  Pseudom onas aeruginosa  a n d  E. coli.
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Are resistant organisms more or less virulent?
C u rre n t e v id e n c e  sho w s th a t  p la n k to n ic  b a c te r ia  m a y  b e  in h ib ite d  b y  sub - 
M IC s  o f  a n t ib io t ic s  (F o n se c a , et a l  2 0 0 4 ). S u c h  g ro w th  l im ita tio n  c a u s e s  a  d e c re a s e  in  
v iru le n c e . H o w e v e r , w h e n  b a c te r ia  b e c o m e  re s is ta n t  to  a n tib io tic s  (a s  in  th e  c a s e  o f  
b io f ilm  b a c te r ia  w h e n  e x p o se d  to  su b -M IC s  o f  a n t ib io t ic s ) , w ill  th e re  b e  a n y  
f lu c tu a tio n  in  v iru le n c e  p ro p e rtie s?
In  a  c lin ic a l se ttin g , p a tie n ts  s u f fe r in g  fro m  Pseudom onas  b a c te r ia l  in fe c tio n s  
m a y  b e  a d m in is te re d  a n tib io tic s . H o w e v e r , i f  th e  p a th o g e n ic  b a c te r ia  a re  r e s is ta n t  to  
th e  a n tib io t ic s  a p p lie d , c o m p e tin g  f lo ra  m a y  b e  e ra d ic a te d  re s u lt in g  in  th e  ra p id  
p ro l ife ra tio n  o f  a n tib io tic  re s is ta n t p h e n o ty p e s  (D a n c e r , 2 0 0 4 ). A l th o u g h  a n tib io tic  
a id e d  c o lo n iz a tio n  o f  m a m m a lia n  t is su e s  b y  re s is ta n t  b a c te r ia  m a y  b e  c la s s i f ie d  a s  a n  
in d ire c t in c re a se  in  v iru le n c e , r e s is ta n t b a c te r ia  m a y  a lso  e x h ib it  a  m o re  d ire c t 
in c re a se . In  th e  p re s e n t s tu d y  th re e  v iru le n c e  d e te rm in a n ts , l ip o p o ly s a c c h a r id e  (L P S ), 
p ro te a s e s  a n d  c y to to x in s  ( le u c o c id in ) , w e re  a n a ly se d  in  b io f i lm  b a c te r ia  in  th e  
a b se n c e  a n d  p re se n c e  o f  su b -M IC s o f  s e le c te d  a n tib io tic s  (a m p ic il l in , n a l id ix ic  a c id  
a n d  s tre p to m y c in ) . W h ile  th e  c o n c e n tra t io n  o f  v im le n c e  fa c to rs  ( le u c o c id in  a n d  
p ro te a s e s )  d id  n o t  s ig n if ic a n tly  a lte r , th e ir  a c tiv it ie s  in c re a se d  in  th e  p re s e n c e  o f  su b - 
M IC s  o f  s e le c te d  a n tib io tic s  (T a b le  15 a n d  T a b le  16; C h a p te r  5). H e n c e , q u a li ta tiv e  
a n d  q u a n tita t iv e  m e a su re m e n ts  o f  v iru le n c e  p a ra m e te rs  ( lip o p o ly s a c c h a r id e , 
le u c o c id in  a n d  p ro te a se s )  d e te rm in e d  th a t th e  v iru le n c e  o f  b io f i lm  b a c te r ia  
(Pseudom onas aeruginosa) in c re a se s  w h e n  tre a te d  w ith  s u b -M IC s  o f  se le c te d  
a n tib io tic s .
L ipopolysaccharide (LPS)
L P S  w a s  a n a ly se d  fo r its  c o n tr ib u tio n  in  im p le m e n tin g  th e  a n t ib io t ic  re s is ta n c e  
p h e n o ty p e  in  Pseudom onas aeruginosa  (F ig u re  35 ). I t  w a s  n o te d  th a t  th e
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d isa p p e a ra n c e  o f  h ig h  m o le c u la r  w e ig h t O  a n tig e n s  in  th e  p re s e n c e  o f  s u b -M IC s  o f  
a n tib io tic s  m ig h t r e su lt  in  re s is ta n c e  b y  c re a tin g  a  p e rm e a b ili ty  b a r r ie r  to  h y d ro p h il ic  
a n tib io tic  m o le c u le s . H o w e v e r , d o w n  re g u la tio n  o f  O  a n tig e n s , m a y  a ls o  c o n tr ib u te  to  
th e  v iru le n c e  o f  th is  o rg an ism  in vivo , p ro v id e d  th e re  is  so m e  b a s a l le v e l o f  im m u n ity  
in  th e  in fe c te d  p a tie n t.
T h e  e n d o to x ic  e f fe c t o f  L P S  is  d u e  to  its  lip id  A  c o m p o n e n t (G u ts m a n n , e t a l
2 0 0 0 ). H o w e v e r , i t  is  th e  O  c h a in  a tta c h e d  to  th e  lip id  A  a n d  c o re  p o ly s a c c h a r id e  th a t 
e lic its  a  s tro n g  im m u n e  re sp o n se  (T ra u tm a n n , 1998). A  s tro n g  im m u n e  re sp o n s e  
m o u n te d  a g a in s t O  a n tig e n  o f  P seudom onas aeruginosa  in  a c u te  in fe c t io n s  w ill 
m e d ia te  o p so n o p h a g o c y tic  k illin g  o f  b a c te r ia  (G o ld b e rg  &  P ie r , 19 96 ; P r e c i a d o e /  al.,
2 0 0 5 ). R e su lts  f ro m  th e  p re s e n t s tu d y  in d ic a te  a  p o s s ib le  sh if t  in  p h e n o ty p e  o f  
Pseudom onas  fro m  th e  S to  th e  R  fo rm  (F ig u re  35) a n d  th u s , a  c o r re sp o n d in g  sh ift 
f ro m  a c u te  to  c h ro n ic  life s ty le . T h is  o b s e rv a tio n  m a y  h a v e  c lin ic a l s ig n if ic a n c e , as in  
th e  a b se n c e  o f  a n tib io tic s  th e  p a th o g e n  h a s  o n ly  to  d e a l w i th  th e  im m u n e  re sp o n s e  
a g a in s t  it. H o w e v e r, i t  is  su g g e s te d  th a t w h e n  a n tib io tic s , in  a d d it io n  to  a lre a d y  
e x is tin g  im m u n e  re sp o n se  b r in g  a b o u t a  sy n e rg is tic  e f fe c t, th e  p a th o g e n  c a n  n o  lo n g e r  
a f fo rd  to  k e e p  th e  O  s id e  c h a in  a n d  th u s , d o w n  re g u la te s  its  p ro d u c tio n . T h is  m a y  h e lp  
th e  p a th o g e n  to  c o n fu se  th e  im m u n e  sy s te m  a n d  e sc a p e  its  d e tr im e n ta l e f fe c ts  
(G o ld b e rg  &  P ie r , 1996).
Leucocidin
In v e s tig a tio n s  c a rr ie d  o u t o n  le u c o c id in  (2 9  k D a  c y to to x in )  p r o d u c e d  b y  
Pseudom onas aeruginosa  b io f ilm s  in  p re se n c e  o f  a m p ic ill in , h a v e  s h o w n  a n  
u n m is ta k a b le  in c re a se  in  its v iru le n c e  p o te n tia l  (F ig u re  58 ). P seudom onas aeruginosa  
b io f ilm s  tre a te d  w ith  su b -M IC  o f  a m p ic il l in  (8 p g  m L '1) s h o w e d  a t le a s t  50%  in c re a se  
in  its  le u c o c id in  cy to to x ic  a c tiv ity  w h e n  c o m p a re d  to  c o n tro ls  (b io f i lm  s a m p le s
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u n e x p o s e d  to  a n y  a n tib io tic s )  a n d  m o re  th a n  2 0 0 %  in c re a se  in  a c tiv ity , w h e n  
c o m p a re d  to  c y to to x ic  a c tiv ity  o f  le u c o c id in  f ro m  P seudom onas aeruginosa  
p la n k to n ic  c e lls  (F ig u re  58). T h is  d ra m a tic  in c re a se  in  v iru le n c e  p o te n tia l  w a s  
re c o n f irm e d  w h e n  m e a su re s  o f  o n c o s is  w e re  d e te rm in e d  f ro m  p h a s e  c o n tra s t  im a g e s  
o f  S p 2  c e lls  t re a te d  w ith  le u c o c id in  iso la te d  f ro m  d if fe re n t sa m p le s  (F ig u re  5 9 ). I t  w a s  
a s su m e d  th a t th e  m o re  v iru le n t th e  le u c o c id in , th e  g re a te r  w o u ld  b e  th e  d e g re e  o f  
o n c o s is  (as  d e te rm in e d  b y  in c re a se  in  d ia m e te r  o f  c e lls ) . A c c o rd in g ly , P seudom onas  
aeruginosa  b io f ilm  sa m p le s  tre a te d  w ith  su b -M IC  o f  a m p ic il l in  e x h ib i te d  th e  
m a x im u m  a m o u n t o f  c y to to x ic  a c tiv ity  to w a rd s  S p 2  ce lls . S p 2  c e ll d ia m e te r  in c re a s e d  
m o re  th a n  5 0 %  w h e n  tre a te d  w ith  le u c o c id in  is o la te d  f ro m  P seudom onas aeruginosa  
b io f ilm s  tre a te d  w ith  su b -M IC  o f  a m p ic ill in  (8  p g  m L '1), c o m p a re d  to  c o n tro l s a m p le s  
(b io f ilm  c e lls  u n e x p o se d  to a n tib io tic s ) , a n d  m o re  th a n  2 5 0 %  w h e n  c o m p a re d  to  
Pseudom onas aeruginosa  p la n k to n ic  c e lls  (F ig u re  59 ; F ig u re  60  a n d  T a b le  15).
A n  in c re a se  in  th e  v iru le n c e  p o te n tia l  o f  le u c o c id in  f ro m  P seudom onas  
aeruginosa  b io f ilm s  in  th e  p re se n c e  o f  su b -M IC  o f  a m p ic il l in  (8 p g  m L '1) m ig h t 
a c tu a lly  tra n s la te  to  a  s im ila r  o b se rv a tio n  in  c lin ic a l c o n d itio n s . A c c o rd in g ly , 
a n tib io tic  tre a tm e n t o f  p a tie n ts  su ffe r in g  fro m  c h ro n ic  b io f ilm  in fe c t io n s  m a y  c a u se  
m o re  h a rm  th a n  g o o d . B o th  L P S  p a t te rn  c h a n g e s  a n d  in c re a s e d  a c tiv ity  o f  le u c o c id in  
o f  Ps. aeruginosa  tre a te d  w ith  su b -M IC  o f  a m p ic ill in  (8 p g  m L '1) in d ic a te  a n  in c re a se  
in  v iru le n c e  o f  th e  o rg a n ism . H o w e v e r , fu r th e r  in v e s tig a t io n s  w e re  c a r r ie d  o u t to  
d e te rm in e  i f  a  s im ila r  in c re a se  in  v iru le n c e  m ig h t a lso  o c c u r  in  p ro te a s e s  p ro d u c e d  b y  
Ps. aeruginosa.
P ro teases
P ro te a se s  p ro d u c e d  b y  Pseudom onas aeruginosa  w e re  id e n t if ie d  b y  
z y m o g ra p h y  (F ig u re  61 ). A c tiv ity  o f  th e se  p ro te a se s  w a s  a s s a y e d  u s in g  a z o c a s e in  a s  a
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su b s tra te . P ro te o ly t ic  re le a se  o f  su lp h a n ila m id e  g ro u p  a tta c h e d  to  a z o c a s e in  w a s  
e s tim a te d  a t a  w a v e le n g th  o f  4 4 0 n m , a n d  w a s  fo u n d  to  b e  p ro p o r tio n a l to  p ro te a s e  
a c tiv ity . Pseudom onas aeruginosa  m o n o s p e c ie s  b io f ilm s  e x p o s e d  to  s u b -M IC  o f  
a m p ic il l in  (8 p g  m L '1) sh o w e d  m a x im u m  p ro te a se  a c tiv ity  (T a b le  16). M o re  th a n  
10 0%  in c re a se  in  p ro te a se  u n it  a c tiv ity  w a s  o b s e rv e d  fo r  p ro te a s e  p r o d u c e d  b y  
P seudom onas aeruginosa  b io f ilm  sa m p le s  tre a te d  w ith  a m p ic il l in  a n d  a b o u t  8 5 %  
in c re a se  in  a c tiv ity  w a s  o b se rv e d  w h e n  c o m p a re d  w i th  p ro te a s e s  p ro d u c e d  b y  
p la n k to n ic  Pseudom onas aeruginosa. T h e se  re su lts  a re  in d ic a tiv e  o f  a n  in c re a s e  in  
v iru le n c e  in  th e  p re se n c e  o f  su b -M IC  o f  a m p ic il l in  (8 p g  m L '1), a n d  th u s  m a y  h a v e  
c lin ic a l s ig n if ic a n c e .
Antibiotic exposure and virulence in binary biofilms
In  m o s t  n a tu ra l  an d  in d u s tr ia l e n v iro n m e n ts  b io f ilm s  c o n s is t  o f  c o m p le x  
c o m m u n itie s  c o n s is tin g  o f  m u ltip le  m ic ro b ia l  sp e c ie s  a c tin g  in  c o n s o r tiu m  (E lv e rs  et 
al., 2 0 0 1 ). C o m p le x  in te r-sp e c ie s  a n d  in tra -sp e c ie s  in te ra c tio n s  a re  s a id  to  ta k e  p la c e  
w ith in  su c h  b io f ilm s  th a t m a y  in f lu e n c e  th e  o v e ra ll d y n a m ic s  o f  b io f i lm  fo rm a t io n  
a n d  a n tim ic ro b ia l  su sc e p tib il itie s  (E lv e rs  e t al., 2002). M u ltis p e c ie s  b io f i lm s  m a y  b e  
m o re  s ta b le  a n d  h a v e  c h a ra c te r is t ic s  p e r ta in in g  to  e n h a n c e d  a n tim ic ro b ia l  re s is ta n c e . 
A lth o u g h  th e re  e x is t  m a n y  e x a m p le s  fo r  c o m p le x  m ix e d  sp e c ie s  n a tu ra l  a n d  in d u s tr ia l  
b io f ilm s  (E lv e rs  et al., 2 0 0 2 ), p u b lis h e d  re p o r ts  o n  m u ltip le  sp e c ie s  m e d ic a l  b io f i lm s  
a re  s ti ll a  ra r ity  (h o w e v e r , c o m p le x  m ix e d  sp e c ie s  b io f i lm s  h a v e  b e e n  in te n s iv e ly  
s tu d ie d  in  th e  c a se  o f  d en ta l p la q u e s  (E lv e rs  et al., 2 0 0 1 ). H o w e v e r , th e  e x is te n c e  o f  a  
b in a ry  o r  m u ltip le  sp e c ie s  m e d ic a l b io f ilm  is  a  s tro n g  p o s s ib i l i ty , w h e n  v ie w e d  in  
lig h t o f  th e  c o m m o n  m a jo r  b io f ilm  p a th o g e n s  is o la te d  f ro m  in fe c t io n  s ite s  in  th e  
h u m a n  b o d y . F o r  in s ta n c e , E. coli a n d  o th e r  G ra m -n e g a tiv e  o rg a n ism s  a re  c o m m o n  
b io f ilm  p a th o g e n s  iso la te d  fro m  u r in a ry  c a th e te r  in fe c t io n s  a n d  b a c te r ia l  p ro s t i t i s  (F u x
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et al., 2 0 0 3 ). T h e re  e x is ts  th e  p o s s ib i l i ty  th a t  th e se  d if fe re n t G ra m -n e g a tiv e  o rg a n ism s  
e x is t  a s  b in a ry  o r  m u ltisp e c ie s  b io f ilm s .
P re v io u s  p a s s a g e s  in  th is  d is c u s s io n  h a v e  re la te d  to  th e  e ffe c t o f  a n t ib io ic s  o n  
th e  re s is ta n c e  a n d  v iru le n c e  o f  m o n o s p e c ie s  b io f ilm s  o f  Pseudom onas aeruginosa. I t  
w a s  s e e n  th a t  c h a n g e s  in  o u te r-m e m b ra n e  p ro te in  e x p re s s io n  a n d  L P S  p a t te rn s  o f  
m o n o s p e c ie s  b io f ilm s  c o u ld  b e  lin k e d  to  th e  in c re a se d  re s is ta n c e  c h a ra c te r is t ic s  o f  
m o n o s p e c ie s  Ps. aeruginosa  b io f ilm s . A lso  th e  v iru le n c e  o f  m o n o s p e c ie s  b io f ilm s  
w ith  re s p e c t  to  k e y  v iru le n c e  fa c to rs , le u c o c id in  a n d  p ro te a s e s  in c re a s e d  a t  le a s t  tw o ­
fo ld  in  th e  p re s e n c e  o f  a n tib io tic s  (F ig u re  58 ; T a b le  16). A n a ly s is  o f  r e su lts  
(p e r ta in in g  to  a n tib io tic  re s is ta n c e  a n d  v iru le n c e )  o b ta in e d  f ro m  a n t ib io t ic -c h a lle n g e d  
b in a ry  b io f ilm s  a lso  in d ic a te s  re su lts  b ro a d ly  s im ila r  to  m o n o s p e c ie s  b io f i lm s  (F ig u re  
58 ; F ig u re  59 ; T a b le  6; T a b le  16).
2 D -P A G E  a n a ly s is  in d ic a te d  a p p e a ra n c e  o f  s e v e ra l n o v e l o u te r  m e m b ra n e  
p ro te in s , w h ile  o th e rs  w e re  in a p p a re n t in  th e  p re s e n c e  o f  su b -M IC s o f  a m p ic i l l in  (8  
jug m L '1). In te re s tin g ly  a  c o m p a riso n  o f  th e  n o v e l p ro te in s  th a t  w e re  a p p a re n t  in  th e  
d if fe re n t a n tib io tic  (A m P , N aL  a n d  S T ) tr e a te d  s a m p le s  y ie ld e d  n o  c o m m o n  p ro te in s , 
in d ic a tin g  th a t e x p re s s io n  o f  th e s e  p ro te in s  m a y  b e  re la te d  to  u n iq u e  a n tib io t ic  
re s is ta n c e  m e c h a n ism s  sp e c ific  to  a  p a r tic u la r  a n tib io tic . A lte rn a tiv e ly , th e s e  m a y  b e  
p ro te in s  th a t  a re  p ro d u c e d  b y  th e  o rg a n ism  to  a d a p t to  th e  e n v iro n m e n t (m o d if ie d  w ith  
a n tib io tic s )  a n d  m a y  n o t b e  d ire c tly  in v o lv e d  in  re s is ta n c e . A  c o m p a r is o n  o f  O M P s  
th a t  w e re  in a p p a re n t a f te r  a n tib io tic  t r e a tm e n t o f  b in a ry  b io f ilm s  e x h ib i te d  p ro te in s  
th a t  m a y  b e  re la te d  to  re s is ta n c e . A m o n g  th e s e  w e re  88 k D a , 58  k D a , 41 k D a , 35  k D a  
a n d  a  2 7 .5  k D a  p ro te in s  (T ab le  13 p a r ts  1, 2  a n d  3; C h a p te r  4). D o w n  r e g u la t io n  o f  
k e y  O M P s  m a y  p re v e n t a n tib io tic s  fro m  a c c u m u la tin g  w ith in  c e lls , a n d  th u s  fo rm  a 
p o s s ib le  so u rc e  fo r  a n tib a c te r ia l re s is ta n c e . H o w e v e r , fu r th e r  p ro te o m ic  a n a ly s is  (e .g .,
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m a s s  sp e c tro m e tr ic  a n a ly s is )  o f  th e  a b o v e  m e n tio n e d  p ro te in s  a re  r e q u i re d  b e fo re  a  
m o re  c o m p le te  p ic tu re  o f  th e ir  ro le  in  a n tib io t ic  re s is ta n c e  e m e rg e s .
L P S  b a n d in g  p a tte rn s  o f  b in a ry  b io f ilm s  w e re  s im ila r  to  th o se  o f  m o n o s p e c ie s  
b io f ilm s . G e n e ra lly , a  n u m b e r  o f  h ig h  m o le c u la r  w e ig h t b a n d s  c o r re sp o n d in g  to  O  
a n tig e n ic  re g io n s , p re v io u s ly  a p p a re n t in  c o n tro l c e lls , b e c a m e  in a p p a re n t  o n  a d d it io n  
o f  su b -M IC  o f  a n tib io tic s . T h e  d is a p p e a ra n c e  o f  h ig h  m o le c u la r  w e ig h t  b a n d s  w a s  
fu r th e r  a c c e n tu a te d  in  th e  case  o f  e lu a te  s a m p le s  tr e a te d  w ith  su b -M IC s  a n tib io tic s . 
W h ile  l ip id  A  re g io n s  ( lo w  m o le c u la r  w e ig h t  b a n d s)  w e re  m in im a l fo r  b io f i lm  c e lls  
tr e a te d  w ith  su b -M IC  a n tib io tic s , e lu a te  c e lls  e x p o se d  to  s u b -M IC  o f  n a l id ix ic  a c id  (4 
p.g m L '1) sh o w e d  m o re  b a n d s  c o r re sp o n d in g  to  th e se  re g io n s  (c o m p a re  F ig u re s  3 9  a n d  
4 0 , C h a p te r  5). T h is  c o u ld  o n ly  m e a n  th a t  th e  e n d o to x in  p ro d u c t io n  in c re a s e d  in  
e lu a te  s a m p le s  tr e a te d  w ith  a n tib io tic s  w h e n  c o m p a re d  to  b io f ilm  c e lls . H o w e v e r , it  
s ti ll r e m a in s  to  b e  se e n  i f  su c h  a n  in c re a s e  tra n s la te s  to  a n  in c re a s e  in  v iru le n c e  
a s s o c ia te d  w ith  e n d o to x in  o f  Ps. aeruginosa.
C y to to x in s  ( le u c o c id in )  a n d  p ro te a s e s  iso la te d  fro m  b in a ry  b io f i lm s  e x h ib ite d  
m a rg in a l d e c re a se s  in  a c tiv ity  w h e n  c o m p a re d  to  m o n o s p e c ie s  b io f i lm s  o f  
Pseudom onas aeruginosa  tre a te d  w ith  su b -M IC  o f  a n tib io t ic s  (se e  T a b le s  15 a n d  16). 
T h is  o b se rv a tio n  m a y  n o t be su rp r is in g , a s  g e l c o lu m n  f ra c tio n s  c o r re s p o n d in g  to  Ps. 
aeruginosa  p ro te a se s  a n d  le u c o c id in s  n e e d  n o t  c o n ta in  th e  sa m e  p ro te in s  a s  th o se  
f ro m  E. coli. H e n c e , a  sy n e rg is tic  e f fe c t re su lt in g  f ro m  s im ila r  e n z y m e s  f ro m  th e se  
tw o  sp e c ie s  c o -ffa c tio n a tin g , le a d in g  to  a n  in c re a se  in  a c tiv ity  o f  e i th e r  o f  th e se  
e n z y m e s  m a y  b e  d isc o u n te d . H o w e v e r , th e  re su lts  s till in d ic a te  th a t  th e  b in a ry  
b io f ilm s  o f  Pseudom onas aeruginosa  a re  s ta b le  e n titie s  a n d  m a y  e x h ib i t  e n h a n c e d  
v iru le n c e  c o m p a ra b le  to  m o n o sp e c ie s  b io f ilm s  o f  th e  s a m e  sp e c ie s . T h e  re su lts  
o b ta in e d  in  th is  sec tio n , in d ic a tin g  in c re a se s  in  v iru le n c e  o f  b in a r y  b io f i lm s  o f  
Pseudom onas aeruginosa  in  p re s e n c e  o f  su b -M IC s  o f  se lec ted  a n tib io t ic s , is  in  sh a rp
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c o n tra s t  to  th o se  re p o r te d  b y  F o n s e c a  a t al. (2 0 0 4 ) . A lth o u g h  F o n s e c a  a n d  c o lle a g u e s  
re p o r te d  a  d e c re a se  in  v iru le n c e  a n d  h e n c e , p a th o g e n ic  p o te n tia l  o f  P seudom onas  
aeruginosa  in  p re s e n c e  o f  su b -M IC  a n tib io tic s , i t  m a y  b e  n o te d  th a t  th e ir  w o rk  w a s  
c a r r ie d  o u t o n  p la n k to n ic  fo rm s a n d  n o t  b io f ilm s . T h is  o b s e rv a tio n  g iv e s  c re d e n c e  to  
th e  s u g g e s tio n  th a t p h y s io lo g ic a l d iffe re n c e s  b e tw e e n  th e s e  tw o  s ta te s  (p la n k to n ic  an d  
b io f ilm )  m a y  p la y  m a jo r  ro le s  in  d e te rm in in g  v iru le n c e  p o te n tia l  o f  P seudom onas  in  
p re s e n c e  o f  su b -M IC s  o f  s e le c te d  a n tib io tic s  (a m p ic il lin , n a l id ix ic  a c id  a n d  
s tre p to m y c in ) .
C o n c lu s io n s
Im m u n o c o m p ro m ise d  p a t ie n ts  in fe c te d  w ith  P seudom onas  in fe c t io n s  (a s  in  th e  
c a se  o f  s e c o n d a ry  Pseudom onas in fe c tio n s  in  c y s tic  f ib ro s is  p a t ie n ts )  a re  t r e a te d  w ith  
a  ra n g e  o f  a n tib io tic s  sp a n n in g  d if fe re n t c la s se s  (H a u s e r  a n d  S rira m , 2 0 0 5 ). T h e  
re su lts  d is c u s s e d  h e re  a r ise  f ro m  e x p e rim e n ts  c a r r ie d  o u t w i th  th re e  s u c h  c la s s e s  o f  
a n tib io tic s , v iz . P -lac tam s (a m p ic il lin ) , q u in o lo n e s  (n a lid ix ic  a c id )  an d  
a m in o g ly c o s id e s  (s tre p to m y c in ) .
In  re sp o n se  to  su b -M IC s  o f  a n tib io tic s , b io f ilm  b a c te r ia  h a v e  b e e n  s h o w n  to  
b e h a v e  in  d iv e rse  w a y s . A s  a  re su lt  o f  a d a p tin g  to  a  n e w  e n v iro n m e n t ( th e  p re s e n c e  o f  
a n tib io tic s ) , b io f ilm  b a c te r ia  c h a n g e  th e ir  o u te r  m e m b ra n e  p ro te in  a n d  L P S  p a tte rn s . 
C h a n g e s  in  th e  L P S  s tru c tu re  a lso  su g g e s t th e  p o s s ib le  le a k  o f  a n t ib io t ic  in a c tiv a tin g  
p ro te in s  (p - la c ta m a se s ) . N o v e l p ro te in s  th a t a p p e a r  a n d  th o se  th a t  b e c o m e  re d u c e d  o r  
u n d e te c ta b le  (p o s s ib ly  p o rin  p ro te in s  th a t h a v e  se le c tiv e  a f f in ity  fo r  s o m e  a n tib io t ic s )  
m ig h t  in d ic a te  p h e n o ty p ic  c h a n g e s  to w a rd s  re s is ta n c e , a s  w e ll  a s  e p i to p ic  c h a n g e s . 
S u c h  c h a n g e s  w ill h e lp  th e  b a c te r ia  re s is t  a n tib io tic s  th a t  ta rg e t  th e m  a n d  w il l  h e lp  
th e m  su rv iv e  in  a n tib io tic -ric h  e n v iro n m e n ts .
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O n  th e  v iru le n c e  fron t, th e  L P S  c h a n g e s  (d is a p p e a ra n c e  o f  th e  O  a n tig e n )  m a y  
su g g e s t m e c h a n ism s  th a t  h e lp  th e  p a th o g e n  e v a d e  h o s t im m u n e  re sp o n s e . W h ile  n o  
s ig n if ic a n t q u a n tita tiv e  c h a n g e s  in  th e  p ro d u c tio n  o f  p ro te a s e s  a n d  le u c o c id in s  w e re  
o b se rv e d , q u a li ta tiv e  c h a n g e s  w e re  se e n . A c tiv itie s  o f  p ro te a s e s  a n d  le u c o c id in s  
s ig n if ic a n tly  in c re a se d  w ith  re sp e c t to  c o n tro l s a m p le s  in  th e  p re s e n c e  o f  s u b -M IC  o f  
s e le c te d  a n tib io tic s .
T h e se  re su lts  su g g e s t a  p o s s ib le  m o d e l (F ig u re  6 3 ) fo r  in v ivo  b io f ilm  
p a th o g e n e s is  a n d  v iru le n c e  in  th e  p re s e n c e  o f  su b -M IC s o f  s e le c te d  a n tib io t ic s  
(a m p ic il lin , n a lid ix ic  a c id  a n d  s tre p to m y c in ) . F ig u re  63  i l lu s tra te s  th e  p ro b a b le  
b e h a v io u r  o f  a n  in vivo  b io f ilm  m o d e l to w a rd s  su b -M IC  o f  a n tib io tic s . T h e s e  b io f ilm s  
m a y  h a v e  c h a ra c te r is t ic s  s im ila r  to  th o s e  fo u n d  in  p a t ie n ts  su f fe r in g  f ro m  c y s tic  
f ib ro s is  o r  o th e r  b io f ilm -re la te d  d ise a se s . B io f ilm s  o f  P seudom onas aeruginosa  a re  
m a jo r  c o m p lic a tio n s  th a t re su lt  in  s e c o n d a ry  in fe c tio n s  o f  c y s tic  f ib ro s is  p a t ie n ts  
(H o ib y  et al., 2 0 0 1 ). H o w e v e r, a s  o p p o s e d  to  p la n k to n ic  fo rm s , th e i r  p a th o g e n ic  
p o te n tia l  is s ig n if ic a n tly  lo w er, a n d  a s  su c h  th e y  a re  m o re  im p o r ta n t  in  c h ro n ic  
in fe c tio n s  (H o ib y  e t a l., 2 0 0 1 ). H e n c e , th e se  p a th o g e n s  m a y  e x p re s s  o n ly  th a t  le v e l o f  
v iru le n c e  (b a sa l)  n e e d e d  to  d e v e lo p  c h ro n ic  in fe c tio n s . C u rre n t m e d ic a l  t r e a tm e n t o f  
m e d ic a l b io f ilm s  in v o lv e s  a n tib io tic s , e ith e r  s in g ly  o r  in  c o m b in a tio n  (A a ro n  et al., 
2 0 0 2 ). T h e  ra tio n a le  b e h in d  u s in g  a n tib io t ic s  is  th e ir  a b i l i ty  to  d e c re a s e  v ia b i l i ty  a n d  
v iru le n c e  o f  p la n k to n ic  fo rm s a n d  h e n c e , a  c o r re sp o n d in g  d e c re a se  in  th e ir  p a th o g e n ic  
p o te n tia l  (F o n se c a  et al., 2 0 0 4 ). H o w e v e r , re su lts  p re s e n te d  w ith in  th is  th e s is  sh o w  
th a t  b io f ilm s  a n d  p la n k to n ic  s ta te s  o f  Pseudom onas  a re  p h y s io lo g ic a lly  d if f e re n t  a n d  
th u s , b e h a v e  d iffe re n tly  in  th e  p re s e n c e  o f  su b -M IC s  o f  a n t ib io t ic s . A l th o u g h  th e  
c o n c e n tra t io n  o f  v iru le n c e  p ro te in s  ( le u c o c id in s  a n d  p ro te a s e s )  d o  n o t  a lte r  
s ig n if ic a n tly , th e ir  cy to to x ic  a n d  p ro te o ly tic  a c tiv it ie s  a re  e n h a n c e d  in  th e  p re s e n c e  o f  
su b -M IC s  o f  s e le c te d  a n tib io tic s  (a m p ic il lin , n a lid ix ic  a c id  a n d  s tre p to m y c in )  a n d
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may cause much more damage to host factors than can be expected for chronic 
infections unexposed to antibiotics (Table 15 and Table 16; Chapter 5). This would 
result in an increase in the pathogenic potential of the organism and hence, its disease 
causing ability. Hence, the use of antibiotics to treat in vivo biofilm infections may 
actually worsen prognosis rather than improve it, if the patient is allowed to develop 
sub-MIC levels of antibiotic at the infected site.
Figure 63: Schem atic representation illustrating a possible biofilm  m odel o f pathogenesis in 
presence o f sub m inim al inhibitory concentrations o f antibiotics (am picillin , nalid ixic acid and 
streptom ycin). In the absence o f  antibiotics (F igure 63A), biofilm  bacteria ( A )  secrete proteases 
( O ) and leucocidins ($) ) having basal levels o f virulence, and m ay be partly responsib le for 
virulence. The ratio o f dam aged epithelial cells ((*)) to healthy ep ithelia  (O ) is low . Sim ilarly  
the ratio o f  dam aged leucocytes or w hite blood cells ( Q  ) to healthy ones ( j p  ) is also basal. 
H owever, in the presence o f antibiotics (O )  (F igure 63B), although there is no sign ificant increase 
in the levels o f  production o f virulence factors (proteases and leucocidins), the activity o f these 
determ inants significantly increase causing dam age to m ore cells.
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Suggestions for future work
A lth o u g h  th e  re su lts  p re se n te d  w ith in  th is  th e s is  a tt r ib u te  a n tib io tic  re s is ta n c e  
to  in h e re n t b a c te r ia l c e llu la r  m e c h a n ism s , fu r th e r  w o rk  h a s  to  b e  c a r r ie d  o u t  to  
c o n firm  th is  h y p o th e s is .
(1) M a n u a l d e te rm in a tio n  o f  m o le c u la r  w e ig h ts  o f  p ro te in s  f ro m  S D S -P A G E  
a n d  2 D -P A G E  m a y  n o t  re su lt  in  re p ro d u c ib ly  a c c u ra te  re su lts . H e n c e , a d v a n c e d  
p ro te o m ic  te c h n iq u e s  lik e  M A L D I-T O F  sp e c tro m e try  h a v e  to  b e  e m p lo y e d  to  id e n tify  
a ll  n o v e l o u te r  m e m b ra n e  p ro te in s  a n d  th o se  p ro te in s  th a t  h a v e  d is a p p e a re d  in  th e  
p re s e n c e  o f  su b -M IC s  o f  a n tib io tic s . Id e n tif ic a tio n  w ill g re a tly  e n h a n c e  th e  p ro c e s s  o f  
p ro te in  e lim in a tio n  a n d  c o m p a riso n  th a t  h a s  b e e n  a d o p te d  in  th is  th e s is  to  id e n tify  
o u te r  m e m b ra n e  p ro te in s  th a t m a y  p o te n tia l ly  p la y  a  ro le  in  a n tib io t ic  re s is ta n c e .
(2 ) S ig n if ic a n t q u a n tita tiv e  c h a n g e s  in  p ro te in  f ra c tio n s  w h ic h  e m e rg e d  b e fo re  
le u c o c id in  a n d  p ro te a se  fra c tio n s  fo r  su b -M IC  a n tib io t ic  tr e a te d  s a m p le s  w h e n  
c o m p a re d  to  c o n tro ls . A lth o u g h  S D S -P A G E  a n a ly s is  w a s  c a r r ie d  o u t fo r  th e se  
p ro te in s , fu r th e r  p ro te o m ic  a n a ly s is  h a s  to  b e  c a r r ie d  o u t to  d e te rm in e  a n y  p o s s ib le  
re la tio n  to  a n tib io tic  re s is ta n c e .
(3 ) Q u a n tita tiv e  an d  q u a lita tiv e  a n a ly s is  o f  f lu c tu a tio n s  o f  v iru le n c e  in  
p re se n c e  o f  su b -M IC s  o f  a n tib io tic s  w e re  c a rr ie d  o u t o n ly  fo r  L P S , a n d  s e c re te d  
v iru le n c e  fa c to rs  ( le u c o c id in s  a n d  p ro te a se s )  o f  b io f ilm s . O th e r  m a jo r  v iru le n c e  
p a ra m e te rs  lik e  E P S  in  b io f ilm s  o r  f la g e l la  m e d ia te d  s w im m in g , ty p e  I V  p i l i  m e d ia te d  
tw itc h in g , e tc . o f  b a c te r ia l  c e lls  d e ta c h e d  f ro m  b io f ilm s  (e lu a te  c e lls )  m a y  a lso  b e  
te s te d .
(4 ) T h e  sp re a d  o f  b io f ilm -re la te d  in fe c tio n s  w ith in  th e  h o s t  is  r e la te d  to  
d e ta c h m e n t o f  in fe c tiv e  d o ses  o f  c e lls  f ro m  b io f ilm s . C irc u la tio n  o f  L P S  r e le a s e d  
fro m  p la n k to n ic  fo rm s  in to  th e  b lo o d  is  re sp o n s ib le  fo r  th e ir  sy s te m ic  e n d o to x ic  
e ffe c ts . M o n ito r in g  d e ta c h m e n t o f  b io f ilm  c e lls  a n d  re le a se  o f  b io f ilm  L P S  in  th e
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p re s e n c e  o f  su b -M IC s  o f  a n tib io tic s  m a y  h e lp  g iv e  a  m o re  a c c u ra te  p re d ic t io n  o f  
v iru le n c e  f lu c tu a tio n s .
(5 ) B a s e d  o n  th e  re su lts  o b ta in e d  f ro m  in v itro  v iru le n c e  a s s a y s , th e  in vivo  
m o d e l o f  b io f ilm  v iru le n c e  ( illu s tra te d  in  F ig u re  63 ) w a s  p ro p o se d . I t  n o w  r e m a in s  to  
te s t  th is  h y p o th e s is  in  a  su ita b le  ch ro n ic  in fe c t io n  m o d e l.
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